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Introduction to the Supplement: Directions for Future Patient-Centered and 
Comparative Effectiveness Research for People With Serious Mental Illness in a 
Learning Mental Health Care System
Lisa Dixon, MD
This supplement, while ambitious in scope, presents its 
major concepts with elegance and clarity. In this critical 
appraisal of mental health services treatment and out-
comes, the authors have extended the utility of research 
findings by systematically gathering data on the experiences 
and preferences of numerous stakeholders. Key among 
the report’s conclusions is the need for patient-centered, 
patient-developed measures that can be used at all levels of 
a learning system to assess service provision approaches, 
compare treatment interventions, and improve outcomes.
This group of measures, the report argues, should 
reflect the values and preferences of service users and 
other stakeholders while being customizable to individ-
ual treatment goals. Some measures may be helpful to 
all stakeholders, and others may be relevant primarily 
to specific groups such as service users, family members, 
clinicians, or organizational leaders. While such instru-
ments are essential for improving mental health care, 
frameworks and methods for studying the treatment pro-
cess from the studied person’s view are rare and nascent 
in their development.
An important insight of the report is that reliable 
information, while critical, has its limitations. At a mini-
mum, the effort to make patient-centered measures use-
ful requires that structures be in place to routinely assess 
service users’ preferences and goals, measure progress 
toward those goals, and facilitate the flow of informa-
tion from consumers to clinicians to organizational 
leaders and back down the chain. However, information 
alone will not substantially improve quality of services 
or individual outcomes. The complexity and variability 
of stakeholder needs make tools such as pay for perfor-
mance seem like hammers, when jeweler’s tools might be 
closer to what is appropriate.
The report, thus, suggests that strong, supportive 
relationships—between clinicians and service users and 
among organizational staff  at various levels—are the key 
to sustainable improvements in treatment and outcomes. 
Organizational practices and cultures that nurture such 
relationships are therefore critical, given the strong impli-
cation of this report that the therapeutic and recovery-
enhancing relationships between users and professionals/
clinicians/providers are the essential—and most endan-
gered—element in mental health services. Administrative, 
fiscal, and policy impediments to forming such relation-
ships must be addressed rather than regarded as inevitable.
While there are plenty of talented, trained people to 
provide face-to-face services to individuals with serious 
mental illnesses, the necessary policies, funding priori-
ties, and workplace settings for making optimal use of 
these talents are in short supply. The recommendations 
of this report, which places multiple stakeholder perspec-
tives at the heart of its analysis, represent a sea change 
from most service improvement approaches, which have 
typically taken a narrower view. In this era of health care 
reform and rapid change within health systems, numer-
ous natural experiments provide important opportunities 
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People with serious mental illnesses have benefited 
from consumer advocacy, dissemination of  recovery-
promoting practices, and state and federal reforms such 
as parity and legal protections. At the same time, many 
people continue to experience significant disability that 
may affect cognition and their ability to engage and 
interact with others, guide and adhere to treatment, 
and navigate successfully within institutions and sys-
tems. Despite recent efforts to improve the quality of 
care for this diverse group, vexing challenges remain. 
These include the difficulties of  changing the focus of 
care from acute symptom control and relapse preven-
tion to long-term, recovery-focused care, coordinating 
care among different providers, and adapting interven-
tions to different settings with multiple, fluctuating 
funding streams.
Both the Patient Protection and Affordable Care Act 
and numerous state initiatives have strong potential to 
improve patient-centered outcomes if  corresponding 
patient-centered measures are developed and imple-
mented. These reform efforts present important oppor-
tunities for researchers to evaluate alternative delivery 
models and to integrate service users into the process of 
developing both services and patient-centered outcome 
measures.
The primary goal of  this report is to provide the back-
ground and theoretical framework necessary to shift the 
focus of  existing care systems and research programs 
away from short-term clinical outcomes and toward 
long-term, recovery-focused outcomes that are patient-
centered and can be used to facilitate learning within 
health systems. Our primary audience includes research-
ers, funding agencies, and policy makers, although this 
report may also be of  interest to clinicians and service 
users.
Approach
We worked with stakeholders (payers, providers, service 
users, and consumer advocates) and technical experts 
to develop a definition of “care delivery intervention” 
for individuals with serious mental illnesses, a theoreti-
cal model of a care system to serve this population, and 
an analytic framework and key questions to guide future 
research. We also conducted a narrative review to illu-
minate the complexities that must be addressed when 
considering system change. Finally, we used the model of 
care, analytic framework, and narrative review to iden-
tify patient-centered measures and metrics, key research 
questions, and high leverage points in the system—those 
places where a small amount of change-related effort is 
likely to produce large results.
Results
Definition of Care Delivery Intervention. Recognizing 
the key roles of the mental health consumer movement, 
autonomy, and choice in the shifting climate of medical 
and mental health care, we defined “care delivery inter-
vention” based on several foundations of patient-cen-
tered care and services: (1) a focus on the outcomes most 
important to service users, (2) collaborative partnerships 
focused on care solutions that build strong consumer-
provider relationships, (3) ongoing exploration of service 
users’ reasons for seeking or ending care, and (4) ongoing 
provision of information relevant to the service user and 
the consumer-provider dyad.
Theoretical Model of Care: A  Learning Service System 
for Individuals With Serious Mental Illnesses. The theo-
retical model of the care delivery system was developed 
to be a learning system that (1) is patient centered and 
patient directed to the greatest extent possible; (2) encom-
passes services beyond those typically provided in clinical 
or medical settings; (3) recognizes the dynamic nature of 
service users’ needs and desires over time, thus includes 
ongoing assessment and adaptation of services; and (4) 
is responsive to feedback and functions, with the goal of 
continuously improving service delivery and patient-cen-
tered outcomes.
Analytic Framework to Guide Future Patient-Centered 
Outcomes Research and Comparative Effectiveness 
Research. The analytic framework, intended to guide 
and highlight opportunities for research that evaluate 
all components of a mental health system, contains six 
key topic areas: (1) resource acquisition and distribution; 
(2) populations served; (3) the delivery system, including 
delivery structures, organizations, and providers; service 
packages; and delivery methods and characteristics; (4) 
patient-centered outcomes; (5) delivery system and pro-
vider performance measures; and (6) feedback systems 
and methods.
Narrative Review. The components of our narrative 
review, developed in collaboration with stakeholders and 
experts, corresponded to the six primary domains of our 
analytic framework noted above. The findings from our 
review informed key questions for comparative effective-
ness and patient-centered outcomes research.
Stakeholder Perspectives Our research review led to 
several key conclusions about stakeholder perspectives:
1. Consumers, families/carers, and providers predictably 
diverge in their assessments of consumer needs for 




2. Demonstrable progress has been made in engag-
ing stakeholders in evaluating treatment and ser-
vices and in formulating federal, state, and local 
policy. Organization and financing models, however, 
are often taken as inevitable and trump many of the 
expressed opinions and evidence from these groups 
and individuals.
3. The most commonly agreed upon needs of stake-
holders include choice, respect for persons, safety and 
material living needs, and competence of care.
4. Processes of collaboration in consumer-provider rela-
tionships are complicated and easier to imagine than 
achieve.
5. The unintended consequences of treatment receive 
scant attention in outcomes research. As a result, ser-
vices and systems lose the opportunity to be self-cor-
recting, learning systems.
6. People come to health and mental health systems 
with a variety of beliefs about the nature, causes, and 
consequences of mental illness. Cultural competence 
requires recognition of such differences.
Service User and Carer Involvement in System Design 
and Redesign, Research and Evaluation, and Development 
of Patient-Centered Outcomes Collaboration in con-
structing knowledge and assessing outcomes of treat-
ment and services is central to a patient-centered system 
of mental health services. Consumers possess knowledge, 
skills, and conceptual frameworks that are needed in the 
research process. Such resources are essential to deter-
mining which questions are posed, the methods used for 
data collection and analysis, and the ways in which results 
are interpreted.
Resource Acquisition and Distribution Resources 
for providing services to people with serious mental ill-
nesses are largely acquired and distributed through the 
public sector and, in particular through state Medicaid 
programs, which vary significantly in terms of funding, 
benefits, and delivery organizations. Overall, these finan-
cial structures have resulted in cost savings to states and 
private health plans, reductions in out-of-pocket costs for 
consumers, reductions in emergency department use, and 
increased crisis referrals. There is significant variation, 
however, in outcomes, suggesting that the details of the 
financing structures are important.
Care and Service Delivery for Individuals With Serious 
Mental Illnesses: Structures, Service Packages, Delivery 
Methods, and Delivery Characteristics Evidence exists 
for a number of methods and characteristics of care 
delivery systems and services that are necessary, if  not 
sufficient, to achieve improved patient-centered outcomes 
for people with serious mental illnesses. Existing reviews, 
however, underscore the need for better definitions and 
constructs as well as methodologically rigorous research 
using measures that are validated for this heterogeneous 
population.
Patient-Centered Quality Improvement in Mental 
Health, System and Provider Performance Measures, and 
Methods of Feedback To improve the patient centered-
ness and quality of services provided to individuals with 
serious mental illnesses, we have proposed a patient-
centered learning system of care that adapts to feedback 
over time. We reviewed six types of quality improvement 
activities for potential use to promote system learning 
and adaptation: (1) electronic health records (EHRs) and 
health information technology, (2) audit and feedback 
procedures, (3) pay-for-performance, (4) public report-
ing of performance data, (5) implementing patient-cen-
tered, evidence-based practices and guidelines, and (6) 
process-improvement initiatives. Evidence is weak for the 
effectiveness of most of these initiatives in medical set-
tings, and little is known about their impact in behavioral 
health settings.
Feedback System and Methods for a Learning 
System Despite national calls for significant health sys-
tem changes, the last two decades of health care reform 
and quality improvement efforts have produced, at best, 
slight to modest improvements in outcomes for individu-
als with serious mental illnesses. Complexity science offers 
an alternative approach to understanding and improving 
systems. Although there is a large and varied literature on 
this topic, only some of this has been tapped by health 
care and mental health services researchers.
Discussion and Conclusions
Despite recent efforts and improvements in approaches 
to service delivery, we have encountered many conflicts 
and disconnects while producing this report—between 
the type, structure, and funding of services and the needs 
of consumers; between the processes of service delivery 
across settings and over time; and between traditional 
clinical outcome measures and the outcomes favored by 
the individuals receiving care. There are also significant 
disconnects between the perspectives of providers, fami-
lies/carers, researchers, and consumers.
Thus, we were faced with the difficult task of devel-
oping innovative and emergent approaches to reduce the 
disconnects described above, building upon and gleaning 
as much useful information as possible from a research 
base with pervasive flaws. As a result, this report has no 
doubt perpetuated some of these same flaws. With that 
caveat in place, we offer a brief  summary of our most 
important conclusions:
1. We lack sufficient outcome measures that have been 
developed by or in concert with service users, or evalu-
ated rigorously by service users. Development of these 
measures is crucial and should be a primary aim of 
mental health research in the near future.
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2. Information regarding the outcomes that service users 
value the most and least remains limited. Developing 
a clear and representative understanding of the most 
common values among service users, cultural differ-
ences within and across these values and understand-
ing the full range of these values, should be a primary 
aim of the next generation of mental health services 
research.
3. Some attempts have been made to link individual out-
comes to service packages, service characteristics (eg, 
continuity, therapeutic relationship), and performance 
measures, but consistency within and across outcome 
measures is lacking, and the measures used are fraught 
with problems when viewed from a patient-centered 
perspective. The mental health system needs feedback 
methods based on new patient-centered outcomes 
that are causally linked to services, processes, and 
structures.
4. To more appropriately target changes in processes of 
care and institutional structures that affect outcomes, 
we must link patient-centered outcomes to process- 
and structure-related measures.
5. There is a great need for patient-centered measures 
that can be aggregated for use at the organizational 
and system levels, as well as research developing effec-
tive methods for providing feedback using aggregated 
data.
6. More research is needed to compare the relative effec-
tiveness of the many interventions that have been 
developed for individuals with serious mental illnesses. 
Such studies must include real-world patients with 
complex problems.
7. Financing of care and services are complicated and 
structured in ways that prevent coherent, coordi-
nated, and integrated service delivery. Health care 
reform is providing rare opportunities for researchers 
 to compare innovative methods of organizing 
 and financing care.
 8. As in other areas of the health care system, stake-
holders may value and desire services that are not 
effective; strategies, policies, and methods are needed 
for managing and communicating the results of 
comparative effectiveness research in such situations.
 9. In the context of systems, information alone is not 
adequate to produce system changes, although it is 
essential to the redesign process. Complexity science 
provides an alternative perspective regarding the fac-
tors that are likely to produce changes in systems 
(eg, organizational culture) and improvements in the 
outcomes those systems produce.
10. New methods and collaborative processes are 
needed to resolve the inherent tension between 
the needs and perspectives of  researchers, quality 
improvement managers, policy makers, clinicians, 
and consumers.
We challenge comparative effectiveness and patient-cen-
tered outcomes researchers to develop methods that incor-
porate the perspectives of service users for unique and 
individualized assessment, intervention, and outcomes. At 
the same time, researchers must produce the evidence nec-
essary to allow the mental health care system to improve 
the services it delivers to individuals with serious mental 
illnesses and the outcomes those services seek to address.
The opportunities associated with health care reform 
are many, and business as usual, with its incremen-
tal efforts to improve outcomes, is no longer possible. 
Researchers, administrators, policy makers, and clini-
cians are at a crossroads. It is time to take on the chal-
lenge of producing learning systems that can provide real 
patient-centered and patient-directed care to individuals 
with serious mental illnesses.
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Introduction
People with serious mental illnesses can and do lead 
meaningful and productive lives, and many are engaged 
in the process of recovery, both with and without men-
tal health services. Consumer advocacy, dissemination 
of recovery-promoting practices, and state and federal 
reforms, such as parity and legal protections, have led to 
incremental improvements in the quality of services and 
life opportunities for people living with serious mental ill-
nesses. Nevertheless, many people continue to experience 
significant disability, whether episodic or enduring, which 
affects cognition and ability to engage and interact with 
others, guide and adhere to treatment, and navigate suc-
cessfully within institutions and systems.1–4 Despite recent 
efforts to improve the quality of care provided to this 
diverse group, persistent and vexing challenges stand in 
the way of promising and well-intended reforms.5 These 
challenges include changing the focus of care from acute 
symptom control and relapse prevention to long-term, 
recovery-focused care; constructing coherent and inte-
grated services; coordinating care among different pro-
viders; adapting interventions to very different settings 
with different goals and multiple, fluctuating funding 
streams; and renovating service delivery settings where 
high staff  turnover is the norm and continuity of care 
and good therapeutic relationships are the exception.5–8
The complexity of the current system is illustrated in 
figure 1, which lists the many factors affecting care sys-
tems and the individuals they serve, as well as the sec-
tors that provide services, the services provided, and the 
ways in which these services affect individual outcomes. 
Falling through the cracks in this system is common,9,10 as 
is incarceration,11 and efforts to date to improve the qual-
ity and coordination of care have encountered significant 
barriers even in the midst of successes (see Vannoy et al12 
for a telling example).
Adding to this complexity are the many system changes 
now in progress, most notably resulting from the Patient 
Protection and Affordable Care Act (ACA), which is 
expected to significantly expand affordable health care 
coverage to more Americans by requiring individuals to 
have health insurance, expanding Medicaid eligibility13 and 
Medicare drug benefits,14 improving the health care delivery 
system, eliminating exclusions related to preexisting condi-
tions,15 and controlling costs. The ACA also includes pro-
visions for mandated mental health and substance abuse 
treatment that will increase the services offered and extend 
them to a wider population.16 At the same time, state and 
federal budget reductions complicate implementation of 
the ACA. Medicaid expenditures in almost every state are 
being reduced prior to the 2014 mandated expansion, and 
the national debt reduction bill signed by President Obama 
on August 2, 2011, calls for significant federal spending cuts 
in the upcoming decade. In addition, the effects of seques-
tration on Medicare and other health-related programs are 
likely to be significant.17,18 These changes are expected to 
alter the funding landscape for the expansion of Medicaid 
under the ACA and will have important implications for 
the capacity of our mental health service system.
These developments present important opportunities 
and challenges for researchers. The density and sprawl of 
the current system, especially at a time of great change, 
speak to the need for a systematic method of organizing 
research and policy efforts to understand and improve its 
functioning. Implementation of state-level mechanisms 
for tracking and detailing ACA-related transitions in 
health care may provide rich data sources for monitoring 
types and delivery of care and patient outcomes, enabling 
comparative effectiveness research (CER) on a broad 
scale. Meanwhile, the changes brought about by federal 
spending cuts—particularly to Medicaid and Medicare—
will provide important opportunities for studying different 
methods of organizing and financing mental health care.
While these research opportunities are promising, the 
science is hindered by a lack of common understandings 
and definitions and theoretical frameworks that guide our 
understanding of how delivery interventions affect out-
comes. Nonlinear interdependencies among system ele-
ments create an additional set of difficulties. Frameworks 
are needed that encompass all levels of the system, from 
financing and organization of care to linkages between 
service sectors, and that detail how these factors affect 
care delivery, including individual-level coordination of 
care, treatment engagement, and treatment continuation. 
Just as important, research and policy must be informed 
by the real-world contingencies and pragmatics of service 
delivery, incorporating both practice-based evidence and 
evidence-based practices (EBPs).19 Without a relevant the-
oretical framework, we risk a piecemeal approach that is 
much less likely to produce significant changes in the sys-
tem or results that can be integrated in a coherent manner.
This supplement is designed to provide such a guid-
ing framework. The need is abundantly clear from the 
current state of services for people with serious mental 
illnesses, and from the uncertainty surrounding the near-
term future of these services. If  disability is to be limited, 
recovery fostered, and individual outcomes and quality 
of life improved, then all involved parties—researchers, 
funders, policy makers, clinicians, and consumers of 
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mental health services—need integrated frameworks to 
guide research, policy, and care decisions.
Objectives
The background for this report originated in a series 
of meetings held in 2010 by the Agency for Healthcare 
Research and Quality (AHRQ). AHRQ gathered a 
diverse group of stakeholders to discuss issues and iden-
tify research gaps and needs related to serving people 
with serious mental illnesses.20 Stakeholders identified 
several priorities:
 • Conduct CER on service structure and delivery.
 • Shift the research framework from an acute to a chronic 
care model (CCM) for individuals with serious mental 
illnesses.
 • Develop more appropriate outcomes, measures, and 
metrics consistent with this model.
 • Develop an appropriate infrastructure for both CER 
and patient-centered outcomes research (PCOR) meth-
odologies to support longitudinal studies.
 • Increase awareness of the central role of the therapeu-
tic relationship in improving individual outcomes.
Our work was designed to provide the guiding frame-
work needed to achieve these overarching objectives. To 
develop that framework, we pursued six strategic goals: 
First, we developed a stakeholder-driven definition of 
care or service delivery interventions for individuals with 
serious mental illnesses. Such a definition was necessi-
tated by the wide range of needs for services and the sys-
tems providing those services. For example, individuals 
with serious mental illnesses die significantly earlier than 
Fig. 1. Overview of the system serving individuals with serious mental illnesses, and relevant contextual factors.
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their peers without mental illnesses,21–23 with a large pro-
portion of this early mortality attributable to preventable 
causes.24,25 At the same time, many individuals with seri-
ous mental illnesses are either homeless or live in substan-
dard housing,26 even while the evidence is convincing that 
improved housing leads to improvements in both physi-
cal and mental health.27 While such links demonstrate a 
clear need to address housing problems in this popula-
tion, existing funding streams and methods of organiz-
ing care have made it difficult to bridge this important 
gap within the purview of existing care systems.26 With 
these complexities in mind, we defined a care or service 
delivery intervention to reflect the full range of services 
needed, with the understanding that efforts to improve 
patient-centered outcomes will call for a more integrated 
and comprehensive approach to service delivery.
Based on this definition, we developed a patient-cen-
tered and patient-driven theoretical model of the system of 
care—our second goal. This model then informed our third 
project aim: to construct an analytic framework to guide 
future CER and PCOR programs designed to improve 
individual-level, patient-centered outcomes. The model 
and analytic framework were informed by stakeholders, 
technical experts, and the results of our fourth project aim: 
a narrative literature review. We used this review, in com-
bination with stakeholder and expert feedback, to revise 
the model and framework and achieve our fifth goal: to 
identify key questions and leverage points in the system, 
where change is most likely to occur. High leverage points 
are those where a small amount of change-related effort 
will produce large changes in the system.28,29 Our sixth aim 
was to identify measures and metrics corresponding to the 
model of care, the analytic framework, and the key ques-
tions and leverage points identified. This work was also 
carried out as part of the narrative review process.
Limitations
We addressed only the system providing services for adults; 
a similar analysis and report is needed for the child mental 
health system. Also, despite the prevalence of substance 
abuse issues and treatment among individuals with serious 
mental illnesses, it was beyond the scope of our report to 
include an analysis of and recommendations for the addic-
tion treatment system. To bridge this gap, we have included 
a section addressing services for individuals with dual diag-
noses. We also note that many of the conclusions drawn 
here are likely applicable to the addiction treatment system.
It was also beyond the scope of this report to identify 
existing systems of care that are functioning as learning sys-
tems. A recent Institute of Medicine Report entitled “Best 
Care at Lower Cost: The Path to Continuously Learning 
Health Care in America”30 provides clear suggestions and 
approaches for creating the kinds of system we propose here.
Finally, we wish to recognize that the term patient 
remains controversial and is particularly unwelcome for 
some stakeholders and mental health service users. We 
have thus used alternative terms, including consumer and 
service user, whenever possible. At the same time, we were 
constrained by the need to use the well-established terms 
patient-centered outcomes research and patient-centered 
outcomes in order to situate this report in the context of 
other health system reform efforts.
Methods
Engaging Stakeholders and Technical Experts, and 
Clarifying Foundations
Our first task was to convene a stakeholder panel, a techni-
cal expert panel, and consultants (see Acknowledgments) 
to guide and inform our work. The individuals selected for 
these panels represented groups that are experienced and 
invested in care outcomes for people with serious mental 
illnesses, including individuals with mental health diag-
noses. Concurrently, we reviewed seminal publications we 
felt should inform our work, including three Institute of 
Medicine (IOM) reports7,31,32 and a recent monograph on 
criminal justice interventions for individuals with behav-
ioral health problems.33 Key concepts and ideas from 
these publications, two of which were suggested by our 
technical expert panel, served as the foundation for our 
work and are summarized briefly below.
Foundational Materials 
Quality of Care. The IOM’s Crossing the Quality 
Chasm31 report called for improvements in six dimensions 
of health care performance: safety, effectiveness, patient 
centeredness, timeliness, efficiency, and equity. The report 
also asserted that such improvements are impossible 
within the existing system of care. Pointing to inherent 
system design flaws, the authors submit that better care 
requires a new design that is scientifically valid and that 
creates reliable systems in place of old, unreliable ones. 
Changes were proposed at four levels: the experience of 
patients, the functioning of small units of care delivery 
(microsystems), the functioning of the organizations that 
support microsystems, and the environment of policy, 
payment, regulation, accreditation, and other factors 
that shape the behavior, interests, and opportunities of 
the organizations. This hierarchical model is based on the 
contention that quality of actions at the second to fourth 
levels should be defined and evaluated by their effects at 
the first, patient-centered, level.
The report also provides a rationale and framework for 
redesigning the US health care system at each level. Most 
relevant for our work were the following suggestions: (1) 
changes should be bold, explicit, uniformly espoused, com-
prehensive, and patient centered; (2) changes should tie 
quality issues more closely to patients’ experiences, costs, 
and social justice; (3) care should be patient centered, with 
each patient in control of their own care; (4) care should 
be customized, transparent, and based on a high level of 
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accountability to the patient; (5) care should be knowl-
edge based and supported by information systems that put 
knowledge at the point of use; (6) care should be system 
minded with the system assuming responsibility for coor-
dination, integration, and efficiency across what have been 
traditional boundaries and barriers; and (7) care should be 
based on a high degree of cooperation among clinicians. 
The report adopted a complex-adaptive-systems approach 
(see Feedback Systems and Methods for a Learning 
System)34–41 to system redesign and proposed 10 simple 
rules for the redesign process (see figure 2). (Crossing the 
quality chasm: A New Health System for the 21st Century 
by Committee on Quality of Health Care in America; 
Institute of Medicine Staff. Reproduced with permission 
of National Academy Press in the format “republish in 
print” via Copyright Clearance Center.) 
The authors of the report recognize that redesign 
becomes more difficult, and the evidence weaker, as one 
moves from the microsystem to organizational level. 
Nevertheless, they recommend redesign at the organiza-
tional level in at least six areas: (1) more robust systems for 
identifying best practices and ensuring they become stan-
dards of care; (2) better use of information technology 
to improve access to information and to support decision 
making; (3) more investment and persistence in improving 
workforce knowledge; (4) more consistent development of 
effective teams; (5) better coordination of care within and 
among organizations (especially for patients with chronic 
illnesses); and (6) more sophisticated and extensive mea-
surement of performance and outcomes.
Finally, the report recommends changes to payment 
systems to remove barriers to improvement of care; 
research and demonstration project agendas to under-
stand barriers to such changes; high-level, system-wide 
dialogue and research on redesigns of professional 
education and credentialing systems; and legal and 
regulatory reform to make these systems more condu-
cive to continual improvement. They also argued that 
to implement the suggested system redesign, the United 
States needs a directed strategy with national leadership, 
aims, and specific objectives. The ACA can be seen as an 
attempt to develop and implement such a strategy.
Quality of Behavioral Health Care The IOM’s report 
entitled Improving the Quality of Health Care for Mental 
and Substance-Use Conditions7 built on the Crossing the 
Quality Chasm31 report and specifically addressed behav-
ioral health disorders. The report makes two overarching 
recommendations: (1) health care for mental and sub-
stance-use problems and illnesses must be delivered with 
an understanding of the inherent interactions between 
the mind/brain and the rest of the body and (2) the aims, 
rules, and strategies for redesign set forth in Crossing the 
Quality Chasm should be applied throughout behavioral 
health care on a day-to-day operational basis, but tailored 
to reflect the characteristics that distinguish care for these 
problems. The report recommends that organizations 
promote patient-centered care in several ways. First, they 
should incorporate informed patient-centered decision 
making with active patient participation in design and revi-
sion of treatment and recovery plans, use of psychiatric 
advance directives (PADs), and provision of information 
on the availability and effectiveness of treatment options. 
Second, organizations should adopt recovery-oriented 
and illness self-management practices that support indi-
viduals’ preferences for treatment (including medications), 
peer support, and other elements of a wellness recovery 
plan. Third, organizations should maintain effective for-
mal linkages with community resources to support service 
users’ self-management of illness and recovery.
The report also addresses the roles of health plans and 
direct payers, recommending that they pay for peer sup-
port and illness self-management programs that meet 
evidence-based standards; provide consumers with com-
parative information on the quality of care provided by 
practitioners and organizations (and use this information 
themselves when making their purchasing decisions); and 
remove barriers to and restrictions on effective and appro-
priate treatment that may be created by copayments, ser-
vice exclusions, benefit limits, and other coverage policies.
The authors recognize a number of challenges to achiev-
ing these goals in behavioral health, including stigmatiza-
tion and discrimination of service users, the belief that 
consumers pose a danger to themselves or others, and the 
belief that service users with behavioral health problems 
are unable to make decisions about their own treatment. 
In response, the report advocates four approaches at the 
organizational and clinical level to reduce stigma and sup-
port individual decision making: (1) make support of con-
sumer decision making a default organizational policy; 
(2) involve consumers in service design, administration, 
and delivery; (3) provide decision-making support to all 
hcaorppAweNhcaorppAdlO
1 Care based primarily on visits. Care based on continuous healing relationships. 
2 Professional autonomy drives 
variability. 
Care is customized according to 
patient needs and values. 
3 Professionals control care. The patient is the source of control. 
4 Information is a record. Knowledge is shared freely. 
5 Decision making is based on 
training and experience. 
Decision making is based on 
evidence. 
6 “Do no harm” is an individual 
responsibility. 
Safety is a system property. 
7 Secrecy is necessary. Transparency is necessary. 
8 The system reacts to needs. Needs are anticipated. 
9 Cost reduction is sought. Waste is continuously decreased. 
10 Preference is given to professional 
roles over the system. 
Cooperation among clinicians is a 
priority. 
Fig. 2. IOM’s crossing the quality Chasm’s28 10 simple rules for 
microsystem redesign (used with permission).
S5
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
consumers, including those under legal restrictions, man-
dated treatment, or other forms of coercive intervention; 
and (4) support illness self-management practices for all 
consumers, and formal self-management programs for 
individuals with chronic illnesses.
In addition to these reports, our technical expert 
panel also recommended that we review parts of  the 
IOM report Cancer Care for the Whole Patient: Meeting 
Psychosocial Health Needs.32 In addressing the effects of 
a serious chronic illness on the whole person—a concern 
as relevant to mental health as to cancer—the report 
recommends services beyond those typically provided 
by medical systems. The report defines psychosocial 
health services as those “services that enable patients, 
their families, and health care providers to optimize bio-
medical health care and to manage the psychological/
behavioral and social aspects of  illness and its conse-
quences so as to promote better health” (p. 82–83).
The report’s authors propose a comprehensive 
approach for delivering psychosocial services to patients 
with cancer. First, they recommend identifying patients 
with psychosocial needs that are likely to affect their 
health or health care. Second, they suggest working with 
patients to develop appropriate plans for connecting 
them with appropriate psychosocial health services, sup-
porting them in managing their illness, coordinating their 
psychosocial and biomedical health care, and following 
up on care delivery to monitor the effectiveness of ser-
vices and determine whether any changes are needed. The 
report emphasizes that effective patient-provider commu-
nication is central to all these components.
The report also lists a number of psychosocial compo-
nents of whole person–based services for cancer patients, 
which appear equally applicable to individuals with seri-
ous mental illnesses:
 • Providing information about illness, available treat-
ments, health, and services
 • Help in coping with emotions accompanying illness 
and treatment
 • Peer support programs
 • Counseling/psychotherapy
 • Pharmacological management of mental/emotional 
symptoms
 • Comprehensive illness self-management/self-care
 • Assistance in changing behaviors to minimize the 
impact of disease
 • Behavioral health promotion interventions
In addition, the report lists important material and logis-
tical resources for whole-patient care. These apply equally 
to individuals with serious mental illnesses and include:
 • Help in managing disruptions in work, school, and 
family life
 • Family/caregiver education
 • Assistance with activities of daily living/instrumental 
activities of daily living
 • Legal protections and services
 • Cognitive testing and educational assistance
 • Financial advice and/or assistance
 • Financial planning and counseling, including manage-
ment of day-to-day activities (eg, bill paying)
 • Insurance counseling (eg, health, disability)
 • Eligibility assessment/counseling for other benefits (eg, 
social security)
 • Supplemental financial grants
Behavioral Health and Criminal Justice. Finally, because 
many individuals with behavioral health problems find 
themselves involved in the criminal justice system, our tech-
nical experts recommended reviewing a report by Epperson 
et al33 entitled The Next Generation of Behavioral Health and 
Criminal Justice Interventions: Improving Interventions to 
Improve Outcomes. This monograph acknowledges the host 
of factors contributing to justice involvement (Epperson, M., 
Wolff, N., Morgan, R., et al. The next generation of behav-
ioral health and criminal justice interventions: Improving 
interventions to improve outcomes. Rutgers University 
Center for Behavioral Health Services & Criminal Justice 
Research; 2011.), considers the differing etiologies of these 
problems and their associated symptoms, and suggests 
approaches for addressing the full range of challenges that 
affect justice-involved individuals with behavioral health 
problems (see figure  3). The authors describe approaches 
to providing services that address the interactions between 
mental illnesses, addictions, and antisocial pathologies. They 




also argue that expecting mental health treatment to be the 
sole solution to these numerous problems, rather than one 
component of a multipronged solution, may be the primary 
cause of intervention ineffectiveness to date.
Recommendations and considerations were based on a 
daylong workshop with key informants. Representatives 
from community-based programs serving justice-involved 
individuals with serious mental illnesses were invited to 
share their perspectives on the role of behavioral health 
interventions for this population. Several themes emerged 
from the workshop. For example, because of meager 
funding and resources, the basic needs of justice-involved 
individuals (eg, food and shelter) must be met before other 
needs are addressed. In addition, services must be inte-
grated and coordinated, clients must be seen holistically, 
and EBPs, while important, must be approached flexibly 
and considered in light of their feasibility. Finally, philo-
sophical approaches matter (eg, recovery orientation vs 
punishment orientation) and require universal adoption.
The authors describe the wide range of problems that 
are common among justice-involved individuals with 
mental illnesses. These problems concern environment 
(poverty, boredom, housing, lack of opportunities, dis-
crimination, stigma, close proximity to crime, and crimi-
nal culture); mental health (access to care, lack of services, 
compliance/adherence, and symptoms of the illness itself); 
criminal thinking (wanting things “easy,” glorification 
of “outlaw values,” lack of accountability, and criminal 
attitudes); family dynamics (family history of criminal-
ity, family drug abuse, lack of parental boundaries, lack 
of family support); cognitive and coping skills (lack of 
coping skills, difficulty with impulse control, entitlement 
issues, thinking errors, and difficulty managing frustra-
tion); social support (lack of prosocial support and lack 
of positive peers or role models; and victimization (sexual, 
physical, emotional, and psychological trauma).
Engaging justice-involved clients in addressing these 
problems can be quite difficult for providers. Numerous 
person-level factors contribute to this difficulty, including 
lack of motivation or insight, impulsive behavior, disor-
ganization, lack of trust, fragile coping skills, hopeless-
ness, antisocial attitudes and criminality, resistance to 
treatment, poor judgment, trauma (all types), family (lack 
of or intrusive), homelessness, learned behaviors, active 
substance abuse, and addictive behaviors. The authors 
emphasize that it is not enough simply to be aware of these 
co-occurring problems; rather, they must be direct inter-
vention targets because of their link to relapse and recidi-
vism. The report recommends the following approaches:
 • Develop service structures and orientations to address 
co-occurring problems that interact in ways that can 
impair judgment and promote harmful conduct.
 • Adopt and consistently implement a “person-first” 
value into engagement and recovery philosophies.
 • Integrate evidence-based programs in ways that are 
sensitive to real-world considerations (eg, screening 
tools, staffing requirements, philosophies, manualized 
structures, outcome measures, fidelity methods) and 
social conditions (eg, employment, criminal justice 
encounters, housing).
 • Integrate service modalities that address the different 
problems (eg, trauma, criminal thinking, substance 
abuse) that contribute to relapse and recidivism and 
build the skills that will support healthy and safe 
choices and conduct.
Finally, the authors counsel that to make such changes in 
service delivery, “buy-in” is needed at all levels within and 
between organizations and systems serving this population.
Developing a Care Delivery Intervention Construct
Following the formative reviews, our project team, con-
sultants, and panels of stakeholders and technical experts 
held a series of iterative, consensus-building webinars to 
define a care delivery intervention for people with serious 
mental illnesses. Our wide-ranging process reflected the 
breadth of services required that may not be considered 
“care” in many medical contexts. We began with a brain-
storming session to identify the needs of people with 
serious mental illnesses and the boundaries of what our 
definition should include. We aimed for a definition that 
would be accurate, useful for future CER and PCOR, 
and comprehensive without being untenable in scope.
Through our brainstorming sessions, we identified 
basic needs (food and shelter), universal needs, and 
human rights needs, the latter of which seemed relevant 
given the circumstances surrounding some care provision 
for this population (eg, involuntary commitment and 
treatment). We identified needs ranging from autonomy, 
dignity, respect, value, and freedom from discrimination 
and stereotype, to life enrichment, communication, and 
social support. We listed needs common to both medical 
and mental health care, such as access to collaborative, 
therapeutically oriented providers, coordinated services, 
and health information technology that allows data shar-
ing between systems of care. We also listed the need for 
access to tailored approaches: culturally adapted inter-
ventions, gender-specific and life stage-sensitive inter-
ventions, and trauma-informed care (supplementary 
appendix A includes the master list from these brain-
storming sessions).
Having produced a long list of needs, we then asked our 
stakeholder and technical expert panel members to gen-
erate ideas for a care delivery intervention definition that 
would address these needs. Provocative and thoughtful 
discussions ensued as the groups grappled with the task 
of narrowing the definition while sufficiently addressing 
the breadth of needs. A number of questions arose about 
the scope of the definition:
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 “Is any intervention that tackles anything on the needs 
list a care delivery intervention?”
 “Do we include outreach to homeless? Nursing home 
care? What about the preventive impact of a com-
fortable, safe place to live? Where are the system 
boundaries?”
 “Is one of the key messages of this report that there is 
something about having serious mental illnesses that 
creates needs above and beyond the broad vulnerabili-
ties in the general population?”
Participants also questioned assumptions about the cur-
rent care delivery system:
 “Is the underlying assumption that the system isn’t 
working as is? Are we asking how CER can be used to 
re-shape the system?”
 “Instead of fully broken, are we asking how the system 
can be more effective?”
Some began to think ahead about the implications of the 
definition for the later development of the model of care 
and analytic framework:
 “How are services best organized? By diagnosis? Age? 
Type of service?”
 “At the crux is the financing that supports the care 
delivery interventions, whatever they are.”
 “What are the real policy and intervention tools that 
are available? Because we could try to cure poverty but 
we can’t really do that.”
Eventually, the groups began to coalesce around needs 
for the definition:
 “It needs to be broadly defined and dynamic.”
 “It needs to be adaptive as tools change.”
 “It needs to be individualized and person centered.”
 “It needs to be accountable to individuals.”
 “It needs to consider the desired outcomes.”
 “It should be a system that promotes healing and 
recovery, not about coercion and control.”
 “It needs to use the evidence base to support interven-
tions that are consistent with what individuals want. 
This will allow movement forward toward better care 
and outcomes.”
Following these discussions, we empaneled a subgroup 
of stakeholders and technical experts to work with us to 
develop a draft of the definition. The result was presented 
first to another subgroup of panel members and then to 
the broader group, using the extranet of the Developing 
Evidence to Inform Decisions about Effectiveness 
Network. After several rounds of feedback, including a 
face-to-face meeting with project staff  and the full panel 
of stakeholders and experts, revisions were made to arrive 
at the final definition (see below).
Developing a Theoretical Model of the Care 
Delivery System
While the care delivery definition work group honed the 
definition, the project team moved ahead with develop-
ing the model of  care. We set out to create a model that 
(1) accommodated the identified needs of  the popula-
tion, (2) accurately represented the clinical and service 
components identified through defining the care delivery 
intervention, and (3) could be used to guide our under-
standing of  how delivery interventions, at different lev-
els in the system, will affect particular patient-centered 
outcomes among people with serious mental illnesses.
In a series of webinars, our stakeholders and techni-
cal experts suggested numerous approaches to the model. 
Some were focused on chronicity or stage of illness:
 “Consider grouping by first episode. That is, those who 
have just been through a first episode would have a dif-
ferent sequence of events in the model than those who 
have a chronic condition.”
Some approaches were focused on severity of illness and 
impairment:
 “Think about [DSM-IV] Axis IV issues like ability to 
care for basic needs, interpersonal functioning, pro-
ductivity, income earning potential, and identify out-
comes from these.”
Some were focused on the setting where individuals 
would receive care:
 “Consider organizing by intervention setting.”
 “If  we organize by silo we may perpetuate what’s been 
going on rather than recommending how to move 
beyond silos.”
 “We don’t want to split too much, but some splitting 
is required. For example, the homeless need services 
specific to them that are not needed by others.”
Perhaps because members were already anticipating the 
end product, a suggestion was made to organize the model 
by care delivery interventions:
 “One goal of the framework is to demonstrate where 
we have and don’t have evidence. Maybe we should 
organize the model by intervention. For example, here 
is an approach we need evidence for, here is another we 
[already] have evidence for.”
Developing an Analytic Framework to Guide Future 
CER and PCOR
The analytic framework is a diagram, with correspond-
ing narrative, that illustrates opportunities for system-
atic examination and comparison of novel and existing 
care delivery interventions. In addition to specifying 
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the pathways by which these interventions are expected 
to influence patient-centered outcomes, the framework 
identifies leverage points in the system of care where 
PCOR and CER have the greatest potential for improv-
ing patient-centered outcomes. As such, the framework is 
intended to highlight the processes involved in care deliv-
ery and services that could be the focus of research, and 
to stimulate a new set of key questions whose answers 
could fundamentally address processes and outcomes at 
all levels in the model. It is also intended to emphasize 
the promise of natural experiments for examining inno-
vative processes of funding, organizing, and delivering 
services and care. In addition to the narrative explaining 
the framework, we developed sets of key questions that 
need to be answered at key leverage points, and we identi-
fied known or possible risks for harms or adverse events 
that might result from interventions at these points.
We presented the draft analytic framework to our 
stakeholder and technical expert panels for comment and 
discussion and then revised it prior to the face-to-face 
meeting, where it was further refined. The final frame-
work is presented below.
Definition of a Care and Service Delivery Intervention
As our first task, we defined care and service delivery inter-
ventions using the process described above. This definition 
is situated within the shifting climate of medical and men-
tal health care, emphasizing patient-centered and recovery-
oriented care in mental health and recognizing the central 
role of the mental health consumer movement in shaping 
these new directions. Our goal was to approach care and 
service provision research from a patient-centered perspec-
tive that assumes or fosters individual agency, autonomy, 
and choice. For the authors, experts, and stakeholders who 
have contributed to this definition, the key components of 
patient-centered care are the following:
 • The focus of care and services is on the outcomes that 
are most important to individuals, who are considered 
in their cultural context and as whole persons.
 • Care and services are based on a collaborative relation-
ship between providers and service users, who focus on 
health promotion and prevention and come to agree-
ment about the problem and solutions for management.
 • The process includes ongoing exploration of service 
users’ reasons for seeking or ending care.
 • The process includes ongoing provision of informa-
tion relevant to the service user and the relationship 
between service users and providers.
Based on these principles, we propose the definition pre-
sented in figure  4. (Terms Used and their Definitions: 
“Serious mental illness” is any psychiatric disorder of 
sufficient duration and severity to cause functional 
impairment that affects major life activities. “Organized 
delivery process” refers to strategies, protocols, or meth-
ods used to coordinate the planning, provision, or 
funding of services at the individual, practice, organiza-
tion, or system level. “Services” includes interventions 
that address needs typically outside the scope of those 
addressed by the health care system (eg, education, 
employment, housing) and those addressed by the health 
care system. “Providers” is defined as persons providing 
care or services in an organized process of care delivery, 
including peer providers. “Surrogate” is defined as those 
person(s) identified and/or empowered by the patient to 
serve in his/her stead when the patient is unable to do 
so. “Preferred outcomes” are time-varying, dynamic, 
person-centered outcomes that accurately reflect, and are 
accountable to, the preferences, cultural sensitivities, life 
stage, and circumstances of the person. They include the 
following subjective and objective dimensions: psycho-
logical, cognitive, emotional, physical, social, spiritual, 
economic, and environmental.)
A patient-centered intervention for people with serious mental illnesses is defined as: 
An organized process of care or service delivery that is directed by the person receiving 
services. Care and services are delivered collaboratively, attentively, and compassionately, 
with providers as partners who understand and respond to the person’s perspectives, culture, 
and concerns. The delivery process is structured to educate, inform, guide, and assist the 
person to be a knowledgeable consumer of the services relevant to attaining the person’s self-
defined needs, goals, and outcomes, taking into account the person’s individual 
circumstances.  
All individuals, including those who have been diagnosed with a serious mental illness, have 
the right to direct their own care. People who are limited in their ability to direct their care as a 
result of acute symptoms or legal constraints should be provided with the support necessary to 
make as many care-direction decisions as possible. If a person is unable to make informed 
choices about his/her care, providers will rely on historically expressed preferences and values 
and, when available, psychiatric advance directives and designated surrogates to maximize 
the person’s participation in decision-making about services and treatment. Care decisions 
made for persons when they are unable to direct their own care should be based on the 
premise that such decisions will enable those persons to make future choices about their care. 
Care and services provided to service users should take into account available scientific 
knowledge and the resources of the service system. 
Fig. 4. Definition of a patient-centered care and service delivery intervention.
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Culture and Collective Understanding in the Context of 
Patient-Centered Care
This section is based on feedback provided by Roberto 
Lewis-Fernandez, MD (personal communication, October 
7, 2012) and adapted for use in this report. The majority of 
the text remains his.
A limitation of much patient-centered work to date is 
the individualistic perspective on which it is based, which 
reflects the growing individualism of mainstream culture. 
This perspective allows us to unthinkingly move from 
the individual to the health system as though nothing 
stood between them. In fact, individuals sit in communi-
ties—most often and immediately represented by families 
(nuclear and extended)—which transmit and create col-
lective understandings of illness and care that shape, and 
are shaped by, individual views. If  we focus solely on the 
individual, we risk ignoring these important forces and 
their roles in affecting outcomes.
How would a more collective understanding of cul-
ture make a difference? That is, what is wrong with the 
theoretical understanding of culture as a collective pro-
cess that is refracted through the individual and there-
fore accessible to the project of patient centeredness 
by exploring each individual’s views? By pursuing this 
purely individualistic approach, we would likely miss (or 
be delayed in discovering) the importance of alternate 
understandings of processes of care (eg, what recovery 
is, what constitutes treatment, which outcomes are valu-
able) because we would fail to notice their presence in 
whole communities. We would see individual peculiarities 
instead of common views held by substantial subgroups. 
Over time, we would find that our understandings do not 
apply to certain subgroups, and we would have to fund 
disparity-focused research to find out why. It is preferable 
to consider cultural perspectives now, when patient-cen-
tered care is being defined and developed, than to con-
duct remedial research later.
For example, how would patient-centered care work 
when a man in his twenties, with a diagnosis of schizo-
phrenia, has a mother who makes all decisions about his 
care in the context of a community that holds that such 
an approach is appropriate? This describes the experience 
of many service users from immigrant Latino or Chinese 
communities. Or, consider the Fujianese community in 
New York City, in which a young man with schizophre-
nia is expected to work to pay his immigration expenses. 
A recovery priority for families of such men is to maxi-
mize employment capability because the family faces 
danger of retaliation if  they cannot pay their debt. Such 
contextual, collective aspects related to care needs must 
be included in the individual-based, patient-centered 
model if  we are to understand the people we are serving.
These young men could certainly express care needs to 
their providers, but the system would be more likely to 
react if  the information were seen as applicable to a wider 
community. We risk giving short shrift to community-level 
issues when we examine issues only at the individual level. 
It is difficult for a provider or a health system to reorient 
approaches to care if  they do not recognize that the indi-
vidual variations they see among service users are parts 
of a powerful, collective system. It is far more efficient to 
discover the overall influence of the collective understand-
ing and then reveal the individual views that fit within it.
That said, we still must understand service users as indi-
viduals and resist stereotyping them—a risk when we elicit 
personalized views of care from people who represent cer-
tain cultures, particularly our own. We take the collective 
background and understandings for granted and proceed to 
explore the views of the individual patient within this col-
lective understanding. For person-centered care to work, we 
must reveal these collective understandings and choose the 
most appropriate among them when assessing the individual 
in front of us. Of course, the cultures and worlds we inhabit 
have porous borders; most people go in and out of different 
worlds every day as they go about their business, and these 
worlds continuously affect each other. By gaining knowl-
edge about the various worlds inhabited by consumers, we 
can better understand the contextual nuances of expressed 
views and needs. To this end, health systems can acquire a 
wide range of information about the cultural groups they 
serve, providers can be trained based on this information, 
and personalized assessments can inquire about the views 
of family, friends, and community members who have influ-
enced the person’s views about care and services.
A Theoretical Model of the Care Delivery System: 
A Learning Service System for Individuals With Serious 
Mental Illnesses
Our patient-centered model of the service system for 
individuals with serious mental illnesses (figure  5) was 
based on four underlying assumptions. First, care and 
services should be patient centered and patient directed 
to the greatest extent possible. Because of the broad 
range of needs among members of this population, the 
model is designed to encompass services beyond those 
typically provided in clinical or medical settings. While 
the patient-centered approach implies a focus on one 
person, the model assumes that individuals live within 
communities and social networks, most often repre-
sented by families. These networks and communities 
create and transmit collective understandings of illness 
and responses to services that affect individual views. 
Our second assumption was that individuals’ needs and 
desires change over time. As a result, the system must be 
responsive to those changes, adapting services and care as 
needed to achieve person-centered outcomes. Third, the 
care and service system must act as a learning system with 
the goal of continuously improving service delivery and 
patient-centered outcomes. Feedback and learning at the 
individual, provider, organization, and system levels must 
be used to inform and improve individual outcomes and 
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the process of care and service delivery at each of these 
levels. Without such systems in place, we will never know 
what works and what does not work to improve out-
comes. Our last underlying assumption was that to truly 
improve care, feedback and assessment of effectiveness 
must accurately reflect patient-centered service processes 
and outcomes as evidence. In a learning system, aggre-
gated patient-centered process and outcome measures 
should be used to facilitate improvements in performance 
at all levels. At the same time, performance incentives and 
requirements at the system, organizational, provider, and 
financial levels are best when they remain separate from 
process-improvement efforts. This maintains the integrity 
of the learning system by avoiding perverse incentives.
Analytic Framework to Guide Future Patient-Centered 
Outcomes Research and Comparative Effectiveness 
Research: Improving Individual Outcomes
Whereas our model of care depicts the process of care and 
service delivery as we believe it should be conceptualized, 
our analytic framework (see figure 6) is intended to guide 
future PCOR and CER programs. That is, the theoretical 
model is a clinical model, while the analytic framework 
serves to guide research by highlighting opportunities for 
evaluation of processes and outcomes. It is worth noting 
that separating these processes in the analytic framework 
does not preclude the use of common patient-centered 
outcome measures across framework components. For 
example, patient-centered outcome measures can and 
should be aggregated to create indicators of provider-, 
organization-, and system-level performance.
Narrative Review
To determine areas where research is plentiful and areas 
where more evidence is needed to improve care and service 
delivery to individuals with serious mental illnesses, we 
conducted a narrative review of the primary domains in the 
analytic framework. The results, summarized below, are not 
intended to be comprehensive in scope but rather demon-
strative of the breadth of this system and the complexities 
Fig. 5. Theoretical model of a learning care system for individuals with serious mental illnesses.
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involved in system change. When adequate review articles 
were not available, we conducted further searches to iden-
tify primary literature. We searched bibliographic sources 
including PsycINFO, PubMed/MEDLINE, Sociological 
Abstracts, Social Services Abstracts, the Cochrane Library, 
Google Scholar, Health and Psychosocial Instruments, 
and EconPapers, as well as Web sites of agencies and orga-
nizations such as the Substance Abuse and Mental Health 
Services Administration (SAMHSA), the Kaiser Family 
Foundation, the Urban Institute, and Mathematica Policy 
Research. We also asked our technical experts and stake-
holders to suggest publications.
Our search strategy for identifying stakeholder per-
spectives was more comprehensive, including reviews, 
original research publications, and monographs, as well 
as first-person accounts and online sources (see figure 7). 
We also used these sources to identify additional materi-
als for review.
Stakeholder Perspectives
In order to meaningfully assess and develop patient-
centered mental health services and systems, substantial 
shifts are necessary in what we consider as evidence; 
how we collect, interpret, and apply evidence; and how 
we engage stakeholders in these processes. The expertise 
and knowledge of  consumers, families, carers, and pro-
viders are often misunderstood, distorted, or mistrans-
lated in outcomes research and analysis. Our review 
led us to several key conclusions about stakeholder 
perspectives:
 • Consumers, families/carers, and providers predictably 
diverge in their assessments of consumers’ status, out-
comes, and needs for services. They differ in language, 
conceptual frameworks, the bases for their assessments, 
and the way they prioritize needs. These differences are 
most apparent in their definitions—and thus assess-
ments—of recovery processes.
 • Recovery is increasingly being translated into an out-
come by researchers and policy makers. The conden-
sation, standardization, and interpretation involved 
in mainstream outcomes research and evidence-based 
policy may obscure the nuance, complexity, and power 
of the recovery process. Consumer-directed and con-
sumer-informed research is particularly salient here. It 
is important to distinguish between value-based and 
evidence-based outcomes and practices when assessing 
the effectiveness of services. Some treatments and ser-
vices, and the qualities of their provision, are endorsed 
because they enact deeply held values, not necessarily 
because their effectiveness has been established.
 • Demonstrable progress has been made in engag-
ing stakeholders in evaluating treatment and services 
and in formulating federal, state, and local policies. 
Organization and financing models, however, are often 
taken as inevitable and trump many of the expressed 
opinions and evidence from stakeholders. Providers in 
particular are awash in reimbursement criteria and doc-
umentation, ever-changing requirements for account-
ability, and inadequate resources. These strictures make 
it difficult to promote the kinds of healthy working alli-
ances with consumers and families/carers that produce 
continuous healing relationships.
 • The most commonly agreed-upon needs of stakehold-
ers concern qualities of person, place, and relationship. 
Choice, respect for persons, attention to basic safety 
and material living needs, and competence of care, are 
shared aspirations and expectations for mental health 
services. Therapeutic relationships and working alli-
ances are the fulcrum of mental health services, but the 
facilitators and barriers to such partnerships have not 
received adequate attention in research, service design, 
or service provision.
 • Collaborative service user-provider relationships are 
complicated and easier to imagine than achieve. The 
widespread deployment of peer providers within, and 
Fig. 6. Analytic framework to guide future comparative effectiveness and patient-centered outcomes research.
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as adjunct to, mental health services has moved rela-
tively swiftly, as has the number of consumer-operated 
services. It is important to assess these moves with the 
understanding that their goals and mechanisms differ 
from those of more traditional providers.
 • The unintended consequences of treatment receive 
scant attention in outcomes research. As a result, sys-
tems lose the opportunity to be self-correcting enti-
ties. The use of coerced and involuntary treatment in 
hospitals and community settings, as well as the more 
subtle and pervasive manipulation of choice, repre-
sent possible sources of injury or harm for consumers, 
families, and even providers, and may keep people from 
seeking services that might be helpful to them.42 And, 
as in other areas of medicine, consumers may want ser-
vices or treatments that are ineffective or inappropriate. 
Providing patient-centered care in these circumstances 
can be challenging. It is essential to understand the ser-
vice user’s perspectives and goals, provide information 
about why the service is not recommended, and suggest 
alternative approaches.
 • People come to health and mental health systems with a 
variety of ideas and understandings about what mental 
illness is and how to treat, cope, and live with it. These 
ideas are heavily influenced by collective understandings 
about the causes and consequences of illness. At the 
same time, the person receiving services is not merely 
a representative of his or her culture. Cultural compe-
tence requires recognition of difference, not stereotyp-
ing, and it requires that instead of making assumptions, 
we ask about the values, traditions, and practices that 
are part of the person’s biography. Services and treat-
ment relationships must be informed by and responsive 
to the relationship contexts of the person and the col-
lective understandings they may share with others.
The following sections summarize reviews of research, 
meta-analyses, and empirical investigations published 
primarily after 2000 and examining the efficacy of ser-
vices, treatment, and outcome needs and preferences 
of people with serious mental illnesses, family/carers, 
and providers. The focus is primarily on the evidence 
from and about these three stakeholder groups and their 
assessments of the effectiveness of services and systems 
of care for people with serious mental illnesses. After an 
analytic review of the evidence in each area, we identify 
gaps, limitations, and unintended consequences, and we 
suggest directions for future research to inform a learning 
system of care that is patient centered, effective, compre-
hensive, and recovery-promoting.
Service Users: Needs and Preferences 
The involvement of mental health service users in service 
delivery is a new and growing phenomenon. Such involve-
ment is complex, given the history of paternalism in the 
mental health system, the power differential between ser-
vice providers and service users, and the very differing views 
each group holds on multiple issues. Unless such differences 
are addressed, there can be no meaningful involvement. 
Service user involvement needs to apply to all aspects of 
Search Strategy and Results: Stakeholder Perspectives 
Search terms: mental health consumer, psychiatric patient, service user, mental health provider, clinician, psychiatrist, nurse, 
case manager, mental health shared decision making, mental health patient-centered care, family members and mental health 
treatment, mental health outcomes, therapeutic alliance, working alliance, empowerment, autonomy, basic needs, forensic 
psychiatric patients, innovative mental health services, peer providers, serious mental illness provider practices and practice 
interventions, coercion and outcome, seclusion, restraint, consumer run services, consumer-centered or directed outcome 
measures. 
Inclusion: review, meta-analysis, and technical report overviews; summary analytic reviews of conceptual frameworks and 
models; empirical research within past 10 years specific to patient-centered mental health services, consumer needs and 
preferred outcomes and outcome measures, provider needs and interventions, family member needs and preferences, and 
consumer participation in service delivery, research, and policy.  
Sources: Medline, BioMedCentral, PsychInfo, Cochrane Library, Google Scholar, CINAHL, PLoS, PubMed, NLM, 
schizophrenia.com, mindfreedom.com, PeopleWho.com, Somatosphere, DEcIDE Mental Health Consortium. Journal based 
searches: Psychiatric Services, American Journal of Psychiatry, Community Mental Health Journal, British Journal of 
Psychiatry, Psychiatry, Social Science and Medicine, Psychiatric Rehabilitation Journal, Journal of Health and Social Behavior, 
Psychosis, Psychological Medicine, Schizophrenia Bulletin, Culture, Medicine, and Psychiatry, Mental Health Journal, Journal 
of Mental Health Policy and Economics, International Journal of Social Psychiatry and Epidemiology. 
Search Results: Total number of included publications: 335: Reviews and meta-analyses: 22; Consumer needs and 
preferences: 160; Consumer assessment of treatment, identification of needs and preferences, shared decision making, types 
of services, relationships with providers, coercion, safety, choice: 51; Consumers as Providers+ Consumer Peer Run/Directed 
Services: 39; Consumer Participation in Evaluation, Research, and Policy: 44; Consumer Driven/Produced outcome measures: 
26; Family/carer needs and preferences: 20; Provider needs and preferences: 43. Note that some articles were classified in 
more than one category, for example, papers that compared consumer, family, and provider perspectives.
Fig. 7. Search strategy for review of stakeholder perspectives.
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the service delivery system, including professional training, 
service design, delivery, evaluation, and research. User/sur-
vivors, and their organizations, have developed a body of 
experience and knowledge that needs to be recognized and 
respected. Unless there are multiple opportunities for ongo-
ing and open dialogue on these many difficult issues, real 
user involvement will not occur.43(p20)
—Judi Chamberlin, author and activist
A central aim of this section is to respond to Chamberlin’s 
eloquent call to recognize and apply the experience and 
knowledge of service users to improve service deliv-
ery. Along with primary consumers of mental health 
care (those diagnosed with serious mental illnesses), we 
include family members/carers and frontline providers. 
These three stakeholder groups live with, experience, and 
work in mental health services with unique proximity and 
intensity. The studies we reviewed confirm that attend-
ing to consumer assessments of services yields important 
information that can and should be used in learning sys-
tems of care. The evidence of differences between con-
sumer, provider, and family/carer assessments and needs 
is substantial. The challenge is to translate the findings 
from these stakeholders into services and delivery pro-
cesses and to develop the means with which to assess them.
The topics included in this review were derived from 
the stakeholder-generated list of needs and preferences, 
the input of expert consultants and stakeholders in each 
of these areas, the collaboration of our work group, and 
our care delivery definition and theoretical model of care.
Relationships With Providers The quality of consumer-
provider relationships in inpatient and outpatient settings 
is arguably the primary influence on consumer assessment 
of services.44 The foundation and primary referent of con-
sumer needs and preferences for services is their desire for 
informed, respectful, engaged, collaborative, and flexible 
interactions with providers. Numerous studies document 
both the positive influence of working alliances and the 
negative impact of failed therapeutic relationships.45,46
In reviewing these findings, it is helpful to consider how 
the data are gathered and the concepts and frameworks 
for analysis. For example, “satisfaction” may be a limit-
ing and perhaps inapt construct for assessment, as it fails 
to address consumers’ expectations for services. Several 
suggestions for more accurate modes of elicitation and 
analysis, including system responsiveness, have been pro-
posed as alternatives. Hopkins et al47 reviewed 10 studies, 
published between 1998 and 2008, that measured system 
responsiveness to consumer expectations of inpatient 
psychiatric treatment. In assessing system responsiveness, 
the authors argue that attention is shifted away from gen-
eral satisfaction with services and toward the link between 
what the person expects and what is provided. The com-
ponents of responsiveness reviewed by Hopkins et  al47 
included confidentiality, autonomy, respect for dignity, 
prompt attention, quality of amenities, access to social 
support, and choice of provider. The authors identified 
three primary themes in consumers’ notions of respect-
ful treatment: that the system provide a place of safety/
refuge, that it provide inpatient programming, and that 
it support healthy interpersonal relations with staff  and 
others. Brunero et al48 echoed these findings, identifying 
“being happy with the service provided by the consumer 
support worker, having support for services on discharge, 
and feeling safe and secure on the ward” as significant 
predictors of reported satisfaction with inpatient care. 
Mason et al49 pointed out that satisfaction with services 
should be differentiated from loyalty to a particular pro-
vider or treatment setting.
Happel50,51 used focus group methodology to explore 
Australian consumers’ views on effective services, how 
to evaluate them, and barriers to their success. Echoing 
the consistent findings about the importance of strong 
relationships with providers, Happel50,51 found that con-
sumers regarded responsiveness, follow-up, respect, and 
individualized support from clinical staff  as essential to 
their recovery. Continued contact with and support from 
friends and relatives was also a key ingredient, as was the 
consumer’s taking responsibility for his or her own cir-
cumstances and planning. With respect to barriers, infor-
mants identified staffing issues, lack of safety and security, 
isolation, and a focus by staff  on the illness instead of the 
person. In another study, Mason et al49 identified the cul-
tural and religious competence of providers as important 
components of effective services.
Green et al52 added an additional dimension to posi-
tive, trusting relationships with clinicians: longevity. 
Long-term relational continuity of care allowed devel-
opment of close, collaborative relationships, fostered 
good illness and medication management, and supported 
consumer-directed decisions. Clinicians who were com-
petent, caring, trustworthy, and trusting, and who treated 
clinical encounters “like friendships,” increased willing-
ness to seek help and continue in care. Statistical models 
showed positive relationships between recovery-oriented, 
consumer-driven care and satisfaction with clinicians, 
medication satisfaction, and recovery. Relational conti-
nuity affected satisfaction with clinicians, which led to 
improved quality of life (QOL). Ware et al53 found similar 
results, as did Laugharne et al.54 They found that choice, 
trust, and the ability to shift the balance of power as 
needed between the provider and service user occurred 
over time in the consumer-provider relationship. They 
cited personal disclosure about clinicians’ own lives, com-
mon acts of kindness, and conversation outside clinical 
matters as key to this personal approach. As Green et al52 
found, service users viewed trust as a two-way process 
with responsibility shared between partners.
Researchers have made numerous attempts to opera-
tionalize working alliances or therapeutic relationships, 
as evidenced by the 15 or more measures developed to 
date. Bordin55 proposed several key components of the 
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therapeutic or working alliance: agreement on the goals 
and tasks of therapy, strong patient-therapist bonds, and 
positive views about the working process (eg, therapist 
skills, patient perception of therapist’s ability to help). 
More concretely, identifying an unmet need is a proxy for 
therapeutic goals, and meeting previously unmet needs is 
a proxy for task effectiveness. The effects of therapeutic 
relationship type and strength on consumer outcomes, 
however, remain elusive and under investigation.56 Priebe 
et  al57 reviewed the predictive strength of therapeutic 
relationship scores for outcomes in nine prospective stud-
ies, comparing hospitalizations, levels of symptoms, and 
functioning. While each study showed a positive relation-
ship between working alliance and outcomes, no associa-
tion was statistically significant, and the studies varied 
widely in sample size and methodology. In a compan-
ion review of 15 measures of therapeutic relationships, 
McCabe and Priebe58 concluded that while no single scale 
had been adopted widely, each measure reviewed had 
acceptable psychometric properties. Their finding that 
positive therapeutic relationships consistently predict 
better short- and long-term outcomes deserves continued 
attention in measures development and the application 
of research results to service settings. Researchers must 
also account for the variability of treatment goals and 
settings, as well as other influences such as the voluntary 
or involuntary status of the treatment.
Providers face particular challenges in establishing 
positive therapeutic relationships with individuals experi-
encing psychotic symptoms. In such cases, providers may 
avoid discussions about the content of hallucinations 
or delusions out of concern that they will inadvertently 
collude with service users in their symptoms. This leaves 
both service users and clinicians feeling uncomfortable.59 
McCabe and Priebe59 note a lack of systematic, theo-
retically informed training for providers regarding such 
situations, as well as a lack of research on best clinical 
approaches. There is some evidence that the therapeutic 
relationship predicts outcomes of complex psychiatric 
treatment programs in service users with psychosis, but 
more methodologically rigorous research is needed.57 
Fakhoury et al60 evaluated the effectiveness of the thera-
peutic relationship between clinicians and a patient pop-
ulation deemed “difficult to engage.” After controlling 
for other predictors, a positive therapeutic relationship 
predicted fewer hospitalizations and treatment adherence 
in new service users but not in established service users. 
In an Australian study measuring the effect of the work-
ing alliance on recovery for individuals with serious men-
tal illnesses,61 the authors found that changes in working 
alliance predicted recovery, but that changes in recovery 
also predicted the nature of the alliance. Therefore, the 
authors could draw no definitive conclusions regarding 
the causal direction of such relationships. Nonetheless, 
the study suggests that improvements in alliance posi-
tively influence gains in recovery and vice versa.
Summary and Implications Despite near-universal 
agreement that consumer-provider relationships are 
fundamental to meeting consumer needs and improv-
ing assessments of services, there is less certainty about 
whether and how these relationships contribute to 
consumer outcomes. This ambiguity raises interesting 
questions: Is demonstrable impact of positive working 
alliances on outcomes necessary to prioritize the quality 
of consumer-staff  relationships in mental health services? 
If  therapeutic relationships are central to consumers’ 
experience in treatment, would addressing the identified 
obstacles and potential solutions take a central place in 
services research and assessment? The well-recognized 
barriers to improved consumer-provider relationships 
include large case loads, administrative and documenta-
tion demands, staff  turnover, and insufficient resources 
for providing smaller case loads, adequate salaries, and 
administrative assistance. These constraints, however, are 
seldom considered in assessments of responsiveness and 
mutuality in consumer-provider relationships.
Shared Decision Making The foundations of shared 
decision making, another useful framework for examining 
the process of consumer-provider relationships, are similar 
to the principles of autonomy, choice, deliberation, and 
collaboration discussed above.62 Drake et  al63 introduced 
an issue of the Psychiatric Rehabilitation Journal devoted 
to shared decision making with a valuable discussion about 
the meaning and mechanisms of person-centered care in 
mental health, and we point the reader to that work.
Curtis et al64 reviewed the components, background, evi-
dence base, and promise of shared decision making, identi-
fying three essential stages of the process: “(1) information 
and preparation for making a decision; (2) the interactive 
process of discussing and generating a shared decision; and 
(3) systematic opportunities to review and revise decisions 
after they are made” (p. 15). In summarizing their review of 
evidence, they note that (1) implementing shared decision 
making in mental health services will require taking into 
account the context of decisional capacity precedents and 
power; (2) information is lacking on effective and cultur-
ally specific clinical communication strategies; (3) research 
should focus separately on each step in the shared decision-
making process; and (4) the long-term, episodic, and mul-
tidimensional nature of consumer-provider interactions 
require testing and adaptation of extant linear shared deci-
sion-making techniques and technologies (p. 19).
As a matter of mental health policy and practice, 
SAMHSA has given substantial attention to shared deci-
sion making in mental health services, including stake-
holder conferences and commissioned papers to examine 
research, implementation, and training. This initiative is 
consistent with research suggesting that people with serious 
mental illnesses have stronger preferences for shared deci-
sion making than primary care patients, and that among 
this population, those with more negative views of medica-
tions and those who are younger want more participation.65
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Implementing effective shared decision-making 
practices in service settings is challenging but feasible. 
Thompson66 studied patient involvement and partici-
pation in medical settings using focus group interviews 
and workshops. Participation is considered to be a joint 
venture, codetermined by patients and professionals and 
based on reciprocal relationships developed through dia-
logue and shared decision making. Patient participation, 
he observed, “requires a narrowing of the information/
competence gap between professional and patient, with 
some surrendering of power by the professional which 
conveys benefit to the patient, even if  there is no consen-
sus” (p. 1299). In a review of randomized controlled tri-
als (RCTs) of interventions to train physicians and nurses 
to improve patient centeredness in general medical set-
tings, Lewin et al67 found most studies to show significant 
improvements in patient centeredness. However, the con-
nection between decision-making practices and health 
outcomes was not examined in these studies.
The role of technology in shared decision making is 
growing rapidly, as communication technologies expand 
the array of mechanisms for involving consumers in 
mental health care decisions.68,69 Mobile phone and web-
based interventions for symptom management, psycho-
education, and engagement with clinicians show promise 
in feasibility and in improving outcomes. Deegan70 devel-
oped an innovative software program to improve shared 
decision making related to medications, in part based on 
her own personal growth from a passive recipient of pre-
scribed medication to a recovering, more hopeful person 
who uses medication as part of her chosen self-manage-
ment. The software program consists of an interactive 
prephysician visit questionnaire with optional informa-
tional videos. A  one-page report is produced from the 
consumer’s answers and becomes the basis for discussion 
with the prescriber. The program has been implemented 
in a number of clinical settings and is undergoing process 
and outcome assessment. To date, no results are available.
Summary and Implications The quality of consumer-
provider relationships is perhaps one of the best docu-
mented influences on assessments of care and outcomes 
and the least attended to in implementation, intervention 
development and testing, and reform of system-level fac-
tors that impede such relationships. It is clear that con-
sumers prefer high-quality relationships, relationships, 
and that quality shapes the user’s experience of treat-
ment. In order to implement practices that move from 
“adherence to self-determination”62 and thereby improve 
mental health services, research on emerging models and 
mechanisms in these areas is clearly needed.
Coercion in Services and Treatment
“We wonder how a person can be considered a user 
(or consumer) of services which are imposed on them. 
How can restraint, seclusion and forced medication or 
electro-convulsive therapy be understood as ‘mental health 
services’?”71(p216)
Involuntary and/or coerced treatment in inpatient and 
outpatient settings is a highly contested issue among con-
sumers and providers, policy makers, and often families 
and carers. Many consumers consider coerced treatment, 
whether explicit or tacit, to be the most important barrier 
to collaborative, effective services and treatment, as well as 
a source of harm and abuse.71–75 As with other dimensions 
of consumer preference for services, however, opinions and 
experiences regarding the use of coercion vary. Involuntary 
treatment can be a healing, positive experience for a con-
sumer who is catatonic or suffering from psychosis or delu-
sions. Consumers with these symptoms may be unable to 
make informed choices about treatment but may desperately 
need help. Compassionate, caring providers can provide this 
help with dignity and respect. As one reviewer of this docu-
ment stated, “Involuntary treatment has saved my life.”
Prinsen and van Delden74(p70) reviewed the ethical quan-
daries posed by coercive treatment, including seclusion 
and restraint, and concluded that “we can neither rule 
out nor accept coercive measures relying on autonomy or 
dignitarian grounds alone. We do need to know whether 
coercive measures are beneficent to complete the argu-
ment, and therefore research is necessary. For as long 
there is no evidence for positive effects of seclusion, the 
precaution principle of ‘primum non nocere’ [first, do no 
harm] should guide our actions.” Clinicians and mental 
health providers also have concerns about coercion in 
treatment, including disruptions to relationships with 
patients, pressure from family members who either want 
or contest the use of coercion or involuntary hospitaliza-
tion, and the conflict between their roles as agents of the 
state and patient advocates.76
Research on the outcomes of coerced treatment has 
yielded mixed results, ranging from lack of efficacy to 
increased use of services and fewer hospitalizations.77,78 
Kisely et al79(p19) reviewed the evidence on the outcomes 
and efficacy of compulsory outpatient treatment, con-
cluding that “community treatment orders may not be 
an effective alternative to standard care. It appears that 
compulsory community treatment results in no signifi-
cant difference in service use, social functioning or QOL 
compared with standard care. There is currently no evi-
dence of cost effectiveness”. That said, it is important to 
consider the criteria by which effectiveness is assessed. Is 
the standard to provide demonstrable benefit, or to do 
no or minimal harm? The latter is supported in some 
research78,80 but is contested by other findings81,82 and by 
some consumers,71 including the National Coalition of 
Mental Health and Consumer/Survivor Organizations.83 
Assessing the demonstration of benefit is a pressing need 
given the gaps in the evidence and the widespread imple-
mentation of outpatient commitment statutes worldwide. 
For example, the German Federal Court ruled on June 
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20, 2012, that there was no constitutional basis for invol-
untary psychiatric treatment among the general popula-
tion, and it specified the steps required for nonconsensual 
treatment among forensic patients.84,85 Such decisions, 
largely statutory and political in nature, require good 
data on the effectiveness of coerced care.
The European Evaluation of Coercion in Psychiatry and 
Harmonization of Best Clinical Practice (EUNOMIA) 
project is the largest study to date of the outcomes of 
coercion in psychiatric treatment. The study followed 
3  090 individuals from 11 European countries who 
had experienced some form of coerced hospital admis-
sions.86 The individuals were classified as coerced invol-
untary, noncoerced involuntary, and coerced voluntary 
patients. Initial findings 1 and 3 months postdischarge 
found significant improvements in primary psychiatric 
symptoms. The group of individuals who were voluntary 
but coerced, however, showed less improvement than the 
other groups. The authors conclude that when coercion is 
informal rather than done through transparent legal pro-
cedures, the subjective experience of coercion may have a 
particularly negative influence on treatment motivation, 
therapeutic relationships, and outcomes. These findings 
echo those of Phelan et al77 and Link et al81 regarding the 
potency of nuanced forms of coercion and stigmatiza-
tion. The MacArthur Coercion Study provides additional 
details about the coercion-related experiences of indi-
viduals pressured to enter the hospital or involuntarily 
admitted, finding that such experiences are associated 
with variations in the presence of “procedural justice,”87 
defined as having a voice in the process and being treated 
by family and clinical staff  with respect, concern, and 
good faith.
Coercion and Medication Adherence Medication adher-
ence, as a primary goal of community treatment orders 
or outpatient commitments and involuntary hospitaliza-
tion,88 is directly relevant to the prevalence and impact 
of coercive mental health care. Haynes et al89 considered 
trials of ways to help people follow prescriptions across 
several clinical conditions. Counseling, written informa-
tion, and personal phone calls were found to be helpful 
for short-term drug treatments, while in long-term treat-
ments, no simple intervention—and only some complex 
ones—led to improvements in health outcomes. Complex 
interventions included combinations of more convenient 
care, information, counseling, reminders, self-monitor-
ing, reinforcement, family therapy, psychological therapy, 
mailed communications, crisis intervention, and manual 
telephone follow-up. Even with the most effective meth-
ods for long-term treatments, improvements in drug use 
or health were not large. Interestingly, several of these 
studies informed people about adverse effects of their 
medications, with no resulting effects on their use.
However, the side effects of medications are of sig-
nificant concern to consumers and prescribers. Pseudo-
Parkinsonism, dystonias, akinesia, akathesia, and flat 
facial expression caused by conventional antipsychotic 
medications have been replaced with metabolic and 
cardiovascular adverse effects accompanying atypical 
antipsychotics.90,91 Seeman92 pointed out that younger 
individuals may be particularly concerned about the loss 
of attractiveness associated with weight gain. Rosenheck 
et  al93 found that recovery orientation among service 
users (compared to medical orientation) was associated 
with better functioning, fewer symptoms, and less focus 
on reducing medication side effects. The authors con-
clude that recovery models and medical models should 
not be seen as being in opposition to one another.
Despite ongoing efforts by researchers and profes-
sional psychiatric groups to reduce polypharmacy and 
use lowest dose guidelines, progress is slow.94 Various 
forms of leverage and strong persuasion to take medi-
cations are commonplace in mental health services95–97 
and continue to pose ethical, legal, and therapeutic chal-
lenges. While involuntary medication orders in hospital 
and community settings are subject to judicial review, less 
obvious and arguably more pervasive coercive pressures 
are not. Recovery-promoting practices and shared deci-
sion making in medication prescribing lag behind other 
types of interventions and deserve additional interven-
tion research.
Coercion Among Justice-Involved Consumers In view 
of the high prevalence of diagnosed or diagnosable seri-
ous mental illnesses in the prison population,98 we must 
consider the use of coercion in this setting, including in 
jail diversion programs and among parolees whose con-
ditions for release include adherence to mental health 
treatment. Jail diversion programs for people with seri-
ous mental illnesses are increasingly popular, yet the evi-
dence of their effectiveness is restricted to a small number 
of completed studies. At issue is whether jail diversion 
participants feel coerced into mental health treatment, 
and whether feeling coerced influences their treatment 
outcomes. In a study of 900 jail diversion participants in 
13 sites, Cusack et al99 found that 36% of the sample felt 
coerced or moderately coerced to accept jail diversion, 
and 45% felt coerced or moderately coerced to receive 
mental health services. Considering parolees with man-
dated mental health treatment, Skeem and Louden100 
reviewed published and unpublished research between 
1975 and 2005 and found that specialty parole supervi-
sion was associated with better linkage to mental health 
services. The authors did not assess coercion, however. 
While jail diversion and mental health treatment as con-
ditions of parole are likely to be experienced as coercive, 
we lack sufficient evidence to determine how to enhance 
services for these significant populations. Interestingly, 
consistent with the MacArthur and EUNOMIA projects’ 
results and Skeem and Louden’s findings100 regarding 
better outcomes for individuals who experienced trans-
parent coercion, Farabee et al101 found that the criminal 
justice system could serve as a link to treatment rather 
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than solely as a source of coercion for those who would 
not seek services on their own.
Seclusion and Restraint Like involuntary inpatient 
and outpatient treatment, seclusion and restraint in inpa-
tient and emergency settings are controversial forms of 
coercion that consumers find especially traumatic.102 The 
ethics of these practices have been questioned, as has 
their legality, therapeutic value, and effectiveness.74,103 
Muralidharan and Fenton104 reviewed the effectiveness 
of nonpharmacological forms of containment—includ-
ing special observation, locked units and rooms, dees-
calation, and behavioral contracts—and concluded that 
there was insufficient evidence to support these practices. 
Prinsen and van Delden74(p72) conclude: “It is very hard to 
argue that seclusion is the appropriate measure to control 
these circumstances [violence and aggression] when there 
are no data to support this.”
In response to concerns about these practices, various 
attempts have been made to reduce their use. Schacht105 
described the efforts of the National Association of 
State Mental Health Program Directors (NASMHPD) 
to monitor and reduce the use of seclusion and restraint 
in psychiatric treatment. Over a 4-year period from 2001 
to 2005, 150 US hospitals monitored the use of physical 
restraint and seclusion. Over that period, and in conjunc-
tion with training in alternate deescalation and aggres-
sion control strategies, hours of seclusion decreased 
36% and hours of restraint declined by 46%. The num-
ber of service users secluded declined by 26% and the 
number restrained decreased by 12%. The time of seclu-
sion, however, remained at approximately 30 minutes 
per 1 000 inpatient hours, and time in restraint about 45 
minutes. Administrative and staffing changes, specifically 
increases in the ratio of staff  to service users, have also 
been shown to reduce the use of seclusion and restraint. 
Donat106–108 found that changes at these levels reduced use 
by up to 75%.
The scarcity of research on the effectiveness and out-
comes of seclusion and restraint procedures, and the 
continued use of such practices in the face of success-
ful alternative approaches, justifiably add to consum-
ers’ concerns about involuntary and voluntary inpatient 
treatment. Additional research is needed to explore alter-
natives to seclusion and restraint, and to examine the 
effects of these practices on patient-centered outcomes, 
including engagement in care. In a recent promising 
study, Borckardt et al109 developed and tested an engage-
ment model in five psychiatric inpatient units, along with 
a hospital-wide initiative to improve consumer-staff  com-
munication. The engagement model included trauma-
informed care training for staff, changes in unit rules and 
language among staff, involvement of patients in treat-
ment decisions, and improvements to the physical sur-
roundings. The hospital intervention, called AIDET, set a 
template for staff-patient communication: Acknowledge 
patients, Introduce yourself, clarify the Duration of the 
contact, Explain the reason for the contact, and Thank 
the patient. The implementation of these practices 
resulted in a substantial decrease in the use of seclusion 
and restraint.
Gaps and Limitations in Research on Coercion The evi-
dence base for the effectiveness of coercion is lacking, and 
the findings from many investigations lead to divergent 
interpretations. Moreover, the lack of consumer/patient 
participation in the design, implementation, and assess-
ment of innovative interventions, as well as the conduct of 
outcomes research, is a major shortcoming of the current 
evidence base related to coercion.110 Researchers are just 
beginning to explore the unintended consequences of the 
use of coercion, leverage, seclusion, and restraint, and the 
more widespread tacit and deliberate pressures to comply 
with providers or accede to treatment other than one’s 
choice. Kontio et  al102 elicited first-person accounts of 
seclusion and restraint from psychiatric patients that are 
both alarming and informative. While the EUNOMIA 
and MacArthur projects have begun to provide needed 
data, it is crucial that research of this type be launched 
in collaboration with mental health service users. Russo 
and Wallcraft71 asserted that the terminology, defini-
tions, sample selection, measures, analysis strategies, and 
questions in much coercion-related research represent an 
incomplete and limited approach to the subject. Future 
CER on all forms of coercion, seclusion, restraint, and 
other forms of involuntary treatment will benefit from 
improving methods and adopting more inclusive con-
cepts and collaborators in the enterprise.
Consumer-Run Services/Consumers as Providers Here 
we review the evidence on two related but distinct dimen-
sions of patient-centered services: (1) mental health ser-
vices that are developed by, staffed by, and managed by 
identified past or present service users/consumers; and (2) 
past or present service users/consumers as mental health 
providers within clinical settings or treatment teams, and 
as employees of an extant agency, program, or clinical 
setting that is part of the mental health service system.
A recent review of the extent of mental health mutual 
support, self-help, and consumer-operated programs in 
the United States identified 7  467 groups overall, with 
1  133 consumer-operated services serving over 500  000 
members per year.111 From a research perspective, con-
sumer-directed programs and services are so varied, with 
such unique locations and arrangements with existing 
mental health service systems, that it is difficult to pro-
duce useful categories and typologies for analysis and 
comparison. Salzer, as cited in Campbell and Leaver,112 
proposed this distinction: “Consumer-operated services” 
are planned, managed, and provided by consumers. 
“Consumer partnership services” are delivered by con-
sumers, but the control of the program is shared with 
non-consumers. “Consumers as employees” refers to 




A number of program description and research reviews 
have documented the spread and variety of consumer-
directed services.113 Doughty and Tse114(p263) reviewed 
English-language research published after 1980 that com-
pared consumer-led mental health services with tradi-
tional mental health services. “Overall,” they concluded, 
“consumer-led services seemed to report equally positive 
outcomes for their clients as traditional services, particu-
larly for practical outcomes such as employment, income, 
education or living arrangements, and in reducing hospi-
talizations and the cost of services. Results were varied for 
client satisfaction and recovery, and some negative find-
ings were reported”. As part of a large project involving 
the Center for Mental Health Services and NASMHPD, 
Campbell and Leaver112 reviewed the background and evi-
dence for organized peer support. They described inno-
vative and successful programs, and included resources 
for technical assistance. Tan, Mowbray, and Foster (add 
citation below) identified four goals of these services: (1) 
to provide a safe, supportive community environment; 
(2) to provide an atmosphere of acceptance; (3) to pro-
mote self-worth, dignity, and respect; and (4) to increase 
knowledge by learning from one another.115 In a later 
report, Consumer-Operated Services Evidence Based 
Practices,116,117 findings related to patient-centered out-
comes were updated and were consistently positive. These 
reviews found consistency in improved symptoms, cop-
ing skills, satisfaction with life, and social networks and 
support. There are also a number of descriptive, analytic 
outcome studies on various types of consumer-directed 
services.118–220 These findings are generally consistent with 
those included in the reviews—that is, participants in 
these services gained in coping and social skills, reported 
reduced symptoms, and had increased life satisfaction.
The goals and practices of consumer-operated ser-
vices are often so different from those of traditional 
programs that comparisons require caution and clarity. 
Segal et  al121 conducted an RCT to compare outcomes 
between a board- and staff-run consumer organization 
and a traditional community mental health agency. Of 
the primary recovery-related outcome measures studied, 
social integration, personal empowerment, and self-effi-
cacy improved more in those participants assigned to the 
mental health agency, while symptoms and measures of 
hopelessness did not differ between the two. The authors 
hypothesize that the consumer program’s organizational 
structure may have been no less hierarchical than that of 
the traditional agency, posing challenges to the promotion 
of better patient-centered outcomes. In a related study, 
Hodges et al122 explored the relationship between the use 
of self-help services and professional mental health ser-
vices among people who used only professional services 
and those who used both. Participants who used both 
services reported more satisfaction with professional ser-
vices than the group that used only professional services. 
The authors conclude that self-help services facilitate 
appropriate use of professional services and that the two 
types of services can work in a complementary manner.
In addition to operating programs, mental health ser-
vice consumers are increasingly joining the system as pro-
viders.123 There are many variations in these positions, and 
little is known about individuals who are employed in the 
system but are not open about their diagnoses. Research 
on individual outcomes for clients of consumer-providers 
is in the early stages. In one of the first comparisons of 
consumers as case managers with nonconsumer provid-
ers, Solomon and Draine124 found equivalent outcomes 
for the clients of both groups. Solomon125 described the 
critical ingredients of peer-provided services as (1) expe-
riential learning, (2) mutual benefit, (3) use of natural 
supports, (4) voluntary nature of the services, (5) primary 
control of the service by peer providers, and (6) peers as 
recovering and sober role models. Van Erp et al126 added 
that training, coaching, and supervision are central to 
peer providers’ performance of their treatment roles. In a 
unique clinical trial of a peer-based intervention specifi-
cally designed for African American and Latino consum-
ers with psychosis, Tondora et al125 have thus far learned 
that the peer mentor-patient relationship required more 
than the allotted 6 months to develop, that there were 
challenges in defining the expectations and limits of 
interactions between the two, and that flexibility in roles 
clouded some of the distinctions between the two inter-
vention arms. Similarly, van Vugt et  al126 investigated 
the outcomes of an Assertive Community Treatment 
(ACT) team that included consumer-providers. They 
found positive associations between consumer/provider 
presence in the treatment teams and patient function-
ing, personal recovery needs met, and reduction in time 
spent homeless, but they also saw an increase in hospital 
days. Similar to Tondora et al,127(p477) they concluded that 
“consumer-providers are important participants in out-
patient teams serving clients with severe mental illnesses, 
although integrating these providers as part of a team is 
a slow process.”
In addition to studies of peer performance in clinical 
roles, other publications have examined the challenges 
of implementation and sustainability facing consumer-
operated programs and the attitudes of mental health 
providers toward consumer-providers. Sustainability 
challenges have been primarily financing, credentials, 
affiliations with other mental health providers, man-
aging member/user information, and organizational 
stability.129–131 Studies of attitudes toward and aware-
ness of mental health providers and their willingness to 
integrate consumer-operated services into the local sys-
tem of care have shown that although providers believe 
consumers can provide effective mental health services, 
they have less confidence in consumer-run programs.132,133 
Providers in nonpublic settings, agencies that hire con-
sumers as providers, and agencies that collaborate with 
consumer-run programs are more likely to have made 
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referrals to consumer-operated programs. An Australian 
study of demographic and workforce characteristics and 
their relationship to acceptance of peer providers found 
that receptivity and support for consumer involvement 
in treatment-related activities varied by gender (females 
more supportive), time in the profession (junior people 
more receptive), and time in the job (most senior and 
most junior least receptive).134
Gaps and Limitations in Research on Consumer-Run 
Services and Consumer-Providers There is a growing 
research literature and evidence base assessing the feasi-
bility, operations, effectiveness, and sustainability of con-
sumer-run and consumer-directed mental health services, 
and with consumers as providers within extant services 
and treatment teams.113 Most publications are single-
program descriptive studies. More recent publications 
of comparative outcomes and RCTs, while few in num-
ber, show that such research is challenging but feasible. 
The enthusiasm for exploring the potential and effective-
ness of these various roles for consumers has been both 
value and evidence based. The Centers for Medicare 
and Medicaid Services (CMS), SAMHSA, NASMHPD, 
and consumer organizations have facilitated a great deal 
of progress in developing research and program imple-
mentation tools. Researchers must continue to expand 
the type and quality of evidence in these areas. Several 
innovative practices deserve further investigation: 
Wellness Recovery Action Plans, developed by Mary 
Ellen Copeland135; Peer Mentors/Bridgers;127 Personal 
Assistance and Community Existence, from the National 
Empowerment Center136; and Intentional Peer Support, 
developed by Sherry Mead.137 As Davidson et  al113(p127) 
observed, implementation of peer support in various 
forms in mental health may be “messy and complicated”, 
but it also represents the magnitude of progress toward 
reforms that have been sought for centuries.
Consumer Education of Providers A small number of 
studies have begun to assess consumer-provided education 
as a means to address, among medical providers, prob-
lems of stigma and lack of experience with people who 
have mental illnesses. For example, Bell et al138 reported a 
novel intervention provided by mental health consumer-
educators designed to affect the attitudes of pharmacy 
students. The outcomes measured were social distance, 
attribution, provision of pharmaceutical services, and 
stigmatization of people with schizophrenia and severe 
depression. Compared with the control students, students 
who received the intervention had decreased social dis-
tance scores, more strongly disagreed with statements that 
demonstrated a negative attitude toward people with men-
tal illness, and more strongly agreed with statements that 
demonstrated a positive attitude. Other research, however, 
suggests that such efforts may not be effective. For exam-
ple, Meehan and Glover139 described the experiences of 
11 consumer-trainers of mental health staff in Australia. 
The trainers described a sense of tokenism, voyeurism 
among clinicians, having to give too much of themselves, 
and a lack of clear expectations about their roles and 
tasks. The authors concluded that based on these difficult 
experiences, there is a need for ongoing critical review of 
the way that consumer-educators are engaged in the edu-
cation and training of mental health professionals.
Family and Carers: Needs and Preferences. Family 
members of adults with serious mental illnesses have 
diverse needs and preferences relating to their ability to 
support, care for, and advocate for their family member. 
They also have unique perspectives on consumer needs 
and preferences that are sometimes at odds with those of 
other stakeholders and the consumers themselves. The 
National Alliance on Mental Illness, one of the earliest 
advocacy organizations in the United States, was created 
by close family members of people with mental disorders 
with the goal of improving services and treatment and 
combating stigma. Over time, family-centered advocacy 
organizations have exerted substantial influence on treat-
ment modalities and mental health policies and laws, and 
they have called for resources to promote social integra-
tion of people with mental disorders. The Schizophrenia 
Fellowship, the United Kingdom’s leading family advo-
cacy and support organization, included consumers from 
its inception, while primary consumers have joined with 
family advocates much more recently in the United States.
While family members of consumers often provide 
strong emotional support, link consumers with other 
stakeholders, and serve as the only source of treatment 
history, researchers must recognize that family/carers 
represent their own views and experiences. Unless des-
ignated as surrogates, they are limited in their ability 
to speak for or represent consumers’ perspectives and 
needs. As in other arenas of health care, family mem-
bers/carers and service consumers sometimes disagree on 
treatment needs and preferences, which are key consid-
erations for patient-centered approaches in both clinical 
and research contexts. But despite abundant advocacy 
and support group literature on the views, priorities, and 
assessments of family members/carers and service users, 
the US research literature specifically addressing family 
members’ needs and preferences is comparatively scant. 
The extant research focuses largely on carer burden and 
barriers to involvement related to privacy regulations; the 
effects of carer support groups; the effects of providing 
education and information about psychiatric disorders; 
the convergences and differences between the views of 
carers and the individuals for whom they provide care; 
and the effects of family involvement and interactions on 
consumers’ prognosis and outcomes.
The most abundant research involving family members 
and carers derives from the study of educational/infor-
mational interventions referred to as family psychoedu-
cation. There is considerable evidence that various forms 
of family psychoeducation are effective for educating 
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carers about psychiatric disorders, providing coping strat-
egies, and decreasing the distress of family members and, 
to some extent, consumers.140 This evidence is reviewed 
below in the discussion of care and service packages. 
Here we focus on the beliefs, needs, and preferences of 
family members/carers as they relate to treatment and 
service provision.
A number of international studies have examined the 
role of family members of persons with mental illness 
in terms of their conception of the illness and recovery. 
In Spain, Canive et al141 investigated whether a low-cost 
psychoeducational intervention would decrease family 
distress and burden. Compared with mothers, fathers 
were more optimistic throughout the study about the out-
come of the illness, became more aware of the social and 
financial impact of the illness on the family, and reported 
feeling less annoyed by the service user’s behavior at 
follow-up. While all of the parents acquired a signifi-
cant amount of knowledge about the illness, no signifi-
cant score differences were found immediately after the 
intervention or at follow-up, suggesting that psychoedu-
cation for family members alone does not decrease fam-
ily distress and burden. These findings also suggest that 
psychoeducational interventions should consider gender 
differences and family roles. In Australia, Goodwin and 
Happel142,143 found that family members and significant 
others contribute to the smooth delivery of care and 
treatment, particularly when they feel respected and are 
included in communications, but the researchers also 
observed a lack of discussion regarding carer participa-
tion in health care delivery.
Some research has focused on family members from 
specific ethnic groups. Despite the growing Latino popu-
lation in the United States, little research has focused on 
the mental health of Latino caregivers who have a rela-
tive with schizophrenia. Up to three-quarters of Latino 
persons with schizophrenia live with their families, which 
may deviate from the residential pattern among the 
broader population of people diagnosed with serious 
mental illnesses.144 Magana et al144 examined the relation-
ship between Latino caregivers’ mental health and per-
ceived burden and stigma, and their relationships with 
caregiver and service user characteristics. The authors 
found high rates of depressive symptoms among Latino 
families caring for relatives with schizophrenia and noted 
that younger Latino caregivers and those with lower lev-
els of education were at highest risk for depression. The 
authors conclude that interventions for Latino families 
should include attention to mental health and recovery 
among family caregivers.
Scheyett et al145 examined consumers’ and family mem-
bers’ understanding of EBPs within the larger context of 
their mental health service needs and their experiences 
with the mental health service system. Both groups were 
supportive of EBPs but had limited knowledge of them. 
They questioned the context of these proposed practices 
and expressed concern about treatment fidelity in certain 
models, with some family members indicating a lack of 
familiarity with the specifics of some models and a mis-
understanding of the goals or purposes of other EBPs. 
Family members generally viewed the mental health 
service system as underresourced and unable to provide 
EBPs to those in need. They voiced concerns that the 
focus on EBPs would reduce support for the development 
of new services, particularly community and residential 
living opportunities for consumers. Both groups noted 
the need for supporting more productive activity beyond 
supported employment (SEm) 146 EBPs, such as further 
employment and education. Unlike consumers, however, 
the family groups were less concerned with employment 
as a source of earnings and more interested in consum-
ers being involved in meaningful and structured activi-
ties during their days. Medication management was an 
issue both groups viewed positively with regard to EBPs. 
Family members, however, were particularly concerned 
with the short amount of time consumers spent with their 
psychiatrists and were concerned that medication alone, 
without other services in place, was insufficient. Family 
members were particularly concerned with the discrimi-
nation their loved ones experienced in the community 
and in the current mental health system.
Greenberg et  al147 approached their study of family 
members’ contribution to the QOL of consumers with 
serious mental illnesses from the perspective that most 
prior research has focused on the negative impact of 
family member participation on client outcomes. Past 
research focused on lowering expressed emotion among 
family members with little attention to the potential ben-
efits that might result from prosocial family processes 
such as support, warmth, and affection. Greenberg 
et  al147 examined longitudinal data from aging parents 
who were caring for an adult child with schizophrenia, 
finding that the adult children demonstrated higher 
life satisfaction when their mothers expressed greater 
warmth and praise and when their mothers reported the 
quality of  their relationship as being close and mutually 
supportive. The authors noted that a recovery orienta-
tion focused on the strengths of  adults with mental ill-
ness should focus equally on the supportive presence of 
their families.147
Family-based services were reviewed as part of the 
Schizophrenia Patient Outcomes Research Team.148 
While the studies reviewed were not focused specifically 
on assessing family needs and preferences, the authors 
identified ways in which family member involvement 
facilitates positive outcomes. Recommendations included 
that people with schizophrenia who have ongoing con-
tact with their families, including relatives and signifi-
cant others, should be offered a family intervention that 
lasts at least 6–9 months. Interventions of this dura-
tion were found to significantly reduce rates of relapse 
and rehospitalization. Key elements of effective family 
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interventions included illness education, crisis interven-
tion, emotional support, and training in how to cope 
with illness symptoms and related problems. Additional 
benefits of such programs included increased medication 
adherence, reduced psychiatric symptoms, reduced levels 
of perceived stress for service users, improved family rela-
tionships, and lower levels of burden and distress among 
caregivers.
Convergence and Divergence of Stakeholder Opinions.  
Most US research on family needs and preferences has 
assessed the convergence, or lack thereof, between stake-
holder groups in their assessments and preferences for 
treatment and outcomes. Simon et al149 examined whether 
response bias might account for the frequently reported 
differences between consumers and providers. They found 
that the rate of response and type of consumer served did 
not account for the differences, suggesting that these are 
real divergences that deserve continued attention. Lenert 
et  al150 studied whether service users, family members, 
and health care providers valued health outcomes in 
schizophrenia differently and, if  so, to what degree those 
differences might adversely affect clinical and policy deci-
sion making. There were systematic differences in values 
with respect to the possible range of impairment resulting 
from schizophrenia, as well as the common side effects 
associated with medication. Family members of service 
users generally had values that were more similar to those 
of service users than those of health professionals. These 
results emphasize the importance of participation by ser-
vice users and surrogates in clinical decision making and 
treatment plan development.
Fischer et al151 explored the extent and nature of agree-
ment on outcome and service priorities among consum-
ers, their providers, and their family members, as well as 
providers’ and family members’ awareness of consumers’ 
priorities. Overall, the results from this study indicate 
that priorities vary widely among these groups. Providers’ 
and family members’ awareness of consumers’ priorities 
was limited and more similar to their within-group pref-
erences than to those of consumers. When the consumer 
had service contact at least once a month with their pro-
vider, however, agreement between family member and 
provider was greater. While providers tended to value 
control of symptoms, medication management, and case 
management the most, family members and consumers 
tended to value social support, housing, and medical and 
dental services more highly. In another study, Shumway 
et al152 compared policy makers’ perceptions of treatment 
for schizophrenia with those of three primary stake-
holder groups: people receiving treatment for schizo-
phrenia, their family members, and their mental health 
care providers. Because family members were included 
with service users and care providers within the “primary 
stakeholder” comparison group, it is difficult to differ-
entiate the stance toward treatment outcomes between 
family members and consumers. Both the policy makers 
and stakeholders valued improvements in functioning, 
specifically productive and social activity, more than they 
valued improvements in symptoms, particularly deficit 
symptoms and medication side effects. Policy makers 
viewed side effects of treatment as less important than 
did primary stakeholders. The authors note that because 
study participants did not rate the salience of attitudes or 
beliefs, the data provide little insight into the formation 
of preferences for schizophrenia outcomes.152
To create common ground among these groups, a 
broad concept of recovery and remission as more than 
reduction of symptoms alone is needed, along with a 
much more detailed understanding of the outcomes 
valued by stakeholders. Karow et  al153 compared fam-
ily assessments and perceptions of symptom remission 
to the assessments of psychiatrists who treated persons 
with schizophrenia. The study included service users with 
schizophrenia, their family members, and their psychia-
trists. Only 18% of the service users, family members, and 
psychiatrists were in full agreement in how they assessed 
remission. Service users tended to value subjective well-
being as the most important influence on their percep-
tion of remission, while clinicians relied on improved 
symptom scores. For family members, both low symptom 
severity and good subjective well-being were considered 
significantly associated with remission.
Cooperation or conflict among caregivers, consum-
ers, and providers is particularly significant during psy-
chiatric crises. Psychiatric advance directives have been 
proposed as a means for clarifying the wishes of consum-
ers in emergency situations, and for collaboration with 
caregivers and providers with consumers.46,62,97 Swanson 
et al154 studied perceptions of PADs among service users, 
clinicians, and family members, finding that few family 
members reported ever having received information about 
PADs. Most family members and service users agreed 
that advance instructions would help people with mental 
health problems stay well, and consumers with close fam-
ily relationships were more likely to support appointing 
a surrogate. The authors suggested that this is consistent 
with the notion that family members placed themselves in 
the role of surrogate decision maker and therefore were 
supportive of a mechanism that could give them more 
input. Service users and family members generally agreed 
that PADs are a means of avoiding unwanted treatment, 
obtaining needed treatment, and empowering consumer 
choice.154
However, while PADs are widely accepted as useful 
for improving engagement and communication between 
consumer, provider, and caregiver, the implementation 
and use of  PADs in emergency rooms and other crisis 
situations remains problematic, particularly because the 
document may be unavailable or overridden. Swanson 
et  al154 examined similarities and differences among 
families, service users, and clinicians in their attitudes 
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toward, experience with, and understanding of  PADs. 
The study found stark contrasts between service user 
and clinician perspectives on PADs. Only 12.5% of  clini-
cians reported having had a service user with a PAD or 
a legally authorized surrogate decision maker, although 
almost all clinicians said they would recommend that 
a service user do so if  the user were given assistance. 
However, clinicians were much less likely than service 
users to feel that avoiding unwanted treatment was a 
reason for writing a PAD. Rather, clinicians’ primary 
reason for supporting PADs was to help service users 
feel more empowered. Clinicians were much less likely 
than service users to feel that advanced instruction 
would help service users stay well, and clinicians were 
much less likely to view PADs primarily as a means to 
avoid involuntarily treatment.154
Gaps and Limitations in Research on Stakeholder 
Perspectives Most authors suggest that convergence of 
family members’ needs and preferences with those of 
consumers and providers contributes to treatment adher-
ence and better outcomes, but it is not sufficiently clear 
whether or how shared or divergent views among these 
groups influence treatment outcomes. As stakeholders, 
family members should be considered as discrete from 
service users and providers so that these questions can 
be addressed in research. There also appears to be little 
work, longitudinal or cross-sectional, that examines 
the interactive and dynamic role of family members in 
the service users’ care over time or across populations. 
Research on contemporary perceptions and experiences 
of providing care and support for persons with serious 
mental illnesses should also include investigation of fam-
ily members’ desire or ability to participate in care.
While the dynamic interaction between the service user 
and various stakeholders is important, an essential part of 
patient-centered care is undoubtedly incorporating fam-
ily-centered care. As Scheyett et al145 suggested, however, 
equal consideration must be given to evidence-based pro-
cesses (the processes by which services are provided), and 
recovery outcomes themselves. Families and carers are 
an essential component of the process and the outcome 
and should be a feature of research in these domains. The 
varying roles of family members/carers include sources 
of social support, advocates, participants or surrogates 
in the advance directives of the service user, and liaisons 
in navigating the various systems of care. On the other 
hand, they can exert a negative influence by obstructing 
the individual in obtaining services or simply by failing to 
offer support. Research addressing how to facilitate posi-
tive involvement of families and carers has the potential 
to significantly affect patient-centered outcomes.
Research into ascertaining, measuring, and capitalizing 
on the convergence of stakeholder and consumer needs 
and preferences should continue. Interventions for fami-
lies, such as psychoeducation, and innovative approaches 
such as peer guides and coaching155 require more research, 
particularly concerning implementation and financing.156 
These interventions also require a method for monitoring 
progress and evaluating the various types of outcomes 
people come to prioritize. Clinicians and providers would 
benefit from more training and education in collaborat-
ing with families and facilitating family participation in 
service user care. Due to the demographic diversity in 
the United States and the structure of the economic and 
health care systems, we suggest that future research also 
attempt to parse out the various cross-cultural and socio-
economic factors that impact policy makers, consum-
ers, and families. Finally, the gaps between family and 
consumer perceptions of needs and preferences should 
continue to be examined, as should methods for increas-
ing convergence in such perceptions. The current divide 
regarding the criteria for involuntary treatment is an 
especially important area for investigation.
Providers: Needs and Preferences as Part of a Patient-
Centered Model of Care for Adults With Serious Mental 
Illnesses. As a stakeholder group, “providers” encom-
passes a wide spectrum of health care professionals. 
Within a patient-centered context, a provider can be any 
person (paid or unpaid) and any organization that par-
ticipates in the provision of care or services to people 
with serious mental illnesses. Roles include psychiatrists, 
nurses, case managers, social workers, peer mentors, reha-
bilitation specialists, psychotherapists, and others. While 
a patient-centered approach prioritizes the values and 
goals of the consumer, providers have their own needs 
and preferences. In addition, the practices of those pro-
fessionals are influenced by organizational and fiscal 
conditions.
This section reviews literature that is focused on the 
perspective of the various providers involved in the care, 
assessment, and treatment of adults with serious mental 
illnesses. As with the reviewed research on family mem-
bers of people with serious mental illnesses, many of 
these studies are comparative across stakeholder groups 
(ie, consumer, provider, carer). Another prominent 
theme in this literature concerns shared decision mak-
ing between providers and service users and their roles 
in care provision. In the context of mental health care, 
the current terms for conceptualizing the nature of the 
consumer-provider relationship include clinician-patient 
relationship, therapeutic relationship, working alliance, 
and engagement. As this relationship is the primary site 
of service provision, it represents a key source of recov-
ery tools and processes. Thus, understanding these rela-
tionships, including the characteristics that either help or 
hinder treatment efforts, is critical to improving service 
delivery and patient-centered outcomes.
Several interventions have been launched with provid-
ers to promote a patient-centered approach in clinical con-
sultations. None of the studies reviewed by Lewin et al67 
were specific to mental health, and all were published 
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before 1999, but their focus on clinician-patient relation-
ships suggests their relevance in this context. The authors 
found fairly strong evidence that interventions promoting 
patient-centered care in clinical consultations led to sig-
nificant increases in patient-centered consulting, and that 
training providers in patient-centered approaches may 
improve service users’ satisfaction with care. They found 
little information, however, about effects of such interven-
tions on the health status outcomes of patients, and none 
of the studies included interventions with non-physician 
providers. Intervention trials to improve patients’ trust in 
doctors, reviewed by McKinstry et al,157 have focused on 
components such as training physicians in empathy and 
communication, disclosure of financial incentives in phy-
sician practices, and how to provide introductory educa-
tional visits to the practice. The results showed either no 
or non-significant increases in trust associated with the 
interventions.
Provider Approaches to, and Definitions of, Recovery 
Among People With Serious Mental Illnesses Recovery 
encompasses both symptom remission and more func-
tional aspects of service users’ well-being, such as cog-
nition, social functioning, and QOL. The term clinical 
recovery, distinct from the way that service users and 
family members might describe recovery or remission 
in serious mental illnesses, has emerged from the profes-
sional literature as a concept focused on sustained remis-
sion and restoration of functioning.158 When adopting 
this definition, providers view recovery as something that 
is invariant across individuals and can be measured at 
intervals to establish baselines and rates. Nevertheless, 
viewpoints about recovery among clinicians differ widely, 
ranging from symptom control and improvements in cog-
nition and social functioning to a wide variety of proxy 
measures for treatment outcome and markers of recov-
ery, including engagement and medication adherence.159 
Understanding the terms by which providers measure and 
assess recovery will help us conceptualize how recovery is 
understood by different stakeholder groups and also how 
clinicians relate to their patients in providing care.
With respect to a patient-centered approach to recovery 
and the recovery process, clinicians and researchers have 
placed further constraints on how these are defined.160 For 
example, Slade et al161 suggested that services and provid-
ers that use medication adherence as an indicator of recov-
ery are not, in fact, providing recovery-focused services. 
In another study, Russinova et al162 aimed to empirically 
validate a set of conceptually derived recovery-promot-
ing competencies using the perspectives of mental health 
consumers, consumer-providers, and providers. In their 
evaluation of 37 competencies that were hypothesized to 
enhance clients’ hope and empowerment, respondents 
identified conveying a sense of genuine respect for the 
client as the most important one. Consumers, provid-
ers, and families agreed that the following competencies 
ranked among the 10 most important: helping clients 
learn skills for self-management of psychiatric disorders; 
viewing the client not as an illness or solely as a set of 
symptoms, but as a person; assisting clients in increasing 
their sense of self-value and self-acceptance; nonjudg-
mental listening; and believing in the potential for recov-
ery. Being accessible and the cluster of caring, trusting, 
understanding, believing, and being nonjudgmental were 
considered most relevant by the client group. Russinova 
et al162 suggested that practitioners can foster recovery by 
acknowledging each consumer’s personhood, promoting 
hope, focusing on empowerment, and providing help with 
illness management. In addition, they have developed an 
instrument to measure providers’ recovery-promoting 
competence and to produce guidelines for operationaliz-
ing recovery-related processes among mental health and 
rehabilitation service providers.162
Provider Satisfaction With Work in the Mental Health 
System The mental health system is plagued by work-
force problems such as changes in clinician requirements 
related to the transition to managed care, lack of adequate 
reimbursement, and increasing reliance on staff  with less 
training and fewer qualifications.163 Staff  turnover is a 
significant problem164 that often results in disruptions in 
care and inability of organizations to retain staff  with 
key training and experience. Provider work satisfaction 
is, thus, a topic of great importance, as addressing these 
problems will be critical to system transformation.
Several exceptionally informative studies of the work 
of mental health case managers in various settings, oper-
ating within differing treatment models, provide a robust 
evidence base for assessing the pleasures, perils, and 
promise of this frontline practice.95,165–168 For example, 
Tennille et al168 and Munson et al167 examined the trans-
formative influence of providing care to consumers with 
HIV and depression. Mental health case managers in the 
HIV intervention learned that they knew little about their 
clients despite working with them for years and that add-
ing clinical care for HIV to their responsibilities helped 
them to better understand their clients’ mental health 
recovery.
With respect to provider and client satisfaction, Mason 
et al49 found that both groups shared most values in com-
mon. In particular, systemic and organizational factors 
led to dissatisfaction for both parties. Providers, who 
strove to have more time with consumers but struggled 
with large caseloads and paperwork requirements, noted 
that the opportunity to help very ill people recover and 
lead fulfilling lives was an intrinsic motivator in their 
work. Providers expressed dissatisfaction with other 
demands on their time, which sometimes left them unable 
to provide needed services to clients. Other factors affect-
ing providers’ job satisfaction included poor salary, not 
having the time to participate in professional growth 
opportunities such as additional training, and dealing 
with increases in paperwork required by the transition to 
managed care. One clinician noted that most providers 
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had to have a second or even a third job in order to sup-
port themselves. Low salaries also contributed to the high 
level of turnover in the profession—a major contribu-
tor to consumer dissatisfaction and reduced continuity 
of care.
Providers also valued flexibility and autonomy in their 
jobs, and working with talented coworkers who were 
committed to helping others.49 There were some organiza-
tional factors, however, that strongly influenced provider 
satisfaction. Specifically, providers were dissatisfied when 
agencies issued changes in policies and guidelines for care 
provision but did not provide adequate training in how 
to implement those policies. This led practitioners to 
feel that they appeared incompetent.49 Not surprisingly, 
Aarons and Sawitzky164 found that organizational climate 
affects staff  turnover in mental health agencies. In related 
work, Morris and Bloom169 examined how organizational 
culture and climate in 14 community mental health cen-
ters affected consumers’ assessments of their physical and 
mental health, concluding that culture and climate had 
associations with physical and mental health but not with 
QOL. They also examined the gap between what con-
sumers wanted and what providers were able to deliver. 
Consistent with Mason et al,49 consumers and providers 
both wanted to spend more time with each other, and 
system barriers such as paperwork and caseload created 
a gap.
Amering et al170 took a unique approach to assessing 
providers’ perceptions of care provision: evaluating their 
attitudes toward PADs. Nurses and psychiatrists were 
assessed on their knowledge of advance directives and 
asked to draft one as if  they were patients themselves. 
Among participating clinicians, 54% knew about PADs, 
55% considered them legally appropriate, and 29% con-
sidered them inappropriate. Interestingly, 75% of provid-
ers rejected certain methods of therapy in their mock 
PADs; 30% excluded the use of neuroleptic medications, 
and 46% rejected electroconvulsive therapy. The authors 
hypothesized that attempting to identify one’s own needs 
and demands as a possible recipient of forced treatment 
is a fruitful way to form an opinion about the possibilities 
and limitations of advance directives.170
Gaps and Limitations on Provider Perspectives The 
most significant limitations of the evidence in this area 
concern the lack of careful investigation and interven-
tions designed to address organizational barriers to 
provider-patient relationships, provider morale, and pro-
vider tenure. This work is needed to inform and imple-
ment organizational changes that will improve outcomes 
and consumer assessments of the recovery-promoting 
qualities of services and treatment. The organization 
and financing of mental health delivery has been taken 
as a given and has not been subjected to sufficient scru-
tiny, particularly with respect to the ways that financ-
ing approaches affect both the mental health workforce 
and the linkages between those workforce effects and 
patient-centered outcomes. Research is needed to address 
unintended consequences for providers and for the devel-
opment and sustainability of effective and acceptable 
consumer-provider relationships. For example, Hassan 
et  al171 noted that practicing psychiatrists must balance 
the often contradictory demands of practicing medicine 
(eg, dealing in a neutral, disengaged way with illness) and 
practicing morality (eg, dealing with people whose behav-
ior is morally proscribed), while others163 have noted that 
because mental health workers are responsible for treat-
ing people with mental illness, providing mental health 
care itself  has become stigmatized. A  great deal more 
information is needed to fully understand the demands 
mental health work places on practitioners and the ways 
in which these demands affect patient-centered outcomes.
Service User and Carer Involvement in System Redesign, 
Research and Evaluation, and Development of Patient-
Centered Outcomes. Collaboration in constructing 
knowledge and assessing outcomes of treatment and 
services is central to a patient-centered system of men-
tal health services. In this context, it is important to rec-
ognize that the quality of research derives not from the 
types or social labels of researchers but from their exper-
tise, rigor, and analytic skills. Consumers possess knowl-
edge, skills, and conceptual frameworks that are essential 
for determining which questions to pose, which methods 
to use for data collection and analysis, and how to inter-
pret results. For example, developing patient-centered 
outcome measures and scales needs to be a prominent 
goal for mental health researchers. To create valid mea-
sures, researchers will need to construct these indicators 
from carefully derived assessments of service users’ and 
other stakeholders’ concepts, experiences, and goals. The 
World Psychiatric Association172 outlined 10 recommen-
dations for collaborative work between mental health 
practitioners, service users, and family/carers, stating the 
following:
Service users and their families have an important role in 
advocacy in order to enhance the reputation of  mental 
health expertise and services as well as that of  people with a 
lived experience of  mental ill health. In recent years, service 
users and carers have been involved positively in a range of 
activities including advocacy for support for research, care 
and social inclusion, and self-help projects. As service users 
and family carers typically lack the power to interact equally 
with professionals and government decision makers, assis-
tance in developing this power is mutually important for 
them and for the WPA [World Psychiatric Association] and 
the wider international mental health community. (p. 229)
In assessing the present and future participation of con-
sumers and other stakeholders in the work of evaluation, 
research, and policy, it is useful to consider the underly-
ing motivations for doing so, most notably the promo-
tion of individual freedom, inclusiveness, and equity. 
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Collaboration may not lead to uncontested solutions, but 
the process contributes to further inquiry, adjustment of 
positions, and improvement in the evidence base as the 
quality of collaboration improves over time.
It is also useful to distinguish between research that 
is developed and conducted entirely by consumers and 
collaborative research in which consumers serve as 
equal partners in the work or, as is most often the case, 
serve as consultants and coinvestigators. Participatory 
research models abound and are often required elements 
of research applications, but there is little consensus 
about the nature and extent of involvement that quali-
fies for participatory processes. Studying the results of 
these different methods of stakeholder engagement, 
including individual outcomes, is worthy of research. 
Rose111 has written extensively about the complexities of 
consumer-directed and collaborative research in men-
tal health. She and her colleagues posit that the “cen-
tral tension” in these endeavors exists between differing 
paradigms for understanding mental disorders, noting 
that these different paradigms can lead to differences in 
assessments of appropriate methodologies for scientific 
enquiry. To address this problem, Rose and colleagues 
propose using a multiperspective paradigm and a multi-
method approach. They also call for increasing service 
user involvement is setting research questions, developing 
interventions and assessments, creating and consolidat-
ing structures to develop service user and carer research, 
and using research designs that are consistent with service 
user preferences. Work completed by Consumer Quality 
Initiatives, Inc. represents an excellent example of a con-
sumer-directed and consumer-staffed organization con-
ducting high-quality research on consumer perspectives 
about mental health service quality.173,174
There is widespread agreement that patient-centered 
and patient-informed assessment differs in focus and 
methodology from other forms of outcomes research. 
Qualitative methods play a prominent role in identify-
ing the factors that service users feel should be measured, 
and they can be used to follow the evolution of meth-
ods and measures to continue improving their usefulness 
across stakeholders. Formative methods should also play 
a key role in measure development. Similarly, qualitative 
methods are useful for identifying services that consum-
ers find most valuable. Quantitative measures (eg, based 
on surveys and medical records) can be developed from 
these foundational understandings.
A number of  studies describe consumer evaluations 
of  mental health services using research methods and 
various collaborative arrangements, including the devel-
opment of  assessment scales and outcome measures. 
For example, Oades et al175 developed a consumer- con-
structed scale to evaluate mental health service provision; 
Ochocka and colleagues175,176 developed a participatory 
action project involving consumers and professionals; 
Reeve et  al177 described and analyzed their experiences 
as consumer-researchers within a community mental 
health research project; and Love et al178 developed and 
implemented a user satisfaction survey in an inner-city 
community mental health center. Each of  these exam-
ples adds to the evidence base for the feasibility, chal-
lenges, and utility of  consumer involvement in service 
evaluation.
Making Services Work for Consumers,179 a report 
from the International Initiative for Mental Health 
Leadership, provides an extensive catalogue of worldwide 
programs designed to involve consumers in every aspect 
of mental health service development and evaluation. 
While the United States sometimes lags behind Europe 
and Australia with respect to innovations in this area, 
the challenges associated with consumer involvement are 
not confined to the United States. For example, Bennetts 
et  al180 investigated the mechanisms and challenges of 
extensive consumer participation in transforming mental 
health services in Victoria, Australia. They describe an 
ongoing lack of clarity among all parties regarding the 
proper extent of consumer participation, even with the 
general consensus that such participation in the education 
and training of mental health professionals is essential.
Nilsen et al181 reviewed methods of consumer involve-
ment in developing health care policy and research, clini-
cal practice guidelines, and patient information materials. 
Their analysis was confined to RCTs, and it focused on 
outcome measures such as response rates, elicitation of 
consumers’ views, influence of consumers in decisions 
about outcomes and resource allocation, assessment of 
the involvement process or products, and the costs of 
involvement. Consumer interviewers were found to have 
a small influence on survey results compared with staff  
interviewers, and the involvement of consumers in devel-
oping informed consent documents had little impact on 
forms compared with those constructed by investiga-
tors.182–184 Face-to-face and telephone contact was more 
effective than mailed surveys in engaging consumers in 
setting community health priorities. Consumer involve-
ment tended to change the types of priorities that were 
proposed. The authors concluded that it was feasible to 
conduct trials of the effects of consumer involvement.
Resource Acquisition and Distribution
This section examines how mental health services for 
people with serious mental illnesses are funded and how 
various financing structures affect their outcomes. The 
extensive literature in this area covers topics including 
national health reforms; state experiments; changes in 
private sector coverage; and cost shifting and risk shar-
ing between different levels of government, between the 
public and private sectors, and between systems of care 
and individuals/families. Some studies compare vari-
ous financing models, with the aim of reducing unnec-
essary service utilization and improving individual-level 
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outcomes. This section is organized around the following 
domains:
1. Costs, expenditures, and financing mechanisms.
2. Parity for insurance coverage and adequacy of mental 
health benefits.
3. Carve-outs, capitation, and managed behavioral health 
care.
4. Financing services to promote consumer choice.
5. Financing medications for populations with serious 
mental illnesses.
6. Reimbursement structures and models for service 
integration.
This section concludes with a discussion on research 
gaps, implications for CER and PCOR, and suggestions 
for key leverage points.
Much of the literature on care financing is policy 
focused or descriptive, rather than comparative. Policy 
changes in the 1990s, however—as well as the develop-
ment of capitated models, carve-outs, managed care 
for behavioral health, and implementation of parity for 
mental health benefits—offer interesting opportunities 
for natural experiments in both the public and private 
sectors. That said, we could not identify any systematic 
reviews or meta-analyses addressing financing strategies. 
Most comparative studies are observational, relying on 
analyses of Medicaid claims or administrative data, or 
data from large employers and integrated health systems. 
Additionally, much of the literature dates from more 
than 5 years ago, and more recent publications often use 
or cite data from older studies. The most recent literature 
addresses recent health care reform initiatives and are 
thus largely editorial.
Perhaps most important, literature on financing pri-
marily addresses models and outcomes related to ser-
vice delivery rather than patient-centered outcomes. 
For example, while the literature will often indicate that 
financial incentives may affect quality of care, it may not 
specify which elements of care quality will be affected 
or whether quality of care refers to the delivery-system 
level (eg, length of stay or rates of hospitalization) or 
the patient-outcomes level (eg, health status, function-
ing, reduced comorbidities, or access to and satisfaction 
with care). The literature also describes and measures the 
relationships between various financing models (man-
aged care, capitation under various risk arrangements, 
fee for service), health care service use (number of visits, 
hospitalizations, length of stay, repeat visits, emergency 
department use, medication use and adherence), and 
costs. However, examinations of the links between financ-
ing structures and consumers’ experiences of care or 
patient-centered outcomes appear to be largely absent in 
this literature. We highlight the distinction between out-
comes that are system or service oriented and those that 
are patient centered, as this represents a significant gap 
in the literature. Despite these limitations, the literature 
provides important evidence of the ways that various 
financing mechanisms address service users’ needs.
Financing Complexities. It is difficult to get a full pic-
ture of  the costs of  treating people with serious mental 
illnesses. About $113 billion was spent on mental health 
treatment in the United States in 2005, representing 
about 6% of total health care expenditures.185 Between 
1986 and 2005, there were significant shifts in the dis-
tribution of  mental health costs across provider type 
and by payer. While expenditures for specialty mental 
health care increased from $19.5 million in 1986 to $54.4 
million in 2005,185 the percentage of  these expenditures 
relative to all sources of  expenditures dropped from 
61.3% to 50% over the same period. This decrease was 
due primarily to the higher percentage of  spending on 
prescription medications, from 7.4% ($2.4 million) to 
26.6% ($30 million). The distribution of  expenditures by 
payer also shifted to private insurance, perhaps owing 
to parity laws, and to Medicaid, with a corresponding 
decrease in expenditures by other state and local sources. 
Of the $113 billion spent on mental health nationwide 
in 2005, 28% was through Medicaid. Medicaid spend-
ing for people with serious mental illnesses accounts for 
about 10.7% of all expenditures for mental health care.185 
SAMHSA projects that spending for mental health and 
substance abuse services will increase to $239 billion by 
2014, with prescription drugs being the fastest-growing 
component of  spending. Projections are also likely to be 
significantly affected by the “imminent and serious men-
tal health needs of  returning combat veterans” and natu-
ral disasters, economic conditions, and shifting political 
environments.186
The literature in this area is extensive but fragmented. 
For example, Fenton et al187 compared a residential crisis 
treatment program with general hospital psychiatric care 
and found that acute treatment episode cost was $3 046 
per person for the residential program compared with 
$5 549 for hospitalization (1995 dollars). Six-month treat-
ment costs were $19 941 for residential crisis treatment 
and $25 737 for psychiatric hospital care, demonstrating 
the cost-effectiveness of this program. In a study of one 
large employer covering 1.66 million lives through private 
insurance with a managed behavioral health plan that 
included behavioral health services, Peele et  al188 found 
that annual expenditures (based on 1996 claims data) 
for people with bipolar disorder were $2  470, or 400% 
higher than for people with other behavioral health dis-
orders. People with bipolar disorder also paid more out-
of-pocket costs annually ($538) than people with other 
behavioral health needs ($232), a discrepancy due in part 
to higher hospitalization rates. People with bipolar dis-
order had significantly more admissions for medical con-
cerns than people with other behavioral health disorders. 
Overall, people with bipolar disorder represented 3.0% of 
the group with behavioral health claims but accounted for 
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12.4% of all behavioral health expenditures. The authors 
conclude that prevention and long-term management of 
bipolar disorder could potentially reduce hospitalizations 
and substantially reduce behavioral health expenditures. 
In another study of a large health maintenance organiza-
tion (HMO), Simon and Unutzer189 reported that costs 
of mental health and substance abuse treatment for peo-
ple with bipolar disorder were six times higher than for 
patients with depression, and 20 times higher than for the 
control group. Of particular note, mental health and sub-
stance abuse services accounted for less than half  (45%) 
of all medical costs for patients with bipolar disorder, 
only 10% for all health costs for patients with depression, 
and only 5% for the control group. This further suggests 
that medical costs are a significant portion of overall 
costs for people with serious mental illnesses.
Gilmer et al190 demonstrated that full-service partner-
ships (FSP) that provide housing for people with serious 
mental illnesses and engage them in treatment increased 
outpatient costs (measured in 2007 dollars) by $9  180 
per person over a 3-year period, but reduced inpatient 
costs by $6  882 and emergency service costs by $1  721 
per person. This study measured changes in housing sta-
tus, receipt of disability benefits, employment, mental 
health services use, and costs for adults in San Diego’s 
FSP program and self-reported QOL for FSP and home-
less clients receiving services. The reductions in costs for 
inpatient, emergency, and justice system services offset 
82% of FSP program costs. It should be noted that while 
the FSP did not fully offset all costs, recovery outcomes 
were significantly improved: the number of days spent 
in congregate or residential housing situations increased 
by 99% (from 74 to 174 days) and the number of days 
spent homeless decreased by 69% (from 191 to 62 days). 
Additionally, receipt of disability benefits (including 
Supplemental Social Security Income or Social Security 
Disability Insurance) increased from 53% to 70%, sug-
gesting that the FSP program significantly improved cli-
ents’ housing stability and income.
Rothbard et al191 conducted several studies of care costs 
for people with serious mental illnesses and HIV, dem-
onstrating that people with both illnesses had the highest 
annual medical and behavioral health Medicaid treatment 
expenditures ($20  038 per person, 2008 dollars) com-
pared with people with either serious mental illnesses only 
($16 253 per person) or HIV only ($14 714 per person). 
In a study using New Hampshire Medicare and Medicaid 
claims data from 1999, Bartels et  al192 estimated average 
annual per-capita Medicaid and Medicare expenditures 
for people with schizophrenia compared with people with 
depression, dementia, and other medical disorders (defined 
as all other dually eligible individuals who did not have a 
psychiatric disorder). They found that older adults had the 
highest per-capita expenditures ($39 154–$43 461), primar-
ily for nursing home care, compared with younger adults 
with schizophrenia ($25 633 for ages 19–44 and $31 529 
for ages 45–64), primarily for outpatient care. They also 
found that per-capita expenditures for people diagnosed 
with schizophrenia were $11  304 higher than for people 
diagnosed with depression and $28  256 higher than for 
individuals with medical but no psychiatric disorders. The 
authors concluded that schizophrenia is one of the most 
expensive disorders across the age span and that expendi-
tures increase with age.
The literature on costs of  mental health in pris-
ons is no less varied. A report by the US Department 
of  Justice found that in 1999, 16% of  state prison-
ers reported a history of  mental illness.193 Glied and 
Frank194 reported that by 2006, as many as 7% of  those 
with such illnesses may have been incarcerated. Wolff195 
estimated costs of  reentry planning and the first year 
of  postrelease services for inmates with mental illness, 
based on an assumption that about 96  000 inmates 
would reenter the community with mental health prob-
lems in a 1-year period. Extrapolating from a sample of 
male adult inmates in New Jersey, about 11% of  whom 
had a serious mental illness, costs for mental health 
treatment were estimated to range from $6 000 per case 
for basic management in the community to $19 985 for 
ACT (2003 dollars). Costs for substance abuse treat-
ment were estimated to be $3 894 per individual.195 In 
another study, Alemi et  al196 compared the costs of 
colocating probation and substance abuse treatment 
(“seamless treatment”) when clients select their treat-
ment. Relative costs of  treatment were $38.84 per client 
per day for seamless treatment compared with $21.60 
for conventional services. Although the seamless treat-
ment group had lower recidivism, the cost savings did 
not offset program costs.
An older but important study on the costs of psy-
chiatric drugs in the Iowa prison system demonstrated 
that overall expenditures for psychiatric drugs increased 
28-fold from $7 974 in 1990 to $381 893 in 2000, or from 
$2.91 to $81.38 per inmate.193 Use, however, increased 
only by a factor of five. The study further assessed costs 
and use by class of drugs. Per-inmate expenditures for 
antipsychotic drugs increased from $2.15 in 1990 to 
$19.29 in 2000, while use remained relatively constant, 
reflecting increased prescribing of atypical antipsy-
chotic medications as first-line treatments. The largest 
growth was seen in the use and cost of antidepressants. 
Expenditures for this class of drugs increased by $47.56 
per inmate over the 10-year study period (from $2.30 in 
1990 to $49.86 in 2000) and accounted for almost two-
thirds (62.4%) of the overall increase in expenditures for 
psychiatric drugs. Per-inmate expenditures for other psy-
chiatric drugs also soared between 1990 and 2000, includ-
ing mood stabilizers ($55.30 per inmate), and anxiolytics 
and hypnotics ($61.00). The authors question whether 
the increased use of psychiatric drugs in prison is accom-




A study from the United Kingdom by Barrett and 
Byford197 evaluated the costs and benefits of a program 
for inmates at high risk of serious reoffending due to 
personality disorder. Provided in stand-alone units in 
hospitals and prisons, the program uses a range of thera-
peutic approaches to motivate change and reduce recidi-
vism risk, including cognitive-behavioral and dialectical 
behavior therapy. Costs were computed over a 25-year 
period, with total program costs equal to £37 082 per cli-
ent per year (2005–2006 pounds) compared with £19 408 
per client per year in usual care. Although the higher 
costs of the program were accompanied by lower aver-
age rates of serious offenses, the incremental cost of the 
intervention was not cost-effective. Sensitivity analyses 
were conducted on level of prison security (high, moder-
ate, and low), conviction rates, program duration (1 year 
compared with 25 years), and discount rates of 0% and 
6%. With the exception of the program being provided 
in a low-security, low-cost prison, the cost-benefit ratios 
showed that costs exceeded benefits of reduced serious 
reoffending.
Funding Streams. Services for people with serious 
mental illnesses are funded in numerous ways, includ-
ing Medicaid, Medicare, federal block grant funds, state 
general assistance funds, employer-based coverage,198 the 
Department of Veteran’s Affairs, and the Department 
of Defense for military personnel.199 Non-health–
related funding streams come from the Social Security 
Administration200 and the Department of Housing 
and Urban Development.201 These institutions provide 
income-, employment-, and housing-related funds.
There are four important issues related to financing for 
researchers to consider. First, each funding stream has its 
own rules governing program eligibility, scope of coverage 
for services, and use of funds. Even a cursory examination 
of the continuum of services and their alignment (or lack 
of thereof) with statutory limitations reveals the complex-
ity of financing services and illuminates why “seamless” 
care can be so difficult.198 These circumstances can create 
challenges for developing and testing alternative funding 
arrangements. Second, because most health and mental 
health services for people with serious mental illnesses are 
financed through Medicaid, a program jointly paid for by 
federal and state governments, it is critical to understand 
how state Medicaid programs are structured and how 
federal and state Medicaid policies are changing under 
health reform. Third, reimbursement mechanisms can 
affect the quality of services if  they either fail to reimburse 
for needed services or do reimburse for services that may 
be harmful if  provided in excess. Finally, Medicaid is not 
run uniformly across the country. Above the basic “floor” 
that consists of federally required services for federally 
mandated populations, each state can choose to expand 
eligibility rules to provide mandated services for optional 
populations, increase the scope of services beyond federal 
mandates for eligible populations, and determine which 
optional populations are eligible for which optional ser-
vices. Additionally, the federal government allows demon-
stration projects to test innovative strategies to meet the 
needs of the state through “waiver” options. Thus, access, 
quality, and scope of care, as well as the comprehensive-
ness of service packages that determine individual out-
comes, may vary substantially by state.
The complex array of funding mechanisms and state 
choices present both opportunities and challenges for 
CER and PCOR. While we can learn much from states’ 
successful experiences and best practices, the primary 
challenge for researchers is making valid comparisons 
between financing structures. Moreover, programs are 
implemented within varying state political and organi-
zational contexts. As a result, for example, people with 
similar sociodemographic, medical, and mental health 
characteristics may have different outcomes under pro-
grams that appear to be similar. Geographically based 
financial characteristics may be a key factor to consider 
in understanding and assessing improvements in out-
comes for people with serious mental illnesses.
Costs, Expenditures, and Financing Mechanisms. The 
literature on costs, expenditures, and macrolevel financ-
ing can be classified into three groups. The first group 
represents a substantial body of literature that describes 
national trends in the costs and expenditures for mental 
health services, delineates the shifts in financing from 
private to public systems, and describes trends in decen-
tralization from federal to state and county systems of 
care.198,202–210 These articles are descriptive in nature, 
typically use existing national or state administrative 
databases, and tend to be policy focused rather than com-
parative. Important, this literature is not generally linked 
to patient-centered outcomes.
The second literature group focuses on the advantages 
and disincentives of different payment structures and on 
opportunities for creating and aligning financial incen-
tives to improve quality of care and cost savings.210–215 
These articles focus on changes in service delivery systems, 
with some attention to developing payment mechanisms 
to support service integration (eg, how to finance medical 
homes for individuals with serious mental illnesses). As 
with the first group, these publications do not typically 
address patient-centered outcomes except to suggest that 
the incentives created by various financing strategies may 
affect quality of care and individual outcomes. Patient 
outcomes and specific quality improvement targets, how-
ever, are not generally articulated.
A third group of articles is more focused on costs and 
financing for individuals with specific diagnoses, such as 
schizophrenia, or serious mental illnesses with co-occur-
ring substance-abuse disorders. This literature presents 
specific cost trends and service use and highlights the 
need for more research on subpopulations.192,216 These 
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articles, which also do not specifically address patient-
centered outcomes, are oriented toward systems-level 
analysis and are focused on identifying expenditures and 
their sources or comparing expenditures across different 
sources or between different disorders. This literature is 
not typically oriented toward individual outcomes.
Summary and Implications The current state of  mac-
rolevel literature on resource acquisition and distribu-
tion is helpful for understanding national and state 
trends, costs and expenditures, and policy issues related 
to financing for mental health service systems for people 
with serious mental illnesses. At this time, however, it is 
not particularly useful for addressing the effects of  dif-
ferent financing or distribution approaches on patient-
centered outcomes. Existing studies generally capitalize 
on administrative data, very little of  which includes 
measures of  patient-centered outcomes. This raises key 
research questions: Given the other goals of  financing 
systems, how might these systems be used to improve 
patient-centered outcomes? How can we embed patient-
centered outcome measures in administrative data to bet-
ter understand how financing structures affect outcomes 
for people with serious mental illnesses? Answering these 
questions will require more research and better models 
that directly link resource acquisition and distribution 
policy to specific patient-centered outcomes and experi-
ence of  care.
Parity for Insurance Coverage and Adequacy of Mental 
Health Benefits. Prior to 1996, inequities existed 
between medical and behavioral health care coverage 
requirements. The Mental Health Parity Act of 1996 
prohibited private health plans from placing greater lim-
its on behavioral health services than on medical health 
services. Despite this mandate, however, consumers con-
tinued to experience differential limits on the number of 
visits and covered days, as well as greater out-of-pocket 
expenses for behavioral health services compared with 
medical care.217 In response, the federal government 
passed the Mental Health Parity and Addiction Equity 
Act, which was implemented in 2010.217
Several studies have demonstrated that the Mental 
Health Parity and Addiction Equity Act increased cover-
age for behavioral health services and use of such services. 
It also reduced out-of-pocket expenses for consumers 
covered under both private and public health plans,218–220 
including the Federal Employee Health Benefits Program 
(FEHBP).221 Several studies have addressed service use 
following parity.218,219,221–225 Comparisons of FEHBP and 
non-FEHBP plans indicated no significant differences in 
inpatient care226 or substance abuse treatment services.227 
Rates of initiation and engagement for substance abuse 
services, however, were greater within FEHBP plans than 
comparison plans,227 and use of mental health services and 
psychiatric medications declined in non-FEHBP plans.226 
The latter finding raised concerns about access and quality 
of care in non-FEHBP plans. The FEHBP plans, which 
were under a 2001 presidential directive to increase par-
ity for a wide range of mental and behavioral health ben-
efits, were also seen as significantly more likely than private 
plans to implement a “carve-out” contract to better man-
age the costs of behavioral health services.228 The use of 
carve-outs (see below) is believed to explain the lack of 
increase in total spending following implementation of 
parity requirements.221,227,228 It should also be noted that 
because care for most people with serious mental illnesses 
is publicly financed, enhancing parity in the private sector 
may not be the most effective financing tool to improve 
patient-centered outcomes for this population, even 
though it may increase access and improve outcomes for 
people with milder or intermittent mental illness.
Summary and Implications The literature on parity sug-
gests that it (1) creates incentives for insurance plans to 
use managed behavioral health care contracts to control 
costs and utilization; (2) generally does not increase over-
all costs to plans and may result in decreased expenditures, 
particularly if  carve-outs are initiated and both medical 
and behavioral health services are managed similarly; (3) 
reduces out-of-pocket costs for consumers; and (4) does 
not threaten access to mental health services. In fact, par-
ity may lead to modest improvements in the quality of 
mental health and substance abuse services. Additionally, 
the literature is vague on the effect of parity on important 
patient-centered outcomes and service users’ experience 
of care, particularly initiation and engagement, prior 
authorization requirements, wait times for treatment, 
improvements in health status, and continuity and satis-
faction with care. Because care for a majority of people 
with serious mental illnesses is financed through the pub-
lic sector, parity may not be the most effective financing 
tool for improving patient-centered outcomes for people 
with serious mental illnesses.
Carve-Outs, Capitation, and Managed Behavioral Health 
Care. There is a significant, albeit dated, body of 
 literature on managed behavioral health carve-outs 
(MBHCOs), capitation, and the development of man-
aged care for behavioral health care services.
Carve-outs were developed in the mid-1990s in both 
the public and private sectors to address rising costs for 
inpatient services, contain risk, and improve efficiency 
and access to care.229 Carve-outs are based on the eco-
nomic principles of economies of specialization and eco-
nomics of scale, price negotiation, and selection.230 While 
carve-outs can create economics of scale for specialized 
services, separating mental health from other health ser-
vices with respect to payment and management also frag-
ments care delivery, and it creates incentives that further 
dissociate primary care providers from clients needing 
mental health services.
Contractual Arrangements Frank and Glied205 
reported that carve-outs in the private sector create a 
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variety of financial incentives for specialty care referral 
and medication prescribing, create disincentives for treat-
ment and follow-up care for people with serious men-
tal illnesses because of inadequate reimbursement, and 
move medical decision making away from using EBPs.205 
These results suggest that the details of a carve-out con-
tract are important for identifying which incentives and 
disincentives are in play and, more importantly, how the 
incentive structure is likely to affect individual outcomes. 
Similarly, several studies highlight a wide variation in 
organizational and contractual arrangements among 
state Medicaid carve-outs for behavioral health services.
Aspects of contracting that seem particularly impor-
tant to individual-level outcomes include risk-sharing 
arrangements (eg, out-of-pocket costs to consumers, 
possibly reducing access to care) and provider networks 
(eg, access to specialty care for people with serious men-
tal illnesses). Administrative readiness, the procurement 
process, previous experience providing services in a capi-
tated model, and program monitoring and evaluation are 
more likely to indirectly affect service user outcomes by 
creating either stronger or weaker organizational models 
of care that affect access to and quality of care.231–233 In 
most studies assessing carve-outs, however, models and 
data for linking contract components to patient-centered 
outcomes are missing.232
States have had varying degrees of success with carve-
outs. New Mexico’s experience capitating Medicaid 
services through a single for-profit private corporation 
resulted in significant administrative problems, including 
complex documentation requirements, increased admin-
istrative burden on providers, inadequate administra-
tive oversight, insufficient attention to the rural safety 
net, payment problems, and high turnover among pro-
viders.234–236 Similarly, Florida learned that even when 
program implementation successfully creates a fully inte-
grated mental health delivery system with financial and 
administrative mechanisms that support a shared clini-
cal model, there remain concerns about access to care, 
stability, efficiency, and shifting of risk from the public 
sector downstream to private organizations with lim-
ited oversight or support.237 These and other real-world 
experiments suggest that variation in contract details can 
alter the MBHCO’s ability to achieve financial viability, 
serve its target populations, and improve individual out-
comes.238 CER and PCOR projects examining alternative 
financing and distribution approaches resulting from the 
ACA and recent Medicaid waivers could shed light on 
which contractual elements are most likely to result in 
improved patient-centered outcomes.
Costs and Utilization Behavioral health carve-outs 
have been widely reported to result in cost reductions 
in both private-sector MBHCOs205,230,231,239–244 and state 
Medicaid programs.232,245–248 Grieve et  al246 further con-
cluded that in Colorado, the capitated model with a for-
profit component (the “joint venture” model) was more 
cost-effective than the not-for-profit capitated or fee-for 
service models. Carve-outs have also been observed to 
reduce overall behavioral health service use in both pub-
lic232 and private249 arenas. They reduce use of psychiat-
ric emergency services,250 shift use from inpatient care to 
outpatient and community-based services,247,250 reduce 
the duration and intensity of treatment,248 increase cri-
sis referrals, and increase the use of second-generation 
antipsychotic medications.250 Significantly, studies have 
demonstrated that utilization tends to (1) decrease for 
services for which the MBHCO is financially at risk and 
(2) increase or show no change for services for which the 
MBHCO is not financially at risk.203,251 What is not clear 
is whether these system changes affect patient-centered 
outcomes or quality of care. This is an important ques-
tion that could be addressed by CER and patient-cen-
tered outcome researchers.
It is also important to understand changes in societal 
or distributional costs resulting from different financ-
ing arrangements. In a series of recent publications, 
researchers compared treatment and societal costs 
among three risk-based financing strategies in Florida: 
a large Medicaid HMO with a fully integrated premium 
covering general medical, mental health, and pharmacy 
services; Medicaid fee for service; and a private managed 
care organization with a fee-for-service behavioral health 
carve-out. In the first study, the authors found that the 
unadjusted total treatment costs for people enrolled in 
the HMO were 50% lower than costs for fee-for-service 
enrollees.252 The difference was largely explained by infor-
mal utilization practices that limited access to clozapine. 
They also found little difference in the costs of physical 
health services by financial risk arrangement. In a follow-
up study, however, Shern et al253 found that although the 
Medicaid managed care plan resulted in cost savings, 
the savings were either diminished or eliminated when 
including all societal costs, including private and family 
expenditures. In particular, people in Medicaid managed 
care plans appeared to receive significantly more infor-
mal caregiving than people in fee-for-service plans. The 
authors pointed out that most budgets are determined 
within an agency or organization, with little concern over 
the distributional effects to other sectors. This is problem-
atic, as people with serious mental illnesses may require 
multiple services across sectors and payers. It is, thus, 
essential to understand the distributional and societal 
cost impact of different risk-based financing strategies.253
Several studies have also highlighted differences in utili-
zation among subpopulations being served in MBHCOs. 
For example, comparing two captitation models and a 
fee-for-service model in Colorado’s Medicaid program, 
Kaskie et  al248 found that utilization among older ben-
eficiaries decreased more in the “joint-venture” capitated 
model, in which a for-profit organization collaborated 
with a community mental health agency, than in the non-
profit public capitated model. This was consistent with 
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the organizations’ different management philosophies, 
but it did not hold true for younger beneficiaries. Costs 
were also reported to be higher for older clients. Among 
welfare beneficiaries in Massachusetts, Norton et  al247 
found a decrease in total per-person expenditures, a con-
current shift from inpatient to outpatient care, and no 
evidence of cost shifting to the medical sector. However, 
these findings contradicted what was found in a sample 
of Medicaid beneficiaries eligible due to a mental disabil-
ity, suggesting important differences between welfare and 
Social Security Income recipients receiving mental and 
substance abuse services through the same program.247 
These findings suggest that more research is needed 
addressing differential effects and relationships of pay-
ment structures to patient-centered outcomes on priority 
subpopulations. In particular, more information is needed 
regarding the effects of different payment structures on 
individuals in rural and other underserved areas lacking 
access to mental health specialists, members of minor-
ity groups, clients with low literacy, those with different 
diagnoses, and clients with major medical comorbidities.
Individual-Level Outcomes The effect of carve-outs 
on individual outcomes varies significantly from study to 
study. Results remain unclear,254 are missing from analy-
ses altogether,247,248 or are mixed.230,249,251,255 Cohen and 
Bloom256 reported that continuity of care, an important 
aspect of care from the service user’s perspective, was 
greater in capitated models than in a traditional fee-for-
service model. Similarly, Cuffel et al232 found no signifi-
cant differences in outcomes among different models of 
capitation but did find a difference between capitation 
and fee-for-service models. Ridgely et  al237 voiced con-
cerns about access, quality, and outcomes but did not 
elaborate on underlying causes. Typical of this literature, 
the aspects of carve-outs that are most likely to affect 
outcomes (eg, risk-sharing arrangements, provider net-
works, prior authorization, and service limits) were not 
made explicit. To date, few studies have addressed the 
underlying question of how financing structures relate to 
patient-centered outcomes and recovery among people 
with serious mental illnesses, in part because the data 
necessary to address these questions are not easily avail-
able from claims or administrative data. Key questions 
remain: Under what conditions does a shift from inpa-
tient to outpatient care improve patient-centered out-
comes? Which settings are preferred by service users and 
under what circumstances?
Summary and Implications Capitation, carve-outs, and 
managed care have become important tools for managing 
costs and utilization in behavioral health care. Overall, 
carve-outs for behavioral health services have resulted in 
cost savings and reductions in inpatient hospital use and 
a shift in utilization from inpatient to outpatient settings 
across sectors and over time. The literature clearly shows 
that carve-outs can create powerful and disparate incen-
tives as well as disincentives, depending on how risk and 
contractual elements are handled. Services for which an 
MBHCO is not at risk will tend to increase while services 
that do present risk will tend to decrease. Carve-outs 
also have the potential to increase service delivery frag-
mentation, create issues in coordination and medication 
use, and affect service user health status and other out-
comes of interest to consumers. Two important questions 
remain: What are the specific organizational and contrac-
tual/risk-sharing aspects of carve-outs that improve out-
comes for people with serious mental illnesses, and what 
patient-centered outcomes are affected?
Studies of carve-outs also demonstrate that a broad-
based analysis may mask important differences among 
subpopulations and that contractual arrangements are 
critical in understanding how carve-outs affect individ-
ual outcomes. Furthermore, outcomes among studies on 
carve-outs tend to focus more on service delivery issues 
and, as a result, do not fully or adequately address patient-
centered outcomes. Discrete and subgroup analyses 
remain important, as does research reflecting the impor-
tance of outcomes of concern to consumers, something 
which is currently missing from this body of literature. 
To address this issue, better measures of patient-centered 
outcomes need to be embedded within administrative 
and claims databases for use by researchers assessing dif-
ferent financing mechanisms.
Bundled Payments. Bundled payments have been 
described as payments that are based on the average costs 
of care and made to a provider organization to cover all 
expenses associated with a discrete illness episode. Under 
a bundled payment mechanism, providers are at risk for 
overutilization and outliers.257 CMS began experimenting 
with bundled payments for coronary bypass in the late 
1990s, which resulted in $17 million in savings in the first 
27 months of the program.258 CMS is currently consid-
ering implementing bundled payments for hospitals and 
common inpatient services. More recently, bundled pay-
ments have been incorporated in cancer treatment,257 end-
stage renal disease,259 and, in the Netherlands, diabetes 
care, chronic obstructive pulmonary disease care, and 
vascular risk management.260
Birkmeyer et al261 and Miller et al262 found significant 
variation in the costs of surgical procedures and post-
care management across the country and across different 
types of providers under Medicare. A preliminary evalu-
ation of bundled payments in the Netherlands showed 
improved organization and coordination of care, better 
collaboration among health care providers, and better 
adherence to care protocols. However, it also appeared 
that bundled payments resulted in large price variations 
that could not be fully explained by differences in ser-
vices, as well as increased administrative burden due to 
outdated technology.260 Similarly, Draper263 reported that 
management of bundled payments would benefit from 
improved clinical information technology tools. He cited 
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a long list of organizational and management efficiency 
tools and processes as important factors in the successful 
application of bundled payments.
Any application of bundled payments to the delivery 
and management of services for people with serious men-
tal illnesses would need to account for (1) the inherent 
variation in service needs by demographic and clinical 
factors, (2) the potentially wide and uncertain variation 
in service needs over time within an illness episode, (3) 
the need for services that are typically outside the medical 
sector, (4) adequacy of payment relative to risk, and (5) 
the “patient centeredness” of payment and the potential 
to pay for services that include a wider range of provid-
ers, such as peer providers. Bundled payments offer the 
potential to align provider incentives to promote system 
efficiencies for mental and behavioral health services. At 
the same time, it will be important to ensure that realized 
efficiencies and provider incentives are evaluated against 
patient-centered outcomes, not cost savings alone.
Financing Services to Promote Consumer Choice.  
Promoting consumer choice is at the heart of patient-cen-
tered care. The discussion above makes clear that financ-
ing methods and structures can exert a powerful influence 
on how care is delivered and received. Dewa et al234 com-
pared consumer choice under three financing structures: 
fee for service, a capitated prospective payment model, 
and a blended model (capitation with elements of fee for 
service). These comparisons showed that each financing 
structure embodied a different set of incentives, with the 
fee-for-service model providing the fewest incentives for 
encouraging shared decision making in care. The authors 
suggest that changes to the reimbursement system are 
needed to encourage the shared-care practice model. 
They also concluded that changes in financing alone are 
not sufficient to promote the shared-care model.234
Self-directed care programs are designed to promote 
consumer choice and patient engagement in their own 
recovery by giving them control over public funds to pur-
chase services and supports.264,265 The federal Office of the 
Assistant Secretary for Program Evaluation recently com-
missioned a systematic review of consumer-directed care, 
which should be available in the near future (R. G. Frank, 
PhD, personal communication, May 23, 2012). Results 
from an earlier pilot program on self-directed care found 
positive outcomes for participants, including spending less 
time in inpatient and justice settings and spending almost 
half  of the funds on individual treatment.266 In 2003, CMS 
created the “Money Follows the Person” (MFP) program 
with the goal of creating a flexible financing mechanism 
that would allow people with long-term needs and high 
use of institutional care to receive appropriate care in the 
community or at home. The program allowed funds to 
“move” with people as their needs and preferences for 
setting change. Given that people with serious mental ill-
nesses experience changes in health status and move in 
and out of institutional care, this model may hold prom-
ise. CMS awarded $6.5 million to nine states—California, 
Idaho, Maine, Michigan, Nevada, Pennsylvania, Texas, 
Washington, and Wisconsin—resulting in numerous ini-
tiatives. Additionally, CMS increased federal matching 
funds for home- and community-based services to pro-
mote more “rebalancing” of services at the state level. 
Because of the ways in which funding operates at the 
state level, the MFP essentially required states to enact 
legislation that would allow transfer of money between 
funding streams—a difficult task. States have experienced 
varying degrees of success with this program. For exam-
ple, Alakeson265 identified three main barriers to explain 
lack of program development: the absence of a strong 
evidence base to support the effectiveness of self-directed 
care for serious mental illness, uncertainty over the 
appropriate scope of self-directed care, and the absence 
of sustainable funding sources. MFP programs were set 
to expire in 2011 but were continued through the ACA 
for another 5 years. Thirteen states will receive more than 
$45 million in the first year of the program, and more 
than $621 million through 2016.267 These efforts provide 
natural experiments ripe for comparisons.
The federal government also instituted a “Cash and 
Counseling Demonstration and Evaluation” program 
that expanded opportunities through Medicaid by 
funding demonstration projects that shifted the fund-
ing model to one in which program participants—all of 
whom were disabled, including those with serious men-
tal illnesses—were free to choose the types and amounts 
of services and supports they believed were best able to 
meet their disability needs.268 Research from the programs 
in New Jersey, Arkansas, and Florida suggests that con-
sumers’ control over personal care greatly improves their 
satisfaction with care arrangements and their outlook on 
life,269,270 and that it is a viable model for people with seri-
ous mental illnesses.271
Summary and Implications Consumer-directed care 
is an important component of patient-centered care 
and can promote engagement and satisfaction among 
service users. Financing mechanisms have been suc-
cessfully developed to achieve consumer-directed care 
and appear to be viable for people with serious mental 
illnesses. Further comparisons are needed to provide a 
clear understanding of the effects of different approaches 
to financing consumer-directed care on patient-centered 
outcomes.
Medication Financing. Costs for prescription medica-
tion have soared in the past 20 years, increasing from $10 
billion in 1998 to $25 billion in 2008.185 For people with 
serious mental illnesses, two issues regarding financing 
for prescription drugs are of particular importance: the 
increasing use of carve-outs to control costs and service 
utilization, and the recent development of the prescrip-
tion drug benefit under Medicare Part D. As noted above, 
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MBHCOs and other types of capitated plans are typically 
not at risk for the costs of prescription drugs. Comparisons 
of these different approaches have produced conflicting 
results. Several studies report that, compared with tradi-
tional fee-for-service plans, MBHCOs in state Medicaid 
programs have either decreased costs for or increased 
use of psychiatric medications.243,255,272 In contrast, other 
studies have found that use, continuity, or adherence was 
reduced under carve-out arrangements,272,273 or that there 
were no significant differences between carve-out plans 
and traditional fee-for-service plans for medication use.251 
More research is needed to determine the effects of differ-
ent arrangements on individual outcomes and to identify 
the factors producing these differential results.243
The Medicare Modernization Act of 2003 shifted med-
ication coverage from Medicaid to Medicare for people 
who were eligible for both programs.274 More recently, 
Medicare was expanded to create prescription drug cov-
erage for all Medicare beneficiaries, known as the Part 
D program. This change significantly increased coverage 
and reduced out-of-pocket costs for consumers, but the 
private sector responded with a complex array of pro-
grams and administrative and management structures to 
take advantage of this new opportunity. Concerns about 
the Part D program included disruption in service, con-
fusion about enrollment, increased costs, and cost shift-
ing. A number of researchers hypothesized that because 
of the complexity of the program, some dually eligible 
beneficiaries would experience disruptions in or barri-
ers to access to medications, in addition to other treat-
ment gaps.254,274–278 Although dually eligible beneficiaries 
were automatically enrolled in Part D to mitigate these 
concerns, Huskamp et  al279 reported that emergency 
department visits were significantly higher for those who 
experienced access problems under Part D, raising ques-
tions about its effects on quality of care.279 Zivin et al,280 
however, found no significant differences in enrollment 
between beneficiaries with depression and cognitive 
impairments and those without these difficulties.280
Prior Authorization and Cost Sharing Prior authori-
zation policies and cost sharing are two additional tools 
that have been effectively used to control medication 
costs.281–283 Studies in general populations have reported 
that prior authorization and cost-sharing requirements 
have reduced access to and continuity of prescription 
medications,283,284 increased use of emergency depart-
ments,279 reduced availability and use of medications,274 
and reduced medication adherence.285 These findings 
raise concerns about the effects of such approaches on 
vulnerable individuals with serious mental illnesses, who 
already experience reduced access and continuity of care 
and are less likely to adhere to medications.
Summary and Implications The literature on financing 
for prescription drugs shows variation in access and use 
for both Medicaid and Medicare clients, highlighting the 
importance of understanding the details of health plans’ 
administrative and risk-sharing arrangements and the 
effects of these arrangements. In particular, more infor-
mation is needed about the effects of elements such as 
prior authorization and cost-sharing arrangements on 
clinical and patient-centered outcomes. For the most 
part, analyses have been limited to assessments of costs 
and utilization.
Reimbursement Structures and Models for Service 
Integration. This section addresses how current finan-
cial arrangements affect service integration within and 
between systems of care, and the extent to which they 
affect patient-centered outcomes. Specific methods and 
models of service integration and care coordination are 
discussed more fully elsewhere in this report.
The Need for Service Integration There is widespread 
agreement that a subset of people with serious men-
tal illnesses require ongoing, coordinated, and multiple 
interventions to appropriately and adequately address 
their needs. The array of services include medical care, 
mental health services, addiction treatment, social ser-
vices, transitional services for people moving in and out 
of different levels and systems of care, housing, educa-
tion, employment, and services related to the justice sys-
tem. For example, people with serious mental illnesses 
are more likely to have major physical health and sub-
stance-related comorbidities,286,287 and more likely to use 
emergency department services, than people who do not 
have these disorders.216,250 They are also more likely to be 
unemployed, to have low income,195,288 and to have hous-
ing issues.195,289,290 Additionally, people with serious men-
tal illnesses may need different services at different stages 
of the recovery process.291,292
There is also consensus that current financing arrange-
ments have not been organized or adequately funded to 
create comprehensive, seamless, and coordinated systems 
of care. The President’s New Freedom Commission on 
Mental Health identified “unfair treatment limitations 
and financial requirements placed on mental health ben-
efits in private health insurance” as one of several major 
obstacles to appropriate care for people with mental 
health disorders.5 The IOM’s report on improving the 
quality of health care for mental health and substance-
use conditions7 documents the lack of coordination for 
people needing mental health and substance-abuse treat-
ment. This includes lack of coordinated general medical 
and behavioral health services within and between health 
care settings, and between health and other systems of 
care, such as vocational rehabilitation, social services, 
disability services, employee assistance programs, and 
criminal justice settings. This report identifies fragmenta-
tion in policy and financing and unclear accountability 
as important factors driving these discontinuities. In par-
ticular, financing arrangements such as carve-outs and 
managed behavioral health care may negatively affect 
the system’s ability to create integrated, comprehensive 
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systems of care. The IOM report makes four recommen-
dations to improve individual outcomes through financ-
ing: (1) establish parity for coverage of mental health 
and substance-abuse treatment, (2) reorient the state pro-
curement process to give the greatest weight to quality 
of care, (3) use quality-of-care measures in the procure-
ment and accountability process, and (4) reduce empha-
sis on grant-based financing and increase use of funding 
mechanisms that link funds to quality-of-care measures.31 
Although the mental health parity acts have addressed 
the first of these recommendations and the ACA contains 
provisions for addressing the latter, much remains to be 
done to implement such practices, and research is needed 
to understand the linkages between these strategies and 
patient-centered outcomes.
Funding Streams in Silos and Barriers to Integration An 
important consideration in serving people with serious 
mental illnesses is how to provide a comprehensive array 
of services, many of which fall outside the traditional 
medical model, in a system where financing is “siloed” 
(ie, financed for discrete and limited sets of services), 
decentralized, fragmented, and largely uncoordinated. 
Funding for mental health services comes from a vari-
ety of sources, each with its own rules and regulations. 
Medicaid is the primary source of federal and state funds 
for mental health services, and it is a primary source of 
insurance for consumers with serious mental illnesses. 
The situation is more complicated for users with co-
occurring substance-abuse disorders. Because of the dif-
fering eligibility requirements and benefits of the various 
funding streams, it is extremely challenging to commingle 
or blend funds targeting mental health and substance 
abuse.286
One particularly vexing question is how best to finance 
and provide care for co-occurring mental health and sub-
stance-abuse services. Almost 26% of people with serious 
mental illnesses also experience substance abuse or depen-
dence.185 Data from the 2010 National Survey on Drug 
Use and Health found that among the 2.9 million adults 
(aged 18 and older) with co-occurring mental illnesses 
and substance abuse disorder, 36% received no treatment 
for either condition. This rate was even higher for people 
with both co-occurring disorders in the justice system.185 
In addition, significant numbers of homeless individuals 
with co-occurring disorders who are eligible for either 
Social Security Income or Social Security Disability 
Income did not apply or were denied support because of 
missed appointments, lack of documentation, or inability 
to be reached by the agency.289 Clark et al216 reported that 
within five state Medicaid programs, people with serious 
mental illnesses and co-occurring substance-abuse dis-
orders were more likely to use expensive emergency and 
hospital services and less likely to use community-based 
treatment compared with people with serious mental ill-
nesses without substance-abuse disorders. In general, 
people with co-occurring mental health and substance 
abuse are at higher risk for a wide array of poorer out-
comes, including high service use, repeated hospitaliza-
tions, higher costs of care, nonadherence to prescribed 
medications and treatment, homelessness, HIV infection, 
incarceration, and higher family burden.293
Mental health and substance-abuse services are 
financed through separate resource streams, delivered 
by different providers, and subject to different eligibility 
rules and limitations. Medicaid is the primary payer for 
mental health services, and states have expanded cover-
age to maximize federal matching dollars. Medicaid pays 
for about 15% of substance-abuse services (an optional 
service), and while most states offer some coverage for 
substance-abuse treatment, the benefits are not as exten-
sive as for mental health. Additionally, people who receive 
disability income based on a substance-abuse diagno-
sis are not eligible for Medicaid, creating difficulties for 
blending funding and coordinating care.286 Osher and 
Drake293 provided a concise history of how the funding 
and organization of mental health and substance-abuse 
programs at the federal level kept eligibility and treat-
ment separate, and how changes have evolved over time. 
In particular, they pointed out the powerful disincen-
tives for service integration due to the fact that licensure 
monitoring and program administration are handled by 
different authorities. These divisions are exacerbated by 
medical education, licensure and credentialing require-
ments, quality assurance standards, differences in con-
ceptual frameworks and philosophies of treatment, and 
mistrust and competition for limited resources.286
Sterling et al294 noted that carve-out programs in both 
the public and private sectors delink mental health and 
substance-abuse services from other health care, reduc-
ing both access and quality of care. Private sector cover-
age for behavioral health often excludes substance-abuse 
treatment, even when other psychiatric services are 
covered. In the public sector, block grant funding may 
cover only community-based outpatient treatment and 
residential care, rather than the full spectrum of needed 
services. Additionally, Medicaid reimbursement often 
excludes psychologists, social workers, and family thera-
pists, who are among the primary providers of substance-
abuse treatment.294 This has been addressed, in part, 
through the Medicaid Services Rehabilitation Option, 
which offers states a more flexible mechanism to provide 
mental health services, including (1) the ability to offer 
services in community settings or the client’s home or 
work environment; (2) reimbursement for a wider range 
of professionals, including paraprofessionals; and (3) a 
broader set of services, such as life skills for everyday 
functioning.295 Other barriers include annual dollar or 
service limits on substance-abuse treatment; restricting 
access to specific populations (such as pregnant women 
or homeless individuals); differences in organizational 
and professional cultures between general health, men-
tal health, and substance-abuse providers; weak clinical 
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linkages between primary care and behavioral health 
settings; policies around confidentiality that reduce or 
inhibit communication and coordination of care between 
settings and providers; and administrative resistance to 
blending funding because of problems of accountability 
in bundled payments.294,296
Despite these issues, a number of states and programs 
have successfully colocated services, blended funding 
streams (making it difficult or impossible to determine 
which source pays for which service), or “braided” fund-
ing streams (where multiple funding streams are used to 
provide a package of services but sources for services 
can be identified). There are many difficulties in improv-
ing access to co-occurring mental health and substance-
abuse services, however. Two suggested mechanisms 
include pay-for-performance (P4P) and payment mecha-
nisms to promote brief  screening, brief  intervention, and 
referral to treatment (SBIRT) for substance misuse. Use 
of P4P is just beginning in the behavioral health arena, in 
part because of concerns over adverse selection, but early 
results are not encouraging. (See the discussion of P4P 
in the section Patient-Centered Quality Improvement 
in Mental Health System and Provider Performance 
Measures, and Methods of Feedback). The American 
Medical Association Common Procedural Terminology 
and the Medicaid and Medicare Common Procedure 
Coding System provide reimbursement codes for screen-
ing, brief  intervention, and referral, but once individuals 
are referred for treatment, the financing problems delin-
eated above become apparent. In addition, states and 
private insurance companies must agree to adopt these 
codes to increase treatment referrals, and SBIRT codes 
have not yet been widely used in state Medicaid programs. 
In short, significant challenges remain if  we are to inte-
grate funding and distribution of care to adequately and 
appropriately provide services to people with co-occur-
ring mental health and substance-dependence/substance-
abuse disorders.
Medical Homes The primary care medical or health 
home model, discussed in detail later in this report, was 
developed to address needs for comprehensive, integrated, 
and coordinated services for children with special health 
care needs. It has been adapted to other populations with 
multiple and/or chronic conditions that require a wide 
scope of medical, behavioral, and social service inter-
ventions. Several public and private sector models have 
been recommended as potential solutions for improving 
outcomes for people with serious mental illnesses. These 
include (1) the integrated model with colocation of the 
full spectrum of medical and social services, as seen in 
the Cherokee Behavioral Health System in Tennessee (a 
federally qualified health center[FQHC]) and the Crider 
Center in Missouri (also a FQHC); (2) partnerships 
between community mental health centers and FQHCs 
such as the Integrated Policy Initiative in California; (3) 
the “Diamond Initiative” in Minnesota, an innovative 
payment model that uses a case-rate payment system297; 
(4) the Kaiser Permanente model of care, which fully inte-
grates financing and service delivery; and (5) the Veteran’s 
Health Administration model of care.298 A newer form of 
the medical home, the behavioral health home, focuses on 
integration and coordination of care, including medical 
care, but is located within specialty behavioral health care 
settings. This model is discussed in more detail below, in 
the section National Health Care Reform and the and the 
Affordable Care Act.
Financing structures to promote the medical home 
model include monthly care coordination payments to 
support the medical home structure; a visit-based, fee-
for-service component; and performance-based incen-
tives to promote quality and efficiency goals. Many state 
Medicaid demonstration projects use one or more of these 
components. Fields et al215 compared seven integrated sys-
tems of care and concluded that a modest per-member-
per-month payment is a necessary incentive to motivate 
physicians to adopt care coordination mechanisms that 
are needed in a medical home model. They also suggested 
that performance incentives would be helpful for promot-
ing coordinated and high-quality care.215 While these ele-
ments are echoed by others, there is little consensus on 
the best way to incentivize comprehensive, coordinated 
care in the primary care system across the spectrum of 
needs for people with serious mental illnesses.214 Common 
incentive mechanisms are reviewed below.
Evidence of the impact of medical home models on 
individual outcomes is limited but generally positive, 
including increased use of preventive care, improvements 
in physical health, and increased likelihood of having 
a usual source of care.297 Shortell and McCurdy298 sug-
gested that payment mechanisms that increase greater 
interdependency between hospitals and physicians are 
necessary to encourage development of integrated sys-
tems.298 Within the research and policy communities, 
however, there are questions about the efficacy and effec-
tiveness of the medical home model applied to people 
with serious mental illnesses. Alakeson et al297 have noted 
that primary care in the private sector is typically ill 
suited to meet the needs of people with serious mental 
illnesses because of restricted time and reimbursement 
for visits, provider training issues, the inability to directly 
address the wide service needs of this population, fee-for-
service billing structures, and prohibitions in Medicaid 
for same-day billing for primary care and behavioral 
health care.210,297
Integrating Emergency Services With the Mental Health 
System of Care Psychiatric emergency department visits 
have increased significantly since the 1990s.299,300 A recent 
study on the care process for psychiatric emergency 
department visits by Weiss et  al301 found that psychiat-
ric service users experience longer wait times and longer 
lengths of stay. The authors speculated that this is due in 
part to lack of availability of inpatient psychiatric beds, 
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resulting at least in part from low reimbursement rates 
for inpatient mental health hospitalizations. Similarly, the 
study showed that lengths of stay were significantly longer 
for people aged 41–59 when being placed for community-
based services, and significantly longer for older people 
when placement required hospitalization. This suggests 
a serious gap in the availability of appropriate sever-
ity- and age-appropriate placements. The study showed 
how a lack of output-related capacity can have delete-
rious effects and highlighted the importance of linking 
and integrating emergency department services into the 
larger mental health system to improve access to aftercare 
options. The authors call for further research on length 
of stay at emergency departments that have various lev-
els of integration with outside psychiatric facilities.301 An 
earlier study of the general population in Canada found 
similar results.302
Innovative Financing at the State Level to Integrate 
Services Rules and regulations that are attached to the 
various funding streams often conflict with the goal of 
creating a comprehensive and seamless system of care 
for people with serious mental illnesses. Nevertheless, a 
number of states are funding clinically integrated men-
tal health services, using strategies that include (1) flex-
ible block-grant funds and state dollars to bridge services 
for people with co-occurring disorders; (2) modification 
of regulations regarding specific service definitions and 
billing codes; and (3) use of risk contracts and admin-
istrative services–only mechanisms through managed 
care organizations that manage a diverse portfolio of 
funding streams and so are able to create the impression 
of a coordinated system from both provider and client 
perspectives.286
California, for example, adopted a recovery-oriented 
approach using a “full service partnership”—a flexible-
funded collaboration between mental health agencies, 
law enforcement, education, social services, and housing 
and employment agencies. The program, which provides 
seamless access to individualized recovery-oriented ser-
vices for people with serious mental illnesses, has resulted 
in lower rates of homelessness, incarceration, hospital-
ization, and unemployment.303 California also tested the 
financial viability of an ACT model that used an inte-
grated service agency model to provide a comprehensive 
array of behavioral, medical, social, housing, and employ-
ment services. Over a 4-year period, costs associated 
with ACT were lower for the treatment group than for 
a randomly assigned control group.304 The program also 
demonstrated increased workforce participation in both 
urban and rural areas, reduced hospitalizations, increased 
program retention, and increased leisure and social activ-
ities.304 No significant differences were noted for long-
term hospitalizations, arrest, conviction, measures of 
self-esteem, symptomatology, substance abuse, homeless-
ness, or QOL. The capitated integrated model was helpful 
for creating a unified service delivery structure and for 
creating some positive individual-level outcomes.304,305 An 
older study of an attempt by the Oregon Health Plan (the 
state Medicaid program) to integrate mental health and 
substance-abuse treatment showed that it evolved into 
a carve-out approach. Issues that impeded integration 
included changes in the administration and management 
of substance-abuse benefits, financial losses experienced 
by the health plans, lack of provider training, and lack of 
incentives for providers to refer clients to substance-abuse 
treatment.306
There are also examples of recent innovative state strat-
egies to improve care for populations with serious men-
tal illnesses, but outcome data are not yet available. For 
example, Maryland recently created a series of innovative 
financing strategies307 including the Creative Alternatives 
program—a team-based comprehensive case manage-
ment program for high-risk psychiatric patients that 
offers a per-member-per-month fee of $2 410 to provide 
all mental health and psychiatric services. The program 
pays for the member’s regular psychiatric treatment, 
therapy, medications, and case management, as well as 
any supportive care needed. In addition to usual care, the 
program also pays for all psychiatric-related emergency 
department visits and hospitalizations. There are several 
other programs in Maryland that, while not explicitly tar-
geted to people with serious mental illnesses, are likely 
to include this population. These include Connecting 
Patients with Medical Homes and the Shore Wellness 
Program, both of which target high-risk or high-utiliza-
tion patients at risk for rehospitalization and use a lump-
sum capitated payment system to the health system. The 
Maryland Multi-Payer Patient-Centered Medical Home 
also targets payers providing coverage to government 
and private sector employees using a shared-savings 
approach.308
Missouri also recently initiated a 3-year statewide pilot 
program to integrate primary care provided by FQHCs 
and behavioral health services provided by community 
mental health centers. Initial reports suggested that 
critical elements of successful implementation included 
strong leadership; readiness for interagency collabora-
tion; knowledge of the complexities of each agency’s 
organizational structure, culture, funding mechanisms, 
and client base; history of collaboration; local political 
conditions; and sufficient seed funding.309
In addition to these innovative state programs, the CMS 
Innovation Center recently announced its first round of 
innovation awards. The Medicaid Emergency Psychiatric 
Demonstration will test whether Medicaid can support 
higher quality care at a lower total cost by reimbursing 
private psychiatric hospitals for certain psychiatric ser-
vices. Historically, Medicaid has not paid psychiatric hos-
pitals for these services without an admission to an acute 
care hospital first. This demonstration project provides 
$75 million over 3 years to 13 states.310 Under the Bundled 
Payments initiative, CMS will link payments for multiple 
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services received during an episode of care, and providers 
will have the flexibility to determine which services should 
be bundled together. CMS is currently seeking propos-
als to test four different models of bundled payments.308 
Other CMS Innovation initiatives not explicitly target-
ing mental health, but which may affect individuals with 
mental illnesses nevertheless, include the Community-
Based Care Transitions Program, Independence at Home, 
the Pioneer Accountable Care Organization Model, and 
the Comprehensive Primary Care Initiative.310 These new 
models of care offer significant opportunities to test how 
different financing arrangements can improve outcomes 
for people with serious mental illnesses.
Frank Melville Supportive Housing Investment Act 
of 2010 The Frank Melville Supportive Housing 
Investment Act of 2010 made $85 million in funds avail-
able to state housing agencies to provide affordable 
housing for people with disabilities. US Department of 
Housing and Urban Development Section 811 provides 
affordable housing linked with community-based sup-
portive services for the country’s most vulnerable dis-
abled populations. For the first time in the history of the 
Section 811 housing program, integrated programs for 
people with serious mental illnesses are offered through 
partnerships with state Medicaid agencies, thus provid-
ing an opportunity to more easily combine housing with 
mental health services.201 The legislation states that hous-
ing offered under this law is to benefit low-income and 
very low–income people with disabilities; it provides no 
mention of any exclusion based on a record of having 
drug offenses, nor do the recent amendments mention 
eliminating this restriction.311,312
Summary and implications. Integrated systems of 
care are viewed as an important and viable mechanism 
for meeting the complex, chronic service needs of peo-
ple with serious mental illnesses. Key questions about 
the best ways to fund integrated systems remain unan-
swered. Funding sources are diverse, complex, and laden 
with rules and regulations that create barriers to integra-
tion. There are a variety of experiments to test different 
financing tools to improve care for populations with seri-
ous mental health disorders. Opportunities for CER and 
PCOR are ripe and need to be pursued. In particular, 
more research is needed that links financing vehicles and 
arrangements directly to patient-centered outcomes.
National Health Care Reform and the Affordable Care 
Act. The ACA,313 enacted in March 2010, significantly 
increases coverage and financial assistance to low- and 
moderate-income people and makes sweeping changes to 
public insurance programs through benefit expansions 
and opportunities for demonstrations to address costs, 
promote efficiency, and improve coordination for dually 
eligible consumers of services. The law also provides new 
standards for private health insurance, places limits on 
cost sharing and premium requirements, and establishes 
new rules to ensure access to coverage. The ACA further 
authorizes significant funding to states, local govern-
ments, employers, community organizations, and other 
entities through existing and new grants and programs 
to implement the many provisions in the law.314 Current 
federal funding levels for the ACA are estimated to be 
$12.2 billion, with $4 billion going to states and $8.2 bil-
lion allocated to the private sector.315
The ACA offers significant opportunities to test new 
payment and organizational models to better serve peo-
ple with mental illnesses and improve their outcomes. In 
particular, the ACA creates opportunities for states to 
develop a behavioral health home model of care to address 
the needs of people with chronic medical and behavioral 
health conditions. The intent of the legislation was to 
help states promote patient-centered care by improving 
the experience of care and the health of populations, and 
reducing the per-capita costs of health care. The Health 
Home model is designed to specifically address the service 
needs of people with serious mental illnesses and pro-
vide enhanced integration and coordination of primary 
care, behavioral health care, and long-term community 
services for people with chronic illnesses. The legislation 
is also designed to address the shortcomings of serving 
people with serious mental health and substance-related 
needs in primary care medical homes. States wishing to 
take advantage of this option will receive a 90% fed-
eral match for eight quarters.316 States have a number of 
options for how to organize and finance services within 
this arrangement, including an in-house model, in which 
all required services are housed within a single organiza-
tion; a colocation model, where different organizations 
operate as a team to provide services; and a facilitated 
referral model, where services are offered in more than 
one location. The legislation also allows states to adopt 
a tiered payment structure to account for severity of 
condition and the capabilities of designated providers or 
health teams. States are not limited to the “per-member-
per-month” payment mechanism.317 These changes raise 
an important research question: How do patient-centered 
outcomes associated with the behavioral health home 
model compare with those associated with the primary 
care medical home model?
Under health care reform, the role of Medicaid and 
other public insurance programs that fund most care for 
people with serious mental illnesses will likely expand.318 
Garfield et  al319 noted that under the ACA, states have 
the option to provide “benchmarked” coverage for new 
beneficiaries, which will likely be less than the full level 
of Medicaid benefits. Thus, new beneficiaries are likely 
to experience gaps in coverage for mental health–related 
needs. Medicaid expansions and “essential benefits pack-
ages” are two key policy options for states.319 Based on 
an analysis of data from the National Health Interview 
Survey, Long and Stockley320 suggested that compre-
hensive reforms are more successful at addressing gaps 
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in coverage than limited, narrower efforts. Through a 
roundtable forum with national and state policy makers, 
the Kaiser Commission on the Uninsured highlighted the 
differences in coverage needs between people with mild/
moderate mental illness and those with serious mental ill-
nesses, as well as the lack of consensus regarding future 
coverage decisions by states. Policy makers did agree that 
the medical home model is the most appropriate mecha-
nism for meeting the needs of people with serious mental 
illnesses and that the current public health system lacks 
adequate capacity and coordination to meet the needs of 
such beneficiaries who are newly eligible.321
In addition to these reforms, new state insurance 
exchanges and Accountable Care Organizations are in 
the early stages of formation and program development, 
offering researchers and policy makers a unique oppor-
tunity to study and influence program development. 
There are many outstanding questions regarding what 
the Accountable Care Organizations will comprise, what 
their goals are, and how they will function. Additional 
key questions around insurance exchanges and integrated 
systems include the following: What is the best way to 
integrate services for people with serious mental illnesses 
and improve patient-centered outcomes? What are the 
best financing tools and policies to ensure appropriate, 
timely, comprehensive, and high-quality care for people 
with serious mental illnesses? How will the new financing 
structures affect patient-centered outcomes?
Implications for CER and PCOR The research on 
resource acquisition and distribution is largely focused 
on questions of policy and service delivery, not on 
patient-centered outcomes. While the extant literature 
may not have been intended to address these outcomes, 
it is now clear that studying the links between financing 
approaches and individual outcomes is critically impor-
tant. The lack of any systematic reviews, or even indi-
vidual studies on key topic areas, makes this a fertile area 
for investigation of the links between patient-centered 
outcomes and the myriad topics covered in this review: 
costs, capitation and managed care, carve-outs, prescrip-
tion drugs, and integrated systems of care. Additionally, 
an important but seemingly neglected area of study is 
the impact of funding on quality of care. The ways that 
funding streams are used or integrated have significant 
potential to limit or place ceilings on the types and scope 
of services and benefit packages, which in turn can affect 
quality of care and individual outcomes. Health care 
reform offers important opportunities to better under-
stand these issues as they relate to people with serious 
mental illnesses. Because implementation is so recent, we 
do not yet know the outcomes of these experiments.
Measures and metrics for costs and expenditures 
tend not to be linked to patient-centered outcomes in 
any meaningful way. Instead, they are limited to macro- 
or system-level variables, focusing on total or aver-
age expenditures for care in various settings, among 
different providers and for specified services. This was to 
be expected to some degree, as most articles we reviewed 
do not focus on the individual consumer, and they pres-
ent limited patient-centered outcome data at the systems 
level. This gap raises fundamental questions about how 
to collect data related to patient-centered outcomes and 
embed them in the claims and administrative databases 
on which most cost and expenditure analyses are based. 
Indeed, methods for integrating such data warrant fur-
ther exploration in and of themselves.
Another consistent theme in our review was the need 
for more subpopulation analyses and analyses at more 
discrete levels of measurement. Individuals with seri-
ous mental illnesses belong to a variety of subgroups 
that might be classified using any number of conceptual 
schemes, including age, gender, race, diagnosis, under-
served status (economic, insurance, geographic, access to 
care), homelessness, veteran status, physical or addiction 
comorbidities, or involvement with the justice system. 
Research clearly shows differences among these groups, 
and combining these subpopulations may mask signifi-
cant variability in the effects of different financing tools 
on outcomes. New CER and PCOR projects evaluating 
financing mechanisms should address outcomes for these 
subpopulations.
Similarly, more discrete and disaggregated analyses 
would be useful for understanding the effects of specific 
aspects of capitation, managed care, carve-outs, and 
other financing structures on a number of measures. 
These include (1) mental health status, functionality, and 
patient-centered outcomes for specific subpopulations, 
including elderly individuals, those in underserved and 
rural areas, and people grouped by diagnosis or gen-
der; (2) shifts in costs from private to public sectors, and 
from plans and employers to individuals and families; (3) 
how risk assessment and assignment are determined and 
how this affects patient-centered outcomes; and (4) what 
incentives embedded in carve-out plans and management 
will ensure provision of quality care.
This review also identified a number of gaps in the 
literature and specific research needs related to resource 
acquisition and distribution of funds for services to indi-
viduals with mental illnesses. The field would benefit from 
two activities in particular, both with a focus on patient-
centered outcomes: a systematic review of state efforts to 
blend funding streams and development of better meth-
ods for comparing resource allocation and distribution 
across geopolitical and service jurisdictions (state-level 
comparisons).
External Influences and Unintended Outcomes  
Economic and political forces affect how policy and 
financing structures are developed and implemented, 
how health systems are developed, how providers 
are reimbursed, and how consumers access services. 
Financing structures and source of  coverage have been 
linked to varied disparities in access, quality of  care, 
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and outcomes. Moreover, the economy exerts great pres-
sure to contain costs, particularly as the costs of  state 
Medicaid programs continue to soar. The expansion of 
coverage under health reform intensifies this pressure. All 
the elements that shape health care reform—the econ-
omy, national and state elections, lobbying efforts—will 
shape financing policy, resource acquisition, allocation, 
and distribution for mental health services. Additionally, 
the ways in which financing interfaces with service deliv-
ery are significantly shaped by how public and private 
care systems interpret and implement policy. This can 
best be seen in the wide variation across state Medicaid 
programs. Large managed-care organizations in both 
sectors have a leadership role to play in establishing via-
ble systems of  care for people with serious mental health 
problems.
In addition, small changes in policy can produce unex-
pectedly large effects in care provision. For example, add-
ing a billing code for care coordination could create strong 
incentives for systems to provide such services. It is equally 
important to understand how different agents of change 
are affected. For example, a plan to decentralize financ-
ing from a state agency to local entities may save money 
for the state, but county mental health departments and 
local service providers may experience major disruptions 
in contracting, resulting in disrupted care for service users. 
Thus, the benefits and costs of policy changes may not be 
held equally throughout the health system. Clearly, more 
research on comparative effectiveness and patient-cen-
tered outcomes is needed to fully understand how financ-
ing policy affects individual service users.
Key Leverage Points Because services for people with 
serious mental illnesses are financed largely through the 
public sector, the most influential leverage points with 
respect to resource acquisition and distribution include 
federal policies for Medicaid, Medicare, block grants, 
and other funding sources. States have the flexibility to 
alter their Medicaid financing mechanisms, including by 
changing the ways that capitated plans are designed and 
implemented, designing risk and risk-sharing arrange-
ments between plans and providers, calculating case 
mix–based reimbursement and enhancements, imple-
menting changes in billing codes and reimbursement 
methods, and adding new payment mechanisms to sup-
port integrated care models such as medical or behav-
ioral health homes and peer-provided services. Moreover, 
there are significant opportunities to study the develop-
ment and implementation of the new Accountable Care 
Organizations and state insurance exchanges under cur-
rent health reform, as well as the roles played by state 
insurance commissioners in shaping policies that affect 
people with serious mental illnesses.
Another major leverage point would be to develop 
methods to systematically embed common patient-cen-
tered outcome variables in administrative and claims 
data. This would take resources, long-term commitment, 
and policies requiring or incentivizing reporting on 
the part of states and providers. While this task may 
seem daunting, we stand to gain a great deal of insight 
from databases that link expenditures, use, and costs to 
patient-centered outcomes. This knowledge could inform 
changes to financing structures that create platforms for 
service delivery, with the goal of improving outcomes for 
people with serious mental illnesses.
Finally, the private insurance market presents an impor-
tant leverage point. While parity laws have been helpful in 
increasing access, the extent of their impact is not clear. 
Parity laws notwithstanding, it may be that incentivizing 
the private sector to promote better preventive and early 
intervention services, medication adherence, and conti-
nuity of care may reduce transitions of individuals with 
serious mental illnesses to publicly funded systems of 
care. Large employers and HMOs have the ability to scale 
their services to meet the mental and behavioral health 
needs of people with serious mental illnesses.
Summary and Implications A review of the literature on 
financing for people with serious mental illnesses reveals 
a number of important limitations and opportunities for 
CER and PCOR. Specifically, studies on cost trends do 
not address patient-centered outcomes but are useful for 
understanding the broader perspective on how services 
are financed. Parity is useful for some purposes, but 
because most people with serious mental illnesses receive 
publicly funded services, this vehicle affects a smaller 
proportion of individuals with these disorders. Increased 
coverage and lower out-of-pocket costs for consumers 
may be useful for reducing the rate of disability of dis-
ability through earlier intervention and more effective 
treatment of acute episodes.
Capitation, carve-outs, and managed care have been 
increasingly used to fund and manage behavioral services 
for individuals with serious mental illnesses. Overall, 
carve-outs for mental and behavioral health services have 
resulted in cost savings and reductions in inpatient hospi-
tal use and a shift in utilization from inpatient to outpa-
tient settings across sectors and over time. The literature 
clearly shows that carve-outs can create powerful and 
disparate incentives and disincentives, depending on how 
risk and other elements are handled in contracts. The 
variation in the experience of different states highlights 
the importance of understanding the details of contrac-
tual arrangements within the context of local political 
and health systems.
Consumer-directed care is an important component of 
patient-centered care and can promote engagement and 
satisfaction among service users. Financing mechanisms 
developed to achieve consumer-directed care appear to 
be viable for people with serious mental illnesses. Finally, 
integrated systems of care, including primary care medi-
cal homes and behavioral health homes, are viewed as 
important and viable mechanisms for meeting the com-
plex, chronic service needs of people with serious mental 
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illnesses. Key questions remain, however, about the best 
ways to fund integrated systems. Funding sources are 
diverse, complex, and laden with rules and regulations 
that create barriers to integration. A  variety of experi-
ments are underway to test different financing tools to 
improve care for populations with serious mental illnesses.
Financing structures for services for people with seri-
ous mental illnesses are strongly influenced by a number 
of factors, including macrolevel economic trends and 
political forces, policy interpretation and implementa-
tion, and state and local capacity. Research opportuni-
ties in comparative effectiveness and patient-centered 
outcomes are ripe and need to be pursued. In particu-
lar, many ACA initiatives provide important opportuni-
ties for naturalistic experiments testing different ways to 
address long-term difficulties in financing services.
Populations Served
The depth and sprawl of the mental health care and ser-
vice delivery system are extensive, and its boundaries are 
indistinct. The array of individuals who interact with this 
system is correspondingly vast, with consumers of mental 
health services having a wide range of attributes, many 
of which have bearing on the types of care and services 
these individuals are attracted to and those that are appro-
priate and effective in meeting their needs. Moreover, this 
diverse population encompasses a variety of subgroups 
that might be categorized in a number of meaningful 
(albeit not always permanent) ways. These include gender, 
culture, life course, diagnosis, illness course or severity, 
personal history, socioeconomic status, addiction or phys-
ical comorbidities, housing status, involvement with the 
justice system, and level of engagement or reluctance to 
be involved with the service system. Our narrative review 
showed that many of these variables are powerful modera-
tors and mediators of treatment effects and, most likely, 
patient-centered outcomes. However, our understanding 
of how best to tailor and match care and services to the 
particular characteristics and preferences of individuals 
is underdeveloped. CER and PCOR promise methods of 
moving toward a much better understanding of how to 
best serve the diverse individuals in this population.
Care and Service Delivery for Individuals Diagnosed 
With Serious Mental Illnesses: Structures, 
Service Packages, Delivery Methods, and Delivery 
Characteristics
Throughout the United States, there is now a great deal 
of focus on reform of health care funding and delivery 
systems, driven largely by fiscal crises and by the frustra-
tions of citizens and businesses about inadequate access, 
increasing expenses, poor coordination of care, and inade-
quate and disparate outcomes. Combined with, and argu-
ably propelling, these reform efforts is a contemporary 
philosophy that emphasizes service users’ preferences for 
health-related outcomes rather than more conventional, 
paternalistic approaches to care provision. Such factors 
have resulted in both the ACA and numerous state initia-
tives to redesign how care is delivered. Taken together, 
these reform efforts present unprecedented opportuni-
ties for evaluating redesigned care delivery structures and 
implementing services guided by the preferences of those 
who receive care.
There is a well-established, long-standing, and con-
tinuing need to improve care quality for individuals with 
serious mental illnesses.5,7,322 In this section, we review the 
philosophies and models of care that guide and influence 
mental health care and service delivery, the key charac-
teristics of an effective delivery system for those with seri-
ous mental illnesses, and the interventions and programs 
that, based on current evidence, should be considered as 
components of the package of services available to this 
population.
When we set out to map the care and service delivery 
system in preparation for our literature review, we antici-
pated finding aspirational philosophies of care (eg, psy-
chosocial rehabilitation movement, recovery movement) 
dictating essential characteristics of care delivery (eg, 
effective engagement, continuity of care). We expected 
to identify models of care with well-articulated and well-
delineated domains (eg, the CCM) that would define an 
associated package of services (eg, case management, 
crisis services, education, self-management support) that 
would be reflected in particular care delivery structures 
(eg, the Patient-Centered Medical Home, the Clubhouse 
Model). But in an ironic reflection of what it must be like 
to organize and provide services in this complex system, 
we struggled to appropriately classify these models, ser-
vices, and methods. As has been pointed out by many who 
have conducted reviews, terms are inadequately defined 
(eg, continuity of care), are used inconsistently (eg, ACT 
used both as a model of care and as a package of ser-
vices), and often have significant commonalities and over-
lapping components (eg, the CCM and integrated care).
One of the key challenges to conducting CER as it 
relates to care delivery for those with serious mental ill-
nesses will be to agree upon a common taxonomy, clear 
definitions, and consistent use of terms. Until that agree-
ment is in place, classification of the components of a 
model of care and service delivery is somewhat arbitrary. 
As a consequence, we have organized our review accord-
ing to where we think these components best fit in the 
model we developed, but we acknowledge that they may 
fit in multiple categories.
Care and Service Delivery Models and Structures 
Psychosocial Rehabilitation. As the locus of care 
shifted from the psychiatric inpatient hospital to the com-
munity during the deinstitutionalization movement of 
the 1960s and 1970s, an unintended consequence was that 
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the mental health system became more fractured, and 
care and services became less accessible and less coordi-
nated. This left many individuals unable to get their needs 
met or to navigate the overwhelmingly complex new sys-
tem. Simultaneously, the care culture was beginning to 
migrate from an illness model focused on presumed limi-
tations to one focused on social functioning. In the wake 
of these changes arose the psychosocial rehabilitation 
(PSR) movement. The goal of PSR is to help individu-
als develop the skills needed to participate in the com-
munity and lead a fulfilling and meaningful life with the 
least amount of professional support. Interventions can 
be classified as PSR to the extent that they are directed 
toward functional improvement and social inclusion,323 
meaning that PSR is not a technique but rather a philoso-
phy. PSR needs are determined by the individual engaged 
in services, depend on his or her environment, and extend 
beyond clinical outcomes to include functional and inter-
personal outcomes. Employment, leisure pursuits, social 
functioning, QOL, and reduced family/carer burden are 
examples of patient-centered outcomes that may be met 
by evidence-based PSR interventions. Such interven-
tions include vocational rehabilitation through SEm or 
relationship building through family interventions, peer 
support, and social skills training.324 PSR philosophies of 
autonomy and self-determination align well with patient-
centered philosophies of care delivery.
Recovery Model In the late 1980s, first-person 
accounts documenting the experience of recovery from 
serious mental illnesses began to appear.325,326 By the 
1990s, reports of long-term follow-up studies327–331 began 
to challenge the pessimistic view of outcomes that was 
dominant at the time. The recovery model was taking 
root,332 producing a new optimism for consumers and 
providers of mental health services, and it has since influ-
enced service delivery around the world.333 This model 
emphasizes that the service user should hold primary con-
trol over the recovery process, and that the process should 
account for the autonomous rights and phenomenologi-
cal experiences of that person.334 The concept of recov-
ery, however, remains ill defined, and most definitions 
have been developed by consensus rather than empiri-
cally. The recovery model has also been used in multiple 
ways (as a model of care, a process, and an outcome) and 
has been criticized for its lack of a strong empirical base, 
although calls to establish a scientific agenda have been 
made.335,336 As an outcome in the literature, recovery has 
been defined both in the short and long term as remission 
of symptoms, resumption of a prior level of functioning, 
or achieving a meaningful life.337 Correlates associated 
with recovery as an outcome have been described,338 and 
limited research has examined recovery as a process.52,339
A distinction has been made between clinical recovery—
the traditional model—and personal recovery. The former 
is outcome based, is rated by an observer, and emphasizes 
symptom reduction and improved functioning through 
effective mental health service intervention. In contrast, 
personal recovery is now understood as a highly unique 
process,340 defined by individuals, that may require nei-
ther symptom reduction nor mental health service utiliza-
tion.341 Like PSR, the recovery model is not a specific set 
of techniques, but rather a philosophy with a collection 
of recovery-oriented, evidence-based interventions that 
include shared decision making, supported cognition, 
supported services, and peer support.336 Also like PSR, 
the recovery model aligns nicely with patient-centered 
care. Individual preferences, consumer-directed care, and 
person-centered outcomes are seen as key components of 
both approaches. Customization of care and services to 
address the unique needs of the individual, with the goal 
of achieving self-defined recovery outcomes, is central to 
the recovery philosophy. Ripe for future CER and PCOR 
are empirical investigation of guidelines for recovery-
oriented practice,342 links between different recovery-
focused approaches and patient-centered outcomes, and 
comparisons of differential effectiveness of recovery-ori-
ented mental health services at levels of the individual, 
provider, organization, delivery system, and society.341,343
Chronic Care Models People with serious mental ill-
nesses are at increased risk of premature mortality, pri-
marily due to preventable chronic conditions including 
heart disease, diabetes, cancer, stroke, and pulmonary 
disease,21–23 some of which are caused or worsened by 
metabolic side effects of psychoactive medications.344–349 
In addition to being at increased risk for life-threatening 
chronic conditions, individuals with mental illnesses may 
be less likely than those without such disorders to receive 
guideline-concordant preventive care.350,351
The last 20  years have seen an increasing effort to 
develop health care delivery models that emphasize a 
comprehensive approach to effective care and manage-
ment of chronic disease. These models focus extensively 
on developing care delivery and financing systems that 
increase continuity of care with a care team that inte-
grates medical and behavioral health, coordinates efforts 
across different care providers and institutions, provides 
increased knowledge about clinical guidelines and the 
comparative effectiveness of various treatment options, 
and increases support and education to service users to 
help them engage in self-management. These efforts have 
resulted in a number of overlapping care delivery models 
that incorporate common elements, and they have driven 
research agendas to assess their overall effectiveness and 
the relative impact of their respective components. These 
models include the CCM,352 collaborative care,353 inte-
grated care,354 and the Patient-Centered Medical Home.355 
Although they are not synonymous with each other, they 
are at times used interchangeably. We have chosen to 
review them together, as the underlying elements share a 
common heritage and values.
Historically, these collaborative care models have 
focused on primary care delivery and have only recently 
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been applied to care for individuals with serious men-
tal illnesses, primarily bipolar disorder,356–358 although 
key components of the models (eg, care management) 
have been used extensively in mental health treatment 
for decades. The advent of health care reform, how-
ever, appears likely to significantly expand the focus on 
chronic disease management and the integration of men-
tal health treatment with primary care using vehicles such 
as Accountable Care Organizations.359
The representative CCM is best considered a “foun-
dation of management”360 rather than a specifically 
defined treatment, and it incorporates six core elements 
(reviewed in figure 8, adapted from Woltmann et al361 and 
Bodenheimer et al362) along with a set of specific services 
commonly used in clinical trials as representative of each 
element. Across different trials, the model’s six elements 
are each defined by a range of services, tasks, and inter-
ventions, and most trials include interventions of only 
two to four elements, rather than all six. Some services, 
however, are commonly used in almost all studies of col-
laborative care (eg, care management).
Components of the CCM have been shown to be effec-
tive in improving patient outcomes in diabetes, conges-
tive heart failure, asthma, depression,362,363 and chronic 
obstructive pulmonary disease,364 although few studies 
have included all or even most of the six components.361 
In a meta-analysis of 112 studies in which one or more 
CCM elements were tested, Tsai et al363 found that overall, 
pooled across diseases and CCM elements, CCM inter-
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Fig. 8. Collaborative Chronic Care Model elements and examples.
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and intermediate clinical outcome measures (eg, HbA1c 
control) for chronic diseases commonly seen in primary 
care. Using metaregression, they examined the indepen-
dent effects of delivery system elements (delivery system 
design, self-management support, decision support, clini-
cal information systems) and found that delivery system 
design and self-management support improved clinical 
outcomes and process-of-care measures. Decision sup-
port improved process measures, but clinical information 
systems did not produce benefit. None of the elements 
resulted in improved QOL. There is also evidence that 
combining CCM elements, especially when including 
self-management, produces synergistic effects, including 
fewer hospitalizations, shorter lengths of stay, and fewer 
emergency or unscheduled visits.364–366 The evidence for 
cost-effectiveness is equivocal366,367 and has considerable 
variation in how economic impact is defined (eg, incre-
mental individual costs, health care utilization, lost pro-
ductivity, cost utility). These recent reviews emphasize the 
importance of significantly expanding research to under-
stand the benefits and costs to practices, payers, and ser-
vice users, and to determine the number and specificity 
of components essential to producing economic benefit.
The CCM has an extensive history of being used in 
efforts to improve the primary care treatment of depres-
sion in a variety of delivery systems, including integrated 
health systems, the Veteran’s Health Administration (VA), 
managed care organizations, preferred provider organiza-
tions, and community-based organizations (eg, FQHCs). 
Two recent systematic reviews and meta-analyses of col-
laborative care treatment for depression found benefits. 
Bower et  al368 found that collaborative care increased 
antidepressant use and improved depression symptoms 
most effectively when case managers were mental health 
professionals and received regular supervision. Thota 
et al369 conducted a meta-analysis and systematic review 
of 32 high-quality collaborative care depression stud-
ies published between 2004 and 2009 and demonstrated 
“robust evidence” of effectiveness of collaborative care in 
improving depression symptoms, adherence to treatment, 
response to treatment, remission of symptoms, recovery, 
and satisfaction with care, as well as slightly improved 
QOL/functional status. They found that amount of case 
management, intervention length, and quality of execu-
tion of the intervention did not relate to depression 
symptom improvement. However, three modifier vari-
ables did relate to the size of the effect: the type of orga-
nization (community-based organization—largest effect; 
VA—least), type of case manager (RN—largest, masters-
level counselor—least), and number of collaborative care 
components out of the eight components assessed (inclu-
sion of four to five components had the largest effect; less 
than four or more than five had the least effects).
An earlier review by Gilbody et  al370 found that col-
laborative care (primarily defined by depression case 
management) produced beneficial outcomes, albeit at an 
increased cost. A later systematic review of the econom-
ics of collaborative care for depression,371 published in 
conjunction with the review of Thota et al369 cited above, 
found good economic value across different measures 
of economic benefit among studies. Of those measuring 
economic benefit in terms of averted health care or pro-
ductivity loss (seven studies), 57% found benefit. Of those 
measuring both benefits and costs (five studies), 60% 
found lower cost due to reduced health care utilization 
or increased productivity, and of those that measured 
economic benefit based on cost utility (six studies), 83% 
found that care was cost-effective.
Although the use of the CCM for primary care depres-
sion treatment has been the subject of extensive research, 
its use as a framework for treatment of serious mental 
illnesses has been minimal. A  notable exception to this 
is bipolar disorder, for which several RCTs have been 
implemented in a variety of health systems using CCM 
intervention elements.356–358,372 Bauer et al356,357 conducted 
an RCT of the CCM specifically for service users with 
bipolar disorder in 11 Veterans Health Administration 
Medical Centers. The intervention randomized hospital-
ized patients to either an outpatient “specialty team” men-
tal health clinic or psychiatrist and registered nurse care 
coordinator or usual care managed by a psychiatrist. The 
intervention consisted of multiple components, including 
consumer self-management support, provider decision 
support, extensive nurse case management follow-up, and 
coordination with other providers, hospital liaison, and 
urgent access. The study found broad improvements in 
outcomes, including reduced length of manic episodes; 
improved social role function, mental QOL, and treat-
ment satisfaction; and cost neutrality. Later, Kilbourne 
et al373 reanalyzed data from this study and demonstrated 
that outcomes were comparable for those with and with-
out co-occurring substance-use problems. Similarly, 
Simon et  al358 used a comparable CCM intervention in 
a study conducted in an integrated delivery system (a 
group model prepaid health plan), replicating some of 
the Veterans Health Administration findings, including 
reduced symptoms and length of manic episodes. He also 
found that the costs of the intervention group were mod-
estly higher than for the usual care control group.
A recent meta-analysis and systematic review of 57 
RCTs of CCM interventions361 reported effects on mental 
health symptoms or mental QOL regardless of whether 
the condition of focus for the intervention was a men-
tal health disorder. The meta-analysis found beneficial 
effects on physical and mental health outcomes (depres-
sion symptoms, mental QOL, physical QOL, and social 
role functioning) at little or no net increase in costs, sup-
porting the findings from Bauer et al.357
Integrated Care Models An AHRQ Evidence Report 
published in 2008372 reviewed the evidence for integrat-
ing mental health and primary care services. The report 
examined integration of behavioral health services within 
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primary care settings, as well as the reverse. The former 
focused primarily on depression, anxiety, and substance-
use disorders. The report’s authors concluded that inte-
grated care within primary care environments clearly had 
benefits over usual care, but neither the extent of inte-
gration nor the implementation of structured processes 
appeared to relate to improved outcomes. The Butler 
review374 identified only three studies of primary care 
integration within specialty care outpatient settings, and 
all were conducted within integrated delivery systems 
(two VA and one HMO) with the inherent advantages of 
such systems in terms of coordination and flexibility of 
funding. These studies identified benefits from “reverse 
integration” (consisting primarily of an advanced prac-
tice nurse to conduct screening and referral or a nurse 
case manager to coordinate referral and follow-up). 
Benefits included reduced costs and improved QOL, 
physical well-being, and quality of medical care (eg, diag-
nosis of common medical problems, increased preven-
tive care). Whether reverse integration can be effectively 
implemented within community settings where funding 
and care are not integrated has yet to be demonstrated, 
due to the many barriers in these settings, including cul-
tural differences between systems, policy and payment 
barriers, and workforce training limitations.297
Unintended Consequences and External Influences The 
ACA established a “health home” option under Medicaid 
that serves enrollees with chronic conditions. This compo-
nent of the ACA allows states to implement a behavioral 
health home for individuals with serious mental illnesses 
and/or substance-use disorders. The likely result is that 
behavioral health agencies will become the primary health 
home for people with serious mental illnesses, responsible 
for ensuring that all health care needs are met and coor-
dinated. According to a recent report by the SAMHSA-
Health Resources and Services Administration Center 
for Integrated Health Solutions,317 this responsibility 
can be met with one of the three models discussed ear-
lier: an “in-house model” in which the behavioral health 
agency provides all the primary care and behavioral 
health services needed by their service users; a colocated 
partnership model in which the behavioral health agency 
arranges a primary care agency to provide primary care 
services onsite; or a facilitated-referral model in which 
the behavioral health agency screens for physical health 
conditions and establishes processes to ensure that ade-
quate and coordinated care is provided in the community 
using a medical case manager. This is a profound and 
innovative change with inadequate research evaluating 
the key elements and structures necessary to adequately 
meet the needs of service users. It has potential to sig-
nificantly improve medical care for people with serious 
mental health disorders, but it also carries risk, as agen-
cies that have little experience or knowledge of primary 
medical care assume that responsibility.
Characteristics and Methods of Care and Service 
Delivery. The core of any process designed to improve 
outcomes for those with serious mental illnesses should 
comprise evidence-based services, delivered by care sys-
tems and structures, that are adapted for different popu-
lations and responsive to the articulated preferences of 
those receiving services. It has become clear that inter-
ventions for addressing the complexities of  those living 
with chronic illnesses—especially those with a serious 
mental illness—must be embedded in a coherent and 
interactive system of care that empowers and supports 
service users.352 Of the variety of  care models developed 
to address the complexity of  delivering care to those with 
chronic conditions, some are specific to serious mental 
illness and others are focused more broadly on chronic 
medical disease. Both are influenced by a host of  bio-
psychosocial variables that can negatively or positively 
affect a person’s management of and adaptation to a 
given condition. Evidence exists for several characteris-
tics of  care delivery that are necessary, if  not sufficient, 
to achieve improved patient-centered outcomes. These 
include engagement of service consumers, continuity of 
care with clinicians or teams, effective communication 
and a strong working or therapeutic relationship between 
consumers and providers, continuity of  treatment across 
modalities (eg, inpatient to outpatient care), provision of 
information and education about illness and treatment, 
training and support in skills to manage the chronic con-
dition, and supports within the system to maximize the 
likelihood that the right treatment is given at the right 
time to the right person according to their desires. We 
review these key components of  care in the sections that 
follow.
Effective Engagement in Initial and Ongoing Treatment 
Planning Individuals enter the mental health system in 
myriad ways, including well beyond the onset of symp-
toms,375–377 and often at critical periods, such as through 
a visit to the emergency department during an acute 
episode of illness or after an arrest. An individual’s ini-
tial experiences with the system may significantly affect 
the course of their care, and yet the best approaches for 
engaging individuals in care at various entry points are 
poorly understood. Recent evidence suggests that these 
initial experiences can be unpleasant and, at worst, 
traumatic.301,378
When an individual comes into contact with the care 
delivery system, it is often unclear what first step is likely 
to result in the best outcomes for that person. For exam-
ple, are initial resources better spent on engagement and 
developing care relationships, or on screening and coor-
dinating triage to appropriate services? Accessing the 
system is only the first step in an ongoing process of plan-
ning, obtaining, and maintaining stable care and services. 
Empirically validated interventions are of little worth if  
we do not understand the variables that influence initial 
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and prolonged engagement and disengagement from men-
tal health services. Our knowledge of the extent to which 
individuals with serious mental illnesses fail to access the 
mental health care system is limited379 and based on dated 
epidemiologic surveys.182,184,380 What we do know sug-
gests that a large proportion of those who might benefit 
from services fail to seek them.379 Common reasons for 
not seeking care include not perceiving a need for treat-
ment, believing the problem will self-correct, wanting to 
solve the problem on one’s own, and the perception that 
treatment will not be effective.184 This raises ethical and 
practical questions of how and whether to connect with 
marginalized populations that may not want to partici-
pate in care or services, or may not want what is typically 
offered. This also highlights the need to better understand 
how to develop services that are appealing, have value to 
consumers, and facilitate engagement, and subsequently 
how to effectively inform consumers about those services 
and how to access them.
Both engagement and disengagement appear to be 
poorly conceptualized in the literature, are rarely defined 
explicitly, and lack acceptable measures.381 Consequently, 
attendance is commonly used as a proxy for engage-
ment, despite acknowledgement that attendance alone 
is not sufficient for engagement and may, in fact, repre-
sent nothing more than fear of involuntary treatment. 
Other conflating variables that are often used to estimate 
engagement include continuity of care and the therapeu-
tic relationship. A review by O’Brien et al381 found that 
approximately 30% of service users with mental health 
needs drop out of contact with services. Kreyenbuhl 
et al379 reported rates of treatment dropout among indi-
viduals with serious mental illnesses to range from 16 
to 67%, depending on the sample and how disengage-
ment was operationalized. Correlates of disengagement 
include younger age, ethnic minority status, comorbid 
substance abuse, low social functioning, and social iso-
lation. Treatment dropout is especially high during the 
initial period of treatment.379 A number of reviews have 
attempted to identify reasons for disengagement. As 
reported by consumers, reasons include unsympathetic 
providers, not being listened to, not being able to actively 
participate in decision making, being dissatisfied with 
services,381 a desire to be independent, and loss of control 
due to medication effects.382
Motivational interviewing (MI) is both an approach 
and a set of techniques to assist individuals in resolving 
ambivalence and committing to a behavioral change.383 
Initially developed for increasing engagement in sub-
stance-abuse treatment, MI has been studied among 
those with comorbid substance-use disorders and seri-
ous mental illnesses. Outcomes reported in those studies, 
however, have generally been limited to mental health 
and substance use rather than engagement.384 There has 
been surprisingly little investigation of the use of MI or 
other motivational enhancement techniques to enhance 
or promote engagement in the broader population of 
individuals with serious mental illnesses. When MI strate-
gies have been implemented in this population, they have 
generally been used to enhance outcomes for behavioral 
health targets, such as weight loss for individuals tak-
ing antipsychotic medications385 or smoking cessation.386 
In a meta-analysis of MI across varying populations, 
Lundahl et al387 identified 34 studies that measured treat-
ment engagement as an outcome of MI. MI showed a 
5–15% advantage over no treatment and a slight but not 
significant advantage over other viable treatments. These 
heterogeneous studies, while not limited to samples of 
individuals with serious mental illnesses, nevertheless 
demonstrate the potential of MI to enhance engagement. 
Further investigation in this area is warranted.
In related work, Kreyenbuhl et al379 summarized empir-
ically supported interventions and those with promise 
for increasing engagement in mental health services. 
They cited research support for low-intensity interven-
tions focused on system facilitators such as appointment 
reminders, priority outpatient appointments after hospi-
talization, and outpatient engagement during hospitaliza-
tion. Also supported are medium-intensity interventions, 
such as critical time interventions to strengthen individu-
als’ ties to service providers and social networks during 
times of transition,388 and high-intensity interventions 
such as ACT and Intensive Case Management (ICM) for 
those at highest risk of failing to engage.389 Assessing cul-
tural context also has the potential to improve engage-
ment, both by attending to each individual’s social setting 
and by recommending services that are consistent with 
and acceptable to the individuals in their settings.390
It is increasingly recognized that many individu-
als who discontinue services do so because they are not 
involved in decision making, do not feel listened to, and 
are dissatisfied with services. In response, recommenda-
tions have been made to develop partnership382 and self-
determination treatment models that emphasize shared 
decision making, reduction of community barriers to 
self-determination, education of stakeholders, modifica-
tion of legislation that restricts empowered decisions, and 
streamlining of interventions to ease participation.62
A recent review by Curtis et al64(p15) cited evidence that 
people with serious mental illnesses generally have a 
greater desire to be actively involved in treatment deci-
sions than those in general medical settings and are 
especially interested in decisions related to use of psychi-
atric medications. The authors emphasized that shared 
decision making is “especially useful when more than 
one viable option exists, when there is a conflict about 
which option is ‘best,’ or when outcomes are dependent 
on acceptance and follow-through by the person using 
the treatment or services,” a common situation in mental 
health care delivery. They identified three essential com-
ponents for effective shared decisions: information and 
preparation for making a decision, the interactive process 
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of discussing and generating a shared decision, and sys-
tematic opportunities to review and revise decisions after 
they are made. However, despite the relevance of shared 
decision making to mental health treatment, few studies 
have been conducted with these populations and in these 
settings.
Summary and Implications Rates of failure to engage in 
mental health services are understudied, as are the reasons 
for such failure and interventions to promote engagement 
and prevent disengagement. Research is needed to deter-
mine appropriate outreach strategies that are consistent 
with and respectful of the preferences of those outside the 
service system, as well as strategies that retain the engage-
ment of those within the system who desire continued 
care. There is incipient support of patient-centered care 
interventions that encourage activation, empowerment, 
and shared decision making as means of attracting and 
sustaining individuals in care. It should be noted, how-
ever, that a primary mission of patient-centered care is 
to honor individual preferences, which at times includes 
respecting decisions to forego care.
Therapeutic Relationship/Working Alliance The deg-
ree of alliance between provider and service user within 
a therapeutic relationship is widely acknowledged as an 
important nonspecific component of the care delivery 
process. There is both qualitative and quantitative evi-
dence that positive relationships facilitate engagement 
in services and, over time, foster recovery52,382 for indi-
viduals with serious mental illnesses. In a meta-analytic 
review, Martin et al391 found evidence that working alli-
ance was moderately associated with conventional psy-
chotherapy outcomes, although only 23% of the studies 
reviewed included service users with serious mental ill-
nesses. Moreover, psychotherapy treatment settings are 
quite different from those in which individuals with seri-
ous mental illnesses commonly receive treatment. Priebe 
et al57 conducted a systematic review and identified nine 
studies that prospectively tested association of therapeu-
tic relationships with outcomes (functioning, symptom 
level, and hospitalization) in studies of individuals with 
schizophrenia spectrum disorders. Due to the small num-
ber of available studies and the heterogeneity of methods 
used, the authors were unable to conduct the planned 
meta-analysis, concluding that evidence for the predictive 
value of the therapeutic relationship for treatment out-
comes in this group is limited.
Summary and Implications Existing reviews of the 
association between the working alliance or therapeutic 
relationship and outcomes underscore the need for meth-
odologically rigorous research on working alliances using 
measures validated for use among people with serious 
mental illnesses. Measuring these relationships at base-
line and over time, linking them to patient-centered out-
comes, and considering mediators of these relationships 
could provide the information necessary to understand 
how these relationships affect engagement and outcomes.
Continuity of Care Over Time and Across Care Settings, 
Services, and Providers In addition to solid engagement 
and development of a strong working or therapeutic alli-
ance, continuity of care is considered one of the essen-
tial components of high-quality care, particularly in the 
treatment of chronic and relapsing conditions. Its defini-
tion, however, has changed over time with the changing 
health care system and the advent of consumer empower-
ment, and its relationship to other concepts such as coor-
dination of care, integrated care, and case management 
is unclear.392 Gulliford et  al393 identified two meanings 
of continuity of care: as a “continuous caring relation-
ship” over time and as “seamless service” over time and 
across services, organizations, and care settings. A com-
prehensive review by Haggerty et al394 elaborated on this 
definition to include three dimensions of continuity: 
informational (availability of information on past care 
events and personal information), management (con-
sistency of approach to caring for the service user in a 
manner responsive to the user’s changing needs), and 
relational (ongoing relationship between service user and 
a care team). Contact continuity—regular and consistent 
contact with a service continuum—is a fourth dimension 
that has been included by some researchers.395
A strong case has been made that continuity of care 
is even more essential in the care of those with serious 
mental illnesses than those with other chronic conditions, 
due both to the necessarily increased complexity of the 
service system394 and to illness-related individual char-
acteristics that may interfere with consumers’ ability to 
provide comprehensive information about treatment dur-
ing acute episodes when treatment history may be most 
important.52 Given the importance placed on continuity 
of care by major health policy institutes in Britain, the 
United States, and Canada, there is a surprising lack of 
consistency in defining the concept. Moreover, the lack of 
consensus around a set of standardized measures, despite 
repeated calls for such development over the past two 
decades, is surprising.394,396,397 Addressing these deficits 
would allow for thorough evaluations of the effects of 
different types of continuity of care on individual out-
comes and would facilitate the development of interven-
tions to improve those found to be most important.394,395
Given the difficulty in defining the term and distin-
guishing it from overlapping concepts, it is similarly 
difficult to summarize the impact of continuity-of-care 
interventions on service user outcomes. In primary care, 
improved performance on related concepts (coordination 
of care, integration, patient centeredness) is related to bet-
ter quality of care, better health, and lower cost at both 
individual and population levels.392 For those with serious 
mental illnesses, the vast majority of research is observa-
tional and examines associations between continuity of 
care and a wide range of outcomes—costs, utilization, 
engagement in treatment, coordination of care, recov-
ery, QOL, and symptoms. Crawford et al397 reviewed the 
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evidence for factors influencing continuity of care using 
several measures. They found that a number of service 
user characteristics relate to withdrawal from treatment, 
including ethnic minority status, unemployment, social 
isolation, and lower socioeconomic status. This review 
found that information sessions and consumer training 
provided during inpatient stays, as well as visits by outpa-
tient staff, improved follow-up outpatient care. They also 
found that interventions designed to improve continu-
ity of care, including ACT, case management, and com-
munity mental health teams, reduced rates of treatment 
withdrawal for up to 24  months. A  Canadian study398 
found that higher continuity, as rated by both observ-
ers and service users, was associated with better general 
and disease-specific QOL and service satisfaction. A cost 
analysis for this same study found that observer-rated 
continuity of care was associated with lower hospital cost 
but higher community cost, with no statistical difference 
in total costs.399
The importance of incorporating service user views 
on continuity of care has been repeatedly emphasized.393 
Green et al52 found that relational continuity combined 
with recovery-oriented, consumer-directed care was 
related to increased satisfaction with care, fewer psychi-
atric symptoms, better recovery outcomes, and enhanced 
QOL.
Summary and Implications Continuity of care is a multi-
dimensional concept that has been neither clearly defined 
nor differentiated from related concepts. As emphasized 
by most reviews, there is a great need to develop widely 
accepted definitions of continuity of care and its multiple 
dimensions, as well as to develop standardized patient-
centered measures of continuity-of-care components that 
incorporate the values and voices of people with serious 
mental illnesses. There is a need to use such measures 
to examine the extent to which they relate to consumer-
preferred outcomes, and to compare the effectiveness of 
different interventions designed to increase continuity of 
care. Concepts of continuity of care are highly empha-
sized in both national and state health reform efforts. 
This increases the urgency of the development of good 
measures in order to evaluate the impact on outcomes 
for those with serious mental illnesses and to evaluate the 
delivery system itself.
Providing Education and Information Education and 
information are considered important aspects of care, 
particularly in the context of chronic conditions. As 
noted elsewhere in this report, the prevalence of comor-
bid chronic medical problems among those with serious 
mental illnesses suggests that this population’s educa-
tional and informational needs are both multifaceted and 
substantial. Formal psychoeducation programs tend to 
be broad, covering information about diagnoses, antici-
pated course, symptoms, and available psychiatric and 
psychosocial treatment options and their corresponding 
benefits and risks. These programs can also be narrow, 
however, focusing on specific aspects of illness manage-
ment such as medication (eg, optimal dose, side effects, 
importance of adherence) or specific wellness strategies 
(eg, sleep hygiene, diet, physical activity). In a review 
of illness management strategies, Mueser et  al400 found 
that providing broad-based psychoeducation increased 
individuals’ knowledge about mental illness but did not 
affect symptoms, social functioning, using medication as 
prescribed, rehospitalizations, or relapses. Similarly, the 
authors found that providing specific medication-related 
psychoeducation increased knowledge about medica-
tion, but they found little evidence that it affected other 
outcomes studied. Despite the lack of effect of such pro-
grams on clinical outcomes, the authors assert that gain-
ing knowledge is essential to making informed decisions 
about treatment. They concluded that psychoeducation, 
when provided as a component of an illness management 
program that includes behavioral tailoring for medication, 
coping skills training, and training in relapse prevention, 
is recommended for individuals with serious mental ill-
nesses.400,401 A more recent review of psychoeducation for 
schizophrenia found that didactic psychoeducation inter-
ventions delivered individually or in groups improved both 
clinical and patient-centered outcomes. Psychoeducation 
improved medication adherence, reduced rates of rehos-
pitalization (and length of stay) and relapse, improved 
social and global functioning, and increased satisfaction 
with treatment.402 The trials included in these reviews pre-
dominantly included individuals diagnosed with schizo-
phrenia. Rouget and Aubry401 reviewed the efficacy of 
psychoeducational approaches used to treat bipolar dis-
order and similarly concluded that increasing knowledge 
through psychoeducation, particularly as part of a more 
complex intervention, decreases risk of rehospitalization 
and relapse through improved treatment adherence that 
resulted in improvements in illness course—a very impor-
tant patient-centered outcome.401
Formal psychoeducation programs have been devel-
oped to provide education and information to both indi-
viduals with mental illnesses and their families. Family 
psychoeducation is recommended for individuals with 
serious mental illnesses,140 particularly for those with 
a recent exacerbation of illness, based on findings that 
family psychoeducation interventions of sufficient dura-
tion (optimally 6–9 months) significantly reduce rates of 
rehospitalization and relapse, improve treatment adher-
ence, reduce perceived stress, and produce better voca-
tional outcomes—important outcomes for patients as 
well as their families.
Educational efforts can be as limited as informing peo-
ple about their particular diagnoses, or as broad as those 
targeting improved health and wellness by simultaneously 
providing education and information about both mental 
and physical health conditions.403 A recent review of life-
style interventions for individuals with serious mental ill-
nesses found that manualized programs with a combined 
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activity and education approach were most likely to be 
effective and improve mental health status and QOL, 
while programs focused on general wellness or only on 
health promotion education were less successful.404
Summary and Implications It appears that providing 
psychoeducation to individuals and families increases 
knowledge and positively influences clinical outcomes. 
Access to information about mental illness is cru-
cial to individuals’ ability to make informed decisions 
about their care, and being informed may be an impor-
tant patient-centered outcome. If  that is the case (and 
researchers should address this question), education for 
individuals should perhaps be considered as ends in addi-
tion to means. That said, the effects of providing edu-
cation and information on engagement and therapeutic 
alliance remain to be investigated, as do their effects on 
patient-centered outcomes.
Trauma-Informed Care The impact of trauma can be 
profound in terms of negative effects on health, mental 
health, social functioning, and well-being, particularly 
when individuals have experienced multiple incidents 
or intentional interpersonal violence.405 The influential 
Adverse Childhood Experiences study406 showed a strong, 
graded relationship between a number of categories of 
adverse childhood events (psychological, physical, sexual 
abuse; emotional and physical neglect; marital discord; 
violence against mother; living in household with sub-
stance abuse or mental illness; or ever imprisoned) and 
each of numerous adult health risk behaviors (smoking, 
severe obesity, physical inactivity, depressed mood, sui-
cide attempts, alcoholism, any drug abuse, greater than 
50 sexual partners, and a history of having a sexually 
transmitted disease). Despite this evidence, the mental 
health and substance-use service delivery systems histori-
cally have not fully considered the effects of trauma his-
tory on treatment and outcomes. Most service users with 
trauma histories have not been screened for, nor do they 
carry (when appropriate), a primary diagnosis of post-
traumatic stress disorder (PTSD).405 Thus, implications 
of past trauma and opportunities for appropriate inter-
vention are missed, and those meeting PTSD criteria are 
often not provided with the evidence-based interventions 
for that disorder.407,408
As the association between experiences of trauma and 
subsequent psychiatric illness and substance misuse is 
increasingly recognized, especially in the publicly funded 
mental health and substance-abuse treatment systems,405 
“trauma-informed care” is emerging as an important area 
for further study. Rates of trauma history in these popula-
tions may be as high as 90% or greater.409–411 There is also a 
high frequency of individuals with serious mental illnesses 
and trauma histories in the correctional system,412 where 
rates of sexual and other violence are significantly greater 
among prisoners with mental illness compared with those 
without such illnesses, and where traumatic victimization 
has increasingly been identified as a major problem.413,414
The push to adopt trauma-informed care as a frame-
work for all behavioral health treatment appears to be 
driven primarily by the consumer movement and the 
publicly funded mental health service system. Between 
2001 (when 12 states formed a network to share ideas 
about improving the service system to better screen for 
trauma and to address its sequelae) and 2009, the num-
ber of states with explicit trauma-related activities (eg, 
mission statements addressing effects of trauma and cor-
responding policies and guidelines) grew to 44. In 2005, 
SAMHSA supported the development of a National 
Center for Trauma-Informed Care. These and other major 
policy and advocacy activities undertaken by SAMHSA 
and NASMHPD are reviewed in a 2008 technical report 
entitled “Models for Developing Trauma-Informed 
Behavioral Health Systems and Trauma-Specific 
Services.”405 In 2011, SAMHSA continued to emphasize 
trauma as a strategic focus of the agency, advocating for 
a public health approach to trauma and for the screening, 
early intervention, and treatment of trauma as a common 
practice in health, behavioral health, social service, and 
criminal justice systems.415
Those advocating for a transformation of mental health 
care envision a system “in which all components…have 
been reconsidered and evaluated in the light of a basic 
understanding of the role that violence plays in the lives 
of adults, children and adolescents, and families or care-
givers…[The system] accommodates the vulnerabilities 
of trauma survivors and allows services to be delivered in 
a way that will avoid inadvertent re-traumatization and 
will facilitate consumer participation in treatment.”405 It 
is a system that embeds a set of core values throughout 
the organization and all clinical interactions, including 
emotional and physical safety, trustworthiness, consumer 
choice and control, collaboration between service users 
and providers and among agencies and systems, treat-
ment planning, and building of empowerment skills.416
Given the prevalence of activities to advance trauma-
informed systems of care, the lack of studies that system-
atically test the effects of such care is surprising. Some 
of the core principles of trauma-informed care (eg, col-
laboration and consumer choice) have been shown to be 
important characteristics of service systems independent 
of trauma-informed principles, as discussed elsewhere 
in this report. One pre-post study evaluated the effect 
of implementing NASMHPD’s six core strategies for 
improving trauma-informed care on the use of seclu-
sion and restraint in a child and adolescent hospital, and 
showed a modest reduction in events. Outcomes were 
measured for only 6 months, however.417
While there has been little evaluation of systems inter-
ventions to promote trauma-informed care, there is con-
siderable evidence on trauma-specific services. A  recent 
Cochrane review418 of psychological treatments of PTSD 
found strongest support for trauma-focused cognitive 
behavior therapy including exposure, with immediate 
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and follow-up benefits (compared with wait list or usual 
care) on clinician-rated and self-reported traumatic stress 
symptoms, depression, anxiety, and PTSD diagnosis 
after treatment. Stress management and eye movement 
desensitization and reprocessing were also effective in 
improving most measures, compared with usual care and 
wait list. Interestingly, in contrast to trauma-focused cog-
nitive behavior therapy, neither of these latter interven-
tions demonstrated effectiveness on self-reported stress 
symptoms.
Integrated Care for PTSD and Substance-Use 
Disorders Two recently published systematic reviews of 
integrated419 and concurrent420 treatment of co-occurring 
PTSD and substance-use disorders concluded that inte-
grated or concurrent treatments were effective in reducing 
substance use, PTSD, and other mental health symp-
toms and that these effects lasted at follow-up periods. 
Neither integrated nor closely coordinated concurrent 
interventions showed superior results over nonintegrated 
sequential interventions, however. Both reviews identified 
significant weaknesses in study methods and the need for 
rigorous RCTs and emphasized the importance of long-
term follow-up for future research.
Trauma and PTSD in Adults With Serious Mental 
Illnesses Adults with serious mental illnesses have 
higher rates of interpersonal violence history than the 
general population, with reported rates ranging from 49% 
to 100% in study samples, including high rates of child-
hood sexual abuse (median across studies = 34%), child-
hood physical abuse (53%), adult sexual assault (38%), 
and adult physical assault (77%).421 Mueser et al411 found 
that 43% of service users with serious mental illnesses 
being treated in the public mental health system experi-
enced PTSD, but that very few of those (less than 3%) had 
the diagnosis listed in their chart. Traumatic experiences 
and PTSD diagnosis are associated with poorer clinical 
functioning and increased health care utilization in this 
population. In addition, a recently published review of 
PTSD in adults with serious mental illness421 established 
that, similar to the general population, interpersonal vio-
lence history and diagnosis of PTSD is correlated with 
substance abuse and other psychiatric disorders, home-
lessness, impaired functioning, poorer QOL, and increase 
in risk and self-harm behaviors. Unfortunately, there 
is a high rate of failure to identify trauma history and 
PTSD diagnosis among individuals with other serious 
mental illnesses, leading to failure to provide appropriate 
evidence-based treatments. These histories also result in 
higher health care utilization and costs.
Few rigorous trials have been conducted on the effects 
of PTSD interventions among individuals with PTSD and 
other serious mental illnesses, largely because of concerns 
among clinicians that such interventions would exacerbate 
symptoms. Cognitive behavioral therapy (CBT), however, 
has been shown to be beneficial in the treatment of schizo-
phrenia without exacerbation of symptoms, and the few 
RCTs that have been conducted with a focus on PTSD 
have demonstrated beneficial effects.421 Mueser et  al422 
conducted an RCT of CBT treatment of PTSD with 108 
patients with a major mood disorder or schizophrenia 
and found outcomes superior to treatment as usual over a 
6-month period. Due to concerns over patient tolerability, 
their intervention did not use exposure as a core compo-
nent. Recently, Lu and colleagues (2012) demonstrated 
that community providers could be trained to deliver CBT 
for PTSD with high fidelity in this population. Despite its 
demonstrated efficacy in general populations, few stud-
ies have examined exposure-based therapy in populations 
with serious mental illnesses, due to concerns over symp-
tom exacerbation. However, a tantalizing open pilot trial 
of a multicomponent intervention that included exposure 
treatment found significant reductions in PTSD symp-
toms and anger, and improvement in mental health func-
tioning and quality of social relationships.424
Summary and Implications The well-established rela-
tionship between trauma—especially ongoing interper-
sonal violence—and psychiatric symptoms and functional 
impairment has led to broad demands to develop trauma-
informed systems of care. However, the basic param-
eters of trauma-informed care are inadequately defined 
to allow testing of the effectiveness of such care system 
transformations. Research on trauma-informed care is in 
its infancy, key components of trauma-informed care need 
to be defined, and rigorous intervention trials are needed.
Trauma-specific treatments focused on addressing 
chronic PTSD, on the other hand, have a significant evi-
dence base demonstrating the comparative effectiveness 
of interventions. Even here, however, more well-con-
trolled trials are needed to test their effects among indi-
viduals with other serious mental illnesses. It is important 
that such trials explicitly evaluate the immediate and long-
term impact on symptoms other than PTSD symptoms, 
including potential harms, drop-out rates, and potential 
positive changes in psychological growth and healing.407
Despite the evidence supporting exposure-based thera-
pies, few clinicians use these interventions in their treatment 
of clients with PTSD, believing that such interventions are 
contraindicated.407 Moreover, a relatively high percentage 
of clients receiving treatment for trauma sequelae drop out 
or continue to meet PTSD criteria following treatment. 
Studies are needed evaluating the effectiveness of specific 
treatments related to service user characteristics, and test-
ing effective means of training and disseminating evidence-
based interventions to general mental health practitioners. 
Finally, integrated treatment of trauma-specific mental 
health interventions with substance abuse treatment is 
another area that has been identified as needing more com-
parative effectiveness trials to examine the effectiveness of 
different models of integrated care.420
Peers as Providers and Supporters of Care and 
Services There is a growing literature examining con-
sumer- or peer-led care and service provision as an 
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alternative or complementary adjunct to professional 
care, based on the belief  that individuals who are suc-
cessfully living with serious mental illnesses can provide 
important understanding, support, experience, and advice 
to others with these disorders.425,426 In addition, peer sup-
port groups are thought to be mutually beneficial. Many 
of these relationships occur informally, but efforts have 
increasingly focused on developing peer-run mutual sup-
port programs (eg, the Hearing Voices Network, http://
www.hearing-voices.org) and on training peers to serve as 
providers of more traditional services. While evidence for 
the effectiveness of peer-led models of care and service 
delivery is limited, inconsistent, and uses varied outcome 
measures, it suggests that, at minimum, trained peers 
produce outcomes similar to those produced by profes-
sionals. In a recent review, Repper and Carter426 reported 
evidence from two studies that confirm no difference was 
found in hospital admission rates or length of stay when 
peers provided treatment, compared with treatment pro-
vided in usual care, while another study demonstrated 
longer community tenure among individuals assigned 
to peer support workers, compared with those assigned 
to usual care. Because of the scant availability of RCTs 
evaluating the impact of employed peer support workers, 
these authors extended their review to include nonexperi-
mental designs that allowed a more complete picture of 
potential benefits of services provided by peers. From this 
literature it appears that peer support workers may actu-
ally be more successful than professionals at promoting 
hope and belief  in recovery; encouraging empowerment; 
and increasing engagement, self-esteem, self-efficacy, self-
management, social inclusion, and social networks. There 
also appear to be benefits for the peer support workers 
themselves, including those mentioned above as well as 
the opportunity for disclosure and meaningful, valued 
work in a supported context.
Summary and implications. There is a clear need to 
establishing an evidence base for the effectiveness of 
peer-supported services. Future research requires RCTs 
and CER that compare consumer-led models applied in 
varying ways (eg, as adjunctive to care or as an engage-
ment strategy) with traditional services and as stand-
alone services.
Unintended Consequences and External Influences 
While involving peer support workers in broader care and 
service delivery models may produce many benefits, the 
impact on the peer support worker must be considered as 
well. Where accountability and boundaries begin and end 
may be less clear with peer support workers compared 
with professionals, warranting continuous attention to 
the cumulative effects of vicarious stress and trauma. 
That said, there is currently no evidence suggesting that 
peer-support models harm peer-support workers.
Care and Service Packages for Specific Subpopulations. It 
is beyond the scope of this report to review the evidence 
for the myriad mental health care interventions and ser-
vice packages delivered in usual-care practice settings. 
We have, however, reviewed service packages targeting 
specific populations in an effort to identify population-
specific key leverage points in the mental health system.
Justice-Involved Individuals Individuals with serious 
mental illnesses are disproportionately represented in the 
criminal justice system. Although prevalence estimates 
vary and it is widely recognized that most estimates are 
likely underrepresentative of actual prevalence rates, a 
meta-analysis of 62 surveys from 12 countries found that 
14% of offenders suffer from at least one major mental ill-
ness.427 Applying this figure to the most recent published 
census data from the Bureau of Justice Statistics427 yields 
an estimate of nearly 700 000 adults with serious men-
tal illnesses under correctional supervision. In a recent 
study by the Vera Institute of Justice428 that combined 
data from five criminal justice and mental health agen-
cies in the Washington, D.C. area (2  874 individuals), 
the authors found that many of those arrested with men-
tal health needs were not known to community mental 
health providers. Most (83%) were known to at least one 
criminal justice agency during the study period, yet the 
Department of Mental Health knew of only 59% of those. 
Of the 666 cohort members with mental health needs 
who came into contact with the justice system, 46% were 
not identified as having a mental health need and 33% 
of arrestees known by the Department of Mental Health 
to have a psychotic spectrum disorder were not identi-
fied by any of the criminal justice agencies. Identification 
rates were even lower for individuals with other diagno-
ses (eg, anxiety, depression). This report brings attention 
to the problem of underrecognition of mental illness by 
service systems but also highlights potential opportuni-
ties for cross-agency coordination. The authors provide 
recommendations for improving identification through 
targeted information-sharing initiatives, increasing inter-
agency communication, expanding strategies for engag-
ing underserved groups, and linking individuals with 
providers across agencies.
Early identification of mental illness and appropriate 
service provision should be important goals of the crimi-
nal justice system because offenders with mental illness 
are more likely than those without these disorders to fail 
under correctional supervision (ie, have their parole or 
probation revoked or suspended), and twice as likely to 
return to prison within 1 year of release.429 Despite recog-
nition of this troubling situation, interventions to iden-
tify and serve justice-involved individuals with serious 
mental illnesses have not yet demonstrated any meaning-
ful reduction in the overrepresentation of such persons in 
the justice system.33
Criminal justice models include diversion from the 
jail system, mental health courts, specialty mental health 
probation or parole, jail aftercare, and community reen-
try programs. Mental health models include Forensic 
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Assertive Community Treatment and Forensic Intensive 
Case Management. These interventions are well-described 
elsewhere.33 They have in common their focus on provi-
sion of psychiatric services (frequently in the community, 
as most individuals eventually enter parole or probation) 
with the goal of reducing recidivism.
There is a dearth of empirical outcome research to sup-
port these interventions. What little research exists has 
focused almost exclusively on criminal justice outcomes 
to the exclusion of mental health outcomes, and is limited 
by serious methodological issues. In their meta-analysis 
of 37 effect sizes from 25 studies assessing the effective-
ness of interventions for justice-involved individuals with 
a mental illness, Martin et al430 tentatively concluded that 
these interventions were modestly effective in reducing 
criminal justice involvement but had no significant effects 
on mental health service use, medication use, or mental 
health outcomes. In contrast, Morgan et al431 synthesized 
treatment effects of interventions on criminal recidivism 
(ie, return to the criminal justice system) and psychiatric 
recidivism (ie, placement in a psychiatric hospital), find-
ing strong positive treatment effects on general mental 
health symptoms and coping, and moderate effects on 
institutional adjustment and behavioral functioning. 
Mean effect sizes for criminal and psychiatric recidivism 
were inconclusive, however, and the review was limited 
by the quality of available research and limited numbers 
of RCTs.
In another review of contemporary interventions for 
justice-involved individuals with serious mental illnesses, 
Skeem et  al429 found no support for the presumed link 
between symptom control and reduced recidivism,432 a 
prevailing belief  that has shaped the development of many 
of these interventions but has scarcely been tested. These 
authors suggest instead that the relationship between 
mental illness and criminal behavior, in most cases, is fully 
mediated by a third variable (eg, poverty, social learning) 
that establishes and maintains criminal risk factors. They 
further suggest that these findings demonstrate that tra-
ditional services are not the sole solution, and they argue 
for the design of a new generation of person-centered ser-
vices tailored to the actual (rather than perceived) needs 
and risks of justice-involved individuals with serious 
mental illnesses. For example, there is emerging evidence 
that offenders with mental illness are equivalent in their 
criminal thinking431 and antisocial attitudes412 compared 
with nonmentally ill offenders. This suggests that in addi-
tion to their mental health needs, justice-involved indi-
viduals with serious mental illnesses have needs related 
to criminogenic characteristics that must be addressed. 
Interventions that treat co-occurring issues of criminality 
and mental illness remain a significant deficit. Another 
explicit and well-documented need among a substantial 
majority of these individuals is substance-abuse treat-
ment.11 Additionally, and not unrelated for many, there is 
an evident need for trauma-based services and treatment. 
Wolff  and Shi433 found a significant relationship between 
trauma history and both addictive behaviors and crimi-
nal involvement.
Summary and Implications Consistent with the policy 
focus of the criminal justice system, research focusing 
on interventions to serve justice-involved individuals 
has concentrated primarily on criminal recidivism as an 
outcome, with mental health outcomes secondary. These 
interventions appear to influence criminal recidivism 
only modestly at best. While they may influence imme-
diate mental health outcomes, there is no clear evidence 
that they influence psychiatric recidivism at all. Further, 
while it is widely believed that improving mental health 
outcomes will reduce criminal recidivism, this approach 
has been shown to be oversimplified, and there has been 
a call to redesign patient-centered interventions for jus-
tice-involved individuals to address the heterogeneity 
of criminogenic, mental health, substance-abuse, and 
trauma needs.
Unintended Consequences and External Influences 
Justice-involved individuals with mental illnesses are 
often presented with an array of programs that, taken 
together, risk causing difficulties because their goals are 
not necessarily compatible. In addition to the lack of 
evidence that “polyprogramming” is effective, such pro-
gramming may be neither cost-efficient nor helpful when 
resources are limited.33
Individuals With Comorbid Substance Abuse Indivi-
duals with serious mental illnesses are at greater risk of 
developing alcohol- and drug-use disorders, with rates of 
substance abuse or dependence estimated at between 40% 
and 70%.351 These substance-related problems contrib-
ute substantially to early mortality in this population,351 
and individuals with serious mental illnesses are also at 
higher risk of adverse psychiatric, social, and medical 
consequences from even moderate use.384,434 Higher risks 
of medical comorbidities and premature mortality likely 
result from a convergence of many factors, including 
increased incidence of harmful behaviors, toxic effects of 
substances, and unintended interactions with psychoac-
tive medications.435 Medical care that is more sporadic or 
of poorer quality compounds this risk and is related to 
poorer access to care, increased rates of poverty, unem-
ployment, lack of insurance, discomfort of primary care 
providers regarding treating individuals with serious 
mental illnesses, and lack of coordination between the 
general medical system and the behavioral health spe-
cialty care system with primary responsibility for treating 
the psychiatric illness.
People with serious mental illnesses and co-occurring 
substance-use disorders have less motivation to change, 
are harder to engage, drop out of treatment programs at 
higher rates, and make slower treatment progress than 
individuals with substance-use disorders but no other 
mental disorders.436 Studies of psychosocial interventions 
designed to treat this population consistently report high 
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rates of attrition and relapse. Not surprisingly, given prob-
lems with engagement and treatment dropout, evidence 
for the effectiveness of these treatments is inconsistent. 
A  2008 Cochrane Review found little compelling evi-
dence to support one treatment over another,437 although 
the same group conducted a later systematic review384 
using more liberal study inclusion criteria and found that 
MI had the best evidence for reducing substance use over 
a short period of time and, when combined with CBT, 
also had positive effects on mental state. The few studies 
that incorporated contingency management also showed 
potential to reduce substance use and, when combined 
with MI and CBT, to increase retention in treatment. 
The support for CBT alone was inconsistent, although 
the length of CBT treatment and the underlying diag-
nosis (schizophrenia or bipolar disorder) may moderate 
effectiveness. Finally, long-term integrated residential 
treatment programs also showed some positive effects on 
reduced substance use.
Consensus recommendations for the treatment of 
people with both serious mental illnesses and substance-
use disorders by an expert panel of academic and state 
mental health system experts were published in 2005.434 
They called for programs that integrate addiction treat-
ment with psychiatric treatment that includes MI, relapse 
prevention, 12-step facilitation, and case management—
especially during vulnerable periods—to help the indi-
viduals navigate services and remain in treatment. Drake 
et  al438 reviewed evidence for integrated models of care 
for dually diagnosed individuals and found promise in 
programs that provided comprehensive integrated care 
that included MI, assertive outreach, medication man-
agement, skills training, and individual and group sub-
stance-abuse counseling for service users and families.
Druss and von Esenwein435 conducted a systematic 
review of interventions designed to improve medical care 
for persons with mental and addictive disorders (but not 
specifically those dually diagnosed). They found six RCTs 
that spanned a continuum of approaches to improving 
medical treatment, ranging from facilitated referrals to 
primary care to team-based care to colocation of medi-
cal consultants within specialty mental health settings. 
Three of the six studies examined inpatient or residential 
treatment programs, and the primary comparison was 
referral to primary care. Compared with this common 
but relatively basic comparison intervention, they found 
that linkages to primary care were better in the interven-
tion groups (five of six studies) and that the interventions 
resulted in improved process measures of medical qual-
ity (five of five). In terms of medical outcomes, however, 
results were mixed. Overall, they found that the interven-
tions were cost neutral.
Summary and Implications There is ample opportu-
nity to improve psychosocial interventions and quality 
of medical care for those with serious mental illnesses 
and substance-use disorders. In particular, models of 
integrated care need to be examined, including integrating 
general medical care into specialty care settings. Testing 
is needed on a range of approaches that vary based on 
diagnostic populations, local and state policy and fund-
ing characteristics, and overall resources available.
Unintended Consequences and External Influences 
There continue to be funding and structural barriers to 
coordinated and integrated services for the treatment 
of persons with both serious mental illnesses and sub-
stance abuse and dependence. These barriers necessitate 
collaboration and coordination among different govern-
mental agencies and funders at the federal, state, county, 
and local levels. In addition, as the Medicaid population 
expands under the ACA, it will be important to moni-
tor whether benefits are reduced and whether integration 
inadvertently results in reduced rehabilitative and recov-
ery services for people with serious mental illnesses. State 
efforts to reorganize care in response to the ACA, by 
using medical or mental health homes and Accountable 
Care Organizations, should provide interesting opportu-
nities to study different forms of integrated care.
Individuals Desiring or Prescribed Medications Psy-
cho pharmacologic treatment of  all serious mental health 
disorders has long been standard practice. A great deal 
of  research has led to the development of  treatment algo-
rithms and practice guidelines,149,322,439–442 yet studies have 
shown that there are continuing deficiencies in the qual-
ity of  medication prescribing,149 suggesting that clarified 
recommendations are insufficient to improve medica-
tion-based treatment of  serious mental illnesses.443
Research on consumer perspectives regarding medica-
tion guidelines could shed light on failed implementation 
and lack of adherence,444–446 but we know very little about 
what individuals with serious mental illnesses want with 
respect to their medications. Instead, a great deal of clini-
cal research has focused on the problem of medication 
nonadherence (often pejoratively termed “noncompli-
ance”)—the prevailing explanation for why people with 
these diagnoses have low rates of participation in EBPs.62 
Experts have identified factors associated with nonad-
herence, including believing medications are no longer 
needed, poor insight, distress associated with specific side 
effects (eg, sedation among people with bipolar disorder, 
or weight gain among people with schizophrenia),445 gen-
eral fear of medication side effects, and inadequate effi-
cacy with persistent symptoms.447 As a potential solution 
to this problem, researchers have tested supplementing 
medication with psychosocial interventions, including 
CBT, Family Based Services,149,448 Cognitive Adaptation 
Training, and ACT,446 and have found these to increase 
adherence446,449 while simultaneously addressing func-
tional symptoms not managed by medications.446,450,451 
However, to our knowledge, research addressing con-
sumer perspectives on medication adherence and how it 
relates to psychosocial services is largely absent and much 
needed.
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Corrigan et  al62 call for a paradigm shift away from 
the current value-based perspective that people who do 
not opt for prescribed treatments are flawed or otherwise 
symptomatic (and, implicit in that assumption, require 
more aggressive motivation for compliance) toward a 
self-determination framework where treatment decisions 
truly allow choices, including those that are ultimately the 
“wrong” choices (ie, those that may not lead to health, 
wellness, or the achievement of patient-defined goals). 
In the era of PCOR opportunities, moving away from the 
traditionally paternalistic focus on nonadherence toward 
empowering consumers in a shared process of treatment 
negotiation and planning may be more in line with what 
consumers want and may better help those who choose to 
take medications take them more effectively.
Individuals Who Do Not Want to Take Psychiatric 
Medications Problems with adherence and discon-
tinuation of  prescribed psychiatric medications are 
among the most common complaints lodged by mental 
health clinicians about their patients. Significant nega-
tive side effects, including movement disorders, weight 
gain, and metabolic problems, combined with inad-
equate symptom control and sedation, suggest that 
service users have logical reasons for reducing or elimi-
nating their use of  medications.445 The growth of  online 
information sources outside the service system (eg, 
http://www.alternativementalhealth.com/directory/ 
search.asp) that provide support for people wanting 
to avoid or discontinue psychiatric medications sug-
gests that this is an area in need of  attention by mental 
health researchers.
Although rare, some mainstream alternatives have been 
proposed for people who do not want to take medications 
or who prefer to limit their use of medications as much as 
possible. These include antipsychotic postponement (for 
those recently diagnosed who may experience spontane-
ous remission),452 dose-reduction or low-dose medication 
strategies,452 and noncontinuous targeted treatment.453 
These strategies are more likely to be employed by alterna-
tive programs such as those based on the Open Dialogue 
(OD)454,455 or Soteria models.456,457
Evidence exists for antipsychotic postponement, par-
ticularly when paired with psychosocial interventions.452 
In one study of targeted treatment,452 course of illness 
(including rehospitalization rates) was similar for those 
receiving continuous and those receiving noncontinuous 
targeted medication when those in the targeted drug arm 
of the study also received enriched psychosocial clinical 
care and early intervention. In another study, however, 
individuals diagnosed with recent-onset schizophrenia 
had similar relapse rates regardless of study arm, but 
those characterized as having multiple episodes in the tar-
geted treatment arms had much higher relapse and rehos-
pitalization rates than those in the maintenance arm.458 
The most recently published treatment recommenda-
tions from the Schizophrenia Patient Outcomes Research 
Team149 do not endorse a targeted treatment approach, 
but concede that for select individuals diagnosed with 
recent-onset schizophrenia who refuse continuous main-
tenance pharmacotherapy, or for whom some other con-
traindication exists, targeted treatment is an alternative. 
They counsel, however, that it should be pursued only 
when the individual can be monitored closely enough 
that the targeted intervention can be initiated at the earli-
est signs of clinical exacerbation.
Beyond the studies described above, and those exam-
ining the effects of short-term medication withdrawal 
or medication “holidays,” we were unable to find recent 
evaluations of programs that provide services specifically 
to individuals who do not want to take medications. If  
services are to become patient centered and successfully 
engage all individuals with serious mental health prob-
lems, programs focusing on alternatives to medications 
need to be developed for those who prefer to limit medi-
cations or are unwilling to use them.
Overweight Individuals Over 42% of adults with a 
serious mental illness are obese, due in part to adverse 
effects associated with antipsychotic medications.90 
Moreover, fewer than 20% of people with schizophre-
nia engage in regular moderate exercise, and people with 
schizophrenia tend to have poorer diets than the general 
population.404 Modest weight loss (5% or greater) results 
in clinically significant reductions in cardiometabolic 
risk, and a growing literature compares the effectiveness 
of various interventions aimed at improving diet, reduc-
ing weight, and increasing physical activity. Bartels and 
Desilets404 conducted a systematic review and analysis 
of this literature, concluding that lifestyle interventions 
have been inconsistently effective in producing clinically 
significant weight loss and that effective interventions 
have succeeded in only a minority of participants. The 
factors driving success in such programs remain unclear, 
but programs are more likely to succeed if  they last 3 
months or longer and incorporate both education- and 
activity-based approaches. The Schizophrenia Patient 
Outcomes Research Team141 recommendations suggested 
that overweight individuals diagnosed with schizophre-
nia be offered a psychosocial weight loss intervention 
that is at least 3 months in duration and focuses on psy-
choeducation and nutritional counseling, caloric expen-
diture, portion control, behavioral self-management, goal 
setting, regular weighing in, self-monitoring of diet and 
physical activity, and modification of diet and physical 
activity. In addition to the potential weight loss benefits 
of these interventions, evidence reviewed in this report141 
suggested that providing early behavioral intervention to 
individuals recently diagnosed with serious mental ill-
nesses, or new to antipsychotic medications, can prevent 
greater weight gain compared with controls not receiving 
psychosocial intervention.
In addition, there is an urgent need for the development 
of medications that are not associated with weight gain 
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and other side effects.459 In the absence of such agents, 
additional research comparing approaches to preventing 
and managing antipsychotic-associated weight gain is 
needed,439,445,460 particularly given the high rates of medi-
cation discontinuation and the differential side-effect 
profiles in existing comparative effectiveness studies.459,461
There is an important emerging literature on the effi-
cacy of various adjunctive medications that, when used 
in combination with antipsychotics, attenuate antipsy-
chotic-related weight gain and metabolic abnormalities. 
Numerous studies have examined the efficacy of adjunc-
tive Metformin in prevention and treatment of antipsy-
chotic-induced weight gain, with results supporting its 
use,462–464 particularly with first-episode or drug-naïve 
patients and in combination with lifestyle intervention.465 
Sibutramine and topiramate have also shown some ben-
efit, while amantadine and orlistat appear less effective 
and less tolerable.460 More research of this nature is 
needed, as well as a better understanding of the risks of 
weight gain when patients are taking multiple psychiat-
ric medications together (each with its own and perhaps 
additive effects on weight).466 Finally, further study of 
the pharmacogenetics that influence response to antipsy-
chotic medications may inform personalized medicine 
that limits weight gain.466–468
Unemployed or Underemployed Individuals Interested in 
Working Because the onset of serious mental health prob-
lems typically occurs in adolescence and early adulthood, 
these disorders have the potential to affect educational 
attainment, employment, and earning potential.469 Despite 
such barriers, most people with serious mental illnesses 
want to work,470 and evidence shows that paid employment 
can improve a wide variety of patient-centered and other 
outcomes, including service use and costs.471–473
Supported employment (SEM) is widely acknowl-
edged as an EBP for individuals with serious mental ill-
nesses. The Schizophrenia Patient Outcomes Research 
Team140 recommends that SEm be offered to any person 
with schizophrenia who expresses an interest in working. 
The review group found no evidence to support concerns 
that engagement in SEm leads to increased stress, exac-
erbation of  symptoms, or other negative clinical out-
comes. Rather, they found that RCTs have consistently 
demonstrated the effectiveness of  SEm in attaining com-
petitive employment, working more hours, and earning 
better wages than those not receiving SEm. Individual 
Placement and Support is the most researched of  the 
SEm models and has been shown to produce better 
competitive employment outcomes than alternative 
vocational programs, regardless of  background demo-
graphic, clinical, and employment characteristics.146 The 
major components of  SEm are (1) competitive employ-
ment in the community without extended preparation 
(contrasted with prolonged preemployment preparation 
typical of  traditional vocational rehabilitation mod-
els), (2) integration of  employment and mental health 
services, (3) an emphasis on client preference and choice 
regarding jobs, and (4) the availability of  ongoing job 
supports. Dixon et al140 found that outcomes were clearly 
superior when more components of  the model were in 
place, although they noted that effectiveness of  individ-
ual model components has not been adequately studied. 
The one exception to this is integration of  mental health 
and vocational services, which was associated with better 
outcomes.
In addition, described below are several alternative 
approaches for improving employment outcomes among 
individuals with serious mental illnesses, some of which 
are being disseminated and implemented in community 
settings. To date, however, little research has evaluated 
their effectiveness, so this is an area where good compara-
tive effectiveness studies could lead to improvements in 
a key patient-centered outcome. The Clubhouse Model 
has shown promise for improving employment outcomes 
for individuals with serious mental illnesses. While it 
began as a support system for individuals with serious 
mental illnesses, some programs have become structur-
ally more like day treatment programs; subsequently, the 
term is now used to refer to a broad range of programs 
with varying levels of fidelity to the original Clubhouse 
Model. The model’s early roots as a consumer-led pro-
gram heavily influence its patient-centered approach to 
care and services. Members attend Clubhouses volun-
tarily and determine their level of participation and the 
type of work activities in which they engage. The goal of 
the program is to involve members in a community that 
promotes recovery through relationships and responsi-
bilities within and outside the Clubhouse. In addition to 
community-based employment and vocational supports, 
Clubhouses offer a range of services including education, 
housing, outreach, advocacy, health care assistance, sub-
stance-abuse services, and recreational opportunities.474
Despite the model’s long history and its prolifera-
tion in numerous countries, reviews assessing outcomes 
among members are sparse. A 2010 review produced by 
the International Center for Clubhouse Development 
for SAMHSA’s National Registry of Evidence-based 
Programs and Practices475 examined three outcomes 
(employment, QOL, and recovery) measured across 
two studies, only one of which was experimental. That 
study,476,477 an RCT comparing SEm outcomes for par-
ticipants in ACT and Clubhouse, showed that over 2 
years, Clubhouse members worked more days and hours 
per job than ACT participants and earned more wages. 
Additional analyses including independent and transi-
tional employment outcomes and SEm outcomes over 
30  months showed that Clubhouse members worked 
more weeks and earned a higher hourly wage than ACT 
participants.476
Affirmative businesses, or social firms, are another 
model with potential to improve employment outcomes 
for individuals with mental health problems. Developed 
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in Trieste, Italy, in the 1970s, affirmative businesses have 
gained prominence in Europe and, to a lesser extent, 
in the United States and other countries. The goals of 
such businesses are two-fold: to gainfully and meaning-
fully employ individuals with disabilities in a coopera-
tive work environment and to provide a needed service. 
For example, after learning that the city had a significant 
problem with abandoned scooters in a certain area, man-
agers of the Trieste cooperative recognized an oppor-
tunity and staffed a scooter-salvaging workshop with 
disadvantaged youth, many of whom had histories of 
stealing scooter parts to sell on the streets.478 Affirmative 
businesses empower individuals and foster communities 
and a sense of commitment though a social mission. In 
a qualitative study of work life among individuals with 
serious mental illnesses working in a social enterprise, 
workers reported a sense of belonging and of compe-
tence in being a good worker, and that a quality work 
life meant establishing relationships with coworkers and 
supervisors.479 The goals and opportunities supplied by 
social firms may provide an opportunity for individuals 
with serious mental illnesses to realize important work-
related, patient-centered outcomes. There is insufficient 
evidence at this time, however, to support this model as a 
method of improving employment or psychosocial out-
comes. Research is needed comparing the effectiveness of 
these to other employment programs.
Summary and Implications SEm has clear evidence of 
its effectiveness among individuals with serious mental 
illnesses. While the Clubhouse and social firms are unique 
and patient-centered interventions, additional outcome 
research is needed to support these alternative mod-
els of care. Additionally, a metasynthesis of qualitative 
research on the employment-related views of people with 
serious mental illnesses480 found several barriers that, if  
addressed, might improve outcomes. These include barri-
ers to ongoing support within and beyond the workplace 
and systems barriers, such as financial disincentives for 
working and lack of funding for vocational resources.
Individuals Who Are Homeless or at Risk for Home-
lessness The deinstitutionalization movement has 
meant reductions in extended hospital stays for individu-
als with serious mental illnesses. An unintentional conse-
quence of this transition, combined with other economic 
and housing-related factors, has been inadequate, incon-
sistent, or unstable housing for many individuals with 
mental illnesses.481 Choice in housing is very important to 
consumers, with many consumers choosing more auton-
omous living situations when given the opportunity.481 
Piat and Bloom481 asked consumers and case managers 
to rank their housing preferences on a list that ranged 
from one’s own apartment to a hospital. The authors 
found that most consumers preferred living in settings 
with more autonomy than their current living situations 
provided. Similarly but to a lesser degree, case managers 
also favored increased autonomy, preferring housing with 
both more structure and clinical involvement (eg, super-
vised apartments).
Housing First and supported housing programs have 
been developed to address housing needs by providing 
flexible, need-based services and the supports neces-
sary to place and keep individuals living independently 
in community-integrated housing. Philosophically, 
Housing First programs are distinguished from other 
programs in that they emphasize choice and require 
neither engagement with the mental health system nor 
sobriety, to qualify for a permanent residence. Indeed, in 
at least one study,482 Housing First decreased homeless-
ness and increased perceived choice and led to decreased 
psychiatric symptoms, partially mediated by mastery. In 
contrast, traditional programs typically require absti-
nence and participation in treatment. Housing First and 
traditional interventions also differ in that the former 
focuses on housing stability as a primary policy out-
come, while the latter targets addiction through behav-
ioral approaches with the goal of  improving clinical 
outcomes. Kertesz et al290 contrasted these differences in 
their review of outcome studies of  Housing First and 
traditional housing interventions for homeless indi-
viduals with addiction. They concluded Housing First 
achieved excellent housing retention, while traditional 
programs produced reductions in addiction severity but 
limited long-term housing success. They suggested that 
future research should compare both types of  interven-
tions, in RCTs, with appropriate measures for both types 
of  outcomes, as well as analyses of  which programs are 
optimal for meeting the specific needs and preferences of 
homeless individuals.
ACT programs also address housing as part of a com-
prehensive package of mental health and other services. 
Nelson et al483 reviewed eight studies that compared ACT 
to a variety of other models, including ICM, case man-
agement, residential housing, and residential treatment 
(which included case management, treatment for sub-
stance abuse, and housing supports). The best outcomes 
for housing stability were programs that included housing 
and other support, followed by ACT alone. Compared 
with standard care, ACT showed improved outcomes for 
(1) housing stability; (2) reduced hospitalizations and 
shorter hospital stays (which were offset by increased use 
of outpatient treatment and social services); (3) higher 
levels of engagement with treatment and social service 
staff; (4) client satisfaction with services; (5) some evi-
dence of improved functioning and adaptation to com-
munity living; (6) positive self-ratings of overall health 
and well-being; (7) improved ability to meet basic needs; 
and (8) improved ability to access material supports from 
others.483 Controversy surrounds ACT programs, how-
ever. Many are not recovery focused, and their paternal-
istic approach can be seen as intrusive and coercive.484
Rogers485 conducted a systematic review of various 
types of  supported housing, including those already 
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described here, and found several well-controlled studies 
of  supported housing programs and several studies con-
ducted with less rigorous designs. Overall, the literature 
suggests that supported housing can improve the living 
situation of  individuals with serious mental illnesses and 
can help up to about 80% of people to stay in apartments 
or homes over an extended period. Additionally, the 
review suggests that although supported housing does 
not consistently reduce psychiatric symptoms, it can 
reduce rehospitalization, improve QOL, and increase 
satisfaction with living situation, when housing quality is 
good. The review found that ICM services generally lead 
to better housing outcomes, and clinical supports can 
mitigate isolation if  that is a problem. Housing subsidies 
or vouchers appeared to be helpful in getting and keep-
ing individuals housed, and housing services appeared 
to be cost-effective and to reduce the costs of  other 
social and clinical services. They also noted that having 
access to affordable housing and having a well-integrated 
service system is also important to improving housing 
outcomes.
Individuals in Crisis We can surmise that for many 
individuals with serious mental illnesses, avoidance of 
hospitalization—and particularly coercive admission—
is a patient-centered outcome. Advanced crisis plan-
ning through the use of psychiatric advance directives 
(PADs), joint crisis plans, and safety plans holds promise 
for reducing hospitalization and compulsory admissions. 
PADs are documents created by consumers of mental 
health services who anticipate a need for future service 
use and elect to make their preferences for care known 
in advance. PADs may be executed entirely by the indi-
vidual, while joint crisis plans involve carers and a third 
party who mediates negotiation of the plan. Whereas 
PADs and, to a lesser extent, joint crisis plans are com-
prehensive in their scope and sometimes include arrange-
ments and provisions outside of psychiatric care (eg, who 
will care for my pet while I’m in the hospital), safety plans 
are specifically oriented around keeping an individual safe 
when suicidal behavior emerges. Henderson et al486 con-
ducted an RCT comparing use of inpatient services and 
legal coercion between individuals who created a joint 
crisis plan for their care and those receiving standard 
care. They found that the use of an advance plan reduced 
the number of admissions and significantly reduced use 
of legally invoked, involuntary treatment. In an earlier 
pilot study, use of such documents helped the majority of 
participants feel more involved in their care, more posi-
tive about their situation, and more in control of their 
mental health problem.487 In addition to these patient-
centered outcomes, the collaborative process of creating 
these documents has potential to increase empowerment 
and improve therapeutic relationships.
Once individuals enter psychiatric crises, an appropri-
ate and prompt response can minimize further deteriora-
tion. Generally, the intent of crisis services is to provide 
immediate intervention in response to critical incidents 
in acute phases of illness in order to reduce the risk of 
relapse and reduce repeat hospitalizations. Murphy and 
colleagues488 compared RCTs of crisis intervention mod-
els with standard care for people with serious mental 
illnesses. Crisis intervention appears to reduce hospital 
readmission, particularly for mobile crisis teams provid-
ing in-home response. Further, crisis intervention reduces 
family burden and is a more satisfactory form of care 
than hospitalization for both service users and families/
carers. At 3 months postcrisis, mental state was superior 
in those who received crisis intervention to those receiv-
ing standard care. Whether crisis intervention is more 
cost-effective than hospital care remains an area for 
investigation.
Compared with inpatient hospitalization, residential 
treatment programs are a less restrictive alternative to 
acute psychiatric crisis and are characteristically quite 
different in approach and philosophy of care. While 
implementation differs, residential treatment programs 
share common characteristics: fewer residents than typi-
cal hospital settings, a caring milieu including intense and 
regular supportive therapeutic contact, less emphasis on 
medication, and a less stigmatizing approach to the treat-
ment of psychosis.489 Still, these care settings are inap-
propriate for some individuals, including those who are 
not interested in care, are actively violent to themselves 
or others, have serious medical needs that would be bet-
ter met in psychiatric departments in general hospitals, 
and are actively using substances (though this is not an 
absolute exclusion in some of these settings). In an over-
view of residential care alternatives for acutely psychotic 
individuals, Lichtenberg489 reported that with regard to 
clinical and psychosocial outcomes, these models are 
comparable to inpatient treatment and generally cost less, 
although research investigating their long-term effects 
and costs is needed.
While other programs (eg, intensive outpatient treat-
ment) are being implemented as alternatives during 
crisis, we were unable to find research evaluating their 
effectiveness. More evaluations of existing crisis inter-
vention protocols and programs are needed. A recently 
published Cochrane review of crisis intervention for peo-
ple with severe mental illnesses included only six studies 
with a total of 984 people.490 The authors considered the 
methods of these studies poor (ie, crisis care was poorly 
defined, samples were not generalizable) and concluded 
that current crisis intervention efforts may lack sufficient 
empirical support.
Summary and Implications Alternatives to inpatient 
hospitalization during crisis show promise for improv-
ing clinical and patient-centered outcomes, as well as 
being cost-effective. Understanding which approaches 
and characteristics of crisis management produce opti-
mal outcomes may create opportunities to improve crisis 
management and reduce relapse and rehospitalization.
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Individuals at High Risk for Disengagement and 
Rehospitalization ACT was developed in response to the 
“revolving door” phenomenon among service users with 
serious mental illnesses. ACT is a comprehensive set of 
time-unlimited clinical, rehabilitation, and support (hous-
ing, employment, social) services provided directly by a 
multidisciplinary team in the community setting. Caseloads 
are low (1:10) and shared among the team, which typically 
includes a psychiatrist, nurse, case manager, and other pro-
fessional, paraprofessional, and sometimes peer staff.491
ACT has proliferated and become one of the most 
intensively studied interventions in community mental 
health.492 On the basis of its evidence, it is a recommended 
program for treating individuals who have schizophre-
nia, are recently homeless, or are at risk of repeated 
hospitalizations.140 ACT has been adapted for a variety 
of populations and has demonstrated improved mental 
health outcomes (eg, symptom severity, psychiatric hos-
pitalizations)493,494 and community outcomes (eg, housing 
stability, educational attainment). It has not been shown 
to improve outcomes for individuals with co-occurring 
mental health and substance-abuse disorders.495
There is concern and a wide array of opinions regarding 
whether ACT is coercive and paternalistic. When ACT was 
developed following deinstitutionalization, client prefer-
ences were not central to delivery of care. It was assumed 
that staff were in the best position to determine what cli-
ents needed, and staff values tended to overshadow clients’ 
expressed preferences. Salyers and Tsemberis484 provide an 
excellent examination of the philosophical similarities and 
differences between ACT and the recovery model of care, 
and outline the challenges of integrating recovery concepts 
into the ACT model. They point to the need for ACT to 
align with human rights concepts, the need for providers 
to shift from “clinician as expert” to a more collaborative 
and client-centered treatment approach, and the impor-
tance of shared values and attitudes in creating a trusting 
and respectful relationship with clients. The authors list 
challenges to integrating recovery goals, including man-
datory outpatient commitment, lack of client trust in the 
mental health system’s ability to understand and address 
their needs, constant contact with clients who may not 
want to engage, medication monitoring among people 
who may not want to take medications, and the occa-
sional need for providers to act coercively to be effective. 
Research is needed to adapt ACT programs to make them 
recovery focused and patient centered.
ICM is sometimes described in the literature as a dilu-
tion of ACT, and other times as a heterogeneous group 
of methods combined to meet an individual’s needs.491 
Dieterich et  al496 compared ICM with non-ICM (same 
characteristics with the exception of larger caseloads) and 
standard care across 38 trials in the United States, Canada, 
Europe, and Australia. When ICM was compared with 
standard care, those in the ICM group were significantly 
more likely to remain engaged in the service, had improved 
general functioning, and were more likely to get a job, not 
be homeless, and have shorter hospital stays (particularly 
when they previously had longer stays). Results for men-
tal state and QOL were equivocal, and no differences in 
suicide or all-cause mortality were found. When ICM was 
compared with non-ICM, those in the ICM group were 
more likely to be kept in care; however, no other differences 
emerged. Thus, it is not clear what advantage ICM with 
limited caseloads confers over non-ICM with maximized 
caseloads. There were no trials comparing non-ICM with 
standard care, and such study is warranted.
Summary and Implications ACT and ICM have been 
widely studied and are effective approaches to improving 
certain outcomes for clients with serious mental illnesses. 
Policy makers and providers can target resources more 
effectively when they have a better understanding of 
what works for whom, especially for subpopulations, and 
under what conditions. Importantly, understanding how 
ACT and ICM components can meet service user prefer-
ences without undue coercion is an important task for 
PCOR. In addition, future research on ACT should focus 
on examining preferences of clients enrolled in ACT and 
ICM programs, enhance patient-centered approaches, 
and identify effects of ACT and other ICM programs on 
patient-centered outcomes.
Individuals in Need of Daily Living Assistance or Social 
Skills Training Acute exacerbations of symptoms can 
compromise self-care skills and functioning. Life skills 
programs attempt to enhance QOL by providing rehabili-
tation and training in activities of daily living, including 
communication training, financial awareness, domestic 
skills, personal hygiene, and self-care, as well as stress 
management, medication compliance, forward planning, 
and transportation. Tungpunkom et al497 compared dif-
ferent types of rehabilitation therapy (life skills programs, 
occupational therapy, peer support, and standard care) 
for individuals with serious mental illnesses. Their review 
included seven RCTs with a total of 483 participants. 
The authors concluded that more robust data are needed 
from studies adequately powered to determine whether 
life skills training is beneficial for people with serious 
mental illnesses. They found no significant differences 
in outcomes between the various types of rehabilitation 
therapy and standard care.
Similar to life skills training, social skills training 
is meant to compensate for deficits in skills needed for 
everyday activities and independent living. Social skills 
training typically focuses on interpersonal skill devel-
opment through behavioral instruction, rehearsal, role 
playing, corrective feedback, and positive reinforcement. 
Because social skills training has shown significant effects 
on proximal (skill tests) and distal (community func-
tioning) measures of outcome,498 it is recommended as 
a psychosocial treatment (typically part of a bundle of 
services) for individuals with schizophrenia who demon-
strate social skills deficits.
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Individuals With Cognitive or Social-Cognitive 
Deficits Characteristic of many serious mental illnesses 
are cognitive difficulties, including in areas of attention, 
memory function, and executive function.499–502 Social-
cognitive abilities may also be affected, including facial 
affect recognition,502 social cue perception, Theory of 
Mind (the ability to attribute mental states to another), 
and attributional style.504 These types of cognitive defi-
cits, which are not responsive to pharmacological inter-
ventions504 and in fact may be worsened by them,505 are 
strongly associated with low functioning and have been 
recognized as a rate-limiting barrier to recovery for 
many.502 Cognitive interventions aimed at specific503 and 
broad-based506–511 cognitive and social-cognitive deficits 
have been developed and evaluated in populations with 
schizophrenia and, to a lesser extent, affective disorders. 
Collectively, these interventions are termed cognitive 
remediation (CR). Several meta-analyses and reviews 
have demonstrated that for individuals with schizophre-
nia, brief  or extended CR produces moderate but statisti-
cally significant changes in cognitive functioning, durable 
over 2 years.502 Moreover, although CR interventions do 
not appear to affect clinical symptoms, cognitive improve-
ments resulting from them appear to generalize to long-
term personal and social functioning.502 In the affective 
literature, the Barcelona Bipolar Disorder Programme 
has extended CR to include psychoeducation on cogni-
tion-related issues, problem solving, and family support 
with the explicit aim of improving functional outcomes. 
The modified intervention, functional remediation,512 has 
not yet been evaluated, but rigorous investigation is war-
ranted given growing evidence that supports the use of 
CR for individuals with affective disorders.506,513,514
Older Individuals With Serious Mental Illnesses Not 
unlike many other subgroups described within this report, 
the mental health and substance-use needs of older adults 
are complex and frequently unmet by today’s health care 
delivery system. Bartels515 described the “forgotten terri-
tory” in policy advocacy that older adults with serious 
mental illnesses occupy. These individuals are often left 
out of efforts to advocate for the elderly more generally 
and, by virtue of their age, are ignored by those work-
ing on behalf  of the mentally ill. To date, most clinical 
and research developments applicable to individuals with 
serious mental illnesses have focused on adults younger 
than 65 years, and it is unclear whether findings from 
those studies generalize to older adults.516 Our knowledge 
of appropriate treatments for geriatric mental illness and 
substance misuse has dramatically increased in the past 
25 years, but gaps in understanding remain, and where 
evidence exists, implementation failure is common.516 
Mental health systems are, thus, ill equipped to address 
the unique needs of this population.
Barriers to care at the system, organizational, interac-
tional, and individual levels include a shortage of provid-
ers trained in geriatric mental health,517 limited funding 
or reimbursement for providing developmentally adapted 
mental health programs and specialty services,518 ageism 
and other biases among providers,515,519 providers’ per-
ceptions that certain mental illnesses (eg, depression) are 
a natural part of aging or an unavoidable symptom of 
comorbid medical conditions,520 providers’ low likelihood 
of suspecting substance misuse among the elderly,519 neg-
ative beliefs and stigma surrounding mental illness and 
substance use, and underutilization of mental health and 
addictions services and specialists.517,519 Further, diagno-
sis and treatment are complicated by developmentally 
normative cognitive, functional, and sensory impair-
ments associated with aging; comorbid physical illnesses 
that have impacts on mental health; and medication 
interactions. These factors converge to result in dispro-
portionately untreated mental illness and substance-use 
conditions among older adults, with corresponding and 
significant impacts on health, functioning, QOL, health 
service use, and costs. With the higher overall standard 
of living and better treatments for physical and psychiat-
ric disorders, a greater proportion of adults with serious 
mental illnesses are reaching old age. And with the “baby 
boom” generation now reaching age 65, the challenges 
and costs of treating the growing numbers of older adults 
with serious mental illnesses should be a major focus of 
patient-centered research and mental health service deliv-
ery systems.517,521
Areas ripe for CER and PCOR to improve services to 
this population include (1) identifying older adults with 
serious mental illnesses in need of services, (2) engaging 
them in care, (3) determining the most effective interven-
tions (both pharmacological and psychosocial) for this 
age group, (4) identifying the patient-centered outcomes 
valued by this group, and (5) determining how to best 
deliver interventions to achieve optimal patient-centered 
and clinical outcomes.
We found very few examples of interventions designed 
to engage older adults with serious mental illnesses, and 
published trials suffer from suffered from methodologi-
cal limitations. A systematic review, however, found sup-
port for the positive effects of outreach services.522 This is 
clearly an area for development. There is also a paucity of 
comparisons of needs among older and younger persons 
with serious mental illnesses, and of longitudinal research 
investigating how needs change over time.516 Age may be 
an important moderator of treatment engagement and 
response. Future PCOR focusing on better understand-
ing of moderators of treatment response may lead to bet-
ter matching of service users to existing EBPs and to the 
development of modified or novel interventions.
We found little in the way of evidence-based clinical 
practice guidelines or treatment algorithms specific to 
elderly individuals with serious mental illnesses. There 
is a growing literature, however, showing promising psy-
chosocial interventions that have been adapted or devel-
oped and evaluated for use with middle-aged and older 
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adults.515,516,519,521,523 Bartels and Pratt521 reviewed psycho-
social rehabilitation interventions for older adults with 
serious mental illnesses and identified several important 
areas for future CER and PCOR. First, many of the 
published psychosocial rehabilitation interventions are 
group based, and there is a need for comparisons of those 
approaches with individual interventions that target the 
specific needs and preferences of the consumer. Second, 
existing and novel interventions need to be compared 
with regard to their impacts on cognition, depression, 
social integration, involvement in meaningful activities, 
and chronic medical illness, as these mutable outcomes 
are shown to be strongly associated with poorer function-
ing and lower QOL in older adults with serious mental 
illnesses.524 Bartels and Pratt521 posited a need for inter-
vention strategies that address both physical and mental 
health needs, integrating health promotion, health care, 
and illness self-management. To this we would also add 
preventive health care.
Also highly relevant to PCOR are findings related 
to the delivery of  care, specifically where older adults 
want to receive care and the correlates associated with 
institutional care. Adults with serious mental illnesses 
are more than 1.5 times more likely to be admitted to 
nursing homes than are Medicaid beneficiaries without 
mental illness.525 Mental health treatment in nursing 
homes is often substandard,518 and institutionalization 
is associated with worse health status, decreased avail-
ability of  family supports, more severe overall symp-
tom ratings, greater cognitive impairment, more severe 
functional deficits, more problem behaviors, more 
severe medical problems, and fewer social supports.521 
Given this, it is imperative that the mental health 
delivery system better understand who is a candidate 
for institutional care and who might be better served 
in other settings. Despite popular misconceptions, 
aging with a serious mental illness is not necessarily 
associated with a decline in independent functioning 
or with a need for institution-based long-term care. 
Aschbrenner and colleagues526 found that a substantial 
number of  adults with serious mental illnesses in nurs-
ing homes may have the functional capacity to reside 
in less restrictive settings. When the authors examined 
nursing home admissions and long-stay conversions of 
younger and older residents with and without serious 
mental illnesses, they found that, despite a greater pro-
portion of  residents being classified as having low care 
needs compared with residents without serious mental 
illnesses, those with serious mental illnesses were sig-
nificantly more likely to become long-term residents. 
Data showed that 33% of  the sample of  young residents 
with serious mental illnesses were classified as having 
low-care need, while only 8.5% of  young residents 
without serious mental illnesses were classified as hav-
ing low-care needs. Nevertheless, young residents with 
serious mental illnesses were 3.9 times more likely to 
be long-term residents. This same pattern was shown 
for residents over age 65: 14% of  those with serious 
mental illnesses were classified as having low-care needs 
compared with 6.6% of  those without serious mental 
illnesses, yet older adults with serious mental illnesses 
were twice as likely to be long-term residents.
Especially important to PCOR, Bartels515 found that 
consumers had strong preferences for in-home or inde-
pendent living settings. When asked to choose among 
nursing home, group living setting in the community, or 
independent supported housing, 40% of nursing home 
residents with serious mental illnesses believed that a 
community-based setting would best meet their care 
preferences and needs. Many individuals, however, are 
forced into nursing homes because of a lack of affordable 
community-based residential alternatives. Myopic fiscal 
policies518 act against efforts to establish community-
integrated mental health services, favoring acute medical 
care in inpatient settings rather than targeting rehabili-
tative interventions and support services (eg, Meals on 
Wheels, senior housing, family interventions that target 
physical and mental illness management) that improve 
community living, self-management, social support, and 
health—key factors associated with successful commu-
nity tenure.515
Our review suggests that in order to best serve older 
adults with serious mental illnesses, a reorganization 
of care and service delivery is needed at multiple lev-
els. A necessary prerequisite is the redirection of public 
funds toward community-based care initiatives and the 
development of measures to determine who benefits from 
institutional, community-based, and home-based care 
models. Also required are the development and evalu-
ation of developmentally appropriate engagement and 
treatment interventions and support services, as well as 
evaluation of the implementation of these interventions 
across various settings.
Individuals Interested in Involving Family and Significant 
Others in Care Individuals who maintain relation-
ships with relatives and significant others may elect to 
involve their family members in their mental health care. 
In a qualitative study of the role of family in support-
ing recovery, residents of structured community housing 
identified their families more often than mental health 
professionals, residential caregivers, or friends as those 
who most strongly believed in them and their recovery.527 
Dixon et al140 recommend that when the individual, fam-
ily, and clinician collaboratively agree that family/carer 
participation in treatment is acceptable and desired, an 
intervention lasting at least 6–9 months (or at minimum 
four sessions) should be offered. Such interventions, 
often termed family psychoeducation, include illness edu-
cation, emotional support, training in coping skills, and 
crisis intervention, and have been shown in meta-analyses 
to significantly reduce rates of relapse and rehospitaliza-
tion. Dixon et al140 summarized literature indicating that 
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consumers who receive at least 6 months of family-based 
psychoeducation show improved treatment adherence, 
lower perceived stress, and better vocational outcomes 
than controls. Moreover, their family members reported 
lower levels of burden and distress and improved fam-
ily relationships. The benefits of family psychoeducation 
seem to be even greater for individuals who have had a 
recent relapse of symptoms.
Individuals With Initial-Onset Psychosis Prevention, 
early identification, and treatment of psychosis have 
increasingly been emphasized in mental health programs, 
especially in the United Kingdom, elsewhere in Europe, 
and in Australia, although trials are increasingly being 
done in the United States as well. Early intervention in 
schizophrenia is defined by early detection and phase-
specific treatment using psychological, social, or physi-
cal treatments developed and/or modified for use with 
people at an early stage of the illness.528 A joint consen-
sus statement of the World Health Organization and the 
International Early Psychosis Association articulated 
“universal principles” of early intervention and proposed 
10 strategic recommendations that included early identifi-
cation, primary care treatment, availability of medication 
and psychosocial treatments, family education and sup-
port, and expanded research.529
A number of reviews addressing prevention and early 
intervention have been published in the last 2 years. 
These reviews, in contrast to earlier ones, have begun to 
show evidence of some positive outcomes, although the 
types of interventions vary widely and the evidence is not 
robust. Preti and Cella530 reviewed seven RCTs conducted 
with people identified as at ultrahigh risk of develop-
ing psychosis. Interventions ranged from antipsychotic 
drugs, CBT, combination antipsychotics and CBT, inten-
sive community treatment with family education, and 
Omega-3 polyunsaturated fatty acid supplements (ethyl 
EPA). They concluded that the Omega-3 and CBT were 
effective in reducing transition to psychosis at 12 months. 
Follow-up after 2–3 years showed that effectiveness was 
not maintained after withdrawal of treatment, however, 
and that limited treatment may have delayed but did not 
prevent psychosis onset.
In a 2010 systematic review and meta-analysis of early 
intervention services, CBT, and family intervention for 
people with early psychosis, Bird et al531 concluded that 
early intervention reduced hospital admissions, relapse 
rates, and symptom severity, as well as improved access 
to and engagement with treatment. Family intervention 
alone reduced relapse rate and hospital admission rates, 
whereas CBT alone reduced severity of symptoms but 
had no impact on relapse or hospitalization. The authors 
concluded, however, that longer term benefits of the 
approach and the relative effects of its different compo-
nents need additional research.
Marshall and Rathbone’s 2011 Cochrane Review of 18 
RCTs testing early interventions for psychosis528 found 
that most studies were underpowered to draw firm con-
clusions. An analysis of  the six studies that investigated 
a variety of medication and psychosocial interventions 
to prevent psychosis in those with prodromal symptoms 
found that neither medication alone nor CBT alone 
was effective. A  combination treatment of risperidone, 
CBT, and specialized teams was effective, but only for 6 
months; at 12-month follow-up, benefits were no longer 
present.
Authors of  this review also reported that studies 
examining outcomes in first-episode psychosis found 
few substantial effects on outcomes of suicidality, days 
in hospital at 1 year, relapse, or treatment compliance. 
The largest and highest quality study using a specialized 
team intervention found a few positive findings—better 
compliance with treatment, fewer individuals leaving the 
study early, and fewer “not living independently” after 
5 years. One study found that vocational rehabilitation 
resulted in higher levels of  employment, and another 
suggested that family therapy may have small effects. 
Overall, the authors concluded that early intervention 
shows some promise but that there are questions as to 
whether any effects are maintained over long periods. 
They suggested that larger and more rigorous studies are 
needed.
Correll et  al,532 in a comprehensive review of  early 
intervention approaches, found a variety of  interven-
tions (CBT, antipsychotics, ethyl EPA, and combination 
CBT/antipsychotics) to have beneficial effects on rates 
of  conversion to psychosis, psychopathology, and func-
tioning compared with control conditions. Consistent 
with the Cochrane Review, however, effects did not 
appear to last following termination of  the interven-
tion, with the possible exception of  the ethyl EPA study 
previously cited.
An alternative approach to early intervention is the 
Open Dialogue (OD) model model developed in Finland. 
This model evolved from a social constructionist frame-
work positing that a person’s reality grows out of his or 
her social context and everyday interactions. The model’s 
origins evolved from the Need-Adapted approach pro-
moted by Alanen.533 OD454,455,534 is based on seven core 
principles: immediate intervention within 24 hours of 
first contact; a social network perspective that includes 
the individual, family, neighbors, friends, and, to the 
extent possible, employers, social service, and vocational 
agents; flexibility to adapt to the individual’s changing 
needs; staff  responsibility for the treatment process; con-
tinuity of care; tolerance of uncertainty; and facilitation 
of communication and promotion of dialogue as a means 
of understanding the situation.
The OD model has been implemented almost exclu-
sively in Scandinavia (primarily Finland but also 
Norway). English-language literature on the effectiveness 
of this model is sparse, consisting almost exclusively of 
descriptive studies of first-episode cases of nonaffective 
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psychosis presenting in Western Lapland, Finland, 
between 1992 and 1997. Only one of these455 included a 
comparison group treated under a different model. This 
study compared outcomes of three different populations: 
service users treated during early development of the OD 
model, service users treated during the full development 
period, and a culturally comparable comparison group 
treated in another area of Finland with a more traditional 
hospital-based intervention model, including a heavier 
emphasis on neuroleptic medications. After 2 years, OD 
service users used fewer neuroleptics at the beginning and 
throughout treatment and had fewer days of hospitaliza-
tion than did the comparison group. The OD group also 
had lower rates of relapse, higher rates of employment, 
and lower rates of formal disability. Current evidence 
for this model is insufficient for drawing any conclusions 
about its effectiveness or the efficacy of the various com-
ponents of the system intervention, but results are tan-
talizing. Additional research testing and comparing the 
model in other cultures, with more rigorous designs, is 
warranted.
Summary and Implications Early intervention to pre-
vent or mitigate symptoms of psychosis is a highly desir-
able goal that, if  effective over the long term, would bring 
profound benefits to service users, families, and society by 
promoting recovery, independence, equity, and self-suffi-
ciency and facilitating the uptake of social, educational, 
and employment opportunities.529 Effective interventions 
also have the potential to dramatically reduce health care 
costs. At this point, however, no clear intervention has 
been shown to be effective. Studies are needed to compare 
the effectiveness of different strategies of early interven-
tion and the relative effectiveness of the different com-
ponents, separately and in combination. In addition, the 
value of producing delays in onset should be studied. The 
ability to complete education and obtain additional work 
and social experiences prior to onset has the potential 
to limit disability, reduce social exclusion, and improve 
long-term outcomes.
Unintended Consequences and External Influences 
Bosanac  et  al535 articulate a number of concerns about 
the unintended consequences of early intervention to 
treat psychosis. First, early intervention may divert fund-
ing from the most severe forms of psychotic illness even 
though longer term outcomes are yet to be demonstrated. 
A  second concern is that premature labeling has the 
potential to disrupt employment, academic, and other 
opportunities for those so labeled. Third, early use of anti-
psychotic medications may cause iatrogenic harm, includ-
ing obesity, hyperlipidemia, diabetes, and sudden cardiac 
death. Finally, given preferences of young people and their 
parents for low-intensity community interventions rather 
than psychiatric mental health services and medication, an 
emphasis on early treatment may inhibit access and adher-
ence. These considerations should not be ignored.
Patient-Centered Quality Improvement in Mental 
Health, System and Provider Performance Measures, 
and Methods of Feedback
Donabedian536 divided quality improvement strategies 
into three components: structure, process, and outcomes. 
Structure addresses the extent to which an organization 
or system has the requisite structures in place to deliver 
a service or treatment (eg, trained staff, equipment). 
Process addresses whether the service or treatment was 
actually delivered as well as the manner in which it was 
delivered. Outcomes are measures of response to a treat-
ment or service, whether positive or negative, intended 
or unintended. In addition to Donabedian’s conceptu-
alization, it is worth further characterizing outcomes 
in terms of their patient centeredness. That is, clinical 
outcomes may have greater importance to clinicians (eg, 
symptom control), while other types of outcomes may 
have greater importance to service users (eg, ability to 
work or maintain intimate relationships, irrespective of 
symptoms).151,153,537 For individuals with such preferences, 
symptom-related outcomes are less important and thus 
less patient centered than work- or relationship-related 
outcomes. To date, a majority of performance measure-
ment and quality improvement initiatives have targeted 
clinical processes and outcomes deemed clinically impor-
tant, although some clinical and process outcomes are 
known to be important to service users (eg, prevention of 
hospitalization, continuity of care).
Many measures can be applied to assess quality at the 
level of the individual clinician, facility, or health care 
system. These measures are crucial in that they often 
assess factors related to minimum goals or thresholds for 
acceptable quality in clinical care. Such measures include 
Healthcare Effectiveness Data and Information Set 
(HEDIS)538 measures, as well as the following indicators 
of service quality specific to individuals with diagnoses of 
serious mental illnesses:
1. For specialty mental health outpatient services
a. Continuity of care with the same clinician or team
b. Availability of evidence-based psychological, psy-
chosocial, rehabilitative, cognitive, and substance-
abuse treatments
c. Availability of family psychoeducation programs
d. Frequency of medication management visits
e. Percent of service users with PAD in place
f. Number of days between request for service and 
service visits
g. Availability of crisis management services
h. Availability of alternative services to hospitalization
i. Number of days between hospital discharge and 
outpatient mental health visit
j. Satisfaction with medications/medication side effects




2. For inpatient services and other institutional care
a. Rates of seclusion and restraint
b. Percent of service users with a discharge plan in 
place prior to discharge
c. Availability of medical care
d. Monitoring of medication-related side effects
e. Number of inpatients consistent with facility 
capacity
f. Provision of evidence-based therapeutic and psy-
chosocial services
3. For service users prescribed psychoactive medications 
(irrespective of setting)
a. Percent of service users for whom the dose is within 
an acceptable range
b. Percent of service users with contraindicated medi-
cation prescriptions
c. Percent of service users receiving indicated moni-
toring for medication-related side effects such as 
weight gain, metabolic problems, blood pressure; 
agranulocytosis, and tardive dyskinesia.
In contrast to common indicators of service system or 
provider functioning, many patient-centered measures 
are most appropriately defined as measures of the useful-
ness or helpfulness of services provided, from the service 
user’s point of view. To the extent that clinical measures 
such as symptom control and consumer desire for symp-
tom control are concordant, the clinical measure is also 
patient centered. Discordance in importance between the 
value of the indicator to the clinician or system, and the 
value of that indicator to the service user, presents oppor-
tunities for research that (1) assesses the links between 
clinical outcomes specified as priorities by clinicians and 
those identified as priorities by consumers, (2) develops 
indicators that can be routinely used to measure those 
outcomes service users value the most, and (3) examines 
relationships between patient-centered outcomes, clinical 
services, and processes of care.
The long-standing and continuing need to improve 
the patient centeredness, quality, and appropriateness of 
services provided to individuals with serious mental ill-
ness has been well established.5,7,9,140,322,518,539–541 We have, 
therefore, proposed a patient-centered learning system 
of care—a system that requires feedback and response 
mechanisms so that changes can be made over time in 
response to feedback. Some of the extensive literature on 
quality improvement in health care is relevant to our work 
here, although a great many quality improvement initia-
tives in health care focus on organizational and care pro-
cesses that are not directly patient centered. Nevertheless, 
relevant lessons have been learned about changing sys-
tems of care that have the potential to inform efforts to 
change the mental health care system—a system with 
little penetration of quality improvement programs.541 
Thus, we begin with a discussion of health information 
technology as a building block for quality improvement, 
then present findings from reviews of various quality 
improvement approaches and initiatives in health care 
more generally, followed by a review of their relevance to 
the mental health system. Finally, to the extent possible, 
we discuss their application within systems providing care 
to individuals with serious mental illnesses.
Health Information Technology. Health information 
technology (HIT) has become one of the key structures 
underlying quality improvement in health care. Quality 
improvement and health improvement initiatives rely on 
HIT for decision support, data extraction, surveillance, 
process improvements, aggregation, and feedback at the 
clinician and organizational level, and to assess perfor-
mance for public and internal reporting.542 In particular, 
information from EHRs542 is crucial to these processes, 
as are databases that track service use and current and 
past eligibility for services. The authorization of the 
Health Information Technology for Economic and 
Clinical Health (HITECH) Act emphasized the impor-
tance of implementing these systems, improving them, 
and providing common data elements and standards for 
the exchange of health information.542 A wide variety of 
HIT-driven quality-of-care initiatives have been imple-
mented, with mixed but generally positive, modest effects 
on care quality and efficiency and some improved out-
comes.543–545 The cost-effectiveness of such interventions 
has yet to be determined, however.543–545
Less is known about the value of these systems in behav-
ioral health settings, many of which do not have EHRs in 
place. Their expected importance, however, is underlined 
by SAMHSA’s HIT implementation program strategic 
initiative, which is intended to ensure that providers in 
the behavioral health system—including states, commu-
nity providers, and peer and prevention specialists—fully 
participate with the general health care delivery system in 
the adoption of HIT and interoperable electronic health 
records.546 In particular, EHRs are seen as having signifi-
cant potential for coordinating medical and behavioral 
health care.547 More specific to the model of care proposed 
here, they are an essential component if we are to develop 
a nationwide learning system that can improve quality of 
care and patient-centered outcomes in behavioral health.547
Summary and Implications The rapid adoption of 
EHRs and other HITs, and the requirements related to 
meaningful use of these data and interoperability between 
systems,542,544,547 suggest the importance of developing 
HIT-compatible patient-centered measures for individu-
als with serious mental illnesses that are meaningful and 
acceptable to those individuals and their providers. These 
measures must also be useful as feedback to produce the 
kind of learning behavioral health care system that is suf-
ficiently responsive to the needs and services required to 
improve individual outcomes in this group.
Unintended Consequences and External Influences 
Advances in HIT, HITECH Act requirements, and 
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reforms associated with the ACA are providing incen-
tives to implement EHRs and other HIT systems to 
track, improve, and coordinate care, although behavioral 
health providers other than psychiatrists are currently 
not included in the HITECH initiative. Unintended 
consequences (despite meaningful use requirements) are 
most likely to involve lack of interoperability resulting 
from implementation of a wide variety of EHRs, other 
systems, and multiple performance measures across a 
large number of medical and behavioral health providers. 
To the extent that this happens, data collected will be of 
limited usefulness at a system level or for research.
Audit and Feedback. Audit and feedback—the process 
of assessing clinical processes and outcomes and provid-
ing the information gathered to clinicians and other care 
providers—has long been used as a technique to improve 
quality of care and adherence to treatment guidelines.548 
Reviews of the extant literature on trials of audit and 
feedback in medical settings suggest that such interven-
tions vary in effectiveness, but the wide range of multifac-
eted feedback mechanisms make it difficult to determine 
whether audit and feedback improves clinical outcomes 
generally and which approaches to feedback are effective 
and which are not.549 Audit and feedback assessment may 
be applied at any level in the system—structure, process, 
or outcomes. The information can be used at the indi-
vidual level as an indicator of response to services or 
treatment, or it can be aggregated at the clinician, organi-
zation, or system level.
Effects of audit and feedback in medical settings are 
generally small to moderate in size, with larger effects 
associated with lower levels of concordance with guide-
lines at baseline.550 Some evidence suggests that audit and 
feedback is more effective at improving clinical processes 
than clinical outcomes.549 It appears as well that charac-
teristics of the feedback factor into its effectiveness. That 
is, the most effective feedback is frequent, timely, credible, 
nonpunitive, and delivered both verbally and in writing; 
contains specific suggestions for improvement; is deliv-
ered by a supervisor or senior colleague; and contains 
measurable targets and an action plan.548,550,551
Most of the research on audit and feedback has 
been carried out in medical settings. A  2003 Cochrane 
Collaboration review of outcome measures and needs 
assessment tools for schizophrenia and related disor-
ders552 found no publications that met criteria for review, 
suggesting the limits of the literature in this population. 
A  more recent meta-analysis of audit and feedback in 
a few mental health settings suggests modest positive 
short-term effects similar to those found in medical set-
tings, but no lasting effects on outcomes.553 Most of the 
service users included in this meta-analysis were women 
(two-thirds), and most had affective disorders, although 
two studies included individuals with schizophrenia. 
Conclusions are, thus, limited in their application to 
individuals with serious mental illnesses. The included 
studies used a wide range of outcome assessments, 
including symptom measures (almost universal), needs 
assessments, treatment satisfaction, life satisfaction, 
social support, social and interpersonal functioning, and 
measures of working alliance. Despite the wide range of 
outcome measures collected, the usefulness of particular 
measures for informing and improving clinical processes 
and outcomes remains unknown.
A more promising feedback approach for improving 
care and outcomes among individuals with mental ill-
nesses, particularly serious mental illnesses, measures 
service user and clinician assessments of a wide range of 
domains (eg, unmet needs, global well-being, symptoms, 
general functioning, housing, relationships, finances, psy-
chological distress, and sexuality) and then uses these 
assessments, and their differences, to foster communica-
tion and treatment planning, and to reduce discordance 
in perspectives between clinicians and consumers.343 
A  recent review of such approaches suggests that both 
clinicians and consumers find the feedback useful, that 
it reduces discordance in clinician-consumer assessments, 
that outcomes can be improved, and that such feedback 
can be cost-effective.343
Summary and Implications There is a need to develop 
patient-centered outcome measures that are both mean-
ingful to individuals with mental illnesses and, when 
provided as indicators of care quality to clinicians and 
systems, useful for informing care processes and practices. 
In addition, we need to know the necessary characteris-
tics of audit and feedback procedures, including key com-
ponents of facilitated clinician–consumer discussions. 
We also need to better understand the kind of content 
needed to make feedback useful for informing stakehold-
ers at the system, clinical, and service user levels. We find 
promise in approaches that provide concurrent feedback 
to providers and service users, with prescriptions for dis-
cussions regarding feedback, reducing discordance, and 
increasing collaboration.
Pay for Performance. For more than a decade, P4P has 
been used widely in efforts to improve health care qual-
ity, with programs implemented within a broad range of 
payment arrangements and service settings, including the 
British National Health Service, Medicaid, and a host 
of private health plans and hospitals. Despite its wide-
spread use, evidence to date suggests large variation in 
the effects of P4P on quality-of-care outcomes.554–558 It 
has been used to try to improve quality of care at many 
levels, including for individual providers, at the team and 
organization level (including hospital performance), and 
at the health plan level.
To date, reviews of P4P programs in general health care 
settings suggest that it is more likely to yield improve-
ments in process targets than in outcomes targets.554 In 
addition, there is no evidence to date of positive effects 
S64
C. A. Green et al
of P4P on outcomes measuring patient centeredness, but 
there is evidence that stakeholder involvement in selecting 
and defining targets for improvements produces larger 
effect sizes.554 P4P appears to be most effective when there 
is greater room for improvement from the beginning, 
when it is focused on process and intermediate outcomes 
(eg, cholesterol screening, vaccination) rather than indi-
vidual-level outcomes, when stakeholders are involved in 
setting targets and goals, when the program is communi-
cated clearly and directly to those responsible for making 
changes, and when the P4P target, goals, and methods are 
adapted to the local context.554 A recent large-scale evalu-
ation of long-term patient outcomes in the Medicare 
Premier Hospital Quality Incentive Demonstration, 
however, found that the P4P program did not improve 
mortality outcomes, as had been expected.559 This evalu-
ation included more than 6 million patients treated for 
acute myocardial infarction, congestive heart failure, or 
pneumonia, or who underwent coronary artery bypass 
grafting.
Applications of P4P in behavioral health settings 
have been limited, and questions have been raised about 
whether or not P4P is an appropriate tool when tied to 
clinical behavioral health outcomes.560,561 Of particular 
note are findings that P4P is most effective in general 
health care settings when used to improve process out-
comes with clear, simple targets (eg, preventive screen-
ings, vaccination rates), rather than clinical outcomes, 
especially among complex patients. These findings sug-
gest that at minimum, targeted outcomes need to be care-
fully chosen to improve success. For example, Liptzin561 
argued that while standardization of measures is nec-
essary if  we are to make comparisons across clinicians 
and organizations, general behavioral health measures 
are neither sensitive nor specific enough to reliably mea-
sure treatment outcomes for disorders as varied as those 
encountered in behavioral health settings (eg, depression, 
schizophrenia, PTSD).
Thus, for P4P and other behavioral health quality 
improvement programs, it is a significant challenge to 
find measures that are useful and valid for measuring 
outcomes, that can be agreed upon by relevant stakehold-
ers, and that can be used across payers in order to reduce 
complexity at the clinical level.561 In addition, if  com-
parisons across clinicians and organizations—and corre-
sponding compensation—are to be fairly distributed, risk 
adjustment for differences in case complexity (eg, severity 
of the primary mental health problem, comorbid condi-
tions) is a prerequisite. However, risk-adjustment systems 
in mental health remain poor.561,562 Finally, there must be 
mechanisms in place for collecting, analyzing, summariz-
ing, and then providing data to participating providers 
and organizations, and the quality of these data must be 
trustworthy to be seen as useful to clinicians.561
In a recent review of P4P in behavioral health, 
the authors report results consistent with Liptzin’s561 
concerns. In particular, the most common obstacle to 
P4P implementation was lack of practical, valid out-
come measures for disorders other than depression (for 
which the Patient Health Questionnaire-9 [PHQ-9]563 
was considered acceptable by a range of stakeholders).564 
Measures used to determine pay were consistently pro-
cess based, even among those programs that included the 
PHQ-9 in their measurement package.564 Interestingly, a 
new study provides support for conclusions that a focus 
on process targets, using disorder-appropriate outcome 
measures, has potential for improving behavioral health 
outcomes. Unützer et  al565 studied a P4P program for 
adults with depression in primary care that focused on 
process targets and used the PHQ-9 as an outcome mea-
sure. This program provided training to clinicians in man-
aging depression and regular audit and feedback using a 
well-established approach to facilitate care integration. 
Results of the program were positive, with patients in the 
P4P programs significantly more likely to show a reduc-
tion of 50% on the PHQ-9, or to obtain a score of less 
than 10 (indicating absence of depression) on the mea-
sure, than those not in the P4P programs. Patients in the 
P4P program were also more likely to achieve these out-
comes faster than others. Depression treated in primary 
care represents a less complex condition than the serious 
mental illnesses addressed in this report, but these results 
suggest the value of stakeholder-acceptable measures 
when targeting outcomes improvement.
Summary and Implications Little is known about the 
applicability of P4P in behavioral health settings. To 
evaluate the effectiveness of programs for individuals 
with serious mental illnesses, there is a need for com-
monly acceptable process measures that are linked to 
outcomes for different disorders, as well as appropriate 
disorder-specific, patient-centered outcome measures (in 
addition to common clinical outcome measures). More 
importantly, if  P4P is to be considered fair when imple-
mented in mental health settings, good methods for risk 
adjustment are essential.
Unintended Consequences and External Influences If  
process and outcome measures are used to determine 
compensation in P4P programs, and risk adjustment 
methods for dealing with differences in complexities of 
caseloads are poor, then providers and organizations that 
provide services to those with the greatest and most com-
plex needs may be unfairly penalized. This can also lead to 
unwillingness to provide care to such individuals, reduc-
ing access to care for the most vulnerable. An additional 
problem with unintended consequences is related to ser-
vice users who refuse or are unable to complete outcomes 
assessments, causing resentment among physicians whose 
performance assessment may be affected. This may also 
lead physicians to disenroll noncompliant service users.566 
These problems may present more frequently among ser-
vice users with serious mental illnesses, given the com-
plexity of their mental health conditions combined with 
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oft-comorbid medical and addiction problems and prob-
lems engaging some individuals in services.
Publishing Performance Data. Another mechanism 
used to promote quality improvement in health care in 
recent years has been public reporting of patient care per-
formance data. Reporting has been carried out at several 
levels, including for health plans, hospitals, and providers. 
Most studies of the effects of these efforts have focused 
on mortality or cardiac procedures, although some recent 
studies have examined the effects of reporting on con-
sumer selection of health plans and providers.567
Evidence for the effectiveness of public reporting is 
mixed, and its usefulness has been questioned as a tool 
for improving patient safety or increasing patient cen-
teredness.567,568 In general, some evidence suggests that 
publishing performance data can spur quality improve-
ment efforts and improve some outcomes, but conclu-
sions are limited because most evaluations have focused 
on a small number of studies, many of which examined 
the same reporting systems.567
While no evidence has been found for influences of 
reporting on consumer selection of hospitals, publish-
ing quality information about health plans may affect 
consumers’ selection when they are aware of the infor-
mation and can recall it.568 Quality information may also 
produce some switching from lower performing to higher 
performing health plans.567
Beyond the HEDIS behavioral health measures tar-
geting depression care and posthospitalization follow-
up for mental health hospitalizations, we are unaware 
of  other publicly reported behavioral health measures. 
This is likely a result of  the same difficulties of  measure-
ment and risk adjustment that are detailed in the Pay 
for Performance section. Interestingly, an Australian 
mandate for public reporting of  quality outcomes in 
behavioral health may spur new methods designed to 
address these measurement problems.560 In addition, 
because a large proportion of  mental health care is pro-
vided in publicly funded settings, it is not clear whether 
the market model that underlies this approach has any 
applicability.
Unintended Consequences and External Influences There 
is evidence for a variety of unintended consequences 
related to public reporting of quality data. Individuals 
in neighborhoods with lower socioeconomic status may 
have increased access to care, because public reporting 
attenuates access disparities, but they may also be more 
likely to receive care from poorer performing providers. 
Meanwhile, individuals living in higher socioeconomic 
neighborhoods are more likely to receive care from higher 
performing providers.567 In addition, publishing perfor-
mance data has led poorer performing hospitals to stop 
reporting quality data, led poorer performing providers 
to stop providing care, and led to an unwillingness to care 
for high-risk, complicated patients.567
Almost no information exists about the process 
or effects of publishing performance data in behav-
ioral health for individuals with serious mental illness. 
Problems inherent in measurement of these data, and in 
risk adjustment for complex or high-risk patients, suggest 
that developing methods for fair assessments and pub-
lication of such data will be difficult without negatively 
affecting access to high-quality care for patients in the 
greatest need.
Implementing Patient-Centered EBPs and Clinical 
Guidelines Quality improvement initiatives that have 
been applied in mental health settings have generally 
involved implementation of evidence-based clinical guide-
lines or evidence-based treatments and interventions, 
ranging from medication guidelines569,570 to guidelines for 
psychosocial treatments (cf. Lehman).322 Interestingly, 
many of the psychosocial EBPs—such as SEm, sup-
ported housing, and social skills training—have been 
designed to target outcomes that are patient centered. 
Yet, it is these programs that have encountered the great-
est barriers to broad-based adoption.
Implementation research studies suggest that evidence-
based approaches, like many other efforts to improve care 
quality, have produced mixed results. Generally, greater 
improvements are found in structure and processes of 
care than in patient outcomes.571 In fact, a review of 
implementation of  psychiatric guidelines suggests few 
effects in mental health care; the authors found that 
most effects on performance and outcome were mod-
est at best and temporary.572 In addition, guidelines have 
tended to be narrowly focused and thus less useful for 
more complex patients, particularly those with comorbid 
conditions.573
In response to failures to adopt EBPs or to dissemi-
nate and implement clinical guidelines effectively, imple-
mentation science has increasingly focused on (1) how to 
move evidence-based scientific findings into real-world 
practice settings while maintaining reasonable fidelity, 
(2) identifying and overcoming the barriers to adop-
tion and implementation, and (3) fostering those factors 
that are facilitators of these processes. This field is still 
in its infancy, but some consistency in findings is emerg-
ing. First, effective implementation of EBPs requires a 
complex process that involves organizational leaders and 
policy makers who take the initiative to fund the pro-
gram, involve and support staff  members, and provide 
for other costs during implementation.574,575 This requires 
that policy makers and administrators be given informa-
tion about the value and effectiveness of EBPs and that 
they are shown the links between consumer preferences 
and EBP outcomes.574,575 Also, clinicians need help and 
support to communicate with consumers about EBP 
recommendations and to address their concerns.574,575 
Information is now available about approaches that do 
not work. For example, neither training nor information 
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alone is effective for promoting implementation of 
EBPs.574 Similarly, organization-based (program- or prac-
tice-centered) approaches are more effective than pro-
vider-based approaches, because EBPs that reside only 
within a provider can be lost when he or she leaves an 
organization.574,576 Finally, in the context of organiza-
tionally driven implementation, individual performance 
feedback and coaching show the best improvement in 
improving acquisition of new clinical skills.577
A wide variety of EBPs have been developed targeting 
outcomes for individuals with serious mental illnesses. 
Learning which of these EBPs are most highly valued by 
service users in differing circumstances would be useful.
Process Improvement. Various models of  process 
improvement have been derived from engineering, indus-
try, and other fields and adapted to health care. These 
include the Institute for Healthcare Improvement’s 
rapid-cycle process-improvement efforts using Plan-
Do-Study-Act cycles with learning collaboratives to 
teach process-improvement techniques, Total Quality 
Management, Continuous Quality Improvement, 
Business Process Reengineering, lean thinking, and Six 
Sigma.578 These models, despite their differences, share 
many common characteristics. A recent review of their 
effects in health care systems suggests that they produce 
mostly modest effects when certain necessary, but not 
sufficient, conditions are met.578 In particular, a recent 
comprehensive review of process-improvement strat-
egies commissioned by the Scottish National Health 
Service found that the success of  process-improvement 
efforts depends on the following conditions: provision 
of  the practical and human resources to enable quality 
improvement; active engagement of  health profession-
als, particularly doctors; sustained managerial focus and 
attention on the process-improvement effort; use of  mul-
tifaceted interventions; coordinated action at all levels 
of  the health care system; significant investment in train-
ing and development; and the availability of  robust and 
timely data through supported information technology 
systems. Improvement efforts were most likely to suc-
ceed when these conditions were met and when those 
responsible for implementation recognized the generic 
characteristics of  health care organizations that make 
quality improvement challenging; carefully considered 
and then adapted the interventions to local circum-
stances; involved individuals at all levels of  the organiza-
tion, from front-line clinicians to senior managers; and 
aligned process improvements with existing resources 
and strategy objectives.578
Summary and Implications Health care policy related 
to quality improvement in the United States is increas-
ingly based on linear models that assume that competi-
tion, informed consumers, and a market model will be 
the most effective methods for improving quality of care 
and accountability. The at-best modest effects seen across 
such market-driven models suggest that it may be time to 
develop alternative models for improving quality of care. 
Such innovative models may be particularly important in 
the context of behavioral health, and especially for more 
serious conditions, because quality improvement efforts 
appear to be less effective for individuals with more com-
plex problems.
Key barriers to implementation of process improve-
ments in the mental health system include lack of HIT 
infrastructure, limited staff  resources, and lack of widely 
agreed-upon process measures. In addition, the links 
between existing process measures and patient-centered 
outcomes are unclear. There is a need to identify new 
ways to effectively implement quality improvement ini-
tiatives, including process improvements, in public health 
and mental health settings, and to link those improve-
ments to patient-centered outcomes.541,579
Feedback Systems and Methods for a Learning System
Despite calls for significant changes from the Surgeon 
General,540 the President’s Commission,5 the IOM,7 
and the Schizophrenia Patient Outcomes Research 
Team,322 the last two decades of  health care reform 
and quality improvement efforts have produced, at 
best, slight to modest improvements in outcomes for 
individuals with serious mental illnesses.541 In the 
previous sections, we have reviewed approaches and 
methods used in efforts to improve the quality of 
health care and patient outcomes in medical and men-
tal health settings, concluding that these methods have 
disappointingly limited effects on individual-level out-
comes even when they promote better care processes 
and increase efficiency. They suggest that we have 
adopted less-than-effective approaches to improving 
health care outcomes.
Given the limited success of past efforts, it is critical 
that we take advantage of new opportunities to recon-
sider how we approach care, services, and outcomes 
improvement for people with serious mental illnesses. 
Such opportunities are emerging from new and develop-
ing HITs, changes required by the ACA, the increased 
interest in and focus on recovery and patient-centered 
outcomes, and efforts to reorganize care for patients with 
complex conditions.
Complexity science provides an alternative approach to 
the linear methods suggested by many quality improve-
ment, performance measurement, and feedback models. 
This approach defines care systems as complex adaptive 
systems with fuzzy boundaries and active agents rang-
ing from service users and family members to medical, 
office, and information technology staff, to clinicians and 
administrators. These systems continually self-organize 
and, as they interact with each other and the environment 
in which they exist, allow new behaviors to emerge. The 
systems adapt based on information flow, interaction, 
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and exchange among stakeholder agents through a pro-
cess of learning and sense-making—a process that shapes 
the systems’ responses to information and subsequent 
interactions. Indeed, information by itself  is not expected 
to produce change without an associated process of inter-
action and exchange among system agents and agents in 
the environment.
This approach is consistent with findings from our 
reviews that point to the importance of facilitating inter-
actions within organizations and interactions between 
service users and providers. For example, (1) continuity 
of care with the same clinician over time fosters rela-
tionships that support recovery from serious mental ill-
ness;52 (2) the most effective audit and feedback programs 
encourage discussion between service users and providers 
about the feedback343 and provide frequent, timely, non-
punitive, written feedback with specific suggestions for 
improvement548,551; and (3) the most effective P4P systems 
involve stakeholders in selecting and defining targets for 
improvements, include clear and direct communication to 
those responsible for making changes, and adapt P4P tar-
gets, goals, and methods to the local context.554
Such approaches are much more consistent with those 
suggested by complexity science than are the more com-
mon approaches to performance enhancement and 
quality improvement reviewed here. That is, they are con-
sistent with a focus on how organizational culture and 
climate can promote learning and adaptation among 
systems, and how promoting positive organizations char-
acterized by positive interactions and teamwork—orga-
nizations where individuals and groups flourish—can 
lead to improved performance. There is a large and varied 
literature on these topics,580–595 only some of which has 
been tapped by health care and mental health services 
researchers.
The current system’s inability to substantially improve 
individual outcomes in the face of significant efforts, 
information, and investment suggests that our under-
standing of the ways in which the current system affects 
outcomes is not accurately specified. We propose that 
an alternative, nonpunitive, learning- and interaction-
based focus is necessary to improve quality of care, 
rather than additional efforts to incrementally improve 
outcomes through implementation of EBPs or develop-
ment of slightly better performance measures. Consistent 
with Berwick’s recommendation for the health care sys-
tem as a whole,596 we suggest that it is time for a radical 
paradigm shift—one that is focused on interaction-based 
approaches such as team-based care and patient-centered 
medical and mental health homes. Most important, we 
propose an approach that facilitates learning through 
interactions among all the stakeholders in the system. 
As Berwick has said, “the interaction is not the price of 
care; it is care itself” (p. 51). Through such interactions 
the system itself  has the opportunity to become a learn-
ing system.
The differences between an interaction-based, patient-
centered approach and the care processes characteris-
tic of the current system are substantial. In adopting a 
patient-centered approach to this report, our team was 
confronted time and again with the profound discon-
nect between the care and services offered by the current 
system; the outcomes used to assess the effects of care 
provided; the structures, processes, and service pack-
ages targeted to improve care; and the needs, wishes, and 
desires of the people who receive services. As such, the 
current system knows neither how to routinely measure 
or aggregate patient-centered outcomes nor what most 
of those outcomes should be. Thus, it is not surprising 
that changes to the system have had limited effects on ser-
vice user outcomes. Without information about what the 
outcomes should be, the system cannot adapt to address 
those outcomes. Moreover, key research questions are 
intertwined with availability of the right measures for 
assessing outcomes. If  our measures are not valid, then it 
follows that our answers are incomplete at best.
Early on, as we worked with technical experts and 
stakeholders, we identified two key research questions 
that help illustrate this point. First, how do we best 
involve customers in the design of the care they receive? 
And second, how do we involve customers in the choices, 
development, and selection of outcomes? After review-
ing the literature on stakeholder preferences, however, we 
came to realize that we already knew how to involve cus-
tomers in care design, care development, and outcomes 
selection.343,597–600 We then adopted an alternative perspec-
tive, which resulted in a set of reformulated questions 
that were quite different in tenor from the first set. For 
example, we realized we might more appropriately ask:
 • What are the barriers to involving customers in the 
design of the care they receive and how can these bar-
riers be overcome?
 • What is preventing the system from involving custom-
ers in the choices, development, and selection of the 
outcomes that apply to them, and how can this be 
remedied?
 • What are the outcomes preferred by people with serious 
mental illnesses, and what are acceptable methods for 
measuring those outcomes?
Once we have clear answers to these patient-centered 
questions, we can move to the next stage of the pro-
cess: identifying measures that can be used to evaluate 
progress over time for service users, and those that can 
be aggregated to provide performance feedback to clini-
cians, teams, organizations, the care system as a whole, 
and the community providing financial and other sup-
port for care. In a learning, complex adaptive care sys-
tem, it will be this information, and the interaction and 
response from stakeholders, that drives the adaptation 
needed to improve patient-centered outcomes. Various 
measure-related key questions for CER and PCOR flow 
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easily from this point. Such questions, some of which are 
listed in supplementary appendix C, can be identified at 
all levels specified in the analytic framework (see figure 6), 
working backwards in the model from individual-level 
outcomes. (The original list of all questions generated in 
a face-to-face project meeting with our stakeholders and 
technical experts appears in supplementary appendix B.
It is important to point out, however, that we are still 
in need of a good theoretical model and corresponding 
understanding of how to strengthen the processes that 
produce the positive interactions that lead to adapta-
tion, responsiveness, flexibility, and improved outcomes. 
We have observed effective systems but do not yet truly 
understand how they produce the outcomes they do.601,602 
For example, we do not know how to foster the balanced, 
healthy relationships and interdependencies that pro-
duce trust and that can be used to internalize and process 
information to enable system-level adaptation. Models 
and measures of these processes, in addition to clinical 
processes, are needed.
Fortunately, a great deal of useful research has already 
been conducted on different structural approaches, care 
processes and their characteristics, and different service 
packages (see Care and Service Delivery Models and 
Structures section). Furthermore, a substantial body 
of recent research has addressed consumer and stake-
holder preferences, needs, and desires (see Stakeholder 
Perspectives section). This information on preferences 
needs to be converted to existing outcome measures and 
used to inform adaptation of these measures.
In addition, a large number of existing measures could 
be evaluated for their acceptability and importance as 
patient-centered measures. Many of these measures are 
reviewed in Hermann’s compendium on measurement-
based quality improvement in mental health, and his 
consensus work with stakeholders is an important step 
forward.603,604 Other useful resources for measures that 
might be assessed or evaluated for patient centered-
ness include the Center for Quality Assessment and 
Improvement in Mental Health (http://www.cqaimh.
org/); structural, process, and outcome measures sug-
gested by Pincus et al541; structural measures by Watkins 
et  al605; the Health of the Nation Outcomes Scales606; 
the Australian National Mental Health Performance 
Indicators and Outcomes Measures607; measures of 
patient-centeredness in inpatient settings by Groene 
et  al608; structural, process, and outcome measures for 
people with serious mental illnesses and co-occurring 
medical or addiction problems suggested by Kilbourne 
et al609; and, for patient-centered outcomes, both NIH’s 
Patient Reported Outcomes Measurement Information 
System (http://www.nihpromis.org/) and the extensive 
report from the Bamford Implementation Rapid Review 
Scheme: Patient Outcomes for Measures of Recovery and 
Capturing Feedback from Patients in Order to Improve 
Service Improvement.343
Patient-Centered Outcomes
Routine assessment of patient-reported outcomes…might 
reduce potential discrepancy between patients and profes-
sionals, and improve outcome, although there is little empir-
ical evidence to support this assumption at present…For the 
future development of patient-reported outcomes, the most 
pressing issues are conceptual clarity and the consideration 
of empirical findings, particularly the association with other 
outcomes.608(p25)
Existing Scales and Measurement Techniques There is 
an ongoing need for conceptual models organizing the 
perspectives of different stakeholders, as well as an array 
of valid and reliable measures that are adequately patient 
centered, consumer informed, and sensitive to change. 
Progress is being made, however,291 particularly in the 
area of recovery measures.343 In the sections that follow, 
we briefly review outcome domains that have been identi-
fied as relevant to stakeholders, and we suggest opportu-
nities for researchers in each of these domains.
Recovery Measures Donnelly et  al343 conducted an 
extensive review of measures assessing recovery among 
service users and recovery orientation among provid-
ers. Two key questions guided their review: What are 
the costs and benefits of using these measures? What is 
the relationship between outcomes related to personal 
recovery, and those related to clinical recovery? The 
authors used an integrated, multilevel approach to mea-
surement, feedback, and system transformation, origi-
nally developed as part of the British Mental Health 
Outcomes Measurement Initiative (see figure 9). (Fonagy, 
P., Matthews, R., Pilling, S. The Mental Health Outcome 
Measurement Initiative: Best practice guidance for local 
implementation. Adapted from the report from the Chair 
of the Outcomes Reference Group. Leeds, UK: National 
Institute of Mental Health in England; 2005.) We believe 
this type of approach will be central to developing the 
type of learning system of care we have proposed.
Nevertheless, there are advantages and disadvantages 
to assessing and conceptualizing recovery and outcomes 
as distinct constructs. These are clearly overlapping and 
intersecting domains, but recovery cannot and should 
not be attributed solely or even largely to mental health 
services, unless the causal factors and pathways are iden-
tified. Recovery should be understood as more than an 
outcome of treatment, conceptually and empirically, 
because it is based on a complex array of factors, includ-
ing learning, adaptation, and experience.337 In this light, 
we must consider increasing challenges for measurement 
in general, and recovery in particular, that arise from the 
conceptual bases defining what is being measured, the 
needs and interests of the measure developers, and the 
intended uses of the findings. The central issues concern 
insufficient inclusion of subjective and experiential data, 
whether the factors or domains assessed are as important 
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to service users as they are to other stakeholders, and the 
best methods for eliciting information and conducting 
analyses.161 Researchers who identify themselves as men-
tal health consumers are growing in influence and number, 
and their involvement in many areas of mental health out-
comes assessment will be central to improving the valid-
ity and utility of recovery measures and trajectories.611 
Several measures of recovery and engagement in services 
have been developed with consumer input and direction, 
but we are not aware of recovery measures developed by 
consumers that are in widespread use in evaluation and 
outcomes research. The recovery STAR tool kit612 and 
Refocus recovery manual613 are examples of current con-
sumer-developed recovery practices and indices.
The move by many clinicians and organizations to a 
recovery-oriented model of care has also led to some new 
outcome measures.159 These include measures assessing 
resilience, empowerment, self-esteem, sense of coher-
ence, hope, and recovery. In their early review, McCabe 
et  al610 concluded that self-reported outcomes varied in 
their conceptual and empirical foundations but that 
most targeted satisfaction with treatment. The more 
recent review by Donnelly et al,343 however, identified a 
large number of recovery and recovery-related measures. 
These measures range from individual-level measures of 
recovery to system measures assessing the recovery ori-
entation of services. The review team identified several 
measures across assessment domains that met quality cri-
teria. These included the Recovery Assessment Scale,614 
the Recovery Enhancing Environment Measure,615 the 
Recovery Oriented Systems Measure,616 the Recovery 
Interventions Questionnaire,617 the Recovery-Oriented 
Practices Index,618 the Recovery Promotion Fidelity 
Scale,619 and Recovery Self  Assessment.620
Some of the more recent measures diverge from more 
traditional measures in both their development (more 
likely to involve service users’ perspectives) and their 
topics. For example, Castelein et  al621 compared three 
empowerment scales across a population of people with 
psychotic disorders in the Netherlands: the Empowerment 
Scale, the Personal Empowerment Scale, and the Mental 
Health Confidence Scale. The authors concluded that 
Fig. 9. The benefit pyramid from the British Mental Health Outcome Measurement Initiative337 (used with permission).
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each instrument assessed some level of empowerment 
among persons with serious mental illnesses but noted 
that the definition of empowerment was too broad to have 
convergent validity. The Mental Health Confidence Scale 
was recommended due to its good psychometric qualities 
combined with its clinical usefulness.
Oades et al175 also sought to develop a scale that would 
measure mental health service provision using consumer 
input and a consumer-directed evaluation framework. 
Eleven themes were assessed, yielding two factors, which 
the researchers named empowerment and dehumanization. 
The measure was found to have satisfactory internal con-
sistency and appeared useful with inpatients and outpa-
tients. Further research is needed to establish test–retest 
reliability and criterion validity.
Hope Measures Measures related to hope are largely 
found in the literature on recovery.158,291,343,613,622–625 For 
example, Donnelly et  al342 considered hope to be a cen-
tral domain of the recovery process, along with con-
nectedness, identity, meaning in life, and empowerment. 
Leamy et  al613 also created a conceptual framework of 
recovery that included hope and optimism as one of five 
critical processes of recovery. Donnelly et  al343 reviewed 
a total of seven specific items for hope and optimism in 
three instruments: the Recovery Self-Assessment (RSA), 
which contained two items; the Recovery Enhancement 
Environment measure, which included three items; and the 
Recovery Oriented System Instrument, which contained 
two items. Psychometric properties for these instruments 
were reported as being solid. The authors also noted that 
among the five recovery domains, hope and optimism were 
the least covered in the assessment tools and that more 
research is needed in this area. Similarly, hope is included 
as a primary process in the Stages of Recovery Instrument 
as developed and reported by Andresen et al.291
A 2008 systematic review626 evaluated measures of 
hope used in psychiatry and identified 49 definitions and 
32 instruments. The authors determined that the concept 
of hope encompasses seven different attributes or charac-
teristics, including a time component, future orientation, 
the service user’s goals, the service user’s sense of personal 
control, environment and other circumstances, spiritu-
ality, and personal characteristics. Eleven studies used 
hope as a predictive variable for individual outcomes, but 
results were not conclusive. The authors argued that few 
hope instruments have been used in the mental health 
field and suggested that empirical evidence on the value 
of hope as a predictor of positive outcomes is lacking.
Schrank et al626 conducted a systematic review to eval-
uate the evidence related to hope scales used in mental 
health research, including the determinants of hope, self-
management strategies that promote hope, and interven-
tions to increase hope. The review included 57 studies, 
49 of which were quantitative, with the rest being quali-
tative. Scales assessed included the Snyder Hope Scale, 
the Herth Hope Scale, the Miller Hope Scale, items from 
the Recovery Assessment Scale, the Zimmerman Hope 
Scale, and three other scales used in only one study each. 
All scales included attributes of personal control and 
personal characteristics, and most scales included most 
of the conceptual domains of hope outlined in the 2008 
review (see above). The authors concluded that there is 
sufficient consistency across the instruments to allow 
comparison of determinants, self-management strategies, 
and interventions, but they note that in some cases, com-
paring the scales may not produce accurate results as dif-
ferent scales measure different aspects of hope.
In other studies, Siu et al622 examined the validity of 
a new instrument to assess perceived importance of a 
number of elements in the recovery process, including 
hope. Using a sample of 101 psychiatric inpatients (pri-
marily women with diagnoses of schizophrenia) in Hong 
Kong, the study found that hope was rated important by 
86% of the study participants, and that the measure had 
high internal consistency. Yanos et  al625 used the Beck 
Hopeless Scale to examine negative outcomes resulting 
from internalized stigma, finding that such outcomes 
were mediated, in part, by hope.
As with other measures in the recovery domain, more 
information is needed about consumer perspectives 
related to the different dimensions included in the con-
cept we call “hope,” whether the dimensions of hope are 
valued outcomes, and, if  so, how best to measure them. 
Once these outcomes are measured, we need to know the 
ways that hope can be affected by mental health care and 
other services.
QOL Measures QOL measures have a long history 
in assessments of subjective well-being among individu-
als with diagnoses of serious mental illnesses. Most of 
these measures have been developed specifically for this 
population, querying respondents about multiple life 
domains that range from housing to social relationships. 
Many researchers consider these measures to be patient 
centered, although most measures have been developed 
by researchers and clinicians without the involvement of 
service users. Nevertheless, a distinct advantage of these 
measures is that they have been used as measures of treat-
ment outcomes across a wide variety of interventions 
and have thus been linked to various service programs 
and packages. These include CCMs,361,369 integrated care 
models,297 supported housing programs,485 approaches to 
improving relationships with providers,52 use of a recov-
ery orientation that addresses families’ needs and prefer-
ences,147 and efforts to reduce coercion.79
Several comprehensive reviews of these measures are 
available,627–632 but little is known about how well they rep-
resent consumer preferences or values. Shrivastava et al633 
suggest that differences found in outcomes when survey-
ing service users, relatives, and providers likely result from 
limitations in the measures themselves.291 The fact that 
these measures can be used to identify response to services 
suggests that they may provide an important body of work 
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that, if evaluated and reconfigured to reflect the preferences 
of service users and their families, could provide good indi-
cators of patient-centered, service-related outcomes.
Needs Assessments Assessing the needs of consum-
ers is foundational to their engagement in services and 
the creation of patient-centered service packages. In busy 
public mental health systems, standardized checklists 
and templates are commonplace and are often shaped by 
administrative and fiscal requirements for information, 
rather than consumer preferences. As a result, the cat-
egories and descriptions of personal, social, and clinical 
characteristics are predetermined.
While it is widely recognized that assessment of needs 
must be an ongoing process that is linked to outcome 
evaluation, few instruments are available, despite their 
critical importance in a patient-centered service system. 
The Camberwell Assessment of Need (CAN),634–636 devel-
oped in the mid-1990s, is the most widely used needs 
assessment instrument for people with serious men-
tal illnesses. The CAN has several versions, including 
some recent adaptations that give the instrument value 
in broader applications. Twenty-two areas are evaluated, 
including accommodation, food, self-care, looking after 
the home, daytime activities, physical health, psychotic 
symptoms, information about condition and treatment, 
psychological distress, safety to self  and others, alcohol, 
abuse of drugs, company, intimate relationships, sexual 
expression, child care, access to a telephone, education, 
transport, budgeting, and benefits.
The original CAN relies upon self-report of the ser-
vice user to clinician and then requires the clinician to 
make a rating of need. The developers noted that service 
users and staff  identified a similar number of needs, but 
in different areas. There was most agreement in those 
areas where services were already in place, such as hous-
ing or employment.635 Recently, Trauer et al636 developed 
and piloted a more direct consumer-report version of the 
instrument called the CANSAS-P, adding, for the first 
time, the response option “I do not want to answer this 
question.” Interestingly, it appears that unwillingness to 
discuss a need in the previous version resulted in ratings 
of “no need.” This adaptation of the CAN holds promise 
for patient-centered needs assessment, shows the impor-
tance of understanding consumer perspectives when 
assessing needs, and provides a way to identify domains 
that may need to be addressed in other ways.
Another instrument, the Adult Strengths and Needs 
Assessment (ANSA),637 is an open-source, manualized 
tool designed to support decision-making regarding ser-
vice planning, levels of care, quality improvement initia-
tives, and outcome measurement. The ANSA covers eight 
major domains, using a 0–3 scale for strengths and needs, 
but it begins with “My Life, My Story”—an open-ended 
discussion that sets the framework for the questions that 
follow. It can be adapted to the specific needs of local 
service systems.
Summary and Implications Despite the importance of 
needs assessments in the context of providing patient-
centered services, we were unable to find references 
to additional measures. This is clearly an area of great 
importance, with many opportunities for measurement-
related PCOR. A learning service system cannot function 
without good needs assessment tools to identify appro-
priate and desired services and evaluate whether provided 
services met identified needs.
Therapeutic Relationship/Working Alliance As indi-
cated in our discussion of stakeholder perspectives, con-
sumers value continuity of care with clinicians with whom 
they have good working alliances. A wide variety of mea-
sures have been developed to assess these relationships, 
some of which have been shown to predict both short- 
and long-term outcomes,57,58 although methodologically 
rigorous research that uses validated assessment instru-
ments is needed.57 In particular, research is needed to 
assess working alliance over time, beginning during early 
treatment.57 This, too, is an area where current research 
suggests that improvements in the patient-centeredness 
of measures, which are then linked to patient-centered 
outcomes, could be used to assess system performance.
Adverse Effects: Diagnosis, Treatment, and Coercion  
One of the most important potential contributions of 
consumer-centered and consumer-directed research is in 
the area of unintended and adverse effects of diagnosis, 
treatment, and coercion. While considerable attention has 
been paid to medication side effects and social stigma, 
the research evidence on treatment-related trauma, self-
stigma related to diagnosis and treatment, and disruptions 
in social relationships related to treatment is limited. In 
particular, concerns have been raised about devaluation 
by oneself  and by others following diagnosis, and links 
between these experiences and negative outcomes, such 
as demoralization, income loss, and unemployment.638
Effects of labeling and subsequent devaluation may be 
accentuated by adverse effects associated with antipsy-
chotic medications and the consequences of those effects, 
including poor medication adherence, worsened QOL, 
and increased stigma,639 in addition to serious negative 
health effects.349,640 For example, Seeman92 argued that 
antipsychotics, as a group, increase weight and may lead 
to dry mouth and bad breath, cataracts, hirsutism, acne, 
and voice changes; they may also disturb symmetry of 
gait and heighten the risk for tics, spasms, and incon-
tinence. Each of these side effects has the potential to 
undermine a person’s attractiveness and acceptability 
to others and thus may contribute to discrimination, 
self-stigma, social withdrawal, and disengagement from 
treatment. She proposed that clinicians consider these 
factors when prescribing, and jointly discuss and moni-
tor preventive and therapeutic strategies. While much 
of the attention paid to side effects has concerned their 
impact on health status, Seeman makes a powerful argu-
ment for including body image and social capital as 
S72
C. A. Green et al
patient-centered outcomes. Evidence showing a negative 
association between diagnoses of mental illnesses and 
social capital support this contention,641 but additional 
research is needed to develop appropriate measures of 
social capital for individuals with mental health prob-
lems.642 Similarly, body image has mostly been studied 
as a symptom or indicator of pathology, particularly in 
schizophrenia. The B-WISE is an exception,643 but addi-
tional work is clearly needed to develop patient-centered 
measures of body-image outcomes.
Hamer and Haddad639 reviewed data on adverse effects 
of antipsychotic medications, finding that inconsistency 
in reporting adverse effects was a significant barrier to 
making cross-study comparisons. They called for stan-
dardization in reporting, noted the importance of assess-
ing service users’ subjective experience of medications, 
and suggested that total medication discontinuation 
rates could provide a useful “global outcome measure” 
that incorporates both tolerability and efficacy. Little is 
known, however, about the relationship between this mea-
sure and service user preferences related to medications.
Equally important are measures of coercion. Results 
from the MacArthur Coercion study suggest that indi-
vidual experiences of coercion among those who are 
pressured to enter the hospital or involuntarily admitted 
are strongly associated with the degree to which the pro-
cess is characterized by “procedural justice.”87 Procedural 
justice was defined as having a voice, and being treated 
by family and clinical staff  with respect, concern, and 
good faith during the process of hospital admission. In 
addition, this group has developed validated measures of 
coercion and coercion-related experiences.644–645 Research 
is needed to evaluate best approaches for routine use of 
such measures as patient-centered outcome and indica-
tors of system performance.
Stigma Stigma is an important concept and an insidi-
ous force among people with mental illnesses.647 Stigma 
has been attributed to and associated with a wide range 
of attitudes, behaviors, circumstances, health condi-
tions, social influences, and outcomes, including QOL, 
self-esteem, self-appraisal of competence, recovery, 
empowerment, social support, social integration, psy-
chiatric symptoms, anxiety, avoidance/withdrawal, medi-
cation adherence, secrecy, and social and psychological 
functioning.647–653 Pescosolido et  al654 elucidate the ways 
in which stigma comes to be defined in, and enacted 
through, social interactions, making clear that while 
stigma attaches to individuals, individuals do not develop 
beliefs and attitudes in a void but rather are influenced by 
a host and range of social, economic, cultural, and politi-
cal contexts that shape expectations and cognitive pro-
cessing. This framework654 articulates the ways in which 
these contributing factors interact to produce stigma and 
discrimination, incorporating a wide range of theoretical 
constructs from labeling theory, social network theory, 
the limited capacity model of media influence, the social 
psychology of prejudice and discrimination, and theories 
of the welfare state.
There appear to be three interrelated levels of stigma: 
social, structural, and internalized.647,654 At the social 
level, large groups or societies support stereotypes about 
and against a particular subgroup of people, which may 
be enacted through discriminatory practices, including by 
clinicians.655 Structural stigma exists in the world of poli-
cies, laws, rules, and procedures that restrict the rights of 
the stigmatized group. At the individual level, internalized 
stigma is described as a process by which people in the 
stigmatized group believe or ascribe to stigmas endorsed 
by social groups and/or structural processes and perceive 
themselves as devalued. Theorists also differentiate between 
“felt” stigma—the awareness of negative perceptions of 
having a mental illness—and “self” stigma—defined as 
internal acceptance of negative stereotypes. Both felt 
and self-stigma can lead to avoidance of mental health–
related services656,657 and can negatively affect recovery out-
comes.625,647 Peer-support and peer-delivered services are 
intended, in part, to counteract self-stigma by providing 
role models to transform individuals from disempowered 
“patients” to empowered “persons.” Additional research is 
needed, however, to conceptualize the processes by which 
this transformation takes place, as well as to develop best 
approaches for providing peer-delivered services.
In a 2010 systematic review, Livingston and Boyd647 
evaluated the effects of internalized stigma on people 
with mental illnesses, examining the relationships between 
stigma and sociodemographic, psychosocial, and psychi-
atric factors. The authors found that while none of the 
sociodemographic variables showed consistent significant 
relationships with internalized stigma for people with 
mental illness, psychosocial variables—including hope, 
self-esteem, empowerment/mastery, self-efficacy, QOL, 
and social support/integration—were all significantly and 
negatively associated with internalized stigma. Findings 
related to psychiatric variables were mixed. Symptom 
severity, the most studied variable, was positively associ-
ated with internalized stigma, while treatment adherence 
had negative associations. None of the other psychiatric 
variables, which included diagnosis, hospitalizations, ill-
ness duration, insight, treatment setting, or functioning 
and medication side effects, was found to have significant 
associations. The authors concluded that internalized 
stigma has negative effects on a wide range of outcomes.647
Other researchers have studied the ways in which inter-
nalized stigma affects recovery. Yanos et al625 and Lysaker 
et  al649 have consistently found that internalized stigma 
negatively affects hope and self-esteem. They have also 
developed promising interventions to ameliorate self-
stigma that involve service user narrative techniques 
along with other reflective and reconstructive approaches. 
Lysaker658,659 and Vauth660 examined how the evaluative 
dimension of self-concept (self-efficacy and empower-
ment) mediates psychological effects of self-stigma and 
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coping with stigma. Their findings suggest that an avoid-
ant coping style is a risk factor for anticipatory stigma, 
which erodes self-efficacy and empowerment.
Summary and Implications We know more about the 
origins and production of stigma and self-stigma than we 
know about how to ameliorate stigmatizing beliefs and 
discriminatory behaviors among service providers, or 
how to reduce self-stigma and the effects of discrimina-
tion among service users. Research is needed addressing 
the potential for prevention of treatment-associated self-
stigma and disempowerment, including evaluations of 
the effects of peer-provided services and recovery-focused 
practices. Additional attention is also needed to develop 
programs for helping individuals with serious mental ill-
nesses to overcome the negative effects of stigmatizing 
and discriminatory experiences, including enhancing 
hope, reducing self-stigma, and increasing self-esteem.626
Medication Satisfaction and Medication Side Effects  
Because psychoactive medications often have unwanted 
and unpleasant side effects, medication nonadherence 
is relatively high, particularly among service users with 
schizophrenia.461 Conversely, having a positive attitude 
about medication has been associated with reduced 
symptoms, greater adherence to medications, and better 
community functioning.661,662 A  good understanding of 
satisfaction and satisfaction-related measures is, there-
fore, needed,663 along with development of effective medi-
cations without problematic side effects.459
A number of researchers are developing assessments 
of medication satisfaction. A  new study by Mojtabai 
et  al664 presents psychometric properties of the 40-item 
Patient Assessment Questionnaire (PAQ), which includes 
self-reported medication side effects. Development of the 
PAQ included patient focus groups, and the measure is 
intended as a patient-centered assessment of treatment 
effectiveness. The overall instrument was determined to 
have acceptable feasibility, interitem consistency, and 
construct validity for individuals with schizophrenia spec-
trum disorders. The five subscales, one of which assessed 
medication side effects, were demonstrated to have robust 
convergent and discriminate validity.
A single-question approach has also been validated. 
Vernon et al665 found that an item assessing satisfaction on 
a seven-point scale had acceptable reliability and validity, 
was easy and viable in clinical research, and was poten-
tially useful for clinical practices. Schizophrenia Care and 
Assessment Program Health Questionnaire by Lehman 
et al666 included four questions assessing medication side 
effects, three of which have acceptable internal consis-
tency (feeling tired and sluggish, interferes with normal 
thinking, and feeling fidgety or restless) and acceptable 
test–retest reliability.
The Satisfaction with Antipsychotic Medication 
scale663 is a 33-item instrument that was developed by pro-
fessionals and tested on 787 service users. Although the 
instrument had good internal consistency and acceptable 
consensual validity, the 40% response rate to the ques-
tionnaire suggests that service users may not have found 
it acceptable. Alternatively, the Treatment Satisfaction 
Questionnaire for Medication (TSQM)667 was based on a 
formal conceptual framework, extensive literature review, 
and input from service user interviews that were used to 
select the most relevant questions for a diverse popula-
tion with chronic illnesses. This 14-item self-administered 
questionnaire includes side effects, effectiveness, conve-
nience, and global satisfaction. It is reliable and valid and 
was able to distinguish satisfaction based on method of 
administration, severity of illness, and length of time on 
medication. The results also suggested that the TSQM 
may be a good predictor of medication adherence for dif-
ferent medications and populations.
Gerber and Prince668 evaluated a 35-item survey of sat-
isfaction/dissatisfaction with several treatment-related 
factors among ACT program clients. They found dissat-
isfaction with medication side effects (38%), amount of 
medication (36%), demands of treatment (31%), the extent 
of clients’ influence over treatment (30%), whether the cli-
ent’s opinion was considered in planning treatment (23%), 
and receipt of information about treatment options (20%).
Summary and Implications The studies above suggest 
that measuring medication satisfaction can be relatively 
easy and may have potential to enhance patient-centered 
outcomes (if  such measurement is tied to clinical practices 
that address findings about satisfaction and dissatisfac-
tion). Instruments developed using consumer feedback 
enhance the patient-centered aspect of these tools. Links 
between measurement, clinical responses, and outcomes 
remain to be established.
Summary and Implications for Patient-Centered Outcome 
Measures The measures reviewed in this section represent 
examples of measures that are, or could be developed into, 
patient-centered outcome indicators. Few have been used 
broadly or as performance indicators, and little is under-
stood about how they might be used in aggregated fash-
ion across service users and systems. Moreover, we do not 
know which factors and measures are most important to 
different stakeholders—service users, providers, organiza-
tions, and systems—nor do we understand the mechanisms 
by which care and services affect most of these outcomes. 
A  great deal of research is needed to further develop 
patient-centered outcome measures, to link measures to 
delivered services, to assess the ability of those measures 
to detect treatment and recovery-based improvements, and 
to determine which of these outcomes and process indi-
cators are most useful for providing feedback to improve 
system functioning. Finally, we reviewed no measures that 
are designed to incorporate individually tailored treatment 
outcomes, and these are sorely needed.
The Continuum of Patient-Centered Outcomes to 
More Traditional Clinical Performance and Outcome 
Measures The intent of  our focus on patient-centered 
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outcomes is not to suggest that other types of  clini-
cal and performance measures—or research targeting 
such measures—are of  limited value. We believe these 
other measures are important to a broad range of 
stakeholders, and many may be considered valuable by 
consumers. For example, hospitalizations and rehos-
pitalizations are costly to systems providing care and 
are patient centered in that they are undesirable out-
comes for most consumers. Similarly, structural per-
formance measures such as the availability of  (or links 
to) evidence-based services such as supported hous-
ing, employment, education, and other psychosocial 
services can be important ways to assess the capacity 
of  systems609 and changes made in available services 
over time. Other examples of  broadly valuable mea-
sures include monitoring of  dosages of  prescribed 
medications, polypharmacy and medication interac-
tions, routine medical monitoring of  medications and 
medication-related risks and side effects (eg, metabolic 
consequences of  atypical antipsychotics, lithium lev-
els), follow-up after hospitalization, screening for sub-
stance-related problems, and time to first visit following 
request for treatment. In addition, scientific advances 
may provide opportunities to develop additional mea-
sures that bridge gaps between what have traditionally 
been considered clinical measures and those that are 
more patient centered. For example, a project consul-
tant suggested the following (G. E. Simon, personal 
communication; October 2, 2012):
We need a new generation of fundamentally different mea-
sures. Traditional “clinical” measures are based on notions 
of diagnoses and symptoms. It is becoming increasingly clear 
that those diagnostic categories (like depression, bipolar 
disorder, schizophrenia) are simply “useful fictions” rather 
than true categories. And what we think of as symptoms are 
really epiphenomena of underlying differences in specific 
neuropsychological function (i.e. “anhedonia” is the surface 
manifestation of measurable differences in the anticipation 
of and response to reward [see the NIMH RDOC project for 
a description (http://www.nimh.nih.gov/research-funding/
rdoc/index.shtml)]. This may sound far removed from ser-
vice system issues, but it is not. Outcomes that reflect how 
people’s brains/minds actually function are likely to be much 
closer to what patients/consumers care about than are out-
comes that reflect what providers observe.
In sum, what we propose is that, no matter the source or 
type of outcome measure, service users should be asked 
for their opinions about the value, to them, of  such mea-
sures. We believe they should be asked to identify mea-
sures they think should be used to assess their progress 
over time, and to be involved in identifying key indica-
tors of good system and clinical performance. Then, per-
formance and clinical measures should be linked to, and 
evaluated by, their ability to affect the outcomes that ser-
vice users value the most.
Innovative Methods With Potential for Developing 
Patient-Centered Outcomes
Goal Attainment Scaling Goal attainment scaling is a 
method for evaluating progress toward individualized 
goals. The first step of  the procedure is to construct 
goals for each patient that are observable and measur-
able. The second step is to rate each patient’s progress 
on those goals. A total score across the goals is created 
and standardized. Goals can have differential weight-
ing in this total score. Results from current goal attain-
ment scaling approaches are difficult to compare across 
individuals because the goals, weightings, and anchors 
differ across individuals.669 These difficulties might be 
overcome, however, and if  they were, the advantage of 
goal attainment scaling is that it is person centered with 
individualized goals that are designed to represent real-
istic expectations for each person.670 Creating a measure 
that captures the person centeredness of  goal attain-
ment scaling but can also be aggregated across individu-
als, providers, and health systems may be possible and 
could provide enormous benefit in a learning service 
system.
Willingness to Pay Willingness to pay (WTP) is a tool 
for determining those outcomes of  greatest value to 
patients or other stakeholders. Participants are asked, 
by survey, how much they are willing to pay for specific 
treatment outcomes. The WTP technique is consid-
ered a comprehensive measure of  value that theoreti-
cally includes the respondent’s value for both direct 
and indirect costs, including intangible costs such as 
pain and suffering. Advantages of  WTP as a valuation 
technique are its flexibility across different stakeholder 
groups and its ability to estimate the value of  treat-
ment for those other than the treated individual, usu-
ally referred to as “nonusers” in this literature. A study 
by Mulvaney-Day669 examined the utility of  WTP as a 
tool to assess family members’ perspectives on mental 
health treatment, finding it a useful tool. Additional 
research using WTP with patients might be helpful in 
assessing what is of  greatest value when it comes to 
treatment outcomes.
Discussion and Conclusions
In producing this report, we have repeatedly been con-
fronted with gaps and disconnects—between how services 
are structured and funded and the needs of consumers; 
in the processes of service delivery across settings and 
over time; between the services that are delivered and the 
services consumers want and need; in knowledge about 
the effects of services (or the lack thereof) on consumer 
outcomes; and between traditional clinical outcome 
measures and the outcomes favored by the individu-
als receiving care. There are also significant disconnects 
between the perspectives of providers, families/carers, 
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and researchers, and the perspectives of the consumers/
patients they desire to serve. If  this does not describe a 
system that is broken, it certainly describes a system that 
is not functioning as it should.
We were, thus, faced with a difficult and multipronged 
task: (1) to develop, based on existing resources and 
knowledge, a new vision of  what care should be for peo-
ple with serious mental illness; (2) to describe a system 
in which such care can be delivered in a patient-centered 
manner that is responsive to service user preferences and 
patient-centered outcomes; and (3) to suggest research 
questions, based on current knowledge, to move the 
system from its current state toward this newly envi-
sioned state. In sum, we were faced with the need to 
develop innovative and emergent approaches to reduce 
the disconnects described above, building upon a flawed 
research base and gleaning as much useful informa-
tion as possible from that base. As a result, this report, 
despite our best efforts, has no doubt perpetuated some 
of these same flaws.
With that caveat in place, we turn to our most impor-
tant conclusions. Despite their rather significant implica-
tions, they can be summarized relatively briefly:
1. We lack sufficient outcome measures that have been 
(1) developed by or in concert with service users, or 
(2) evaluated rigorously by service users. Incorporating 
these measures into existing standard clinical assess-
ments is essential to evaluating and improving the 
quality of services provided to individuals with seri-
ous mental illnesses. Development of these measures is 
crucial and should be a primary aim of mental health 
research in the near future.
2. Despite progress in recent years, information remains 
limited regarding the outcomes that service users value 
the most and least. More value-based information is 
fundamental to providing patient-centered care and 
measuring patient-centered outcomes. The next gener-
ation of mental health services research must develop 
a clear and representative understanding of the most 
common values among service users, cultural differ-
ences within and across these values, and the full range 
of these values.
3. Some attempts have been made to link individual out-
comes to service packages, service characteristics (eg, 
continuity, therapeutic relationship), and performance 
measures, but consistency within and across outcome 
measures is lacking, and the measures used are fraught 
with problems when viewed from a patient-centered 
perspective. The mental health system needs feedback 
methods based on new patient-centered outcome mea-
sures that are causally linked to services, processes, and 
structures, and that are useful in one or more of the 
following ways:
a. Measures that aid collaboration between service 
users and providers.
b. Measures that, when aggregated across patients, are 
useful to clinicians as tools for assessing their own 
performance with the individuals they serve.
c. Measures that, when aggregated across clinicians, 
are useful to organizations as tools for assessing 
performance, and in evaluating the effects of service 
packages and quality improvement efforts.
d. Measures that, when aggregated across facilities 
and organizations, are useful to systems and pol-
icy makers for assessing overall performance and 
effects of modifications to factors affecting system 
functioning.
4. Most of the efforts to improve the quality of mental 
health services have focused on improving processes of 
care and ensuring the presence of institutional struc-
tures necessary to provide services. Links between 
patient-centered outcomes and measures of process 
and structure are nearly nonexistent. Such links must 
be established to more appropriately target changes in 
processes and structures that affect outcomes.
5. Very few efforts have been made to aggregate patient-
centered outcomes data to provide performance feed-
back at the organization or system level. Aggregate use 
at the clinician level is very limited. Research develop-
ing solid measures that can be aggregated for use at 
all levels, and research developing effective methods 
for providing feedback using aggregated data, is sorely 
needed.
6. A vast array of interventions, targeting a wide range 
of service and treatment needs, has been developed 
for individuals with serious mental illnesses. Many 
show evidence of effectiveness as measured by con-
ventional measures, but research is needed to compare 
their relative effectiveness using patient-centered out-
come measures. Such studies must include real-world 
patients with complex problems, so that we know how 
to answer questions about best approaches of care 
given individual circumstances, while simultaneously 
providing necessary information to the decision mak-
ers who provide and finance care for these individuals.
7. Financing of care and services is complicated and 
structured in ways that prevent coherent, coordinated, 
and integrated service delivery. These circumstances 
also make comparisons difficult. Changes as a result 
of health care reform are providing opportunities for 
researchers to compare innovative methods of organiz-
ing and financing care. Researchers should take advan-
tage of what are likely to be one-time opportunities.
8. As in other areas of the health care system, stakehold-
ers may value and desire services that are not effective. 
Strategies, policies, and methods are needed for man-
aging and communicating the results of CER in such 
situations.
9. In the context of systems, information alone is not 
adequate to produce system changes, although it 
is essential to the redesign processes. Complexity 
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 science provides an alternative perspective, highlight-
ing factors likely to produce system-level changes 
and subsequent improvements in the outcomes those 
systems produce. In particular, complexity theory 
suggests that the focus of quality improvement 
efforts should not be on methods of providing infor-
mation or incentivizing providers or organizations, 
but rather on the culture and climate of organiza-
tions, how to support teams and employees in ways 
that allow them to flourish, and how to create struc-
tures that promote high-quality interactions and 
teamwork that allow patient-centered information 
to be used to its fullest. Such healthy interactions are 
viewed as the nexus of the information processing 
and sense-making that are the necessary foundations 
of, and motivations for, a learning system.
10. There is an inherent tension between (1) the needs 
and perspectives of researchers, quality improvement 
managers, policy makers, and clinicians, and (2) the 
needs and perspectives of consumers who desire sub-
jective and qualitative assessment and individually 
tailored measurement. Methods and collaborative 
processes are needed to bridge these important gaps.
We challenge researchers studying comparative effective-
ness and patient-centered outcomes to develop methods 
that incorporate the perspectives of service users for 
unique and individualized assessment, intervention, and 
outcomes. At the same time, researchers must produce 
the evidence necessary to allow the mental health care 
system to improve the services it delivers to individuals 
with serious mental illnesses and the outcomes those ser-
vices seek to address.
The key CER and PCOR questions distill around 
identifying what constitutes patient-centered services; 
developing methods for collecting, aggregating, and dis-
tributing information about patient-centered outcomes; 
fostering organizational climates, cultures, and teamwork 
that lead to improved services and outcomes; and estab-
lishing concordance between services delivered and out-
comes that service users value.
Opportunities associated with health care reform are 
abundant, and the business-as-usual approach to improv-
ing outcomes through incremental efforts is no longer 
viable. Researchers, administrators, policy makers, and 
clinicians are at a crossroads. It is time to take on the 
challenge of producing learning systems that can provide 
patient-centered and patient-directed care to individuals 
with serious mental illnesses.
References
 1. Barker PR, Manderscheid RW, Hendershot GE, et al. Serious 
mental illness and disability in the adult household popula-
tion: United States, 1989. Adv Data. 16:1–11.
 2. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. WHO 
World Mental Health Survey Consortium. Prevalence, 
severity, and unmet need for treatment of mental disorders 
in the World Health Organization World Mental Health 
Surveys. JAMA. 2004;291:2581–2590.
 3. Jablensky A, McGrath J, Herrman H, et al.  Psychotic disorders 
in urban areas: an overview of the Study on Low Prevalence 
Disorders. Aust N Z J Psychiatry. 2000;34:221–236.
 4. Merikangas KR, Ames M, Cui L, et al.  The impact of comor-
bidity of mental and physical conditions on role disability in 
the US adult household population. Arch Gen Psychiatry. 
2007;64:1180–1188.
 5. President's New Freedom Commission on Mental Health. 
Achieving the promise: transforming mental health care in 
America. Rockville, MD: DHHS; 2003.
 6. President's New Freedom Commission on Mental Health: 
Subcommittee on Consumer Issues. Shifting to a recovery-
based continuum of community care: a recovery-oriented men-
tal health system. 2003. http://www.mentalhealthcommission.
gov/subcommittee/Consumer_022803.doc.
 7. Institute of Medicine, Committee on Crossing the Quality 
Chasm: Adaptation to Mental Health and Addictive Disorders, 
Board on Health Care Services. Improving the Quality of Health 
Care for Mental and Substance-Use Conditions. Washington, 
DC: The National Academies Press; 2006.
 8. Pincus HA, Page AE, Druss B, Appelbaum PS, Gottlieb 
G, England MJ. Can psychiatry cross the quality chasm? 
Improving the quality of health care for mental and sub-
stance use conditions. Am J Psychiatry. 2007;164:712–719.
 9. Unützer J, Schoenbaum M, Druss BG, Katon WJ. 
Transforming mental health care at the interface with general 
medicine: report for the presidents commission. Psychiatr 
Serv. 2006;57:37–47.
 10. Ridgely MS, Goldman HH, Willenbring M. Barriers to the 
care of persons with dual diagnoses: organizational and 
financing issues. Schizophr Bull. 1990;16:123–132.
 11. James, DJ, Glaze, LE. Mental Health Problems of Prison and 
Jail Inmates. Washington, DC: Bureau of Justice Statistics, 
US Department of Justice; 2006.
 12. Vannoy SD, Mauer B, Kern J, et  al. A learning collabo-
rative of CMHCs and CHCs to support integration of 
behavioral health and general medical care. Psychiatr Serv. 
2011;62:753–758.
 13. Mental Health America. Fact sheet: Medicaid Expansion. 2011. 
http://mentalhealthamerica.net/go/action/policy-issues-a-z/ 
healthcare-reform/fact-sheet-medicaid-expansion/fact-sheet-
medicaid-expansion. Accessed August 8, 2011.
 14. Department of Health and Human Services. Nearly 4 mil-
lion people on Medicare get help with prescription drug 
costs. 2011. http://www.healthcare.gov/center/reports/medi-
care03222011a.html. Accessed August 17, 2011.
 15. Holoahan J, Headen I. Medicaid coverage and spend-
ing in health reform: national and state-by-state results for 
adults at or below 133% FPL. 2011. http://www.kff.org/
healthreform/upload/Medicaid-Coverage-and-Spending-in-
Health-Reform-National-and-State-By-State-Results-for-
Adults-at-or-Below-133-FPL.pdf. Accessed August 15, 2011.
 16. Mental Health America. Fact sheet: State Insurance 
Exchanges. 2011. http://mentalhealthamerica.net/go/action/ 
policy-issues-a-z/healthcare-reform/fact-sheet-state-insur-
ance-exchanges/fact-sheet-state-insurance-exchanges. 
Accessed August 8, 2011.
 17. McDonough JE. Budget sequestration and the U.S.  health 
sector. N Engl J Med. 2013;368:1269–1271.
 18. Spar K, Davis PA, Heisler JH, et al.  Budget “Sequestration” and 
Selected Program: Exemptions and Special Rules. Washington, 
S77
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
DC: Congressional Research Service; 2013. http://www.fas.org/
sgp/crs/misc/R42050.pdf. Accessed September 4, 2013.
 19. Green LW. Public health asks of systems science: to advance 
our evidence-based practice, can you help us get more prac-
tice-based evidence? Am J Public Health. 2006;96:406–409.
 20. Jonas DE, Mansfield AJ, Curtis P, et al.  Identifying priorities 
for patient-centered outcomes research for serious mental ill-
ness. Psychiatr Serv. 2012;63:1125–1130.
 21. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus 
SC. Understanding excess mortality in persons with mental 
illness: 17-year follow up of a nationally representative US 
survey. Med Care. 2011;49:599–604.
 22. Colton CW, Manderscheid RW. Congruencies in increased 
mortality rates, years of potential life lost, and causes of 
death among public mental health clients in eight states. Prev 
Chronic Dis. 2006;3:A42.
 23. Kilbourne AM, Ignacio RV, Kim HM, Blow FC. Datapoints: 
are VA patients with serious mental illness dying younger? 
Psychiatr Serv. 2009;60:589.
 24. Miller BJ, Paschall CB III, Svendsen DP. Mortality and medi-
cal comorbidity among patients with serious mental illness. 
Psychiatr Serv. 2006;57:1482–1487.
 25. Radke AQ, Parks J, Ruter TJ. A call for improved prevention 
and reduction of obesity among persons with serious mental 
illness. Psychiatr Serv. 2010;61:617–619.
 26. Newman S, Goldman H. Putting housing first, making hous-
ing last: housing policy for persons with severe mental illness. 
Am J Psychiatry. 2008;165:1242–1248.
 27. Thomson H, Thomas S, Sellstrom E, et al.  The health impacts 
of housing improvement: a systematic review of intervention 
studies from 1887 to 2007. Am J Public Health. 2009;99(suppl 
3):S681–S692.
 28. Proctor EK. Leverage points for the implementation of evi-
dence-based practice. Brief Treatment and Crisis Intervention. 
2004;4:227–242.
 29. Meadows D. Leverage points: places to intervene in a system. 
Hartland, VT: The Sustainability Institute; 1999.
 30. Institute of Medicine. Best Care at Lower Cost: The Path to 
Continuously Learning Health Care in America: Brief Report. 
National Academy of Science; 2012.
 31. Institute of Medicine, Committee on Quality Health Care in 
America. Crossing the Quality Chasm: A New Health System 
for the 21st Century. Washington, DC: National Academy 
Press; 2001.
 32. Institute of Medicine. Cancer Care for the Whole Patient: 
Meeting Psychosocial Health Needs. Washington, DC: 
National Academies Press; 2008.
 33. Epperson M, Wolff  N, Morgan R, et al.  The Next Generation 
of Behavioral Health and Criminal Justice Interventions: 
Improving Outcomes by Improving Interventions. New 
Brunswick, NJ: Rutgers University Center for Behavioral 
Health Services & Criminal Justice Research; 2011.
 34. McDaniel RR Jr, Driebe DJ. Complexity science and 
health care management. Adv Health Econ Health Serv Res. 
2001;2:11–36.
 35. McDaniel RR. Management strategies for complex adap-
tive systems: sensemaking, learning, and improvisation. 
Performance Improvement Quarterly. 2007;20:21–42.
 36. Miller WL, Crabtree BF, McDaniel R, Stange KC. 
Understanding change in primary care practice using com-
plexity theory. J Fam Pract. 1998;46:369–376.
 37. Anderson RA, Crabtree BF, Steele DJ, McDaniel RR Jr. 
Case study research: the view from complexity science. Qual 
Health Res. 2005;15:669–685.
 38. Crabtree BF, Nutting PA, Miller WL, et  al.  Primary care 
practice transformation is hard work: insights from a 
15-year developmental program of research. Med Care. 
2011;49:28–35.
 39. Crabtree BF, Miller WL, Stange KC. Understanding practice 
from the ground up. J Fam Pract. 2001;50:881–887.
 40. Miller WL, McDaniel RR Jr, Crabtree BF, Stange KC. 
Practice jazz: understanding variation in family practices 
using complexity science. J Fam Pract. 2001;50:872–878.
 41. Stroebel CK, McDaniel RR Jr, Crabtree BF, Miller WL, 
Nutting PA, Stange KC. How complexity science can inform 
a reflective process for improvement in primary care practices. 
Jt Comm J Qual Patient Saf. 2005;31:438–446.
 42. Swartz MS, Swanson JW, Hannon MJ. Does fear of coercion 
keep people away from mental health treatment? Evidence 
from a survey of persons with schizophrenia and mental 
health professionals. Behav Sci Law. 2003;21:459–472.
 43. Chamberlin J. User/consumer involvement in mental health 
service delivery. Epidemiol Psichiatr Soc. 2005;14:10–14.
 44. Johansson H, Eklund M. Patients’ opinion on what constitutes 
good psychiatric care. Scand J Caring Sci. 2003;17:339–346.
 45. Angell B, Martinez NI, Mahoney CA, Corrigan PW. 
Payeeship, financial leverage, and the client-provider relation-
ship. Psychiatr Serv. 2007;58:365–372.
 46. Watson AC, Angell B. Applying procedural justice theory to 
law enforcement’s response to persons with mental illness. 
Psychiatr Serv. 2007;58:787–793.
 47. Hopkins JE, Loeb SJ, Fick DM. Beyond satisfaction, what 
service users expect of inpatient mental health care: a litera-
ture review. J Psychiatr Ment Health Nurs. 2009;16:927–937.
 48. Brunero S, Lamont S, Fairbrother G. Using and understand-
ing consumer satisfaction to effect an improvement in men-
tal health service delivery. J Psychiatr Ment Health Nurs. 
2009;16:272–278.
 49. Mason K, Olmos-Gallo A, Bacon D, McQuilken M, Henley 
A, Fisher S. Exploring the consumer’s and provider’s per-
spective on service quality in community mental health care. 
Community Ment Health J. 2004;40:33–46.
 50. Happell B. Determining the effectiveness of mental health ser-
vices from a consumer perspective: part 1: enhancing recov-
ery. Int J Ment Health Nurs. 2008;17:116–122. Evaluation 
Studies Research Support, Non-U.S. Gov't.
 51. Happell B. Determining the effectiveness of mental health ser-
vices from a consumer perspective: part 2: barriers to recov-
ery and principles for evaluation. Int J Ment Health Nurs. 
2008;17:123–130. Evaluation Studies Research Support, 
Non-U.S. Gov't.
 52. Green CA, Polen MR, Janoff SL, et al. Understanding how 
clinician-patient relationships and relational continuity of 
care affect recovery from serious mental illness: STARS study 
results. Psychiatr Rehabil J. 2008;32:9–22.
 53. Ware NC, Tugenberg T, Dickey B, McHorney CA. An ethno-
graphic study of the meaning of continuity of care in mental 
health services. Psychiatr Serv. 1999;50:395–400.
 54. Laugharne R, Priebe S, McCabe R, Garland N, Clifford D. 
Trust, choice and power in mental health care: experiences of 
patients with psychosis. Int J Soc Psychiatry. 2012;58:496–504.
 55. Bordin ES. The generalisability of the psychoanalytic con-
cept of the working alliance. Psychother Theor Res Pract. 
1979;16:252–260.
 56. Priebe S, McCabe R. The therapeutic relationship in psychi-
atric settings. Acta Psychiatr Scand Suppl. 2006;113:69–72. 
S78
C. A. Green et al
 57. Priebe S, Richardson M, Cooney M, Adedeji O, McCabe R. 
Does the therapeutic relationship predict outcomes of psy-
chiatric treatment in patients with psychosis? A  systematic 
review. Psychother Psychosom. 2011;80:70–77.
 58. McCabe R, Priebe S. The therapeutic relationship in the 
treatment of severe mental illness: a review of methods and 
findings. Int J Soc Psychiatry. 2004;50:115–128.
 59. McCabe R, Priebe S. Communication and psychosis: it’s 
good to talk, but how? Br J Psychiatry. 2008;192:404–405.
 60. Fakhoury WK, White I, Priebe S; PLAO Study Group. Be 
good to your patient: how the therapeutic relationship in the 
treatment of patients admitted to assertive outreach affects 
rehospitalization. J Nerv Ment Dis. 2007;195:789–791.
 61. Hogarty GE, Flesher S, Ulrich R, et al.  Cognitive enhance-
ment therapy for schizophrenia: effects of a 2-year rand-
omized trial on cognition and behavior. Arch Gen Psychiatry. 
2004;61:866–876.
 62. Corrigan PW, Angell B, Davidson L, et  al.  From adher-
ence to self-determination: evolution of a treatment para-
digm for people with serious mental illnesses. Psychiatr Serv. 
2012;63:169–173.
 63. Drake RE, Deegan PE, Rapp C. The promise of shared 
decision making in mental health. Psychiatr Rehabil J. 
2010;34:7–13.
 64. Curtis LC, Wells SM, Penney DJ, et al.  Pushing the envelope: 
shared decision making in mental health. Psychiatr Rehabil J. 
2010;34:14–22.
 65. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do 
patients with schizophrenia wish to be involved in deci-
sions about their medical treatment? Am J Psychiatry. 
2005;162:2382–2384.
 66. Thompson AG. The meaning of patient involvement and 
participation in health care consultations: a taxonomy. Soc 
Sci Med. 2007;64:1297–1310.
 67. Lewin SA, Skea ZC, Entwistle V, Zwarenstein M, Dick J. 
Interventions for providers to promote a patient-centered 
approach in clinical consultations. Cochrane Database Syst 
Rev. 2001;CD003267.
 68. Kimhy D, Myin-Germeys I, Palmier-Claus J, Swendsen J. 
Mobile assessment guide for research in schizophrenia and 
severe mental disorders. Schizophr Bull. 2012;38:386–395.
 69. Ben-Zeev D. Mobile technologies in the study, assessment, and 
treatment of schizophrenia. Schizophr Bull. 2012;38:384–385.
 70. Deegan PE. The lived experience of using psychiatric medi-
cation in the recovery process and a shared decision-making 
program to support it. Psychiatr Rehabil J. 2007;31:62–69.
 71. Russo J, Wallcraft J. Resisting variables: service user/survivor 
perspectives on researching coercion. In: Kallert TW, eds. 
Coercive Treatment in Psychiatry: Clinical, Legal, and Ethical 
Aspects. John Wiley & Sons; 2011:213–234.
 72. Oaks D. The moral imperative for dialogue with organiza-
tions of survivors of coerced psychiatric human rights viola-
tions. In: Kallert TW, eds. Coercive Treatment in Psychiatry. 
Wiley-Blackwell; 2011:187–212. 
 73. Buck-Zerchin DM. Seventy years of coercion in psychiat-
ric institutions, experienced and witnessed. In: Kallert TW, 
eds. Coercive Treatment in Psychiatry. Wiley-Blackwell; 
2011:235–244.
 74. Prinsen EJ, van Delden JJ. Can we justify eliminating coercive 
measures in psychiatry? J Med Ethics. 2009;35:69–73.
 75. Newton-Howes G, Mullen R. Coercion in psychiatric care: 
systematic review of correlates and themes. Psychiatr Serv. 
2011;62:465–470.
 76. Geller JL. The evolution of outpatient commitment in the 
USA: from conundrum to quagmire. Int J Law Psychiatry. 
2006;29:234–248.
 77. Phelan JC, Sinkewicz M, Castille DM, Huz S, Muenzenmaier 
K, Link BG. Effectiveness and outcomes of assisted outpatient 
treatment in New York State. Psychiatr Serv. 2010;61:137–143.
 78. Swartz MS, Wilder CM, Swanson JW, et al.  Assessing out-
comes for consumers in New York’s assisted outpatient treat-
ment program. Psychiatr Serv. 2010;61:976–981.
 79. Kisely SR, Campbell LA, Preston NJ. Compulsory com-
munity and involuntary outpatient treatment for people 
with severe mental disorders. Cochrane Database Syst Rev. 
2011;CD004408.
 80. Priebe S, Katsakou C, Glöckner M, et al.  Patients’ views of 
involuntary hospital admission after 1 and 3  months: pro-
spective study in 11 European countries. Br J Psychiatry. 
2010;196:179–185.
 81. Link B, Castille DM, Stuber J. Stigma and coercion in the 
context of outpatient treatment for people with mental ill-
nesses. Soc Sci Med. 2008;67:409–419.
 82. O’Donoghue B, Lyne J, Hill M, Larkin C, Feeney 
L, O’Callaghan E. Involuntary admission from the 
patients’ perspective. Soc Psychiatry Psychiatr Epidemiol. 
2010;45:631–638.
 83. Health NCoM&OCS. Position statement on alternatives to 
force and coercion in mental health treatment. 2012. http://
www.power2u.org/crisis-alternatives.html.
 84. Bundesgerichtshof Mitteilung der Pressestelle (Federal Court 
Communication from the Press Office). Bundesgerichtshof 




 85. Bundesgerichtshof Mitteilung der Pressestelle. Keine hinre-





 86. Kallert TW, Katsakou C, Adamowski T, et al.  Coerced hos-
pital admission and symptom change–a prospective observa-
tional multi-centre study. PLoS ONE. 2011;6:e28191.
 87. Lidz CW, Hoge SK, Gardner W, et al.  Perceived coercion in 
mental hospital admission. Pressures and process. Arch Gen 
Psychiatry. 1995;52:1034–1039.
 88. Husum TL, Bjørngaard JH, Finset A, Ruud T. A cross-sec-
tional prospective study of seclusion, restraint and involun-
tary medication in acute psychiatric wards: patient, staff  and 
ward characteristics. BMC Health Serv Res. 2010;10:89.
 89. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. 
Interventions for enhancing medication adherence. Cochrane 
Database Syst Rev. 2008;CD000011.
 90. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. 
Metabolic and cardiovascular adverse effects associated with 
antipsychotic drugs. Nat Rev Endocrinol. 2012;8:114–126.
 91. Leung JY, Barr AM, Procyshyn RM, Honer WG, Pang 
CC. Cardiovascular side-effects of antipsychotic drugs: the 
role of the autonomic nervous system. Pharmacol Ther. 
2012;135:113–122.
 92. Seeman MV. Antipsychotics and physical attractiveness. Clin 
Schizophr Relat Psychoses. 2011;5:142–146.
S79
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 93. Rosenheck R, Stroup S, Keefe RS, et al.  Measuring outcome 
priorities and preferences in people with schizophrenia. Br J 
Psychiatry. 2005;187:529–536.
 94. Honer WG, Thornton AE, Sherwood M, et al.  Conceptual 
and methodological issues in the design of clinical trials of 
antipsychotics for the treatment of schizophrenia. CNS 
Drugs. 2007;21:699–714.
 95. Angell B, Mahoney C. Reconceptualizing the case manage-
ment relationship in intensive treatment: a study of staff  
perceptions and experiences. Adm Policy Ment Health. 
2007;34:172–188.
 96. Angell B. Measuring strategies used by mental health provid-
ers to encourage medication adherence. J Behav Health Serv 
Res. 2006;33:53–72.
 97. Monahan J, Redlich AD, Swanson J, et al.  Use of leverage 
to improve adherence to psychiatric treatment in the commu-
nity. Psychiatr Serv. 2005;56:37–44.
 98. Hawthorne WB, Folsom DP, Sommerfeld DH, et  al. 
Incarceration among adults who are in the public mental 
health system: rates, risk factors, and short-term outcomes. 
Psychiatr Serv. 2012;63:26–32.
 99. Cusack KJ, Steadman HJ, Herring AH. Perceived coer-
cion among jail diversion participants in a multisite study. 
Psychiatr Serv. 2010;61:911–916.
 100. Skeem JL, Louden JE. Toward evidence-based practice for 
probationers and parolees mandated to mental health treat-
ment. Psychiatr Serv. 2006;57:333–342.
 101. Farabee D, Haikang S, Sanchez S. Perceived Coercion and 
Treatment Need Among Mentall Ill Parolees. Crim Justice 
Behav. 2002;29:76–86.
 102. Kontio R, Joffe G, Putkonen H, et al.  Seclusion and restraint 
in psychiatry: patients’ experiences and practical suggestions 
on how to improve practices and use alternatives. Perspect 
Psychiatr Care. 2012;48:16–24. 
 103. Appelbaum PS. Seclusion and restraint: congress reacts to 
reports of abuse. Psychiatr Serv. 1999;50:881–882.
 104. Muralidharan S, Fenton M. Containment strategies for peo-
ple with serious mental illness. Cochrane Database Syst Rev. 
2006;CD002084.
 105. Schacht, LM. National Trend in the Use of Seclusion and 
Restraint Among State Psychiatric Hospitals. Alexandria, 
VA: National Association of State Mental Health Program 
Directors Research Institute, Inc. (NRI); 2006.
 106. Donat DC. Impact of a mandatory behavioral consultation 
on seclusion/restraint utilization in a psychiatric hospital. J 
Behav Ther Exp Psychiatry. 1998;29:13–19.
 107. Donat DC. An analysis of successful efforts to reduce the 
use of seclusion and restraint at a public psychiatric hospital. 
Psychiatr Serv. 2003;54:1119–1123.
 108. Donat DC. Impact of improved staffing on seclusion/restraint 
reliance in a public psychiatric hospital. Psychiatr Rehabil J. 
2002;25:413–416.
 109. Borckardt JJ, Madan A, Grubaugh AL, et  al.  Systematic 
investigation of initiatives to reduce seclusion and restraint in 
a state psychiatric hospital. Psychiatr Serv. 2011;62:477–483.
 110. Rose D, Thornicroft G, Slade M. Who decides what evidence 
is? Developing a multiple perspectives paradigm in mental 
health. Acta Psychiatr Scand Suppl. 2006;113:109–114.
 111. Goldstrom ID, Campbell J, Rogers JA, et al.  National esti-
mates for mental health mutual support groups, self-help 
organizations, and consumer-operated services. Adm Policy 
Ment Health. 2006;33:92–103.
 112. Campbell J, Leaver J. Emerging new practices in organ-
ized peer support. Report from NTAC’s National Experts 
Meeting on Emerging New Practices in Organized Peer 
Support March 17–18, 2003. Alexandria, VA: National 
Association of State Mental Health Program Directors, 
National Technical Assistance Center for State Mental 
Health Planning. Produced under contract with the Center 
for Mental Health Services, Substance Abuse and Mental 
Health Services Administration, U.S. Department of Health 
and Human Services; 2003.
 113. Davidson L, Bellamy C, Guy K, Miller R. Peer support 
among persons with severe mental illnesses: a review of evi-
dence and experience. World Psychiatry. 2012;11:123–128.
 114. Doughty C, Tse S. Can consumer-led mental health services 
be equally effective? An integrative review of CLMH ser-
vices in high-income countries. Community Ment Health J. 
2011;47:252–266.
 115. Tan C, Mowbray C, & Foster, J. Consumer-run drop-in 
center study: Technical report: executive summary. Detroit: 
Michigan State University.
 116. Substance Abuse and Mental Health Services Administration. 
Consumer-Operated Services: Getting Started with Evidence-Based 
Practices. Rockville, MD: Center for Mental Health Services, 
Substance Abuse and Mental Health Services Administration, 
U.S. Department of Health and Human Services; 2011.
 117. Substance Abuse and Mental Health Services Administration. 
Consumer-Operated Services: The Evidence. Rockville, MD: 
Center for Mental Health Services, Substance Abuse and 
Mental Health Services Administration, U.S. Department of 
Health and Human Services; 2011.
 118. Brown LD. How people can benefit from mental health 
consumer-run organizations. Am J Community Psychol. 
2009;43:177–188.
 119. Felton BJ. Defining location in the mental health system: 
a case study of  a consumer-run agency. Am J Community 
Psychol. 2005;36:373–386.
 120. Lewis SE, Hopper K, Healion E. Partners in recovery: social 
support and accountability in a consumer-run mental health 
center. Psychiatr Serv. 2012;63:61–65.
 121. Segal SP, Silverman CJ, Temkin TL. Outcomes from con-
sumer-operated and community mental health services: a 
randomized controlled trial. Psychiatr Serv. 2011;62:915–921.
 122. Hodges JQ, Markward M, Keele C, Evans CJ. Use of self-
help services and consumer satisfaction with professional 
mental health services. Psychiatr Serv. 2003;54:1161–1163.
 123. Gates LB, Akabas SH. Developing strategies to integrate peer 
providers into the staff  of mental health agencies. Adm Policy 
Ment Health. 2007;34:293–306.
 124. Solomon P, Draine J. Satisfaction with mental health treat-
ment in a randomized trial of consumer case management. J 
Nerv Ment Dis. 1994;182:179–184.
 125. Solomon P. Peer support/peer provided services underlying 
processes, benefits, and critical ingredients. Psychiatr Rehabil 
J. 2004;27:392–401.
 126. van Erp NH, Hendriksen-Favier AI, Boer M. Training and 
employment of consumer provider employees in Dutch men-
tal health care. Psychiatr Rehabil J. 2010;34:65–67.
 127. Tondora J, O’Connell M, Miller R, et al. A clinical trial of 
peer-based culturally responsive person-centered care for 
psychosis for African Americans and Latinos. Clin Trials. 
2010;7:368–379.
 128. van Vugt MD, Kroon H, Delespaul PA, Mulder CL. 
Consumer-providers in assertive community treatment 
S80
C. A. Green et al
programs: associations with client outcomes. Psychiatr Serv. 
2012;63:477–481.
 129. Chinman M, Young AS, Hassell J, Davidson L. Toward the 
implementation of mental health consumer provider services. 
J Behav Health Serv Res. 2006;33:176–195.
 130. Cleary M, Horsfall J, Hunt GE, Escott P, Happell B. 
Continuing challenges for the mental health consumer work-
force: a role for mental health nurses? Int J Ment Health Nurs. 
2011;20:438–444.
 131. Stewart S, Watson S, Montague R, Stevenson C. Set up to 
fail? Consumer participation in the mental health service sys-
tem. Australas Psychiatry. 2008;16:348–353.
 132. Hardiman ER. Referral to consumer-run programs by mental 
health providers: a national survey. Community Ment Health 
J. 2007;43:197–210.
 133. Hodges JQ, Hardiman ER. Promoting healthy organiza-
tional partnerships and collaboration between consumer-run 
and community mental health agencies. Adm Policy Ment 
Health. 2006;33:267–278.
 134. McCann TV, Baird J, Clark E, Lu S. Mental health profes-
sionals’ attitudes towards consumer participation in inpatient 
units. J Psychiatr Ment Health Nurs. 2008;15:10–16.
 135. Copeland ME. Wellness Recovery Action Plan. Brattleboro, 
VT: Peach Press; 1997.
 136. Fisher DB, Ahrens L. Personal Assistance in Community 
Existence (PACE): an alternative to PACT. Ethical Hum Sci 
Serv. 2000;2:87–92.
 137. Mead S. Intentional peer support. 2012. http://www.mental-
healthpeers.com/booksarticles.html.
 138. Bell JS, Johns R, Rose G, Chen TF. A comparative study of 
consumer participation in mental health pharmacy educa-
tion. Ann Pharmacother. 2006;40:1759–1765.
 139. Meehan T, Glover H. Telling our story: consumer perceptions 
of their role in mental health education. Psychiatr Rehabil J. 
2007;31:152–154.
 140. Dixon LB, Dickerson F, Bellack AS, et  al. Schizophrenia 
Patient Outcomes Research Team (PORT). The 2009 schizo-
phrenia PORT psychosocial treatment recommendations and 
summary statements. Schizophr Bull. 2010;36:48–70.
 141. Cañive JM, Sanz-Fuentenebro J, Vázquez C, et  al.  Family 
psychoeducational support groups in Spain: parents’ distress 
and burden at none-month follow-up. Ann Clin Psychiatry. 
1996;8:71–79.
 142. Goodwin V, Happell B. Consumer and carer participation in 
mental health care: the carer’s perspective: part 1 - the impor-
tance of respect and collaboration. Issues Ment Health Nurs. 
2007;28:607–623.
 143. Goodwin V, Happell B. Consumer and carer participation in 
mental health care: the carer’s perspective: part 2—barriers to 
effective and genuine participation. Issues Ment Health Nurs. 
2007;28:625–638.
 144. Magaña SM, Ramírez García JI, Hernández MG, Cortez 
R. Psychological distress among latino family caregivers of 
adults with schizophrenia: the roles of burden and stigma. 
Psychiatr Serv. 2007;58:378–384.
 145. Scheyett A, McCarthy E, Rausch C. Consumer and family 
views on evidence-based practices and adult mental health 
services. Community Ment Health J. 2006;42:243–257.
 146. Campbell K, Bond GR, Drake RE. Who benefits from sup-
ported employment: a meta-analytic study. Schizophr Bull. 
2011;37:370–380.
 147. Greenberg JS, Knudsen KJ, Aschbrenner KA. Prosocial fam-
ily processes and the quality of life of persons with schizo-
phrenia. Psychiatr Serv. 2006;57:1771–1777.
 148. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB; 
Schizophrenia Patient Outcomes Research Team (PORT). 
The Schizophrenia Patient Outcomes Research Team (PORT): 
updated treatment recommendations 2009. Schizophr Bull. 
2010;36:94–103.
 149. Simon G, Rutter C, Crosier M, Scott J, Operskalski BH, 
Ludman E. Are comparisons of consumer satisfaction with 
providers biased by nonresponse or case-mix differences? 
Psychiatr Serv. 2009;60:67–73.
 150. Lenert LA, Ziegler J, Lee T, Sommi R, Mahmoud R. 
Differences in health values among patients, family mem-
bers, and providers for outcomes in schizophrenia. Med Care. 
2000;38:1011–1021.
 151. Fischer EP, Shumway M, Owen RR. Priorities of consumers, 
providers, and family members in the treatment of schizo-
phrenia. Psychiatr Serv. 2002;53:724–729.
 152. Shumway M, Sentell T, Chouljian T, Tellier J, Rozewicz F, 
Okun M. Assessing preferences for schizophrenia outcomes: 
comprehension and decision strategies in three assessment 
methods. Ment Health Serv Res. 2003;5:121–135.
 153. Karow A, Naber D, Lambert M, Moritz S; EGOFORS 
Initiative. Remission as perceived by people with schizo-
phrenia, family members and psychiatrists. Eur Psychiatry. 
2012;27:426–431.
 154. Swanson JW, Hannon, Elbogen, et al.  Psychiatric advance 
directives: a survey of persons with schizophrenia, fam-
ily members, and treatment providers. Int J Forensic Ment 
Health. 2003;2:73–86.
 155. McKay MM, Gopalan G, Franco L, et al.  A collaboratively 
designed child mental health service model: multiple family 
groups for urban children with conduct difficulties. Res Soc 
Work Pract. 2011;21:664–674.
 156. McGinty K, Worthington R, Dennison W. Patient and fam-
ily advocacy: working with individuals with comorbid men-
tal illness and developmental disabilities and their families. 
Psychiatr Q. 2008;79:193–203.
 157. McKinstry B, Ashcroft RE, Car J, Freeman GK, Sheikh 
A. Interventions for improving patients’ trust in doc-
tors and groups of doctors. Cochrane Database Syst Rev. 
2006;CD004134.
 158. Williams J, Leamy M, Bird V, et al.  Measures of the recovery 
orientation of mental health services: systematic review. Soc 
Psychiatry Psychiatr Epidemiol. 2012;47:1827–1835.
 159. Leucht S, Lasser R. The concepts of remission and recovery 
in schizophrenia. Pharmacopsychiatry. 2006;39:161–170.
 160. Roe D, Mashiach-Eizenberg M, Lysaker PH. The relation 
between objective and subjective domains of recovery among 
persons with schizophrenia-related disorders. Schizophr Res. 
2011;131:133–138.
 161. Slade M, Amering M, Oades L. Recovery: an international 
perspective. Epidemiol Psichiatr Soc. 2008;17:128–137.
 162. Russinova Z, Rogers ES, Ellison ML, Lyass A. Recovery-
promoting professional competencies: perspectives of men-
tal health consumers, consumer-providers and providers. 
Psychiatr Rehabil J. 2011;34:177–185.
 163. Robiner WN. The mental health professions: workforce sup-
ply and demand, issues, and challenges. Clin Psychol Rev. 
2006;26:600–625.
 164. Aarons GA, Sawitzky AC. Organizational climate partially 
mediates the effect of culture on work attitudes and staff  
S81
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
turnover in mental health services. Adm Policy Ment Health. 
2006;33:289–301.
 165. Ware NC, Tugenberg T, Dickey B. Practitioner relationships 
and quality of care for low-income persons with serious men-
tal illness. Psychiatr Serv. 2004;55:555–559.
 166. Uttarkar V. An investigation into community mental health 
staff  experience. J Soc Work Pract. 2010;24:49–61.
 167. Munson M, Proctor E, Morrow-Howell N, Fedoravicius 
N, Ware N. Case managers speak out: responding to 
depression in community long-term care. Psychiatr Serv. 
2007;58:1124–1127.
 168. Tennille J, Solomon P, Blank M. Case managers discovering 
what recovery means through an HIV prevention interven-
tion. Community Ment Health J. 2010;46:486–493.
 169. Morris A, Bloom JR. Contextual factors affecting job satis-
faction and organizational commitment in community men-
tal health centers undergoing system changes in the financing 
of care. Ment Health Serv Res. 2002;4:71–83.
 170. Amering M, Denk E, Griengl H, Sibitz I, Stastny P. 
Psychiatric wills of mental health professionals: a survey 
of opinions regarding advance directives in psychiatry. Soc 
Psychiatry Psychiatr Epidemiol. 1999;34:30–34.
 171. Hassan I, McCabe R, Priebe S. Professional-patient commu-
nication in the treatment of mental illness: a review. Commun 
Med. 2007;4:141–152.
 172. Wallcraft J, Amering M, Freidin J, et  al.  Partnerships for 
better mental health worldwide: WPA recommendations on 
best practices in working with service users and family carers. 
World Psychiatry. 2011;10:229–236.
 173. Delman J, Beinecke RH. Assessing consumer satisfaction 
in the Massachusetts Behavioral Health Partnership. Adm 
Policy Ment Health. 2005;32:373–386.
 174. Delman J. Consumer-driven and conducted survey research 
in action. In: Kroll T, Keer D, Placek P, et al., eds. Towards 
Best Practices for Surveying People with Disabilities. New 
York: Nova Science Publishers, Inc.; 2007:71–87.
 175. Oades LG, Law J, Marshall SL. Development of a consumer 
constructed scale to evaluate mental health service provision. 
J Eval Clin Pract. 2011;17:1102–1107.
 176. Ochocka J, Janzen R, Nelson G. Sharing power and knowl-
edge: professional and mental health consumer/survivor 
researchers working together in a participatory action 
research project. Psychiatr Rehabil J. 2002;25:379–387.
 177. Reeve P, Cornell S, D’Costa B, Janzen R, Ochocka J. From 
our perspective: consumer researchers speak about their 
experience in a community mental health research project. 
Psychiatr Rehabil J. 2002;25:403–408.
 178. Love RE, Caid CD, Davis A Jr. The user satisfaction sur-
vey: consumer evaluation of an inner city community mental 
health center. Eval Health Prof. 1979;2:42–54.
 179. International Initiative for Mental Health Leadership. 
Making Services Work for Consumers. International Initiative 
for Mental Health Leadership; 2011.
 180. Bennetts W, Cross W, Bloomer M. Understanding consumer 
participation in mental health: Issues of power and change. 
Int J Ment Health Nurs. 2011;20:155–164.
 181. Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman 
AD. Methods of  consumer involvement in developing 
healthcare policy and research, clinical practice guidelines 
and patient information material. Cochrane Database Syst 
Rev. 2006;CD004563.
 182. Von Korff M, Nestadt G, Romanoski A, et al.  Prevalence 
of treated and untreated DSM-III schizophrenia. Results 
of a two-stage community survey. J Nerv Ment Dis. 
1985;173:577–581.
 183. National Advisory Mental Health Council. Health care 
reform for Americans with severe mental illnesses: report 
of the National Advisory Mental Health Council. Am J 
Psychiatr. 1993;150:1447–1465.
 184. Kessler RC, Berglund PA, Bruce ML, et al.  The prevalence 
and correlates of untreated serious mental illness. Health Serv 
Res. 2001;36:987–1007.
 185. Substance Abuse and Mental Health Services Administration. 
Mental Health, United States, 2010. HHS Publication No. 
(SMA) 12-4681. Rockville, MD: Substance Abuse and 
Mental Health Services Administration; 2012.
 186. Levit KR, Kassed CA, Coffey RM, et al.  Future funding for 
mental health and substance abuse: increasing burdens for the 
public sector. Health Aff (Millwood). 2008;27:w513–w522.
 187. Fenton WS, Hoch JS, Herrell JM, Mosher L, Dixon L. Cost 
and cost-effectiveness of hospital vs residential crisis care for 
patients who have serious mental illness. Arch Gen Psychiatry. 
2002;59:357–364.
 188. Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipo-
lar disorder: clinical and parity implications. Am J Psychiatry. 
2003;160:1286–1290.
 189. Simon GE, Unützer J. Health care utilization and costs 
among patients treated for bipolar disorder in an insured 
population. Psychiatr Serv. 1999;50:1303–1308.
 190. Gilmer TP, Stefancic A, Ettner SL, Manning WG, Tsemberis 
S. Effect of full-service partnerships on homelessness, use 
and costs of mental health services, and quality of life among 
adults with serious mental illness. Arch Gen Psychiatry. 
2010;67:645–652.
 191. Rothbard AB, Miller K, Lee S, Blank M. Revised cost esti-
mates of Medicaid recipients with serious mental illness and 
HIV-AIDS. Psychiatr Serv. 2009;60:974–977.
 192. Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. 
Medicare and medicaid costs for schizophrenia patients 
by age cohort compared with costs for depression, demen-
tia, and medically ill patients. Am J Geriatr Psychiatry. 
2003;11:648–657.
 193. Lund BC, Flaum M, Adam LA, Perry PJ. Psychiatric pre-
scribing trends and practices in Iowa’s prisons. Psychiatr 
Serv. 2002;53:1023–1024.
 194. Glied SA, Frank RG. Better but not best: recent trends in 
the well-being of the mentally ill. Health Aff (Millwood). 
2009;28:637–648.
 195. Wolff  N. Community reintegration of prisoners with mental 
illness: a social investment perspective. Int J Law Psychiatry. 
2005;28:43–58.
 196. Alemi F, Taxman F, Baghi H, Vang J, Thanner M & Doyon 
V. Costs and benefits of combining probation and substance 
abuse treatment. J Ment Health Policy Econ. 2006;9:57–70.
 197. Barrett B, Byford S. Costs and outcomes of an intervention 
programme for offenders with personality disorders. Br J 
Psychiatry. 2012;200:336–341.
 198. Jacobs S, Steiner J, Schaefer M, Hoge M. Economic grand 
rounds: financing the care of individuals with serious mental 
illness. Psychiatr Serv. 2004;55:1096–1098.
 199. Resnick SG, Rosenheck R. Dissemination of supported 




 200. Drake RE, Skinner JS, Bond GR, Goldman HH. Social secu-
rity and mental illness: reducing disability with supported 
employment. Health Aff (Millwood). 2009;28:761–770.
 201. Technical Assistance Collaborative I. Policy priorities: 
Section 811 Program. 2012. http://www.tacinc.org/Program_
Policy/Sect811_legisltn.php. Accessed May 29, 2012.
 202. Hutchins EC, Frank RG, Glied SA. The evolving private 
psychiatric inpatient market. J Behav Health Serv Res. 
2011;38:122–131.
 203. Frank RG, Goldman HH, McGuire TG. Trends in men-
tal health cost growth: an expanded role for management? 
Health Aff (Millwood). 2009;28:649–659.
 204. Edwards BC, Smith VK. Insights and opportunities: 
Medicaid directors identify mental health issues. Psychiatr 
Serv. 2007;58:1032–1034.
 205. Frank RG, Glied S. Changes in mental health financing since 
1971: implications for policymakers and patients. Health Aff 
(Millwood). 2006;25:601–613.
 206. Frank RG, Glied SA. Mental health in the mainstream of 
health care. Health Aff (Millwood). 2007;26:1539–1541.
 207. Brent RJ. The tax implications of cost shifting in cost-benefit 
analysis in mental health. Appl Econ. 2003;35:943–950.
 208. McAlpine DD, Mechanic D. Utilization of specialty mental 
health care among persons with severe mental illness: the 
roles of demographics, need, insurance, and risk. Health Serv 
Res. 2000;35:277–292.
 209. McKusick DR, Mark TL, King EC, Coffey RM, Genuardi J. 
Trends in mental health insurance benefits and out-of-pocket 
spending. J Ment Health Policy Econ. 2002;5:71–78.
 210. Mechanic D. Challenges in the provision of mental health 
services: some cautionary lessons from US experience. J 
Public Health Med. 1995;17:132–139.
 211. Frank RG, Huskamp HA, Pincus HA. Aligning incentives in 
the treatment of depression in primary care with evidence-
based practice. Psychiatr Serv. 2003;54:682–687.
 212. Sharfstein SS, Goldman H. Financing the medical 
management of  mental disorders. Am J Psychiatry. 
1989;146:345–349.
 213. Kaiser Family Foundation Commission on Medicaid and the 
Uninsured. People with Disabilities and Medicaid Managed 
Care: Key Issues to Consider. 8278. Kaiser Family Foundation; 
2012.
 214. Merrell K, Berenson RA. Structuring payment for medical 
homes. Health Aff (Millwood). 2010;29:852–858.
 215. Fields D, Leshen E, Patel K. Analysis & commentary. Driving 
quality gains and cost savings through adoption of medical 
homes. Health Aff (Millwood). 2010;29:819–826.
 216. Clark RE, Samnaliev M, McGovern MP. Treatment for co-
occurring mental and substance use disorders in five state 
Medicaid programs. Psychiatr Serv. 2007;58:942–948.
 217. Hodgkin D, Horgan CM, Garnick DW, Merrick EL. Benefit 
limits for behavioral health care in private health plans. Adm 
Policy Ment Health. 2009;36:15–23.
 218. Busch SH, Barry CL. New evidence on the effects of state 
mental health mandates. Inquiry. 2008;45:308–322.
 219. Harris KM, Carpenter C, Bao Y. The effects of state par-
ity laws on the use of mental health care. Med Care. 
2006;44:499–505.
 220. Zuvekas SH, Meyerhoefer CD. Coverage for mental health 
treatment: do the gaps still persist? J Ment Health Policy 
Econ. 2006;9:155–163.
 221. Goldman HH, Frank RG, Burnam MA, et  al.  Behavioral 
health insurance parity for federal employees. N Engl J Med. 
2006;354:1378–1386.
 222. McConnell KJ, Gast SH, Ridgely MS, et al.  Behavioral health 
insurance parity: does Oregon’s experience presage the national 
experience with the Mental Health Parity and Addiction 
Equity Act? Am J Psychiatry. 2012;169:31–38.
 223. Zuvekas SH, Meyerhoefer CD. State variations in the out-of-
pocket spending burden for outpatient mental health treat-
ment. Health Aff (Millwood). 2009;28:713–722.
 224. Barry CL, Frank RG, McGuire TG. The costs of mental 
health parity: still an impediment? Health Aff (Millwood). 
2006;25:623–634.
 225. Busch AB, Huskamp HA, Normand SL, Young AS, 
Goldman H, Frank RG. The impact of parity on major 
depression treatment quality in the Federal Employees’ 
Health Benefits Program after parity implementation. Med 
Care. 2006;44:506–512.
 226. Goldman HH, Barry CL, Normand SL, Azzone V, Busch 
AB, Huskamp HA. Economic grand rounds: the price is 
right? Changes in the quantity of services used and prices 
paid in response to parity. Psychiatr Serv. 2012;63:107–109.
 227. Azzone V, Frank RG, Normand SL, Burnam MA. Effect 
of insurance parity on substance abuse treatment. Psychiatr 
Serv. 2011;62:129–134.
 228. Barry CL, Ridgely MS. Mental health and substance abuse 
insurance parity for federal employees: how did health plans 
respond? J Policy Anal Manage. 2008;27:155–170.
 229. Coughlin TA, Zuckerman S, Wallin S, Holahan J. A conflict 
of strategies: Medicaid managed care and Medicaid maximi-
zation. Health Serv Res. 1999;34:281–293.
 230. Frank RG, Garfield RL. Managed behavioral health care 
carve-outs: past performance and future prospects. Annu Rev 
Public Health. 2007;28:303–320.
 231. Donohue JM, Frank RG. Medicaid behavioral health carve-
outs: a new generation of privatization decisions. Harv Rev 
Psychiatry. 2000;8:231–241.
 232. Cuffel BJ, Bloom JR, Wallace N, Hausman JW, Hu TW. Two-
year outcomes of fee-for-service and capitated medicaid pro-
grams for people with severe mental illness. Health Serv Res. 
2002;37:341–359.
 233. Teitelbaum J, Rosenbaum S, Burgess W, DeCourcy L. 
Selected key issues in the development and drafting of pub-
lic managed behavioral health care carve-out contracts. Issue 
Brief George Wash Univ Cent Health Serv Res Policy. 1998; 
3:1–13.
 234. Dewa CS, Hoch JS, Goering P. Using financial incentives 
to promote shared mental health care. Can J Psychiatry. 
2001;46:488–495.
 235. Willging C, Waitzkin H, Wagner W. Medicaid managed care 
for mental health services in a rural state. J Health Care Poor 
Underserved. 2005;16:497–514.
 236. Willging CE. Power, blame, and accountability: Medicaid 
managed care for mental health services in New Mexico. Med 
Anthropol Q. 2005;19:84–102.
 237. Ridgely MS, Giard J, Shern D. Florida’s Medicaid mental 
health carve-out: lessons from the first years of implementa-
tion. J Behav Health Serv Res. 1999;26:400–415.
 238. Aagaard J, Müller-Nielsen K. Clinical outcome of assertive 
community treatment (ACT) in a rural area in Denmark: a 
case-control study with a 2-year follow-up. Nord J Psychiatry. 
2011;65:299–305.
S83
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 239. Vogelsang I. Economic aspects of mental health carve-outs. J 
Ment Health Policy Econ. 1999;2:29–41.
 240. Grazier KL, Eselius LL. Mental health carve-outs: effects 
and implications. Med Care Res Rev. 1999;56 Suppl 2:37–59.
 241. Huskamp HA. How a managed behavioral health care 
carve-out plan affected spending for episodes of treatment. 
Psychiatr Serv. 1998;49:1559–1562.
 242. Zuvekas SH, Regier DA, Rae DS, Rupp A, Narrow WE. The 
impacts of mental health parity and managed care in one large 
employer group. Health Aff (Millwood). 2002;21:148–159.
 243. Bloom JR, Cheng JS, Hu TW, Kang SH, Wallace N. Use of 
antipsychotic medications in treating schizophrenia among 
different financing and delivery systems. J Ment Health Policy 
Econ. 2003;6:163–171.
 244. Grazier KL, Eselius LL, Hu TW, Shore KK, G’Sell WA. 
Effects of a mental health carve-out on use, costs, and payers: 
a four-year study. J Behav Health Serv Res. 1999;26:381–389.
 245. Busch S. Carving-out mental health benefits to Medicaid 
beneficiaries: a shift toward managed care. Adm Policy Ment 
Health. 1997;24:301–321.
 246. Grieve R, Sekhon JS, Hu TW, Bloom JR. Evaluating health 
care programs by combining cost with quality of life meas-
ures: a case study comparing capitation and fee for service. 
Health Serv Res. 2008;43:1204–1222.
 247. Norton EC, Lindrooth RC, Dickey B. Cost shifting in a men-
tal health carve-out for the AFDC population. Health Care 
Financ Rev. 1997;18:95–108.
 248. Kaskie B, Wallace N, Kang S, Bloom J. The implementa-
tion of managed behavioral healthcare in Colorado and the 
effects on older Medicaid beneficiaries. J Ment Health Policy 
Econ. 2006;9:15–24.
 249. Huskamp HA. Episodes of mental health and substance 
abuse treatment under a managed behavioral health care 
carve-out. Inquiry. 1999;36:147–161.
 250. Catalano RA, Coffman JM, Bloom JR, Ma Y, Kang SH. The 
impact of capitated financing on psychiatric emergency ser-
vices. Psychiatr Serv. 2005;56:685–690.
 251. Busch AB, Frank RG, Lehman AF. The effect of a man-
aged behavioral health carve-out on quality of care for med-
icaid patients diagnosed as having schizophrenia. Arch Gen 
Psychiatry. 2004;61:442–448.
 252. Jones K, Chen HJ, Jordan N, Boothroyd RA, Ramoni-
Perazzi J, Shern DL. Examination of the effects of financial 
risk on the formal treatment costs for a Medicaid population 
with psychiatric disabilities. Med Care. 2006;44:320–327.
 253. Shern DL, Jones K, Chen HJ, Jordan N, Ramoni-Perazzi J, 
Boothroyd RA. Medicaid managed care and the distribution 
of societal costs for persons with severe mental illness. Am J 
Psychiatry. 2008;165:254–260.
 254. Donohue JM, Frank RG. Estimating Medicare Part D’s 
impact on medication access among dually eligible beneficiar-
ies with mental disorders. Psychiatr Serv. 2007;58:1285–1291.
 255. Busch SH. Specialty health care, treatment patterns, and 
quality: the impact of a mental health carve-out on care for 
depression. Health Serv Res. 2002;37:1583–1601.
 256. Cohen E, Bloom JR. Managed care and service capacity 
development in a public mental health system. Adm Policy 
Ment Health. 2000;28:63–74.
 257. Ross W, Lynch P, Raju G, et al.  Biomarkers, bundled pay-
ments, and colorectal cancer care. Genes Cancer. 2012;3:16–22.
 258. Cromwell J, Dayhoff DA, Thoumaian AH. Cost savings and 
physician responses to global bundled payments for Medicare 
heart bypass surgery. Health Care Financ Rev. 1997;19: 
41–57.
 259. Swaminathan S, Mor V, Mehrotra R, Trivedi A. Medicare’s 
payment strategy for end-stage renal disease now embraces 
bundled payment and pay-for-performance to cut costs. 
Health Aff (Millwood). 2012;31:2051–2058.
 260. de Bakker DH, Struijs JN, Baan CB, et  al.  Early results 
from adoption of bundled payment for diabetes care in the 
Netherlands show improvement in care coordination. Health 
Aff (Millwood). 2012;31:426–433.
 261. Birkmeyer JD, Gust C, Baser O, Dimick JB, Sutherland JM, 
Skinner JS. Medicare payments for common inpatient pro-
cedures: implications for episode-based payment bundling. 
Health Serv Res. 2010;45:1783–1795.
 262. Miller DC, Gust C, Dimick JB, Birkmeyer N, Skinner J, 
Birkmeyer JD. Large variations in Medicare payments for 
surgery highlight savings potential from bundled payment 
programs. Health Aff (Millwood). 2011;30:2107–2115.
 263. Draper A. Managing bundled payments. Healthc Financ 
Manage. 2011;65:110–6, 118.
 264. Cook JA, Russell C, Grey DD, Jonikas JA. Economic grand 
rounds: a self-directed care model for mental health recovery. 
Psychiatr Serv. 2008;59:600–602.
 265. Alakeson V. Self-directed care for adults with serious 
mental illness: the barriers to progress. Psychiatr Serv. 
2008;59:792–794.
 266. Cook JA, Shore SE, Burke-Miller JK, et  al. Participatory 
action research to establish self-directed care for mental health 
recovery in Texas. Psychiatr Rehabil J. 2010;34:137–144.
 267. U.S. Department of Health and Human Services. Affordable 
Care Act supports states in strengthening community living. 
2011. http://www.hhs.gov/news/press/2011pres/02/20110222b.
html. Accessed May 29, 2012.
 268. Doty P, Mahoney KJ, Sciegaj M. New state strategies to meet 
long-term care needs. Health Aff (Millwood). 2010;29:49–56.
 269. Shen C, Smyer MA, Mahoney KJ, Loughlin DM, Simon-
Rusinowitz L, Mahoney EK. Does mental illness affect con-
sumer direction of community-based care? Lessons from 
the Arkansas Cash and Counseling program. Gerontologist. 
2008;48:93–104.
 270. San Antonio P, Simon-Rusinowitz L, Loughlin D, Eckert JK, 
Mahoney KJ, Ruben KA. Lessons from the Arkansas Cash 
and Counseling program: how the experiences of diverse 
older consumers and their caregivers address family policy 
concerns. J Aging Soc Policy. 2010;22:1–17.
 271. Shen C, Smyer M, Mahoney KJ, et  al.  Consumer-directed 
care for beneficiaries with mental illness: lessons from New 
Jersey’s Cash and Counseling program. Psychiatr Serv. 
2008;59:1299–1306.
 272. Robst J. Changes in antipsychotic medication use after imple-
mentation of a Medicaid mental health carve-out in the US. 
Pharmacoeconomics. 2012;30:387–396.
 273. Ray WA, Daugherty JR, Meador KG. Effect of a mental 
health “carve-out” program on the continuity of antipsy-
chotic therapy. N Engl J Med. 2003;348:1885–1894.
 274. Jones K, Siegel C, Bertollo DN, Samuels J. Impact of the 
Medicare modernization act on dually eligible persons with 
psychiatric diagnoses: a New York State case study. Psychiatr 
Serv. 2009;60:512–519.
 275. Wilk JE, West JC, Rae DS, Rubio-Stipec M, Chen JJ, 
Regier DA. Medicare Part D prescription drug benefits and 
S84
C. A. Green et al
administrative burden in the care of dually eligible psychiatric 
patients. Psychiatr Serv. 2008;59:34–39.
 276. Hall JP, Kurth NK, Moore JM. Transition to Medicare Part 
D: an early snapshot of barriers experienced by younger dual 
eligibles with disabilities. Am J Manag Care. 2007;13:14–18. 
 277. Huskamp HA, Stevenson DG, Donohue JM, Newhouse JP, 
Keating NL. Coverage and prior authorization of psychotropic 
drugs under Medicare Part D. Psychiatr Serv. 2007;58:308–310.
 278. West JC, Wilk JE, Muszynski IL, et al.  Medication access 
and continuity: the experiences of dual-eligible psychiatric 
patients during the first 4 months of the Medicare prescrip-
tion drug benefit. Am J Psychiatry. 2007;164:789–796.
 279. Huskamp HA, West JC, Rae DS, Rubio-Stipec M, Regier 
DA, Frank RG. Part D and dually eligible patients with men-
tal illness: medication access problems and use of intensive 
services. Psychiatr Serv. 2009;60:1169–1174.
 280. Zivin K, Kabeto MU, Kales HC, Langa KM. The effect 
of depression and cognitive impairment on enrollment in 
Medicare Part D. J Am Geriatr Soc. 2009;57:1433–1440.
 281. Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS. 
Unintended impacts of a Medicaid prior authorization pol-
icy on access to medications for bipolar illness. Med Care. 
2010;48:4–9.
 282. Wang PS, Patrick AR, Dormuth C, et  al.  Impact of drug 
cost sharing on service use and adverse clinical outcomes in 
elderly receiving antidepressants. J Ment Health Policy Econ. 
2010;13:37–44.
 283. Law MR, Ross-Degnan D, Soumerai SB. Effect of prior 
authorization of second-generation antipsychotic agents on 
pharmacy utilization and reimbursements. Psychiatr Serv. 
2008;59:540–546.
 284. West JC, Wilk JE, Rae DS, et al.  First-year Medicare Part 
D prescription drug benefits: medication access and continu-
ity among dual eligible psychiatric patients. J Clin Psychiatry. 
2010;71:400–410.
 285. Zivin K, Madden JM, Graves AJ, Zhang F, Soumerai SB. 
Cost-related medication nonadherence among beneficiaries 
with depression following Medicare Part D. Am J Geriatr 
Psychiatry. 2009;17:1068–1076.
 286. Burnam MA, Watkins KE. Substance abuse with mental dis-
orders: specialized public systems and integrated care. Health 
Aff (Millwood). 2006;25:648–658.
 287. Clark RE, Samnaliev M, McGovern MP. Impact of  sub-
stance disorders on medical expenditures for medicaid ben-
eficiaries with behavioral health disorders. Psychiatr Serv. 
2009;60:35–42.
 288. Arbesman M, Logsdon DW. Occupational therapy inter-
ventions for employment and education for adults with seri-
ous mental illness: a systematic review. Am J Occup Ther. 
2011;65:238–246.
 289. Dennis D, Lassiter M, Connelly WH, Lupfer KS. Helping 
adults who are homeless gain disability benefits: the SSI/
SSDI Outreach, Access, and Recovery (SOAR) program. 
Psychiatr Serv. 2011;62:1373–1376.
 290. Kertesz SG, Crouch K, Milby JB, Cusimano RE, Schumacher 
JE. Housing first for homeless persons with active addiction: 
are we overreaching? Milbank Q. 2009;87:495–534.
 291. Andresen R, Caputi P, Oades L. Stages of recovery instru-
ment: development of a measure of recovery from serious 
mental illness. Aust N Z J Psychiatry. 2006;40:972–980.
 292. Cavelti M, Kvrgic S, Beck EM, Kossowsky J, Vauth R. 
Assessing recovery from schizophrenia as an individual 
process. A review of self-report instruments. Eur Psychiatry. 
2012;27:19–32.
 293. Osher FC, Drake RE. Reversing a history of unmet needs: 
approaches to care for persons with co-occurring addictive 
and mental disorders. Am J Orthopsychiatry. 1996;66:4–11.
 294. Sterling S, Weisner C, Hinman A, Parthasarathy S. Access to 
treatment for adolescents with substance use and co-occur-
ring disorders: challenges and opportunities. J Am Acad 
Child Adolesc Psychiatry. 2010;49:637–46; quiz 725.
 295. Kaiser Family Foundation Commission on Medicaid and 
the Uninsured. Medicaid rehabilitation option: overview and 
current policy issues. 2007.
 296. Libby AM, Riggs PD. Integrated substance use and mental 
health treatment for adolescents: aligning organizational 
and financial incentives. J Child Adolesc Psychopharmacol. 
2005;15:826–834.
 297. Alakeson V, Frank RG, Katz RE. Specialty care medical 
homes for people with severe, persistent mental disorders. 
Health Aff (Millwood). 2010;29:867–873.
 298. Shortell SM, McCurdy RK. Integrated health systems. Stud 
Health Technol Inform. 2010;153:369–382.
 299. Pandya A, Larkin GL, Randles R, et  al.  Epidemiological 
trends in psychosis-related Emergency Department visits in 
the United States, 1992–2001. Schizophr Res. 2009;110:28–32.
 300. Hazlett SB, McCarthy ML, Londner MS, Onyike CU. 
Epidemiology of adult psychiatric visits to US emergency 
departments. Acad Emerg Med. 2004;11:193–195.
 301. Weiss AP, Chang G, Rauch SL, et al. Patient- and practice-
related determinants of emergency department length of 
stay for patients with psychiatric illness. Ann Emerg Med. 
2012;60:162–71.e5.
 302. Stolte E, Iwanow R, Hall C. Capacity-related interfacility 
patient transports: patients affected, wait times involved and 
associated morbidity. CJEM. 2006;8:262–268.
 303. Felton MC, Cashin CE, Brown TT. What does it take? 
California county funding requests for recovery-oriented full 
service partnerships under the Mental Health Services Act. 
Community Ment Health J. 2010;46:441–451.
 304. Chandler D, Spicer G. Capitated assertive community treat-
ment program savings: system implications. Adm Policy Ment 
Health. 2002;30:3–19.
 305. Chandler D, Meisel J, McGowen M, Mintz J, Madison K. 
Client outcomes in two model capitated integrated service 
agencies. Psychiatr Serv. 1996;47:175–180.
 306. Laws KE, Gabriel RM, McFarland BH. Integration and its 
discontents: substance abuse treatment in the Oregon Health 
Plan. Health Aff (Millwood). 2002;21:284–289.
 307. Bazinsky KR, Herrera L, Sharfstein JM. Toward innova-
tive models of health care and financing: matchmaking in 
Maryland. JAMA. 2012;307:1261–1262.
 308. Center for Medicare and Medicaid Innovation. Bundled pay-
ments for care improvement. 2012. http://innovations.cms.
gov/initiatives/Bundled-Payments/index.html. Accessed May 
10, 2012.
 309. Schuffman D, Druss BG, Parks JJ. State mental health policy: 
mending Missouri’s safety net: transforming systems of care 
by integrating primary and behavioral health care. Psychiatr 
Serv. 2009;60:585–588.
 310. Center for Medicare and Medicaid Innovation. CMS 
Innovation Awards. 2012. http://innovations.cms.gov/initia-
tives/Innovation-Awards/index.html. Accessed May 10, 2012.
 311. US Congress. HR 1675 (111th Congress): Frank Melville 
Supportive Housing Investment Act of 2009. 2011.
S85
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 312. Technical Assistance Collaborative. Frank Melville Supportive 
Housing Investment Act of 2010: Reforms to HUD’s Section 
811 Program Enacted (Summary). 2011. http://www.tacinc.
org/downloads/Section811%20Legislation/Summary%201-7-
11.pdf.
 313. U.S.Congress. Patient Protection and Affordable Care Act. 
2010; Pub. L. No. 111-148, § 2702, 124 Stat. 119, 318–319.
 314. The Henry J. Kaiser Family Foundation. Patient Cost-
Sharing Under the Affordable Care Act. 2012. http://www.
kff.org/healthreform/upload/8303.pdf.
 315. The Henry J. Kaiser Family Foundation. Health Reform 
Source: ACA Federal Funds Tracker. 2012. http://healthre-
form.kff.org/federal-funds-tracker.aspx#. Accessed May 11, 
2012.
 316. Centers for Medicare and Medicaid. State Medicaid Director 
and State Health Official Letter on Health Homes for Enrollees 
with Chronic Conditions, SMDL #10-024, ACA #12. 2010. 
 317. Substance Abuse and Mental Health Services Agency. 
Behavioral health homes for people with mental health and 
substance use conditions: the core clinical features. 2012.
 318. Garfield RL, Zuvekas SH, Lave JR, Donohue JM. The 
impact of  national health care reform on adults with severe 
mental disorders. Am J Psychiatry. 2011;168:486–494.
 319. Garfield RL, Lave JR, Donohue JM. Health reform and the 
scope of benefits for mental health and substance use disor-
der services. Psychiatr Serv. 2010;61:1081–1086.
 320. Long SK, Stockley K. The impacts of state health reform 
 initiatives on adults in New York and Massachusetts. Health 
Serv Res. 2011;46:365–387.
 321. Kaiser Family Foundation Commission on Medicaid and the 
Uninsured. Medicaid policy options for meeting the needs 
of adults with mental illness under the Affordable Care Act. 
8181. Kaiser Family Foundation; 2011.
 322. Lehman AF, Kreyenbuhl J, Buchanan RW, et  al. The 
Schizophrenia Patient Outcomes Research Team (PORT): 
updated treatment recommendations 2003. Schizophr Bull. 
2004;30:193–217.
 323. Rössler W. Psychiatric rehabilitation today: an overview. 
World Psychiatry. 2006;5:151–157.
 324. Farkas M, Jansen MA, Penk WE. Psychosocial rehabilita-
tion: approach of choice for those with serious mental ill-
nesses. J Rehabil Res Dev. 2007;44:7–21.
 325. Deegan PE. Recovery: the lived experience of rehabilitation. 
Psychosoc Rehabil J. 1988;11:11–19.
 326. Chamberlin J. Confessions of a non-compliant patient. J 
Psychosoc Nurs. 1998;36:49–52.
 327. Harding CM, Zubin J, Strauss JS. Chronicity in schizophre-
nia: fact, partial fact, or artifact? Hosp Community Psychiatry. 
1987;38:477–486.
 328. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier 
A. The Vermont longitudinal study of persons with severe 
mental illness, II: long-term outcome of subjects who ret-
rospectively met DSM-III criteria for schizophrenia. Am J 
Psychiatry. 1987;144:727–735.
 329. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. 
The Vermont longitudinal study of persons with severe men-
tal illness, I: methodology, study sample, and overall status 
32 years later. Am J Psychiatry. 1987;144:718–726.
 330. Harding CM. Course types in schizophrenia: an analy-
sis of European and American studies. Schizophr Bull. 
1988;14:633–643.
 331. Harding CM, Zahniser JH. Empirical correction of seven 
myths about schizophrenia with implications for treatment. 
Acta Psychiatr Scand Suppl. 1994;384:140–146.
 332. Anthony WA. Recovery from mental illness: the guiding 
vision of the mental health service system in the 1990's. 
Psychosoc Rehabil J. 1993;16:11–23.
 333. Warner R. Recovery from schizophrenia and the recovery 
model. Curr Opin Psychiatry. 2009;22:374–380.
 334. Frese FJ III, Stanley J, Kress K, Vogel-Scibilia S. Integrating 
evidence-based practices and the recovery model. Psychiatr 
Serv. 2001;52:1462–1468.
 335. Slade M, Williams J, Bird V, Leamy M, LE Boutillier C. 
Recovery grows up. J Ment Health. 2012;21:99–103.
 336. Silverstein SM, Bellack AS. A scientific agenda for the con-
cept of recovery as it applies to schizophrenia. Clin Psychol 
Rev. 2008;28:1108–1124.
 337. Green CA. Fostering recovery from life-transforming mental 
health disorders: a synthesis and model. Soc Theory Health. 
2004;2:293–314.
 338. Kopelowicz A, Liberman RP, Ventura J, Zarate R, Mintz J. 
Neurocognitive correlates of recovery from schizophrenia. 
Psychol Med. 2005;35:1165–1173.
 339. Roe D. Progressing from patienthood to personhood across 
the multidimensional outcomes in schizophrenia and related 
disorders. J Nerv Ment Dis. 2001;189:691–699.
 340. Substance Abuse and Mental Health Services Administration. 
SAMHSA’s working definition of recovery, updated. 2012.
 341. Slade M. Measuring recovery in mental health services. Isr J 
Psychiatry Relat Sci. 2010;47:206–212.
 342. Le Boutillier C, Leamy M, Bird VJ, Davidson L, Williams J, 
Slade M. What does recovery mean in practice? A qualitative 
analysis of international recovery-oriented practice guidance. 
Psychiatr Serv. 2011;62:1470–1476.
 343. Donnelly, M, Scott, D, McGilloway, S, et  al. Patient out-
comes: what are the best methods for measuring recovery 
from mental illness and capturing feedback from patients in 
order to inform service improvement? A report commissioned 
by the Bamford Implementation Rapid Review Scheme. 
COM/4409/10. Northern Ireland: Bamford Implementation 
Rapid Review Scheme: Patient Outcomes; 2011.
 344. Allison DB, Mentore JL, Heo M, et  al. Antipsychotic-
induced weight gain: a comprehensive research synthesis. Am 
J Psychiatry. 1999;156:1686–1696.
 345. Baptista T, Kin NM, Beaulieu S, de Baptista EA. Obesity and 
related metabolic abnormalities during antipsychotic drug 
administration: mechanisms, management and research per-
spectives. Pharmacopsychiatry. 2002;35:205–219.
 346. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic 
metabolic effects: weight gain, diabetes mellitus, and lipid 
abnormalities. Can J Psychiatry. 2001;46:273–281.
 347. Fontaine KR, Heo M, Harrigan EP, et al. Estimating the con-
sequences of anti-psychotic induced weight gain on health 
and mortality rate. Psychiatry Res. 2001;101:277–288.
 348. Daumit GL, Clark JM, Steinwachs DM, Graham CM, 
Lehman A, Ford DE. Prevalence and correlates of obesity in 
a community sample of individuals with severe and persistent 
mental illness. J Nerv Ment Dis. 2003;191:799–805.
 349. Daumit GL, Goff DC, Meyer JM, et al.  Antipsychotic effects 
on estimated 10-year coronary heart disease risk in the CATIE 
schizophrenia study. Schizophr Res. 2008;105:175–187.
S86
C. A. Green et al
 350. Marder SR, Essock SM, Miller AL, et  al.  Physical health 
monitoring of patients with schizophrenia. Am J Psychiatry. 
2004;161:1334–1349.
 351. National Association of State Mental Health Program 
Directors (NASMHPD) Medical Directors Council. 
Morbidity and Mortality in People With Serious Mental 
Illness. Alexandria, VA; 2007.
 352. Wagner EH, Austin BT, Von Korff M. Organizing care for 
patients with chronic illness. Milbank Q. 1996;74:511–544.
 353. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational 
and organizational interventions to improve the management 
of depression in primary care: a systematic review. JAMA. 
2003;289:3145–3151.
 354. Ouwens M, Wollersheim H, Hermens R, Hulscher M, Grol 
R. Integrated care programmes for chronically ill patients: 
a review of systematic reviews. Int J Qual Health Care. 
2005;17:141–146.
 355. Rosenthal TC. The medical home: growing evidence to sup-
port a new approach to primary care. J Am Board Fam Med. 
2008;21:427–440.
 356. Bauer MS, McBride L, Williford WO, et  al. Cooperative 
Studies Program 430 Study Team. Collaborative care for 
bipolar disorder: part II. Impact on clinical outcome, func-
tion, and costs. Psychiatr Serv. 2006;57:937–945.
 357. Bauer MS, McBride L, Williford WO, et  al. Cooperative 
Studies Program 430 Study Team. Collaborative care for bipo-
lar disorder: part I. Intervention and implementation in a ran-
domized effectiveness trial. Psychiatr Serv. 2006;57:927–936.
 358. Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B. 
Long-term effectiveness and cost of a systematic care program 
for bipolar disorder. Arch Gen Psychiatry. 2006;63:500–508.
 359. Shortell SM, Casalino LP. Health care reform requires 
accountable care systems. JAMA. 2008;300:95–97.
 360. Yatham LN, Kennedy SH, O’Donovan C, et al. Guidelines 
Group, CANMAT. Canadian Network for Mood and 
Anxiety Treatments (CANMAT) guidelines for the manage-
ment of patients with bipolar disorder: update 2007. Bipolar 
Disord. 2006;8:721–739.
 361. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, 
Kilbourne AM, Bauer MS. Comparative effectiveness of col-
laborative chronic care models for mental health conditions 
across primary, specialty, and behavioral health care set-
tings: systematic review and meta-analysis. Am J Psychiatry. 
2012;169:790–804.
 362. Bodenheimer T, Wagner EH, Grumbach K. Improving primary 
care for patients with chronic illness: the chronic care model, 
Part 2. JAMA. 2002;288:1909–1914.
 363. Tsai AC, Morton SC, Mangione CM, Keeler EB. A meta-
analysis of interventions to improve care for chronic illnesses. 
Am J Manag Care. 2005;11:478–488.
 364. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, 
Cornell JE. Systematic review of the chronic care model in 
chronic obstructive pulmonary disease prevention and man-
agement. Arch Intern Med. 2007;167:551–561.
 365. Bodenheimer T, Wagner EH, Grumbach K. Improving 
primary care for patients with chronic illness. JAMA. 
2002;288:1775–1779.
 366. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on 
the Chronic Care Model in the new millennium. Health Aff 
(Millwood). 2009;28:75–85.
 367. de Bruin SR, Heijink R, Lemmens LC, Struijs JN, Baan 
CA. Impact of disease management programs on healthcare 
expenditures for patients with diabetes, depression, heart fail-
ure or chronic obstructive pulmonary disease: a systematic 
review of the literature. Health Policy. 2011;101:105–121.
 368. Bower P, Gilbody S, Richards D, Fletcher J, Sutton A. 
Collaborative care for depression in primary care. Making 
sense of a complex intervention: systematic review and meta-
regression. Br J Psychiatry. 2006;189:484–493.
 369. Thota AB, Sipe TA, Byard GJ, et al. .; Community Preventive 
Services Task Force. Collaborative care to improve the 
management of depressive disorders: a community guide 
systematic review and meta-analysis. Am J Prev Med. 
2012;42:525–538.
 370. Gilbody S, Bower P, Whitty P. Costs and consequences of 
enhanced primary care for depression: systematic review 
of randomised economic evaluations. Br J Psychiatry. 
2006;189:297–308.
 371. Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, 
Chapman DP; Community Preventive Services Task Force. 
Economics of collaborative care for management of depres-
sive disorders: a community guide systematic review. Am J 
Prev Med. 2012;42:539–549.
 372. Kilbourne AM, Post EP, Nossek A, Drill L, Cooley S, Bauer 
MS. Improving medical and psychiatric outcomes among 
individuals with bipolar disorder: a randomized controlled 
trial. Psychiatr Serv. 2008;59:760–768.
 373. Kilbourne AM, Biswas K, Pirraglia PA, et al. Is the collab-
orative chronic care model effective for patients with bipo-
lar disorder and co-occurring conditions? J Affect Disord. 
2009;112:256–261.
 374. Butler M, Kane RL, McAlpine D, et  al.  Integration of 
mental health/substance abuse and primary care. Evid Rep 
Technol Assess (Full Rep). 2008;173:1–362.
 375. Wang PS, Angermeyer M, Borges G, et  al. Delay and fail-
ure in treatment seeking after first onset of mental disorders 
in the World Health Organization’s World Mental Health 
Survey Initiative. World Psychiatry. 2007;6:177–185.
 376. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, 
Kessler RC. Failure and delay in initial treatment contact after 
first onset of mental disorders in the National Comorbidity 
Survey Replication. Arch Gen Psychiatry. 2005;62:603–613.
 377. Wang PS, Berglund PA, Olfson M, Kessler RC. Delays in ini-
tial treatment contact after first onset of a mental disorder. 
Health Serv Res. 2004;39:393–415.
 378. Barnard V, Carson J, Doe E, et al. Personal narratives expe-
riences of psychiatric hospitalization. Narrative Inquiry in 
Bioethics. 2011;1:3–2.
 379. Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from 
mental health treatment among individuals with schizophre-
nia and strategies for facilitating connections to care: a review 
of the literature. Schizophr Bull. 2009;35:696–703.
 380. Health care reform for Americans with severe mental illnesses: 
report of the National Advisory Mental Health Council. Am 
J Psychiatry. 1993;150:1447–1465.
 381. O’Brien A, Fahmy R, Singh SP. Disengagement from mental 
health services. A literature review. Soc Psychiatry Psychiatr 
Epidemiol. 2009;44:558–568.
 382. Priebe S, Watts J, Chase M, Matanov A. Processes of dis-
engagement and engagement in assertive outreach patients: 
qualitative study. Br J Psychiatry. 2005;187:438–443.
 383. Lundahl B, Burke BL. The effectiveness and applicability of 
motivational interviewing: a practice-friendly review of four 
meta-analyses. J Clin Psychol. 2009;65:1232–1245.
S87
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 384. Cleary M, Hunt GE, Matheson S, Walter G. Psychosocial 
treatments for people with co-occurring severe mental ill-
ness and substance misuse: systematic review. J Adv Nurs. 
2009;65:238–258.
 385. Park T, Usher K, Foster K. Description of a healthy lifestyle 
intervention for people with serious mental illness taking 
second-generation antipsychotics. Int J Ment Health Nurs. 
2011;20:428–437.
 386. Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH. 
Motivational interviewing with personalized feedback: a 
brief  intervention for motivating smokers with schizophre-
nia to seek treatment for tobacco dependence. J Consult Clin 
Psychol. 2004;72:723–728.
 387. Lundahl BW, Kunz C, Brownell C, et al. A meta-analysis of 
Motivational Interviewing: twenty five years of empirical 
studies. Res Soc Work Pract. 2010;20:137–160.
 388. Dixon L, Goldberg R, Iannone V, et  al.  Use of  a criti-
cal time intervention to promote continuity of  care after 
psychiatric inpatient hospitalization. Psychiatr Serv. 
2009;60:451–458.
 389. Marshall M, Gray A, Lockwood A, et al. Case management 
for people with severe mental disorders. Cochrane Database 
Syst Rev. 2000;CD000050.
 390. Lewis-Fernández R, Díaz N. The cultural formulation: a 
method for assessing cultural factors affecting the clinical 
encounter. Psychiatr Q. 2002;73:271–295.
 391. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic 
alliance with outcome and other variables: a meta-analytic 
review. J Consult Clin Psychol. 2000;68:438–450.
 392. Uijen AA, Schers HJ, Schellevis FG, van den Bosch WJ. 
How unique is continuity of care? A review of continuity and 
related concepts. Fam Pract. 2012;29:264–271.
 393. Gulliford M, Naithani S, Morgan M. What is ‘continuity of 
care’? J Health Serv Res Policy. 2006;11:248–250.
 394. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, 
McKendry R. Continuity of care: a multidisciplinary review. 
BMJ. 2003;327:1219–1221.
 395. Wierdsma A, Mulder C, de Vries S, Sytema S. Reconstructing 
continuity of care in mental health services: a multilevel con-
ceptual framework. J Health Serv Res Policy. 2009;14:52–57.
 396. Johnson S, Prosser D, Bindman J, Szmukler G. Continuity of 
care for the severely mentally ill: concepts and measures. Soc 
Psychiatry Psychiatr Epidemiol. 1997;32:137–142.
 397. Crawford MJ, de Jonge E, Freeman GK, Weaver T. Providing 
continuity of care for people with severe mental illness- 
a narrative review. Soc Psychiatry Psychiatr Epidemiol. 
2004;39:265–272.
 398. Adair CE, McDougall GM, Mitton CR, et al. Continuity of 
care and health outcomes among persons with severe mental 
illness. Psychiatr Serv. 2005;56:1061–1069.
 399. Mitton CR, Adair CE, McDougall GM, Marcoux G. 
Continuity of care and health care costs among persons with 
severe mental illness. Psychiatr Serv. 2005;56:1070–1076.
 400. Mueser KT, Corrigan PW, Hilton DW, et al.  Illness manage-
ment and recovery: a review of the research. Psychiatr Serv. 
2002;53:1272–1284.
 401. Rouget BW, Aubry JM. Efficacy of psychoeducational 
approaches on bipolar disorders: a review of the literature. J 
Affect Disord. 2007;98:11–27.
 402. Xia J, Merinder LB, Belgamwar MR. Psychoeducation for 
schizophrenia. Cochrane Database Syst Rev. 2011;CD002831.
 403. Yarborough BJ, Janoff SL, Stevens VJ, Kohler D, Green CA. 
Delivering a lifestyle and weight loss intervention to individu-
als in real-world mental health settings: lessons and opportu-
nities. Transl Behav Med. 2011;1:406–415.
 404. Bartels S, Desilets R. Health Promotion Programs for People 
with Serious Mental Illness (Prepared by the Dartmouth Health 
Promotion Research Team). Washington, DC: SAMHSA-
HRSA Center for Integrated Health Solutions; 2012.
 405. National Center for Trauma-Informed Care. Models for 
Developing Trauma-Informed Behavioral Health Systems and 
Trauma-Specific Services. 2008.
 406. Felitti VJ, Anda RF, Nordenberg D, et  al.  Relationship 
of  childhood abuse and household dysfunction to many 
of  the leading causes of  death in adults. The Adverse 
Childhood Experiences (ACE) Study. Am J Prev Med. 
1998;14:245–258.
 407. Vickerman KA, Margolin G. Rape treatment outcome 
research: empirical findings and state of the literature. Clin 
Psychol Rev. 2009;29:431–448.
 408. Tucker WM. How to include the trauma history in the diag-
nosis and treatment of psychiatric inpatients. Psychiatr Q. 
2002;73:135–144.
 409. Substance Abuse and Mental Health Services Agency. 
National Center for Trauma-Informed Care Home Page. 
2012. Accessed June 1, 2012.
 410. Cusack KJ, Frueh BC, Hiers T, Suffoletta-Maierle S, Bennett 
S. Trauma within the psychiatric setting: a preliminary empir-
ical report. Adm Policy Ment Health. 2003;30:453–460.
 411. Mueser KT, Goodman LB, Trumbetta SL, et  al. Trauma 
and posttraumatic stress disorder in severe mental illness. J 
Consult Clin Psychol. 1998;66:493–499.
 412. Wolff  N, Morgan RD, Shi J, Huening J, Fisher WH. Thinking 
styles and emotional states of male and female prison inmates 
by mental disorder status. Psychiatr Serv. 2011;62:1485–1493.
 413. Blitz CL, Wolff  N, Shi J. Physical victimization in prison: the 
role of mental illness. Int J Law Psychiatry. 2008;31:385–393.
 414. Crisanti AS, Frueh BC. Risk of trauma exposure among per-
sons with mental illness in jails and prisons: what do we really 
know? Curr Opin Psychiatry. 2011;24:431–435.
 415. Substance Abuse and Mental Health Services Agency. 
SAMHSA’s strategic initiatives. SMA-11-4666. 2011.
 416. Harris M, Fallot RD. Envisioning a trauma-informed service 
system: a vital paradigm shift. New Dir Ment Health Serv. 
2001;89:3–22.
 417. Azeem MW, Aujla A, Rammerth M, Binsfeld G, Jones RB. 
Effectiveness of six core strategies based on trauma informed 
care in reducing seclusions and restraints at a child and ado-
lescent psychiatric hospital. J Child Adolesc Psychiatr Nurs. 
2011;24:11–15.
 418. Bisson J, Andrew M. Psychological treatment of post-trau-
matic stress disorder (PTSD). Cochrane Database Syst Rev. 
2007;CD003388.
 419. Torchalla I, Nosen L, Rostam H, Allen P. Integrated treat-
ment programs for individuals with concurrent substance use 
disorders and trauma experiences: a systematic review and 
meta-analysis. J Subst Abuse Treat. 2012;42:65–77.
 420. van Dam D, Vedel E, Ehring T, Emmelkamp PM. 
Psychological treatments for concurrent posttraumatic stress 
disorder and substance use disorder: a systematic review. Clin 
Psychol Rev. 2012;32:202–214.
 421. Grubaugh AL, Zinzow HM, Paul L, Egede LE, Frueh BC. 
Trauma exposure and posttraumatic stress disorder in adults 
S88
C. A. Green et al
with severe mental illness: a critical review. Clin Psychol Rev. 
2011;31:883–899.
 422. Mueser KT, Rosenberg SD, Xie H, et al. A randomized con-
trolled trial of cognitive-behavioral treatment for posttrau-
matic stress disorder in severe mental illness. J Consult Clin 
Psychol. 2008;76:259–271.
 423. Lu W, Yanos PT, Gottlieb JD, et al. Use of fidelity assessments 
to train clinicians in the CBT for PTSD program for clients 
with serious mental illness. Psychiatr Serv. 2012;63:785–792.
 424. Frueh BC, Grubaugh AL, Cusack KJ, Kimble MO, Elhai JD, 
Knapp RG. Exposure-based cognitive-behavioral treatment of 
PTSD in adults with schizophrenia or schizoaffective disorder: 
a pilot study. J Anxiety Disord. 2009;23:665–675.
 425. Green CA, Janoff  SL, Yarborough BJ, Paulson RI. The 
Recovery Group Project: development of  an intervention 
led jointly by peer and professional counselors. Psychiatr 
Serv. 2013.
 426. Repper J, Carter T. A review of the literature on peer support 
in mental health services. J Ment Health. 2011;20:392–411.
 427. Fazel S, Danesh J. Serious mental disorder in 23000 prisoners: 
a systematic review of 62 surveys. Lancet. 2002;359:545–550.
 428. Parsons J, Sandwick T. Closing the gap: using criminal justice 
and public health data to improve the identification of mental 
illness. 2012.
 429. Skeem JL, Manchak S, Peterson JK. Correctional policy for 
offenders with mental illness: creating a new paradigm for 
recidivism reduction. Law Hum Behav. 2011;35:110–126.
 430. Martin MS, Dorken SK, Wamboldt AD, Wootten SE. 
Stopping the revolving door: a meta-analysis on the effective-
ness of interventions for criminally involved individuals with 
major mental disorders. Law Hum Behav. 2012;36:1–12.
 431. Morgan RD, Flora DB, Kroner DG, Mills JF, Varghese F, 
Steffan JS. Treating offenders with mental illness: a research 
synthesis. Law Hum Behav. 2012;36:37–50.
 432. Abramson MF. The criminalization of mentally disordered 
behavior: possible side-effect of a new mental health law. 
Hosp Community Psychiatry. 1972;23:101–105.
 433. Wolff  N, Shi J. Victimization and feelings of safety among 
male and female inmates with behavioral health problems. J 
Forensic Psychiatr Psychol. 2009;20:56–77.
 434. Ziedonis DM, Smelson D, Rosenthal RN, et al. Improving 
the care of  individuals with schizophrenia and substance 
use disorders: consensus recommendations. J Psychiatr 
Pract. 2005;11:315–339.
 435. Druss BG, von Esenwein SA. Improving general medical care 
for persons with mental and addictive disorders: systematic 
review. Gen Hosp Psychiatry. 2006;28:145–153.
 436. Horsfall J, Cleary M, Hunt GE, Walter G. Psychosocial 
treatments for people with co-occurring severe mental 
illnesses and substance use disorders (dual diagnosis): 
a review of  empirical evidence. Harv Rev Psychiatry. 
2009;17:24–34.
 437. Cleary M, Hunt GE, Matheson S, Siegfried N, Walter G. 
Psychosocial treatment programs for people with both 
severe mental illness and substance misuse. Schizophr Bull. 
2008;34:226–228.
 438. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, 
Bond GR. Review of integrated mental health and substance 
abuse treatment for patients with dual disorders. Schizophr 
Bull. 1998;24:589–608.
 439. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. Schizophrenia 
Patient Outcomes Research Team (PORT). The 2009 
schizophrenia PORT psychopharmacological treatment rec-
ommendations and summary statements. Schizophr Bull. 
2010;36:71–93.
 440. Lehman AF, Buchanan RW, Dickerson FB, et al. Evidence-
based treatment for schizophrenia. Psychiatr Clin North Am. 
2003;26:939–954.
 441. Moore TA, Buchanan RW, Buckley PF, et  al. The Texas 
Medication Algorithm Project antipsychotic algo-
rithm for schizophrenia: 2006 update. J Clin Psychiatry. 
2007;68:1751–1762.
 442. Suppes T, Dennehy EB, Hirschfeld RM, et  al. Texas 
Consensus Conference Panel on Medication Treatment of 
Bipolar Disorder. The Texas implementation of medication 
algorithms: update to the algorithms for treatment of bipolar 
I disorder. J Clin Psychiatry. 2005;66:870–886.
 443. Shojania KG, Grimshaw JM. Evidence-based quality 
improvement: the state of the science. Health Aff (Millwood). 
2005;24:138–150.
 444. Berk L, Hallam KT, Colom F, et  al.  Enhancing medica-
tion adherence in patients with bipolar disorder. Hum 
Psychopharmacol. 2010;25:1–16.
 445. Velligan DI, Weiden PJ, Sajatovic M, et  al.  Strategies for 
addressing adherence problems in patients with serious and 
persistent mental illness: recommendations from the expert 
consensus guidelines. J Psychiatr Pract. 2010;16:306–324.
 446. Velligan DI, Weiden PJ, Sajatovic M, et al. Expert Consensus 
Panel on Adherence Problems in Serious and Persistent 
Mental Illness. The expert consensus guideline series: adher-
ence problems in patients with serious and persistent mental 
illness. J Clin Psychiatry. 2009;70(suppl 4):1–46.
 447. Mitchell AJ, Selmes T. Why don't patients take their medi-
cine? Reasons and solutions in psychiatry. Adv Psychiatr 
Treatment. 2007;13:336–346.
 448. Miklowitz DJ. The role of the family in the course and 
treatment of bipolar disorder. Curr Dir Psychol Sci. 
2007;16:192–196.
 449. Depp CA, Moore DJ, Patterson TL, Lebowitz BD, 
Jeste DV. Psychosocial interventions and medication 
adherence in bipolar disorder. Dialogues Clin Neurosci. 
2008;10:239–250.
 450. Strakowski SM. Approaching the challenge of bipo-
lar depression: results from STEP-BD. Am J Psychiatry. 
2007;164:1301–1303.
 451. Miklowitz DJ. A review of evidence-based psychosocial inter-
ventions for bipolar disorder. J Clin Psychiatry. 2006;67(suppl 
11):28–33.
 452. Bola JR, Lehtinen K, Cullberg JCL. Psychosocial treatment, 
antipsychotic postponement, and low-dose medication strat-
egies in first-episode psychosis: a review of the literature. 
Psychosis. 2009;1:4–18.
 453. Carpenter WT Jr, Heinrichs DW, Hanlon TE. A compara-
tive trial of pharmacologic strategies in schizophrenia. Am J 
Psychiatry. 1987;144:1466–1470.
 454. Seikkula J, Aaltonen J, Alakare B, et  al. Five-year experi-
ence of first-episode nonaffective psychosis in open-dialogue 
approach: treatment principles, follow-up outcomes, and two 
case studies. Psychother Res. 2006;16:214–228.
 455. Seikkula J, Alakare B, Aalotonen J, et  al. Open dialogue 
approach: treatment principles and preliminary results of a 
two-year follow-up on first episode schizophrenia. Ethic Hum 
Sci Serv. 2003;5:163–182.
S89
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 456. Mosher LR. Soteria and other alternatives to acute psychiat-
ric hospitalization: a personal and professional review. J Nerv 
Ment Dis. 1999;187:142–149.
 457. Mosher LR, Vallone R, Menn A. The treatment of acute 
psychosis without neuroleptics: six-week psychopathology 
outcome data from The Soteria Project. Int J Soc Psychiatry. 
1995;41:157–173.
 458. Gaebel W, Jänner M, Frommann N, et  al.  First vs multi-
ple episode schizophrenia: two-year outcome of intermit-
tent and maintenance medication strategies. Schizophr Res. 
2002;53:145–159.
 459. Lieberman JA. Comparative effectiveness of antipsy-
chotic drugs. A  commentary on: Cost Utility Of The 
Latest Antipsychotic Drugs In Schizophrenia Study 
(CUtLASS 1)  and Clinical Antipsychotic Trials Of 
Intervention Effectiveness (CATIE). Arch Gen Psychiatry. 
2006;63:1069–1072.
 460. Das C, Mendez G, Jagasia S, Labbate LA. Second-generation 
antipsychotic use in schizophrenia and associated weight gain: 
a critical review and meta-analysis of behavioral and phar-
macologic treatments. Ann Clin Psychiatry. 2012;24:225–239.
 461. Lieberman JA, Stroup TS, McEvoy JP, et  al. Clinical 
Antipsychotic Trials of Intervention Effectiveness (CATIE) 
Investigators. Effectiveness of antipsychotic drugs in 
patients with chronic schizophrenia. N Engl J Med. 
2005;353:1209–1223.
 462. Newall H, Myles N, Ward PB, Samaras K, Shiers D, Curtis 
J. Efficacy of metformin for prevention of weight gain in 
psychiatric populations: a review. Int Clin Psychopharmacol. 
2012;27:69–75.
 463. Maayan L, Vakhrusheva J, Correll CU. Effectiveness of med-
ications used to attenuate antipsychotic-related weight gain 
and metabolic abnormalities: a systematic review and meta-
analysis. Neuropsychopharmacology. 2010;35:1520–1530.
 464. Bushe CJ, Bradley AJ, Doshi S, Karagianis J. Changes in 
weight and metabolic parameters during treatment with 
antipsychotics and metformin: do the data inform as to 
potential guideline development? A systematic review of clin-
ical studies. Int J Clin Pract. 2009;63:1743–1761.
 466. Wu RR, Zhao JP, Jin H, et al.  Lifestyle intervention and met-
formin for treatment of antipsychotic-induced weight gain: a 
randomized controlled trial. JAMA. 2008;299:185–193.
 466. Dent R, Blackmore A, Peterson J, et  al.  Changes in body 
weight and psychotropic drugs: a systematic synthesis of the 
literature. PLoS ONE. 2012;7:e36889.
 467. Malhotra AK, Correll CU, Chowdhury NI, et al.  Association 
between common variants near the melanocortin 4 receptor 
gene and severe antipsychotic drug-induced weight gain. Arch 
Gen Psychiatry. 2012;69:904–912.
 468. Carpenter WT, Buchanan RW. Lessons to take home from 
CATIE. Psychiatr Serv. 2008;59:523–525.
 469. Gao N, Schmidt LT, Gill KJ, Pratt CW. Building human capi-
tal to increase earning power among people living with men-
tal illnesses. Psychiatr Rehabil J. 2011;35:117–124.
 470. Mechanic D, Blider S, McAlpine DD. Employing per-
sons with serious mental illness. Health Aff (Millwood). 
2002;21:242–253.
 471. Becker D, Whitley R, Bailey EL, Drake RE. Long-term 
employment trajectories among participants with severe 
mental illness in supported employment. Psychiatr Serv. 
2007;58:922–928.
 472. Bond GR, Resnick SG, Drake RE, Xie H, McHugo GJ, 
Bebout RR. Does competitive employment improve 
nonvocational outcomes for people with severe mental ill-
ness? J Consult Clin Psychol. 2001;69:489–501.
 473. Bush PW, Drake RE, Xie H, McHugo GJ, Haslett WR. The 
long-term impact of employment on mental health service 
use and costs for persons with severe mental illness. Psychiatr 
Serv. 2009;60:1024–1031.
 474. McKay C. Recent research findings from the program for 
Clubhouse Research. Center for Mental Health Services 
Research University of Massachusetts Medical School; 
2005;2:1–2.
 475. SAMHSA's National Registry of Evidence-based Programs 
and Practices. ICCD Clubhouse Model. 2010. http://nrepp.
samhsa.gov/ViewIntervention.aspx?id=189.
 476. Macias C, Rodican CF, Hargreaves WA, Jones DR, Barreira 
PJ, Wang Q. Supported employment outcomes of a ran-
domized controlled trial of ACT and clubhouse models. 
Psychiatr Serv. 2006;57:1406–1415.
 477. Schonebaum AD, Boyd JK, Dudek KJ. A comparison of 
competitive employment outcomes for the clubhouse and 
PACT models. Psychiatr Serv. 2006;57:1416–1420.
 478. Warner R, Mandiberg J. An update on affirmative businesses 
or social firms for people with mental illness. Psychiatr Serv. 
2006;57:1488–1492.
 479. Lanctôt N, Durand MJ, Corbière M. The quality of work life 
of people with severe mental disorders working in social enter-
prises: a qualitative study. Qual Life Res. 2012;21:1415–1423.
 480. Fossey EM, Harvey CA. Finding and sustaining employ-
ment: a qualitative meta-synthesis of mental health consumer 
views. Can J Occup Ther. 2010;77:303–314.
 481. Piat M, Lesage A, Boyer R, et al.  Housing for persons with 
serious mental illness: consumer and service provider prefer-
ences. Psychiatr Serv. 2008;59:1011–1017.
 482. Greenwood RM, Schaefer-McDaniel NJ, Winkel G, 
Tsemberis SJ. Decreasing psychiatric symptoms by increasing 
choice in services for adults with histories of homelessness. 
Am J Community Psychol. 2005;36:223–238.
 483. Nelson G, Aubry T, Lafrance A. A review of the literature on 
the effectiveness of housing and support, assertive commu-
nity treatment, and intensive case management interventions 
for persons with mental illness who have been homeless. Am J 
Orthopsychiatry. 2007;77:350–361.
 484. Salyers MP, Tsemberis S. ACT and recovery: integrating 
evidence-based practice and recovery orientation on asser-
tive community treatment teams. Community Ment Health J. 
2007;43:619–641.
 485. Rogers SE, Kash M, Olschewski A. Systematic review of 
supported housing literature 1993–2008. 2012. http://www.
bu.edu/drrk/research-syntheses/psychiatric-disabilities/
supported-housing/#contributors.
 486. Henderson C, Flood C, Leese M, Thornicroft G, Sutherby K, 
Szmukler G. Effect of joint crisis plans on use of compulsory 
treatment in psychiatry: single blind randomised controlled 
trial. BMJ. 2004;329:136.
 487. Sutherby K, Szmukler GI, Halpern A, et al.  A study of ‘cri-
sis cards’ in a community psychiatric service. Acta Psychiatr 
Scand. 1999;100:56–61.
 488. Murphy S, Irving CB, Adams CE, Driver R. Crisis inter-
vention for people with severe mental illnesses. Cochrane 
Database Syst Rev. 2012;5:CD001087.
 489. Lichtenberg P. The residential care alternative for the acutely 
psychotic patient. Psychiatr Q. 2011;82:329–341.
S90
C. A. Green et al
 490. Murphy S, Irving CB, Adams CE, Driver R. Crisis interven-
tion for people with severe mental illnesses. Schizophr Bull. 
2012;38:676–677.
 491. Rosen A, Mueser KT, Teesson M. Assertive community treat-
ment–issues from scientific and clinical literature with impli-
cations for practice. J Rehabil Res Dev. 2007;44:813–825.
 492. Boust SJ, Kuhns MC, Studer L. Assertive community treat-
ment. In: Stout CE, Hayes RA, eds. The Evidence-Based 
Practice: Methods, Models, and Tools for Mental Health 
Professionals. Hoboken, NJ: John Wiley & Sons Inc; 
2005:31–55.
 493. Lamberti JS, Weisman R, Faden DI. Forensic assertive com-
munity treatment: preventing incarceration of adults with 
severe mental illness. Psychiatr Serv. 2004;55:1285–1293.
 494. Morrissey J, Meyer P, Cuddeback G. Extending Assertive 
Community Treatment to criminal justice settings: ori-
gins, current evidence, and future directions. Community 
Ment Health J. 2007;43:527–544.
 495. O’Campo P, Kirst M, Schaefer-McDaniel N, Firestone M, 
Scott A, McShane K. Community-based services for home-
less adults experiencing concurrent mental health and sub-
stance use disorders: a realist approach to synthesizing 
evidence. J Urban Health. 2009;86:965–989.
 496. Dieterich M, Irving CB, Park B, Marshall M. Intensive case 
management for severe mental illness. Cochrane Database 
Syst Rev. 2010;CD007906.
 497. Tungpunkom P, Maayan N, Soares-Weiser K. Life skills pro-
grammes for chronic mental illnesses. Cochrane Database Syst 
Rev. 2012;1:CD000381.
 498. Kurtz MM, Mueser KT. A meta-analysis of controlled 
research on social skills training for schizophrenia. J Consult 
Clin Psychol. 2008;76:491–504.
 499. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in 
schizophrenia: a quantitative review of the evidence. 
Neuropsychology. 1998;12:426–445.
 500. Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA. 
A meta-analysis of cognitive deficits in first-episode Major 
Depressive Disorder. J Affect Disord. 2012;140:113–124.
 501. Sole B, Bonnin CM, Torrent C, et al. Neurocognitive impair-
ment across the bipolar spectrum. CNS Neurosci Ther. 
2012;18:194–200.
 503. Sachs G, Winklbaur B, Jagsch R, et al. Training of affect rec-
ognition (TAR) in schizophrenia–impact on functional out-
come. Schizophr Res. 2012;138:262–267.
 504. Kurtz MM, Richardson CL. Social cognitive training for 
schizophrenia: a meta-analytic investigation of controlled 
research. Schizophr Bull. 2012;38:1092–1104.
 505. Torrent C, Martinez-Arán A, Daban C, et al. Effects of atypi-
cal antipsychotics on neurocognition in euthymic bipolar 
patients. Compr Psychiatry. 2011;52:613–622.
 506. Naismith SL, Redoblado-Hodge MA, Lewis SJ, Scott EM, 
Hickie IB. Cognitive training in affective disorders improves 
memory: a preliminary study using the NEAR approach. J 
Affect Disord. 2010;121:258–262.
 507. Lahera G, Benito A, Montes JM, Fernández-Liria A, Olbert 
CM, Penn DL. Social cognition and interaction training 
(SCIT) for outpatients with bipolar disorder. J Affect Disord. 
2013;146:132–136.
 508. Combs DR, Elerson K, Penn DL, et al. Stability and general-
ization of Social Cognition and Interaction Training (SCIT) 
for schizophrenia: six-month follow-up results. Schizophr 
Res. 2009;112:196–197.
 509. Roberts DL, Penn DL. Social cognition and interaction train-
ing (SCIT) for outpatients with schizophrenia: a preliminary 
study. Psychiatry Res. 2009;166:141–147.
 510. Penn DL, Roberts DL, Combs D, Sterne A. Best practices: 
The development of the Social Cognition and Interaction 
Training program for schizophrenia spectrum disorders. 
Psychiatr Serv. 2007;58:449–451.
 511. Horan WP, Kern RS, Tripp C, et  al. Efficacy and specific-
ity of social cognitive skills training for outpatients with psy-
chotic disorders. J Psychiatr Res. 2011;45:1113–1122.
 512. Martínez-Arán A, Torrent C, Solé B, et al. Functional reme-
diation for bipolar disorder. Clin Pract Epidemiol Ment 
Health. 2011;7:112–116.
 513. Elgamal S, McKinnon MC, Ramakrishnan K, Joffe RT, 
MacQueen G. Successful computer-assisted cognitive 
remediation therapy in patients with unipolar depression: a 
proof  of  principle study. Psychol Med. 2007;37:1229–1238.
 514. Deckersbach T, Nierenberg AA, Kessler R, et al. RESEARCH: 
cognitive rehabilitation for bipolar disorder: An open trial for 
employed patients with residual depressive symptoms. CNS 
Neurosci Ther. 2010;16:298–307.
 515. Bartels SJ. Commentary: the forgotten older adult with seri-
ous mental illness: the final challenge in achieving the prom-
ise of Olmstead? J Aging Soc Policy. 2011;23:244–257.
 516. Berry K, Barrowclough C. The needs of older adults with 
schizophrenia: implications for psychological interventions. 
Clin Psychol Rev. 2009;29:68–76.
 517. Jeste DV, Alexopoulos GS, Bartels SJ, et  al. Consensus 
statement on the upcoming crisis in geriatric mental health: 
research agenda for the next 2 decades. Arch Gen Psychiatry. 
1999;56:848–853.
 518. Grabowski DC, Aschbrenner KA, Rome VF, Bartels SJ. 
Quality of mental health care for nursing home residents: a 
literature review. Med Care Res Rev. 2010;67:627–656.
 519. Substance Abuse and Mental Health Services Agency. 
Substance Abuse Among Older Adults. 98-3179. Rockville, 
MD: Substance Abuse and Mental Health Services 
Administration; 1998.
 520. Raue PJ, Sirey JA. Designing personalized treatment engage-
ment interventions for depressed older adults. Psychiatr Clin 
North Am. 2011;34:489–500.
 521. Bartels SJ, Pratt SI. Psychosocial rehabilitation and qual-
ity of life for older adults with serious mental illness: recent 
findings and future research directions. Curr Opin Psychiatry. 
2009;22:381–385. 
 522. Van Citters AD, Bartels SJ. A systematic review of the effec-
tiveness of community-based mental health outreach services 
for older adults. Psychiatr Serv. 2004;55:1237–1249.
 523. Kiosses DN, Leon AC, Areán PA. Psychosocial interventions 
for late-life major depression: evidence-based treatments, pre-
dictors of treatment outcomes, and moderators of treatment 
effects. Psychiatr Clin North Am. 2011;34:377–401, viii.
 524. Cohen CI, Vahia I, Reyes P, et al.  Focus on geriatric psychia-
try: schizophrenia in later life: clinical symptoms and social 
well-being. Psychiatr Serv. 2008;59:232–234.
 525. Andrews AO, Bartels SJ, Xie H, Peacock WJ. Increased 
risk of nursing home admission among middle aged and 
older adults with schizophrenia. Am J Geriatr Psychiatry. 
2009;17:697–705.
 526. Aschbrenner KA, Mueser KT, Bartels SJ, Pratt SI. Family 
contact and health status among older adults with serious 
mental illnesses. Psychiatr Rehabil J. 2011;34:295–303.
S91
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 527. Piat M, Sabetti J, Fleury MJ, Boyer R, Lesage A. “Who 
believes most in me and in my recovery”: the importance 
of families for persons with serious mental illness living in 
structured community housing. J Soc Work Disabil Rehabil. 
2011;10:49–65.
 528. Marshall M, Rathbone J. Early intervention for psychosis. 
Schizophr Bull. 2011;37:1111–1114.
 529. Bertolote J, McGorry P. Early intervention and recovery for 
young people with early psychosis: consensus statement. Br J 
Psychiatry Suppl. 2005;48:s116–s119.
 530. Preti A, Cella M. Randomized-controlled trials in people at 
ultra high risk of psychosis: a review of treatment effective-
ness. Schizophr Res. 2010;123:30–36.
 531. Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, 
Kuipers E. Early intervention services, cognitive-behavioural 
therapy and family intervention in early psychosis: systematic 
review. Br J Psychiatry. 2010;197:350–356.
 532. Correll CU, Hauser M, Auther AM, Cornblatt BA. Research 
in people with psychosis risk syndrome: a review of the current 
evidence and future directions. J Child Psychol Psychiatry. 
2010;51:390–431.
 533. Alanen Y. Schizophrenia. Its Origins and Need-Adapted 
Treatment. London: Karnac Books; 1997.
 534. Holmesland AL, Seikkula J, Nilsen O, Hopfenbeck M, Erik 
Arnkil T. Open Dialogues in social networks: professional 
identity and transdisciplinary collaboration. Int J Integr 
Care. 2010;10.
 535. Bosanac P, Patton GC, Castle DJ. Early intervention 
in psychotic disorders: faith before facts? Psychol Med. 
2010;40:353–358.
 536. Donabedian A. The Definition of Quality and Approaches 
to Its Assessment. Ann Arbor, MI: Health Administration 
Press; 1980.
 537. Test MA, Greenberg JS, Long JD, Brekke JS, Burke SS. 
Construct validity of a measure of subjective satisfaction 
with life of adults with serious mental illness. Psychiatr Serv. 
2005;56:292–300.
 538. National Committee for Quality Assurance. HEDIS 2012. 
Washington, DC; 2012.
 539. Hunter R, Cameron R, Norrie J. Using patient-reported out-
comes in schizophrenia: the Scottish Schizophrenia Outcomes 
Study. Psychiatr Serv. 2009;60:240–245.
 540. US Department of Health and Human Services. Mental 
health: A Report of the Surgeon General. Rockville, MD: 
Department of Health and Human Services, Substance 
Abuse and Mental Health Services Administration, Center 
for Mental Health Services, National Institutes of Health, 
National Institute of Mental Health; 1999.
 541. Pincus HA, Spaeth-Rublee B, Watkins KE. Analysis & 
commentary: The case for measuring quality in mental 
health and substance abuse care. Health Aff (Millwood). 
2011;30:730–736.
 542. Blumenthal D. Launching HITECH. N Engl J Med. 
2010;362:382–385.
 543. Chaudhry B, Wang J, Wu S, et al. Systematic review: impact 
of health information technology on quality, efficiency, and 
costs of medical care. Ann Intern Med. 2006;144:742–752.
 544. Buntin MB, Burke MF, Hoaglin MC, Blumenthal D. The 
benefits of health information technology: a review of the 
recent literature shows predominantly positive results. Health 
Aff (Millwood). 2011;30:464–471.
 545. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical deci-
sion-support systems: a systematic review. Ann Intern Med. 
2012;157:29–43.
 546. Substance Abuse and Mental Health Services Agency. Leading 
Change: A  Plan for SAMHSA’s Roles and Actions 2011-
2014. HHS Publication No. (SMA) 11-4629. Rockville, MD: 
Substance Abuse and Mental Health Administration; 2011.
 547. Friedman CP, Wong AK, Blumenthal D. Achieving a nation-
wide learning health system. Sci Transl Med. 2010;2:1–3.
 548. Hysong SJ. Meta-analysis: audit and feedback features impact 
effectiveness on care quality. Med Care. 2009;47:356–363.
 549. van der Veer SN, de Keizer NF, Ravelli AC, Tenkink S, Jager 
KJ. Improving quality of care. A systematic review on how 
medical registries provide information feedback to health 
care providers. Int J Med Inform. 2010;79:305–323.
 550. Ivers N, Jamtvedt G, Flottorp S, et  al. Audit and feed-
back: effects on professional practice and healthcare out-
comes. Cochrane Database Syst Rev. 2012;6:CD000259. 
doi:10.1002/14651858.CD000259.pub3.
 551. Hysong SJ, Best RG, Pugh JA. Audit and feedback and clini-
cal practice guideline adherence: making feedback actionable. 
Implement Sci. 2006;1:9.
 552. Gilbody S, House A, Sheldon T. Outcome measures and 
needs assessment tools for schizophrenia and related dis-
orders. CD003081. 2009. http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD003081/pdf.
 553. Knaup C, Koesters M, Schoefer D, Becker T, Puschner B. 
Effect of feedback of treatment outcome in specialist mental 
healthcare: meta-analysis. Br J Psychiatry. 2009;195:15–22.
 554. Van Herck P, De Smedt D, Annemans L, Remmen R, 
Rosenthal MB, Sermeus W. Systematic review: effects, design 
choices, and context of pay-for-performance in health care. 
BMC Health Serv Res. 2010;10:247.
 555. Ryan AM, Blustein J, Casalino LP. Medicare’s flagship test 
of pay-for-performance did not spur more rapid quality 
improvement among low-performing hospitals. Health Aff 
(Millwood). 2012;31:797–805.
 556. Ryan AM, Blustein J. The effect of the MassHealth hospital 
pay-for-performance program on quality. Health Serv Res. 
2011;46:712–728.
 557. Conrad DA, Perry L. Quality-based financial incentives in 
health care: can we improve quality by paying for it? Annu 
Rev Public Health. 2009;30:357–371.
 558. Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term 
effect of premier pay for performance on patient outcomes. N 
Engl J Med. 2012;366:1606–1615.
 559. Chan L, Doctor JN, MacLehose RF, et  al. Do Medicare 
patients with disabilities receive preventive services? A popu-
lation-based study. Arch Phys Med Rehabil. 1999;80:642–646.
 560. Trauer T. The public reporting of organizational performance 
in mental health: coming soon to a mental health service near 
you. Aust N Z J Psychiatry. 2011;45:432–443.
 561. Liptzin B. Quality improvement, pay for performance, and 
“outcomes measurement”: what makes sense? Psychiatr Serv. 
2009;60:108–111.
 562. Hermann RC, Rollins CK, Chan JA. Risk-adjusting out-
comes of mental health and substance-related care: a review 
of the literature. Harv Rev Psychiatry. 2007;15:52–69.
 563. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity 




 564. Bremer RW, Scholle SH, Keyser D, Houtsinger JV, Pincus 
HA. Pay for performance in behavioral health. Psychiatr 
Serv. 2008;59:1419–1429.
 565. Unützer J, Chan YF, Hafer E, et al.  Quality improvement 
with pay-for-performance incentives in integrated behavioral 
health care. Am J Public Health. 2012;102:e41–e45.
 566. McDonald R, Roland M. Pay for performance in primary 
care in England and California: comparison of unintended 
consequences. Ann Fam Med. 2009;7:121–127.
 567. Fung CH, Lim YW, Mattke S, Damberg C, Shekelle PG. 
Systematic review: the evidence that publishing patient care 
performance data improves quality of care. Ann Intern Med. 
2008;148:111–123.
 568. Faber M, Bosch M, Wollersheim H, Leatherman S, Grol 
R. Public reporting in health care: how do consumers use 
quality-of-care information? A systematic review. Med Care. 
2009;47:1–8.
 569. Miller A, Hall CS, Buchanan RW, et al.  The Texas Medication 
Algorithm Project antipsychotic algorithm for schizophrenia: 
2003 update. J Clin Psychiatry. 2004;65:500–508.
 570. Suppes T, Rush AJ, Dennehy EB, et  al. Texas Medication 
Algorithm Project. Texas Medication Algorithm Project, 
phase 3 (TMAP-3): clinical results for patients with a history 
of mania. J Clin Psychiatry. 2003;64:370–382.
 571. Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-
based clinical practice guidelines on quality of care: a system-
atic review. Qual Saf Health Care. 2009;18:385–392.
 572. Weinmann S, Koesters M, Becker T. Effects of implementa-
tion of psychiatric guidelines on provider performance and 
patient outcome: systematic review. Acta Psychiatr Scand. 
2007;115:420–433.
 573. Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider 
EC. Current guidelines have limited applicability to patients 
with comorbid conditions: a systematic analysis of evidence-
based guidelines. PLoS ONE. 2011;6:e25987.
 574. Fixsen DL, Naoom SF, Blase KA, et  al. Implementation 
Research: A Synthesis of the Literature. FMHI Publication 
#231. Tampa, FL: University of South Florida; 2005.
 575. Aarons GA, Wells RS, Zagursky K, Fettes DL, Palinkas LA. 
Implementing evidence-based practice in community mental 
health agencies: a multiple stakeholder analysis. Am J Public 
Health. 2009;99:2087–2095.
 576. Manuel JK, Hagedorn HJ, Finney JW. Implementing evi-
dence-based psychosocial treatment in specialty substance 
use disorder care. Psychol Addict Behav. 2011;25:225–237.
 577. Miller WR, Sorensen JL, Selzer JA, Brigham GS. 
Disseminating evidence-based practices in substance abuse 
treatment: a review with suggestions. J Subst Abuse Treat. 
2006;31:25–39.
 578. Powell AE, Rushmer RK, Davies HTO. A systematic nar-
rative review of quality improvement models in health care. 
NHS Quality Improvement Scotland; 2009.
 579. Dilley JA, Bekemeier B, Harris JR. Quality improvement 
interventions in public health systems: a systematic review. 
Am J Prev Med. 2012;42:S58–S71.
 580. Glisson C, Hemmelgarn A. The effects of organizational 
climate and interorganizational coordination on the quality 
and outcomes of children’s service systems. Child Abuse Negl. 
1998;22:401–421.
 581. Glisson C. The organizational context of  children’s 
mental health services. Clin Child Fam Psychol Rev. 
2002;5:233–253.
 582. Glisson C, Landsverk J, Schoenwald S, et  al. Research 
Network on Youth Mental Health. Assessing the organiza-
tional social context (OSC) of mental health services: impli-
cations for research and practice. Adm Policy Ment Health. 
2008;35:98–113.
 583. Glisson C, Green P. Organizational climate, services, and 
outcomes in child welfare systems. Child Abuse Negl. 
2011;35:582–591.
 584. Shortell SM. High-performing healthcare organizations: 
guidelines for the pursuit of excellence. Hosp Health Serv 
Adm. 1985;30:7–35.
 585. Spreitzer G, Porath C. Creating sustainable performance. 
Harv Bus Rev. 2012;90:92–99.
 586. Spreitzer G, Sutcliffe K, Dutton J, et al. A socially embedded 
model of thriving at work. Organ Sci. 2005;16:537–549.
 587. Grant AM, Dutton JE, Rosso BD. Giving commitment: 
employee support programs and the prosocial sensemaking 
process. Acad Manage J. 2008;51:898–918.
 588. Grant AM. The significance of task significance: job perfor-
mance effects, relational mechanisms, and boundary condi-
tions. J Appl Psychol. 2008;93:108–124.
 589. Carmeli A, Brueller D, Dutton JE. Learning behaviours in the 
workplace: the role of high-quality interpersonal relationships 
and psychological safety. Syst Res Behav Sci. 2008;26:98.
 590. Ramarajan L, Barsade SG, Burack OR. The influence of 
organizational respect on emotional exhaustion in the human 
services. J Positive Psychol. 2008;3:4–18.
 591. Cameron K. Responsible leadership as virtuous leadership. J 
Bus Ethics. 2011;98:25–35.
 592. Cameron K, Mora C, Leutscher T, et al. Effects of positive 
practices on organizational effectiveness. J Appl Behav Sci. 
2011;47:266–308.
 593. Berg JM, Wrzesniewski A, Dutton JE. Perceiving and 
responding to challenges in job crafting at different ranks: 
when proactivity requires adaptivity. J Organ Behav. 
2010;31:186.
 594. Dutton JE, Heaphy ED. The power of high-quality con-
nections. In: Cameron KS, Dutton, Quinn RE, eds. Positive 
Organizational Scholarship: Foundations of a New Discipline. 
San Francisco, CA: Berrett-Koehler Publishers, Inc; 
2003:263–278.
 595. Hemmelgarn AL, Glisson C, James LR. Organizational cul-
ture and climate: Implications for services and interventions 
resesarch. Clin Psychol (New York). 2006;13:73–89.
 596. Berwick DM, Escape fire. Escape Fire: Designs for the 
Future of Health Care. San Francisco, CA: Jossey-Bass; 
2002:183–210.
 597. Crawford MJ, Robotham D, Thana L, et al.  Selecting out-
come measures in mental health: the views of service users. J 
Ment Health. 2011;20:336–346.
 598. Crawford MJ, Rutter D, Manley C, et al.  Systematic review 
of involving patients in the planning and development of 
health care. BMJ. 2002;325:1263.
 599. Crawford MJ, Aldridge T, Bhui K, et al.  User involvement in 
the planning and delivery of mental health services: a cross-
sectional survey of service users and providers. Acta Psychiatr 
Scand. 2003;107:410–414.
 600. Rutter D, Manley C, Weaver T, Crawford MJ, Fulop N. 
Patients or partners? Case studies of user involvement in 
the planning and delivery of adult mental health services in 
London. Soc Sci Med. 2004;58:1973–1984.
S93
Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness
 601. Paulus RA, Davis K, Steele GD. Continuous innovation in 
health care: implications of the Geisinger experience. Health 
Aff (Millwood). 2008;27:1235–1245.
 602. Nelson EC, Batalden PB, Huber TP, et al.  Microsystems in 
health care: Part 1. Learning from high-performing front-line 
clinical units. Jt Comm J Qual Improv. 2002;28:472–493.
 603. Hermann RC, Palmer H, Leff  S, et al.  Achieving consensus 
across diverse stakeholders on quality measures for mental 
healthcare. Med Care. 2004;42:1246–1253.
 604. Hermann RC, Mattke S, Somekh D, et al.  Quality indicators 
for international benchmarking of mental health care. Int J 
Qual Health Care. 2006;18(suppl 1):31–38.
 605. Watkins KE, Keyser DJ, Smith B, et al.  Transforming mental 
healthcare in the Veterans Health Administration: a model 
for measuring performance to improve access, quality, and 
outcomes. J Healthc Qual. 2010;32:33–42.
 606. Delaffon V, Anwar Z, Noushad F, et  al. Use of Health of 
the Nation Outcome Scales in psychiatry. Adv Psychiatr 
Treatment. 2012;18:173–179.
 607. Brown P, Pirkis J. Mental health quality and outcome meas-
urement and improvement in Australia. Curr Opin Psychiatry. 
2009;22:610–618.
 608. Groene O, Lombarts MJ, Klazinga N, Alonso J, Thompson 
A, Suñol R. Is patient-centeredness in European hospitals 
related to existing quality improvement strategies? Analysis 
of a cross-sectional survey (MARQuIS study). Qual Saf 
Health Care. 2009;18(suppl 1):i44–i50.
 609. Kilbourne AM, Fullerton C, Dausey D, Pincus HA, 
Hermann RC. A framework for measuring quality and pro-
moting accountability across silos: the case of mental dis-
orders and co-occurring conditions. Qual Saf Health Care. 
2010;19:113–116.
 610. McCabe R, Saidi M, Priebe S. Patient-reported outcomes in 
schizophrenia. Br J Psychiatry Suppl. 2007;50:s21–s28.
 611. Wallcraft J, Schrank B, Amering M. Handbook of Service 
User Involvement in Mental Health Research. Hoboken, NJ: 
Wiley; 2009.
 612. Onifade Y. The mental health recovery star. Mental Health 
and Social Inclusion. 2011;15:78–87.
 613. Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. 
Conceptual framework for personal recovery in men-
tal health: systematic review and narrative synthesis. Br J 
Psychiatry. 2011;199:445–452.
 614. Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. 
Examining the factor structure of the recovery assessment 
scale. Schizophr Bull. 2004;30:1035–1041.
 615. Ridgway P, Press A. Assessing the Recovery-Orientation of 
Your Mental Health Program: A User’s Guide for the Recovery-
Enhancing Environment Scale (REE). Kansas: University of 
Kansas; 2004.
 616. Campbell-Orde T, Chamberlin J, Carpenter J, et al. Measuring 
the Promise: A Compendium of Recovery Measures. Vol 2. 
Cambridge, MA: The Evaluation Center at the Human 
Services Resesarch Institute (HSRI); 2005.
 617. Ellis G, King R. Recovery focused interventions: percep-
tions of mental health consumers and their case manager. 
AeJAMH. 2003;2.
 618. Mancini AD, Finnerty MT. Recovery-Oriented Practices 
Index. New York, NY: New York State Office of Mental 
Health; 2005.
 619. Armstrong NP, Steffen JJ. The recovery promotion fidelity 
scale: assessing the organizational promotion of recovery. 
Community Ment Health J. 2009;45:163–170.
 620. O’Connell M, Tondora J, Croog G, Evans A, Davidson L. 
From rhetoric to routine: assessing perceptions of recovery-
oriented practices in a state mental health and addiction sys-
tem. Psychiatr Rehabil J. 2005;28:378–386.
 621. Castelein S, van der Gaag M, Bruggeman R, van Busschbach 
JT, Wiersma D. Measuring empowerment among people 
with psychotic disorders: a comparison of three instruments. 
Psychiatr Serv. 2008;59:1338–1342.
 622. Siu BW, Ng BF, Li VC, Yeung YM, Lee MK, Leung AY. 
Mental health recovery for psychiatric inpatient services: 
perceived importance of the elements of recovery. East Asian 
Arch Psychiatry. 2012;22:39–48.
 623. Dickens G. Mental health outcome measures in the age of 
recovery-based services. Br J Nurs. 2009;18:940–943.
 624. Sowers W; Quality Management Committee of the American 
Association of Community Psychiatrists. Transforming 
systems of care: the American Association of Community 
Psychiatrists Guidelines for Recovery Oriented Services. 
Community Ment Health J. 2005;41:757–774.
 625. Yanos PT, Roe D, Markus K, Lysaker PH. Pathways 
between internalized stigma and outcomes related to recov-
ery in schizophrenia spectrum disorders. Psychiatr Serv. 
2008;59:1437–1442.
 626. Schrank B, Bird V, Rudnick A, Slade M. Determinants, self-
management strategies and interventions for hope in people 
with mental disorders: systematic search and narrative review. 
Soc Sci Med. 2012;74:554–564.
 627. Lehman AF, Postrado LT, Rachuba LT. Convergent valida-
tion of quality of life assessments for persons with severe 
mental illnesses. Qual Life Res. 1993;2:327–333.
 628. Lehman AF. Measures of quality of life among persons 
with severe and persistent mental disorders. Soc Psychiatry 
Psychiatr Epidemiol. 1996;31:78–88.
 629. Lehman AF. Assessment of quality-of-life outcomes in schiz-
ophrenic patients. Am J Manag Care. 1999;5:S612–S619.
 630. Lehman AF. Instruments for Measuring Quality of Life in 
Mental Disorders. I: up to 1996. Quality of Life in Mental 
Disorders. 2nd ed. New York, NY: John Wiley & Sons Ltd; 
2006:71–83.
 631. Gilbody SM, House AO, Sheldon T. Routine administra-
tion of Health Related Quality of Life (HRQoL) and needs 
assessment instruments to improve psychological outcome–a 
systematic review. Psychol Med. 2002;32:1345–1356.
 632. Prince PN, Gerber GJ. Measuring subjective quality of life 
in people with serious mental illness using the SEIqoL-DW. 
Qual Life Res. 2001;10:117–122.
 633. Shrivastava A, Johnston M, Shah N, Bureau Y. Redefining 
outcome measures in schizophrenia: integrating social and 
clinical parameters. Curr Opin Psychiatry. 2010;23:120–126.
 634. Phelan M, Slade M, Thornicroft G, et  al. The Camberwell 
Assessment of Need: the validity and reliability of an instru-
ment to assess the needs of people with severe mental illness. 
Br J Psychiatry. 1995;167:589–595.
 635. Slade M, Phelan M, Thornicroft G, Parkman S. The 
Camberwell Assessment of Need (CAN): comparison 
of assessments by staff  and patients of the needs of the 
severely mentally ill. Soc Psychiatry Psychiatr Epidemiol. 
1996;31:109–113.
 636. Trauer T, Tobias G, Slade M. Development and evaluation 
of a patient-rated version of the Camberwell Assessment of 
S94
C. A. Green et al
Need short appraisal schedule (CANSAS-P). Community 
Ment Health J. 2008;44:113–124.
 637. Praed Foundation. Adult Needs and Strengths (ANSA) 
Communication and Planning Tool Manual and User Guide. 
Praed Foundation; 1999.
 638. Link BG. Understanding labeling effects in the area of men-
tal disorders: an assessment of the effects of expectations of 
rejection. Am Sociol Rev. 1987;52:96–112.
 639. Hamer S, Haddad PM. Adverse effects of antipsychotics as 
outcome measures. Br J Psychiatry Suppl. 2007;50:s64–s70.
 640. Holt RI, Peveler RC. Obesity, serious mental illness and 
antipsychotic drugs. Diabetes Obes Metab. 2009;11:665–679.
 641. De Silva MJ, McKenzie K, Harpham T, Huttly SR. Social 
capital and mental illness: a systematic review. J Epidemiol 
Community Health. 2005;59:619–627.
 642. Almedom AM. Social capital and mental health: an inter-
disciplinary review of primary evidence. Soc Sci Med. 
2005;61:943–964.
 643. De Hert M, Peuskens B, van Winkel R, et al. Body weight 
and self-esteem in patients with schizophrenia evaluated with 
B-WISE. Schizophr Res. 2006;88:222–226.
 644. Gardner W, Hoge SK, Bennett N, et al. Two scales for meas-
uring patients’ perceptions for coercion during mental hospi-
tal admission. Behav Sci Law. 1993;11:307–321.
 645. Lidz CW, Mulvey EP, Hoge SK, et al. The validity of mental 
patients’ accounts of coercion-related behaviors in the hospi-
tal admission process. Law Hum Behav. 1997;21:361–376.
 646. Livingston JD, Boyd JE. Correlates and consequences 
of internalized stigma for people living with mental ill-
ness: a systematic review and meta-analysis. Soc Sci Med. 
2010;71:2150–2161.
 647. Livingston JD, Rossiter KR, Verdun-Jones SN. ‘Forensic’ 
labelling: an empirical assessment of its effects on self-
stigma for people with severe mental illness. Psychiatry Res. 
2011;188:115–122.
 648. Lysaker PH, Roe D, Ringer J, Gilmore EM, Yanos PT. 
Change in self-stigma among persons with schizophrenia 
enrolled in rehabilitation: associations with self-esteem and 
positive and emotional discomfort symptoms. Psychol Serv. 
2012;9:240–247.
 649. Perlick DA, Nelson AH, Mattias K, et al. In our own voice-
family companion: reducing self-stigma of family mem-
bers of persons with serious mental illness. Psychiatr Serv. 
2011;62:1456–1462.
 650. Tsai J, Lysaker PH, Vohs JL. Negative symptoms and con-
comitant attention deficits in schizophrenia: associations 
with prospective assessments of anxiety, social dysfunction, 
and avoidant coping. J Ment Health. 2010;19:184–192.
 651. Björkman T, Svensson B, Lundberg B. Experiences of 
stigma among people with severe mental illness. Reliability, 
acceptability and construct validity of  the Swedish ver-
sions of  two stigma scales measuring devaluation/dis-
crimination and rejection experiences. Nord J Psychiatry. 
2007;61:332–338.
 652. Björkman T, Svensson B. Quality of life in people with severe 
mental illness. Reliability and validity of the Manchester 
Short Assessment of Quality of Life (MANSA). Nord J 
Psychiatry. 2005;59:302–306.
 653. Pescosolido BA, Martin JK, Lang A, Olafsdottir S. 
Rethinking theoretical approaches to stigma: a Framework 
Integrating Normative Influences on Stigma (FINIS). Soc Sci 
Med. 2008;67:431–440.
 654. Wahl OF. Mental health consumers’ experience of stigma. 
Schizophr Bull. 1999;25:467–478.
 655. Corrigan P. How stigma interferes with mental health care. 
Am Psychol. 2004;59:614–625.
 656. Fung KM, Tsang HW, Corrigan PW. Self-stigma of people 
with schizophrenia as predictor of their adherence to psycho-
social treatment. Psychiatr Rehabil J. 2008;32:95–104.
 657. Lysaker PH, Taylor A, Miller A, Beattie N, Strasburger A, 
Davis LW. The Scale to Assess Narrative Development: asso-
ciation with other measures of self  and readiness for recov-
ery in schizophrenia spectrum disorders. J Nerv Ment Dis. 
2006;194:223–225.
 658. Lysaker PH, Buck KD, Hammoud K, Taylor AC, Roe D. 
Associations of symptoms, psychosocial function and hope 
with qualities of self-experience in schizophrenia: com-
parisons of objective and subjective indicators of health. 
Schizophr Res. 2006;82:241–249.
 659. Vauth R, Kleim B, Wirtz M, Corrigan PW. Self-efficacy and 
empowerment as outcomes of self-stigmatizing and coping in 
schizophrenia. Psychiatry Res. 2007;150:71–80.
 660. Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup 
S, Lieberman JA. Cross-sectional and longitudinal relation-
ships between insight and attitudes toward medication and 
clinical outcomes in chronic schizophrenia. Schizophr Bull. 
2009;35:336–346.
 661. Jasovic-Gasic M, Maric N. Risperidon vs. other antipsychot-
ics in schizophrenia: the assessment of patients’ attitudes. 
Psychiatr Danub. 2004;16:127–131.
 662. Rofail D, Gray R, Gournay K. The development and internal 
consistency of the satisfaction with Antipsychotic Medication 
Scale. Psychol Med. 2005;35:1063–1072.
 663. Mojtabai R, Corey-Lisle PK, Ip EH, et  al. The Patient 
Assessment Questionnaire: initial validation of a measure of 
treatment effectiveness for patients with schizophrenia and 
schizoaffective disorder. Psychiatry Res. 2012;200:857–866.
 664. Vernon MK, Revicki DA, Awad AG, et al. Psychometric eval-
uation of the Medication Satisfaction Questionnaire (MSQ) 
to assess satisfaction with antipsychotic medication among 
schizophrenia patients. Schizophr Res. 2010;118:271–278.
 665. Lehman AF, Fischer EP, Postrado L, et al.  The Schizophrenia 
Care and Assessment Program Health Questionnaire 
(SCAP-HQ): an instrument to assess outcomes of schizo-
phrenia care. Schizophr Bull. 2003;29:247–256.
 666. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general 
measure of treatment satisfaction, the Treatment Satisfaction 
Questionnaire for Medication (TSQM), using a national 
panel study of chronic disease. Health Qual Life Outcomes. 
2004;2:12.
 667. Gerber GJ, Prince PN. Measuring client satisfaction 
with assertive community treatment. Psychiatr Serv. 
1999;50:546–550.
 668. Ottenbacher KJ, Cusick A. Goal attainment scaling as a 
method of clinical service evaluation. Am J Occup Ther. 
1990;44:519–525.
 669. Ottenbacher KJ, Cusick A. Discriminative versus evaluative 
assessment: some observations on goal attainment scaling. 
Am J Occup Ther. 1993;47:349–354.
 670. Mulvaney-Day NE. Using willingness to pay to measure 
family members’ preferences in mental health. J Ment Health 
Policy Econ. 2005;8:71–81.
